<SEC-DOCUMENT>0001193125-26-269542.txt : 20260612
<SEC-HEADER>0001193125-26-269542.hdr.sgml : 20260612
<ACCEPTANCE-DATETIME>20260612163010
ACCESSION NUMBER:		0001193125-26-269542
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		19
FILED AS OF DATE:		20260612
DATE AS OF CHANGE:		20260612

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PureCycle Technologies, Inc.
		CENTRAL INDEX KEY:			0001830033
		STANDARD INDUSTRIAL CLASSIFICATION:	PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			X1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-296672
		FILM NUMBER:		261087224

	BUSINESS ADDRESS:	
		STREET 1:		20 NORTH ORANGE AVE
		STREET 2:		SUITE 106
		CITY:			ORLANDO
		STATE:			FL
		ZIP:			32801
		BUSINESS PHONE:		877-648-3565

	MAIL ADDRESS:	
		STREET 1:		20 NORTH ORANGE AVE
		STREET 2:		SUITE 106
		CITY:			ORLANDO
		STATE:			FL
		ZIP:			32801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Roth CH Acquisition I Co. Parent Corp.
		DATE OF NAME CHANGE:	20201026
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>d113098d424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML><HEAD>
<TITLE>424B5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(5) <BR> Registration No. 333-296672<BR> </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(To Prospectus dated June&nbsp;10, 2026) </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>$250,000,000 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g113098g01q01.jpg" ALT="LOGO" STYLE="width:3.93333in;height:0.635167in;">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>PureCycle Technologies, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>4.75% Convertible Senior Notes due 2032 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are offering $250,000,000 principal amount of our 4.75% Convertible Senior Notes due 2032 (the &#8220;notes&#8221;). The
notes will bear interest at a rate of 4.75% per year, payable semiannually in arrears on January&nbsp;1 and July&nbsp;1 of each year, beginning on January&nbsp;1, 2027. The notes will mature on July&nbsp;1, 2032, unless earlier converted, redeemed
or repurchased. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Holders may convert all or any portion of their notes at their option at any time prior to the close of
business on the second scheduled trading day immediately preceding the maturity date. Upon conversion, we will pay or deliver, as the case may be, cash, shares of our common stock, par value $0.001 per share (our &#8220;common stock&#8221;) or a
combination of cash and shares of our common stock, at our election, as described in this prospectus supplement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
conversion rate will initially be 90.2242 shares of common stock per $1,000 principal amount of notes (equivalent to an initial conversion price of approximately $11.08 per share of common stock). The conversion rate will be subject to adjustment in
some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date or if we deliver a notice of redemption, we will, in certain circumstances, increase the
conversion rate for a holder who elects to convert its notes in connection with such a corporate event or convert its notes called (or deemed called) for redemption during the related redemption period (as defined in this prospectus supplement), as
the case may be. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We may not redeem the notes prior to July&nbsp;6, 2029. We may redeem for cash all or any portion of the
notes (subject to the partial redemption limitation described in this prospectus supplement), at our option, on a redemption date on or after July&nbsp;6, 2029 if the last reported sale price of our common stock has been at least 130% of the
conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding
the date on which we provide notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the
notes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On July&nbsp;8, 2030 or if we undergo a &#8220;fundamental change&#8221; (as defined in this prospectus
supplement), then, subject to certain conditions and except as described in this prospectus supplement, holders may require us to repurchase for cash all or any portion of their notes at a specified repurchase date repurchase price or fundamental
change repurchase price, as applicable, equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the relevant repurchase date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The notes will be our general unsecured obligations and will rank senior in right of payment to all of our indebtedness that is
expressly subordinated in right of payment to the notes; equal in right of payment with all of our existing and future liabilities that are not so subordinated, including the Green Convertible Notes (as defined in this prospectus supplement);
effectively junior to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness, including any borrowings under the Revolving Credit Facility (as defined in this prospectus supplement); and structurally
junior to all indebtedness and other liabilities (including trade payables) of our current or future subsidiaries, including the Revenue Bonds. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Concurrently with this offering, we are conducting an underwritten public offering (the &#8220;Concurrent Stock
Offering&#8221;) of 17,570,200 shares of our common stock (or up to 19,854,000 shares of our common stock if the underwriters in the Concurrent Stock Offering exercise their option to purchase additional shares in full) at a price of $8.21 per share
pursuant to a separate prospectus supplement. We expect to use a portion of the net proceeds from this offering and the Concurrent Stock Offering, if consummated, to repurchase for cash approximately $216.0 million in aggregate principal amount at
maturity of our 7.25% Green Convertible Senior Notes due 2030 (the &#8220;Green Convertible Notes&#8221;) including $50.0&nbsp;million in aggregate principal amount at </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
maturity of Green Convertible Notes held by certain entities affiliated with Sylebra Capital Management (the &#8220;affiliated investors&#8221;), in privately negotiated transactions (the
&#8220;Note Repurchase Transactions&#8221;). No assurance can be given as to how much, if any, of the Green Convertible Notes will be repurchased or the terms on which they will be repurchased. Neither the completion of this offering nor the
Concurrent Stock Offering is contingent on the completion of the other or the Note Repurchase Transactions. No assurance can be given that the Concurrent Stock Offering will be completed on the terms described herein or at all. This prospectus
supplement does not constitute an offer to sell, or the solicitation of an offer to buy, any shares of our common stock in the Concurrent Stock Offering, and does not constitute an offer to buy, or the solicitation of an offer to sell, any of the
Green Convertible Notes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We do not intend to apply to list the notes on any securities exchange or any automated dealer
quotation system. Our common stock is listed on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;PCT&#8221;. The last reported sale price of our common stock on June 9, 2026 was $10.80 per share. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B>Investing in our securities involves a high degree of risk. Before making an investment decision, you should carefully read
and consider the risks and uncertainties described under the caption &#8220;<A HREF="#supptoc113098_6">Risk Factors</A>&#8221; beginning on page <FONT STYLE="white-space:nowrap">S-10</FONT> of this prospectus supplement and on page&nbsp;5 of the
accompanying prospectus, as well as the risks and uncertainties described in the documents incorporated by reference herein and therein, including the risk factors incorporated by reference from our most recent Annual Report on <FONT
STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> and, where applicable, subsequent Quarterly Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;10-Q.</FONT></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PRICE: 4.75%, PLUS ACCRUED INTEREST, IF ANY, FROM JUNE 15, 2026 </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Note</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public offering price<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discounts and
commissions<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">242,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Plus accrued interest, if any, from June 15, 2026. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">See the caption &#8220;Underwriting&#8221; for additional information regarding the underwriting discounts
and commissions and estimated offering expenses. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Does not give effect to the underwriters&#8217; over-allotment option. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have granted the underwriters the right to purchase, exercisable within a <FONT STYLE="white-space:nowrap">30-day</FONT>
period, up to an additional $37,500,000<B> </B>principal amount of notes, solely to cover over-allotments. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We expect that
delivery of the notes will be made to investors in book-entry form through The Depository Trust Company on or about June 15, 2026, which will be the second business day following the initial trade date for the notes offered pursuant to this
prospectus supplement (this settlement cycle being referred to as &#8220;T+2&#8221;). Under Rule <FONT STYLE="white-space:nowrap">15c6-1</FONT> under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), trades in the
secondary market generally are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade notes offered hereby prior to the business day preceding the settlement
date will be required, by virtue of the fact that the notes initially will settle T+2, to specify an alternate settlement cycle at the time of any such trade to prevent a failed settlement. Purchasers of the notes who wish to trade the notes prior
to the business day preceding the settlement date should consult their own advisors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Neither the Securities and
Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a
criminal offense. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Morgan Stanley </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Cantor </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>June 10, 2026
</B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>PROSPECTUS SUPPLEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="94%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_1">ABOUT THIS PROSPECTUS SUPPLEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-ii</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_2">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-iv</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_3">INFORMATION WE INCORPORATE BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-v</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_4">PROSPECTUS SUPPLEMENT SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_5">THE OFFERING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-4</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_6">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-10</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_7">CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-37</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_8">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-39</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_9">CAPITALIZATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-40</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_10">DESCRIPTION OF NOTES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-42</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_11">DESCRIPTION OF OTHER INDEBTEDNESS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-79</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_12">THE CONCURRENT TRANSACTIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-85</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_13">MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-86</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_14">CERTAIN ERISA CONSIDERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-96</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_15">UNDERWRITING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-99</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_16">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-110</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc113098_17">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-110</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_2">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_3">INFORMATION WE INCORPORATE BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_4">PURECYCLE TECHNOLOGIES, INC.</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_5">CORPORATE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_6">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_7">CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_8">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_9">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_10">DESCRIPTION OF WARRANTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_11">DESCRIPTION OF RIGHTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_12">DESCRIPTION OF STOCK PURCHASE CONTRACTS AND STOCK PURCHASE
UNITS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_13">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_14">DESCRIPTION OF UNITS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_15">MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_16">FORMS OF SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_17">SELLING SECURITYHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_18">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_19">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_20">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus supplement is part of an automatic registration statement on
<FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> that we have filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) utilizing a &#8220;shelf&#8221; registration process available to us as a &#8220;well-known seasoned
issuer,&#8221; as defined in Rule&nbsp;405 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This document is in two parts. The first part is this prospectus supplement, which describes the terms of this offering. The
second part is the accompanying prospectus, dated June&nbsp;10, 2026, including the documents incorporated by reference therein, which provides more general information, some of which may not apply to this offering. Generally, when we refer to this
prospectus supplement, we are referring to both parts of this document combined. If the description of this offering varies between this prospectus supplement and the accompanying prospectus or any document incorporated by reference into it or into
this prospectus supplement that was filed with the SEC before the date of this prospectus supplement, you should rely on the information in this prospectus supplement, which supersedes the information in the accompanying prospectus. This prospectus
supplement contains information about the notes offered in this offering and may add, update or change information in the accompanying prospectus. Before you invest in any of the notes offered under this prospectus supplement, you should carefully
read both this prospectus supplement and the accompanying prospectus together with the additional information under the captions &#8220;Where You Can Find More Information&#8221; and &#8220;Information We Incorporate By Reference.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You should rely only on the information contained or incorporated by reference in this prospectus supplement and in the
accompanying prospectus or any free writing prospectus that we may provide. We have not, and the underwriters have not, authorized anyone to provide you with different information. No dealer, salesperson or any other person is authorized to give any
information or to represent anything not contained in this prospectus supplement and the accompanying prospectus or any free writing prospectus that we may provide. If anyone provides you with different or additional information, you should not rely
on it. You should not assume that the information contained in this prospectus supplement, the accompanying prospectus, any free writing prospectus that we may provide or any document incorporated by reference is accurate as of any date other than
the date mentioned on the cover page of these documents. We are not, and the underwriters are not, making offers to sell the notes in any jurisdiction in which an offer or solicitation is not authorized or in which the person making such offer or
solicitation is not qualified to do so or to anyone to whom it is unlawful to make an offer or solicitation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are
offering to sell our notes only in jurisdictions where offers and sales are permitted. The distribution of this prospectus supplement and the accompanying prospectus and the offering of the notes in certain jurisdictions may be restricted by law.
Persons outside the United States who come into possession of this prospectus supplement or the accompanying prospectus must inform themselves about, and observe any restrictions relating to, the offering of the notes and the distribution of this
prospectus supplement and the accompanying prospectus outside the United States. This prospectus supplement and the accompanying prospectus do not constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to
buy, any securities offered by this prospectus supplement and the accompanying prospectus by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under Rule <FONT STYLE="white-space:nowrap">15c6-1</FONT> under the Exchange Act, trades in the secondary market are generally
required to settle in one business day, unless the parties to any such trade expressly agree otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Documents
incorporated by reference herein include information and statistics regarding our industry and other information. We obtained this statistical, market and other industry data and forecasts from publicly available information. While we believe that
the statistical data, market data and other industry data and forecasts are reliable, we have not independently verified the data. Any such data and other information is subject to change based on various factors, including those described in this
prospectus supplement and the accompanying </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
prospectus under the caption &#8220;Risk Factors&#8221; and under Item 1A. &#8220;Risk Factors&#8221; in our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> filed
with the SEC, which is incorporated herein by reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">References in this prospectus supplement to the terms
&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;PCT&#8221; or &#8220;the Company&#8221; or other similar terms mean PureCycle Technologies, Inc. and its consolidated subsidiaries, unless we state otherwise or the context indicates
otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_2"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have filed with the SEC an automatic registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the
Securities Act, with respect to the notes being offered by this prospectus supplement. This prospectus supplement, which constitutes part of the registration statement, does not contain all of the information in the registration statement and its
exhibits. For further information with respect to the Company and the notes offered by this prospectus supplement, we refer you to the registration statement and its exhibits. Statements contained in this prospectus supplement as to the contents of
any contract or any other document referred to are not necessarily complete, and in each instance, we refer you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements is qualified in
all respects by this reference. You can read our SEC filings, including the registration statement, over the internet at the SEC&#8217;s website at www.sec.gov. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are subject to the informational reporting requirements of the Exchange Act. We file reports, proxy statements and other
information with the SEC. Our SEC filings are available at the SEC&#8217;s website at http://www.sec.gov. We make available, free of charge, on our website at http://www.purecycle.com, our Annual Reports on Form
<FONT STYLE="white-space:nowrap">10-K,</FONT> Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> and amendments to those reports and statements as soon as
reasonably practicable after they are filed with the SEC. The contents of our website are not part of this prospectus supplement, and the reference to our website does not constitute incorporation by reference into this prospectus supplement any of
the information contained at that site, other than documents we otherwise file with the SEC that are incorporated by reference into this prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_3"></A>INFORMATION WE INCORPORATE BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The SEC allows us to &#8220;incorporate by reference&#8221; into this prospectus supplement the information in documents we
file with it, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be a part of this prospectus supplement, and information that we file later
with the SEC will automatically update and supersede this information. Any statement contained in any document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this prospectus
supplement to the extent that a statement contained in or omitted from this prospectus supplement or the accompanying prospectus, any free writing prospectus, or in any other subsequently filed document that also is or is deemed to be incorporated
by reference herein, modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We incorporate by reference the documents listed below and any future documents that we file with the SEC under
Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act (1)&nbsp;after the date of the initial filing of the registration statement of which this prospectus supplement forms a part prior to the effectiveness of the registration statement and
(2)&nbsp;after the date of this prospectus supplement until the offering of the notes is terminated: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31,
2025 filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001830033/000119312526076801/pct-20251231.htm">February<U></U>&nbsp;26, 2026</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Definitive Proxy Statement on Schedule 14A, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001830033/000119312526127753/d68127ddef14a.htm">March
<U></U>&nbsp;27, 2026</A> (solely with respect to those portions specifically incorporated by reference into our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the year ended December&nbsp;31, 2025);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarterly period ended
March&nbsp;31, 2026 filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001830033/000183003326000014/pct-20260331.htm">May<U></U>&nbsp;6, 2026</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1830033/000119312526011168/pct-20251229.htm">January
<U></U>&nbsp;13, 2026</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1830033/000119312526076587/pct-20260225.htm">February<U></U>&nbsp;26, 2026</A> (Items&nbsp;1.01, 3.03, 5.02 and 8.01 and related exhibits
only), <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1830033/000183003326000007/pct-20260416.htm">April<U></U>&nbsp;
17, 2026</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1830033/000183003326000017/pct-20260507.htm">May<U></U>&nbsp;
11, 2026</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1830033/000119312526266413/d120498d8k.htm">June&nbsp;11, 2026</A>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will not, however, incorporate by reference in this prospectus supplement any documents or portions thereof that are not
deemed &#8220;filed&#8221; with the SEC, including any information furnished pursuant to Item 2.02 or Item 7.01 of our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> unless, and except to the extent, specified in such Current
Reports. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will provide you with a copy of any of these filings (other than an exhibit to these filings, unless the
exhibit is specifically incorporated by reference into the filing requested) at no cost, if you submit a request to us by writing or telephoning us at the following address and telephone number: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PureCycle Technologies, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20
North Orange Ave. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Suite 106 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Orlando, Florida 32801 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Phone:
(877) <FONT STYLE="white-space:nowrap">648-3565</FONT><B>&nbsp;</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-v </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_4"></A>PROSPECTUS SUPPLEMENT SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>This summary highlights certain information about us, this offering and selected information contained elsewhere in or
incorporated by reference into this prospectus supplement and the accompanying prospectus. This summary is not complete and does not contain all of the information that you should consider before deciding whether to invest in the notes. For a more
complete understanding of our Company and this offering, we encourage you to read and consider carefully the more detailed information in this prospectus supplement and the </I>accompanying<I> prospectus, including the information incorporated by
reference in this prospectus supplement and the accompanying prospectus, and the information included in any free writing prospectus that we have authorized for use in connection with this offering, including the information under the caption
&#8220;Risk Factors&#8221; in this prospectus supplement, the accompanying prospectus and in the documents incorporated by reference into this prospectus supplement and the accompanying </I>prospectus<I>. When used in this prospectus supplement, the
terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;PCT&#8221; and &#8220;the Company&#8221; mean PureCycle Technologies, Inc. and its consolidated subsidiaries, collectively.</I> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>The Company </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT is a Florida-based corporation focused on commercializing a patented dissolution recycling technology for polypropylene to
physically separate the polymer from other plastics, colors, odors, and impurities (the &#8220;Technology&#8221;). The Technology was originally developed by The Procter&nbsp;&amp; Gamble Company (&#8220;P&amp;G&#8221;), for restoring waste
polypropylene into resin, called PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin, which has similar properties and applicability for reuse as virgin polypropylene. PCT has a global license for the Technology from P&amp;G
(the &#8220;P&amp;G license&#8221;), which was amended during 2025 to permanently waive the possible clawback of PCT&#8217;s exclusivity for plants located in North America and extend the time in which PCT&#8217;s plants must begin construction and
commence sales in other regions to avoid a clawback of exclusivity under the Amended and Restated Patent License Agreement, dated July&nbsp;28, 2020 (as amended, the &#8220;License Agreement&#8221;). PCT has introduced an important new product to
the global polypropylene market that will assist corporations in meeting their sustainability goals as well as federal and state regulations and mandates, providing consumers with polypropylene-based products that are sustainable, and reducing
overall polypropylene waste in the world&#8217;s landfills and oceans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT&#8217;s process includes the following steps:
Feed <FONT STYLE="white-space:nowrap">Pre-Processing</FONT> (&#8220;Feed PreP&#8221;), and the use of PCT&#8217;s recycling technology for purification and compounding. The Feed PreP step collects, sorts, and prepares polypropylene waste
(&#8220;feedstock&#8221;) for the dissolution recycling process (&#8220;Purification&#8221;). The Purification step is a dissolution recycling process that uses a combination of solvent, temperature, and pressure to return the feedstock to
near-virgin condition through a novel configuration of commercially-available equipment and unit operations. The Purification process puts the plastic through a physical extraction process using supercritical fluids that both extract and filter out
other plastics and additives to purify the color, opacity, and odor of the plastic without changing the bonds of the polymer. By not altering the chemical makeup of the polymer, PCT is able to use significantly less energy and reduce production
costs as compared to virgin resin. Compounding, which involves blending PCT&#8217;s resin with either virgin resin or additives, is a step that can be used on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis. Compounding allows for the modification of the resin to meet the <FONT STYLE="white-space:nowrap">end-user&#8217;s</FONT> qualifications with melt
flow, flexibility, clarity, color and strength. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Recent Developments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Concurrent Offering of Common Stock and Note Repurchase Transactions </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Concurrently with this offering, we are conducting an underwritten public offering of 17,570,200 shares of our common stock (or
up to 19,854,000 shares of our common stock if the underwriters in the Concurrent Stock Offering exercise their option to purchase additional shares in full) at a price of $8.21 per share pursuant to a separate prospectus supplement. We expect to
use a portion of the net proceeds from this offering and the Concurrent </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Stock Offering, if consummated, to repurchase for cash approximately $216.0 million in aggregate principal amount at maturity of the Green Convertible Notes, including $50.0 million in aggregate
principal amount at maturity of the Green Convertible Notes held by the affiliated investors, in the Note Repurchase Transactions, which we entered into concurrently with the pricing of this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No assurance can be given as to how much, if any, of the Green Convertible Notes will be repurchased or the terms on which
they will be repurchased. Neither the completion of this offering nor the Concurrent Stock Offering is contingent on the completion of the other or the Note Repurchase Transactions. No assurance can be given that the Concurrent Stock Offering will
be completed on the terms described herein or at all. This prospectus supplement does not constitute an offer to sell, or the solicitation of an offer to buy, any shares of our common stock in the Concurrent Stock Offering, and does not constitute
an offer to buy, or the solicitation of an offer to sell, any of the Green Convertible Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">After giving effect to the
Note Repurchase Transactions, approximately $34.0 million aggregate principal amount at maturity of the Green Convertible Notes are expected to remain outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with any Note Repurchase Transaction, we expect that the holders of the Green Convertible Notes who agree to
have their Green Convertible Notes repurchased and who have hedged their equity price risk with respect to such notes (the &#8220;hedged holders&#8221;) will unwind all or part of their hedge positions by buying shares of our common stock, including
pursuant to the Concurrent Stock Offering, and/or entering into or unwinding various derivative transactions with respect to our common stock. The amount of our common stock to be purchased by the hedged holders or in connection with such derivative
transactions may be substantial in relation to the historic average daily trading volume of our common stock. This activity by the hedged holders could increase (or reduce the size of any decrease in) the market price of our common stock, including
concurrently with the pricing of the notes, which could result in a higher effective conversion price for the notes. We cannot predict the magnitude of such market activity or the overall effect it will have on the price of the notes offered hereby
or our common stock. See the caption &#8220;Risk Factors&#8212;Risks Related to the Notes and This Offering&#8212;Any repurchases of the Green Convertible Notes may affect the value of the notes and our common stock&#8221; and &#8220;The Concurrent
Transactions.&#8221; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Amendment to Revolving Credit Agreement </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are party to that certain Credit Agreement (as amended, the &#8220;Revolving Credit Agreement&#8221;) dated as of
March&nbsp;15, 2023, with PureCycle Technologies Holdings Corp., PureCycle Technologies, LLC, PureCycle Augusta, LLC and PureCycle (Thailand) Company Limited (collectively, the &#8220;Revolving Credit Facility Guarantors&#8221;), Sylebra Capital
Partners Master Fund, LTD, Sylebra Capital Parc Master Fund, and Sylebra Capital Menlo Master Fund (collectively, the &#8220;Lenders&#8221;), and Kroll Trustee Services (HK) Limited (the &#8220;Administrative Agent&#8221; and &#8220;Security
Agent&#8221;), providing the Company with a revolving credit facility pursuant to which the Company can borrow up to $200&nbsp;million (the &#8220;Revolving Credit Facility&#8221;). On June&nbsp;10, 2026, the Company, the Revolving Credit Facility
Guarantors, the Administrative Agent, the Security Agent and the Lenders executed a Limited Consent and Eleventh Amendment to Credit Agreement, which amends the Revolving Credit Agreement to, among other things, (i)&nbsp;permit this offering and the
Concurrent Stock Offering and (ii)&nbsp;remove as secured obligations certain obligations in respect of the Company&#8217;s Series A Preferred Stock, par value $0.001&nbsp;per share (&#8220;Series A Preferred Stock&#8221;), Series C Warrants and
Pre-Funded Warrants, in each case, owed by the affiliated investors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>New Jersey Recycled Content Approval </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On May 14, 2026, the New Jersey Department of Environmental Protection (&#8220;NJDEP&#8221;) designated PCT&#8217;s PureFive<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin as &#8220;postconsumer recycled content&#8221; (&#8220;PCR&#8221;) under the state of New Jersey&#8217;s Recycled Content Law (the &#8220;Recycled Content Law&#8221;). </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Recycled Content Law requires manufacturers of rigid plastic containers,
beverage containers and other regulated packaging to meet minimum thresholds of postconsumer recycled content. The mandates started at 10% for rigid plastics in 2024 and rise by 10% every three years until reaching 50% in 2036. Food-contact
packaging is exempt from the new regulations until 2027. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">NJDEP&#8217;s PCR designation is a one-year conditional
approval. During the 12 month period following receipt of conditional approval on May 14, 2026, PCT expects to provide NJDEP with documentation of feedstock sources, the type of feedstock processed, PureFive<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> end-use applications, as well as certain compliance information as requested as part of the permanent approval process. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Thailand Facility </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT plans to construct a 130 million pound polypropylene recycling facility in Rayong, Thailand (the &#8220;Thailand
Facility&#8221;). PCT intends to develop the facility at the IRPC Public Company Limited (&#8220;IRPC&#8221;) eco-industrial zone in Rayong. IRPC is an integrated petrochemical operator in Southeast Asia. Its production structure comprises petroleum
and petrochemical complexes, complete with utilities and infrastructure supporting the operations, including a deep-sea port and ample steam and power capacity. PCT intends to leverage this existing site infrastructure to reduce the costs of certain
construction activities. The permitting process has begun for the Thailand Facility, and the Thailand Facility is expected to be completed in late 2027. PCT currently estimates a total investment of $250 million for the Thailand Facility and is
seeking project financing to fund a portion of the investment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Corporate Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our principal executive offices are located at 20 North Orange Avenue, Suite 106, Orlando, Florida 32801. Our telephone number
is (877) <FONT STYLE="white-space:nowrap">648-3565.</FONT> Our website is http://www.purecycle.com. The information contained on or accessible through our website is not part of this prospectus supplement or the accompanying prospectus, other than
the documents that we file with the SEC that are specifically incorporated by reference into the registration statement of which this prospectus supplement is a part. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_5"></A>THE OFFERING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>The summary below describes the principal terms of the notes. Certain of the terms and conditions described below are subject to important
limitations and exceptions. The &#8220;Description of Debt Securities&#8221; section of the accompanying prospectus, as supplemented by the &#8220;Description of Notes&#8221; section of this prospectus supplement, contains a more detailed
description of the terms and conditions of the notes. As used in this section, &#8220;we,&#8221; &#8220;our,&#8221; and &#8220;us&#8221; refer to PureCycle Technologies, Inc. and not to its consolidated subsidiaries, and the common stock of
PureCycle Technologies, Inc., par value $0.001 per share, is referred to as our &#8220;common stock.&#8221; </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Issuer </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">PureCycle Technologies, Inc., a Delaware corporation. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Securities </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">$250,000,000 principal amount of 4.75% Convertible Senior Notes due 2032. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Over-Allotment Option </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We have granted to the underwriters an over-allotment option to purchase up to $37,500,000 aggregate principal amount of additional
notes (equal to 15% of the aggregate principal amount of initial notes offered hereby). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Maturity </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">July&nbsp;1, 2032, unless earlier converted, redeemed or repurchased. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Interest </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">4.75% per year. Interest will accrue from June 15, 2026 and will be payable semiannually in arrears on January&nbsp;1 and July&nbsp;1 of
each year, beginning on January&nbsp;1, 2027. We will pay additional interest, if any, at our election as the sole remedy relating to the failure to comply with our reporting obligations as described under the caption &#8220;Description of
Notes&#8212;Events of Default.&#8221; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Conversion Rights </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Holders may convert all or any portion of their notes, in integral multiples of $1,000 principal amount, at their option at any time
prior to the close of business on the second scheduled trading day immediately preceding the maturity date. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The conversion rate for the notes is initially 90.2242 shares of common stock per $1,000 principal amount of
notes (equivalent to an initial conversion price of approximately $11.08 per share of common stock), subject to adjustment as described in this prospectus supplement. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Upon conversion, we will pay or deliver, as the case may be, cash, shares of our common stock or a combination
of cash and shares of our common stock, at our election. If we satisfy our conversion obligation solely in cash or through payment and delivery, as the case may be, of a combination of cash and shares of our common stock, the amount of cash and
shares of common stock, if any, due upon conversion will be based on a &#8220;daily conversion value&#8221; (as defined under the caption &#8220;Description of Notes&#8212;Conversion Rights&#8212;Settlement upon Conversion&#8221;) calculated on a
proportionate basis for each trading day in a 30 trading day &#8220;observation period&#8221; (as defined under the caption &#8220;Description of Notes&#8212;Conversion </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Rights&#8212;Settlement upon Conversion&#8221;). See the caption &#8220;Description of Notes&#8212;Conversion Rights&#8212;Settlement upon Conversion.&#8221; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In addition, following certain corporate events that occur prior to the maturity date or if we deliver a
notice of redemption, we will, in certain circumstances, increase the conversion rate for a holder who elects to convert its notes in connection with such a corporate event or convert its notes called (or deemed called) for redemption during the
related redemption period (as defined under the caption &#8220;Description of Notes&#8212;Conversion Rights&#8212;General&#8221;), as the case may be, as described under the caption &#8220;Description of Notes&#8212;Conversion Rights&#8212;Increase
in Conversion Rate upon Conversion upon a Make-Whole Fundamental Change or Notice of Redemption.&#8221; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You will not receive any additional cash payment or additional shares representing accrued and unpaid
interest, if any, upon conversion of a note, except in limited circumstances. Instead, interest will be deemed to be paid by the cash, shares of our common stock or a combination of cash and shares of our common stock paid or delivered, as the case
may be, to you upon conversion of a note. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Redemption at Our Option </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We may not redeem the notes prior to July&nbsp;6, 2029. We may redeem for cash all or any portion of the notes (subject to the partial
redemption limitation described in the next succeeding sentence), at our option, on a redemption date on or after July&nbsp;6, 2029 if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for
at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of
redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If we redeem less than all the outstanding notes, at least
$75.0&nbsp;million aggregate principal amount of notes must be outstanding and not subject to redemption as of, and after giving effect to, delivery of the relevant notice of redemption. No &#8220;sinking fund&#8221; is provided for the notes, which
means that we are not required to redeem or retire the notes periodically. See the caption &#8220;Description of Notes&#8212;Optional Redemption.&#8221; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Specified Repurchase Date Repurchase </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On July&nbsp;8, 2030 (the &#8220;specified repurchase date&#8221;), holders may require us to repurchase for cash all or any portion of
their notes in principal amounts of $1,000 or an integral multiple thereof at a repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the specified repurchase date
(the &#8220;specified repurchase date repurchase price&#8221;). See the caption &#8220;Description of Notes&#8212;Repurchase at the Option of Holders&#8212;Repurchase on July&nbsp;8, 2030.&#8221; </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Fundamental Change </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If we undergo a &#8220;fundamental change&#8221; (as defined under the caption &#8220;Description of Notes&#8212;Repurchase at the
Option of Holders&#8212;Fundamental Change Permits Holders to Require Us to Repurchase Notes&#8221;), then, subject to certain conditions and except as described in this prospectus supplement, holders may require us to repurchase for cash all or any
portion of their notes in principal amounts of $1,000 or an integral multiple thereof. The fundamental change repurchase price will be equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but
excluding, the fundamental change repurchase date. See the caption &#8220;Description of Notes&#8212;Repurchase at the Option of Holders&#8212;Fundamental Change Permits Holders to Require Us to Repurchase Notes.&#8221; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Ranking </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The notes will be our general unsecured obligations and will rank: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="40%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">senior in right of payment to all of our indebtedness that is expressly subordinated in right of payment to
the notes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="40%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">equal in right of payment with all of our liabilities that are not so subordinated, including the Green
Convertible Notes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="40%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">effectively junior to any of our secured indebtedness (including all secured debt we incur in the future) to
the extent of the value of the assets securing such indebtedness, including any borrowings under the Revolving Credit Facility; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="40%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">structurally junior to all indebtedness and other liabilities (including trade payables) of our current or
future subsidiaries, including the certain revenue bonds (the &#8220;Revenue Bonds&#8221;) pursuant to the Indenture of Trust, dated as of October&nbsp;1, 2020, between the Southern Ohio Port Authority (&#8220;SOPA&#8221;) and UMB Bank, N.A., as
trustee, which proceeds for their sale were loaned to PureCycle: Ohio LLC, an Ohio limited liability company (&#8220;PCO&#8221;), pursuant to the loan agreement, dated as of October&nbsp;1, 2020, between SOPA and PCO. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">See the caption &#8220;Description of Other Indebtedness&#8221; in this prospectus supplement for a
description of the material terms of the Green Convertible Notes, Revolving Credit Facility and Revenue Bonds. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">As of March&nbsp;31, 2026, the outstanding principal amount of our total consolidated indebtedness for
borrowed money was approximately $403.8&nbsp;million, of which approximately $153.8&nbsp;million was secured indebtedness consisting of the Revenue Bonds and certain equipment financing. As of March&nbsp;31, 2026, our subsidiaries had approximately
$248.9&nbsp;million of liabilities (including trade payables, but excluding intercompany obligations and liabilities of a type not required to be reflected on a balance sheet of such subsidiaries in accordance with GAAP) to which the notes would
have been structurally subordinated. After giving effect to the issuance of the notes (assuming no exercise </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
of the underwriters&#8217; over-allotment option and without giving effect to the use of the proceeds therefrom), the outstanding principal amount of our total consolidated indebtedness for
borrowed money as of March&nbsp;31, 2026 would have been $653.8 million. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The indenture that will govern the notes will not limit the amount of debt or other liabilities that we or our
current or future subsidiaries may incur. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Use of Proceeds </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We estimate that the net proceeds from this offering will be approximately $242.0 million (or approximately $278.3 million if the
underwriters exercise their over-allotment option in full), after deducting the underwriting discounts and commissions and estimated offering expenses payable by us. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We expect to use the net proceeds from this offering, together with the net proceeds from the Concurrent Stock
Offering, if consummated: (i)&nbsp;to pay the approximately $246.3 million cost of repurchasing for cash approximately $216.0 million in aggregate principal amount at maturity of the Green Convertible Notes in the Note Repurchase Transactions as
described below under the caption &#8220;The Concurrent Transactions&#8221;; (ii)&nbsp;to repurchase additional Green Convertible Notes from time to time; and (iii)&nbsp;for working capital and other general corporate purposes. See the caption
&#8220;Use of Proceeds.&#8221; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Note Repurchase Transactions </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Concurrently with the pricing of the notes in this offering, we entered into privately negotiated transactions to repurchase for cash
approximately $216.0 million in aggregate principal amount at maturity of the Green Convertible Notes (including $50.0&nbsp;million in aggregate principal amount at maturity of the Green Convertible Notes held by the affiliated investors) for
approximately $246.3 million (including approximately $57.0&nbsp;million payable to the affiliated investors). No assurance can be given as to how much, if any, of the Green Convertible Notes will be repurchased or the terms on which they will be
repurchased. Neither the completion of this offering nor the Concurrent Stock Offering is contingent on the completion of the other or the Note Repurchase Transactions. This prospectus supplement does not constitute an offer to buy, or the
solicitation of an offer to sell, any of our Green Convertible Notes. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In connection with any Note Repurchase Transaction, we expect that the hedged holders will unwind all or part
of their hedge positions by buying shares of our common stock, including pursuant to the Concurrent Stock Offering, and/or entering into or unwinding various derivative transactions with respect to our common stock. The amount of our common stock to
be purchased by the hedged holders or in connection with such derivative transactions may be substantial in relation to the historic average daily trading volume of our common stock. This activity by the hedged holders could increase (or
</P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
reduce the size of any decrease in) the market price of our common stock, including concurrently with the pricing of the notes, which could result in a higher effective conversion price for the
notes. We cannot predict the magnitude of such market activity or the overall effect it will have on the price of the notes offered hereby or our common stock. See the caption &#8220;Risk Factors&#8212;Risks Related to the Notes and This
Offering&#8212;Any repurchases of the Green Convertible Notes may affect the value of the notes and our common stock.&#8221; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">See the caption &#8220;The Concurrent Transactions&#8221; for a further description of the Note Repurchase
Transactions. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Concurrent Stock Offering </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Concurrently with this offering, we are conducting an underwritten public offering of 17,570,200 shares of our common stock (or up to
19,854,000 shares of our common stock if the underwriters in the Concurrent Stock Offering exercise their option to purchase additional shares in full) at a price of $8.21 per share pursuant to a separate prospectus supplement.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Neither the completion of this offering nor the Concurrent Stock Offering is contingent on the completion of
the other or the Note Repurchase Transactions. No assurance can be given that the Concurrent Stock Offering will be completed on the terms described herein or at all This prospectus supplement does not constitute an offer to sell, or the
solicitation of an offer to buy, any shares of our common stock in the Concurrent Stock Offering. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">See the caption &#8220;The Concurrent Transactions&#8221; for a further description of the Concurrent Stock
Offering. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Book-Entry Form </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The notes will be issued in book-entry form and will be represented by permanent global certificates deposited with, or on behalf of,
The Depository Trust Company (&#8220;DTC&#8221;), and registered in the name of a nominee of DTC. Beneficial interests in any of the notes will be shown on, and transfers will be effected only through, records maintained by DTC or its nominee and
any such interest may not be exchanged for certificated securities, except in limited circumstances. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Absence of a Public Market for the Notes </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The notes are new securities, and there is currently no established market for the notes. Accordingly, we cannot assure you as to the
development or liquidity of any market for the notes. Certain of the underwriters have advised us that they currently intend to make a market in the notes. However, they are not obligated to do so, and they may discontinue any market making with
respect to the notes without notice. We do not intend to apply for a listing of the notes on any securities exchange or any automated dealer quotation system. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Material U.S. Federal Income Tax Considerations </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">For a discussion of the material U.S. federal income tax consequences of the ownership, disposition and conversion of the notes, and the
</P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
ownership and disposition of shares of our common stock into which the notes may be converted, see the caption &#8220;Material U.S. Federal Income Tax Considerations.&#8221;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Trading Symbol for Our Common Stock </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our common stock is listed on Nasdaq under the symbol &#8220;PCT.&#8221; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Trustee, Paying Agent, Security Registrar and Conversion Agent </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">U.S. Bank Trust Company, National Association. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Governing Law </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The indenture and the notes, and any claim, controversy or dispute arising under or related to the indenture or the notes, will be
governed by and construed in accordance with the laws of the State of New&nbsp;York. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Risk Factors </B></P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Investing in our securities involves a high degree of risk. Before making an investment decision, you should carefully read and consider
the risks and uncertainties described under the caption &#8220;Risk Factors&#8221; beginning on page <FONT STYLE="white-space:nowrap">S-10</FONT> of this prospectus supplement and on page 5 of the accompanying prospectus, as well as the risks and
uncertainties described in the documents incorporated by reference herein, including the risk factors incorporated by reference from our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and, where applicable, subsequent
Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q.</FONT> </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_6"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Investing in our securities involves risk. Prior to making a decision about investing in our securities, you should
carefully consider the specific factors discussed under the caption &#8220;Risk Factors&#8221; in our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2025 (the &#8220;Annual
Report&#8221;) and our other filings with the SEC from time to time, which are incorporated by reference in this prospectus supplement and the accompanying prospectus and may be amended, supplemented or superseded from time to time by our Quarterly
Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and other reports we file with the SEC in the future. The risks and uncertainties we have described are not the only risks to which we are exposed. Additional risks and uncertainties not
presently known to us or that we currently deem immaterial may also affect our operations. If any of these risks actually occur, our business, results of operations and financial condition could suffer. In that case, the trading price of our
securities could decline, and you could lose all or a part of your investment. </I></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Risks Related to the Notes and This Offering
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The notes are effectively subordinated to our secured debt and any liabilities of our subsidiaries. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The notes will be our general unsecured obligations and will rank senior in right of payment to all of our indebtedness that is
expressly subordinated in right of payment to the notes; equal in right of payment with all of our existing and future liabilities that are not so subordinated, including the Green Convertible Notes; effectively junior to any of our secured
indebtedness (including all secured debt we incur in the future) to the extent of the value of the assets securing such indebtedness, including any borrowings under the Revolving Credit Facility; and structurally junior to all indebtedness and other
liabilities (including trade payables) of our current or future subsidiaries, including the Revenue Bonds. In the event of our bankruptcy, liquidation, reorganization or other winding up, our assets that secure debt ranking senior or equal in right
of payment to the notes will be available to pay obligations on the notes only after the secured debt has been repaid in full from such assets. There may not be sufficient assets remaining to pay amounts due on any or all of the notes then
outstanding. The indenture governing the Green Convertible Notes does not, and the indenture that will govern the notes will not, prohibit us from incurring additional senior debt or secured debt, nor does it prohibit any of our current or future
subsidiaries from incurring additional liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of March&nbsp;31, 2026, the outstanding principal amount of our
total consolidated indebtedness for borrowed money was approximately $403.8&nbsp;million, of which approximately $153.8&nbsp;million was secured indebtedness consisting of the Revenue Bonds and certain equipment financing. As of March&nbsp;31, 2026,
our subsidiaries had approximately $248.9&nbsp;million of liabilities (including trade payables, but excluding intercompany obligations and liabilities of a type not required to be reflected on a balance sheet of such subsidiaries in accordance with
GAAP) to which the notes would have been structurally subordinated. After giving effect to the issuance of the notes (assuming no exercise of the underwriters&#8217; over-allotment option and without giving effect to the use of the proceeds
therefrom), the outstanding principal amount of our total consolidated indebtedness for borrowed money as of March&nbsp;31, 2026 would have been $653.8 million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The notes are our obligations only, and substantially all of our operations are conducted through, and substantially all of our
consolidated assets are held by, our subsidiaries. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The notes are our obligations exclusively and are not
guaranteed by any of our operating subsidiaries. Substantially all of our operations are conducted through, and substantially all of our consolidated assets are held by, our subsidiaries. Accordingly, our ability to service our debt, including the
notes, depends on the results of operations of our subsidiaries and upon the ability of such subsidiaries to provide us with cash, whether in the form of dividends, loans or otherwise, to pay amounts due on our obligations, including the notes. Our
subsidiaries are separate and distinct legal entities and have no obligation, contingent or otherwise, to make payments on the notes or to make any funds available for that purpose. In addition, dividends, loans or other distributions to us from
such subsidiaries may be subject to contractual and other restrictions, including restrictions in the Revolving Credit Facility and any of our future debt instruments, and are subject to other business considerations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Servicing our debt requires a significant amount of cash, and we may not have
sufficient cash flow from our business to pay our substantial debt, including the notes. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our ability to make
scheduled payments of the principal of, to pay interest on or to refinance our indebtedness, including the notes, and to pay cash amounts due upon conversion of the notes, depends on our future performance, which is subject to economic, financial,
competitive and other factors, many of which are beyond our control. Our business may not continue to generate cash flow from operations in the future sufficient to service our debt and make necessary capital expenditures. If we are unable to
generate such cash flow, we may be required to adopt one or more alternatives, such as selling assets, refinancing or restructuring debt or obtaining additional debt financing or equity capital on terms that may be onerous or highly dilutive. Our
ability to refinance or restructure our indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities or engage in these activities on desirable terms, which could
result in a default on our debt obligations. In addition, any of our existing or future debt agreements may contain restrictive covenants that may prohibit us from adopting any of these alternatives. Our failure to comply with these covenants could
result in an event of default which, if not cured or waived, could result in the acceleration of our debt. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Regulatory actions and
other events may adversely affect the trading price and liquidity of the notes. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We expect that many investors in,
and potential purchasers of, the notes will employ, or seek to employ, a convertible arbitrage strategy with respect to the notes. Investors would typically implement such a strategy by selling short the common stock underlying the notes and
dynamically adjusting their short position while continuing to hold the notes. Investors may also implement this type of strategy by entering into swaps on our common stock in lieu of or in addition to short selling shares of common stock. We cannot
assure you that market conditions will permit investors to implement this type of strategy, on favorable terms or at all. If market conditions do not permit investors to implement this type of strategy, on favorable terms or at all, at any time
while the notes are outstanding, the trading price and liquidity of the notes may be adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The SEC and
other regulatory and self-regulatory authorities have implemented various rules and taken certain actions, and may in the future adopt additional rules and take other actions, that may affect those engaging in short selling activity involving equity
securities (including our common stock). Such rules and actions include Rule 201 of SEC Regulation SHO, the adoption by the Financial Industry Regulatory Authority, Inc. and the national securities exchanges of a &#8220;Limit <FONT
STYLE="white-space:nowrap">Up-Limit</FONT> Down&#8221; program, the imposition of market-wide circuit breakers that halt trading of securities for certain periods following specific market declines, and the implementation of certain regulatory
reforms required by the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. Any governmental or regulatory action that restricts or otherwise affects the ability of investors in, or potential purchasers of, the notes to effect short
sales of our common stock, borrow shares of our common stock or enter into swaps on our common stock could adversely affect the trading price and the liquidity of the notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, the number of shares of our common stock available for lending in connection with short sale transactions and the
number of counterparties willing to enter into an equity swap on our common stock with a note investor may not be sufficient for the implementation of a convertible arbitrage strategy. These and other market events could make implementing a
convertible arbitrage strategy prohibitively expensive or infeasible. We cannot assure you that a sufficient number of shares of our common stock will be available to borrow on commercial terms, or at all, to potential purchasers in this offering or
holders of the notes. If investors in this offering or potential purchasers of the notes that seek to employ a convertible arbitrage strategy are unable to do so on commercial terms, or at all, then the trading price of, and the liquidity of the
market for, the notes may significantly decline. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Volatility in the market price and trading volume of our common stock, the
condition of the financial markets, prevailing interest rates and other factors could adversely affect the trading price of the notes. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We expect that the trading price of the notes will be significantly affected by the market price of our common stock. The stock
market in recent years has experienced significant price and volume fluctuations that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
have often been unrelated to the operating performance of companies. The market price of our common stock has been and may continue to be highly volatile and could fluctuate or decline
significantly for many reasons, including in response to the risks described in this section, elsewhere in this prospectus supplement or in the documents we have incorporated by reference in this prospectus supplement or for reasons unrelated to our
operations, many of which are beyond our control, such as reports by industry analysts, investor perceptions or negative announcements by our customers, competitors or suppliers regarding their own performance, as well as industry conditions and
general financial, economic and political instability and other factors not currently known to us or that we do not currently believe are material. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A decrease in the market price of our common stock would likely adversely impact the trading price of the notes. The market
price of our common stock could also be affected by possible sales of our common stock by investors who view the notes as a more attractive means of equity participation in us and by hedging or arbitrage trading activity that we expect to develop
involving our common stock. This trading activity could, in turn, affect the trading price of the notes. In addition, if investors and potential purchasers seeking to employ a convertible arbitrage strategy are unable to borrow or enter into swaps
on our common stock, in each case on commercially reasonable terms, the trading price and liquidity of the notes may be adversely affected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, the condition of the financial markets and changes in prevailing interest rates can have an adverse effect on the
trading price of the notes. In general, as market interest rates rise, notes bearing interest at a fixed rate generally decline in value because the premium, if any, over market interest rates will decline. Consequently, if you purchase the notes
and market interest rates increase, the market value of your notes may decline. We cannot predict the future level of market interest rates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Despite our current debt levels, we may still incur substantially more debt or take other actions following this offering, which would
intensify the risks discussed above. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Despite our current consolidated debt levels, we and our subsidiaries may be
able to incur substantial additional debt in the future, subject to the restrictions contained in our existing or future debt instruments, some of which may be secured debt. We are not restricted under the terms of the indenture governing the Green
Convertible Notes, and will not be restricted under the terms of the indenture that will govern the notes offered hereby from incurring additional debt, securing existing or future debt, recapitalizing our debt or taking a number of other actions
that are not limited by the terms of the applicable indenture governing the notes or the Green Convertible Notes that could have the effect of diminishing our ability to make payments on our debt, including the notes, when due. The credit agreement
governing the Revolving Credit Facility restricts our ability to incur additional indebtedness, including secured indebtedness, but if the facility matures or is otherwise terminated, we may not be subject to such restrictions under the terms of any
subsequent indebtedness. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We may not have the ability to raise the funds necessary to settle conversions of the notes or the Green
Convertible Notes in cash or to repurchase the notes on July&nbsp;8, 2030, the Green Convertible Notes on August&nbsp;15, 2027 or the notes or the Green Convertible Notes upon a fundamental change, and our future debt may contain limitations on our
ability to pay cash upon conversion or repurchase of the notes or the Green Convertible Notes. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Holders of the
notes will have the right, subject to certain conditions and limited exceptions, to require us to repurchase all or a portion of their notes on July&nbsp;8, 2030 or upon the occurrence of a fundamental change at a specified repurchase date
repurchase price or fundamental change repurchase price, as applicable, equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the applicable repurchase date, as described
under the caption &#8220;Description of Notes&#8212;Repurchase at the Option of Holders.&#8221; In addition, upon any conversion of the notes, unless we elect to deliver solely shares of our common stock to settle such conversion (other than paying
cash in lieu of delivering any fractional share), we will be required to make cash payments in respect of the notes being converted as described under the caption &#8220;Description of Notes&#8212;Conversion Rights&#8212;Settlement upon
Conversion.&#8221; The indenture governing the Green </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Convertible Notes contains similar provisions requiring us to offer to repurchase the Green Convertible Notes on August&nbsp;15, 2027 or upon the occurrence of a &#8220;fundamental change&#8221;
(as defined in the indenture governing the Green Convertible Notes) and gives us the option to pay cash to settle conversions of the Green Convertible Notes. We may not have enough available cash or be able to obtain financing at the time we are
required to make repurchases of the notes or the Green Convertible Notes surrendered therefor or pay cash with respect to the notes or the Green Convertible Notes being converted. In addition, our ability to repurchase the notes or the Green
Convertible Notes or to pay cash upon conversions of the notes or the Green Convertible Notes may be limited by law, by regulatory authority or by agreements governing our then-existing indebtedness. Our failure to repurchase the notes or the Green
Convertible Notes at a time when the repurchase is required by the respective indenture or to pay any cash payable on future conversions of the notes as required by the respective indenture would constitute a default under the indenture or the
indenture governing the Green Convertible Notes, as applicable. A default under either indenture or the fundamental change itself could also lead to a default under agreements governing our then-existing indebtedness. If the repayment of the related
indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness and repurchase the notes or the Green Convertible Notes or make cash payments upon conversions thereof. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our Revolving Credit Facility limits our ability to pay any cash amount upon the conversion or repurchase of the notes. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our Revolving Credit Facility prohibits us from making any cash payments on the conversion or repurchase of the notes. See the
caption &#8220;Description of Other Indebtedness&#8212;Description of Revolving Credit Facility.&#8221; Any new credit facility that we may enter into may have similar restrictions. Our failure to make cash payments upon the conversion or repurchase
of the notes as required under the terms of the notes would permit holders of the notes to accelerate our obligations under the notes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Redemption may adversely affect your return on the notes. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We may not redeem the notes prior to July&nbsp;6, 2029. We may redeem for cash all or any portion of the notes (subject to the
&#8220;partial redemption limitation&#8221; described under the caption &#8220;Description of Notes&#8212;Optional Redemption&#8221;), at our option, on a redemption date on or after July&nbsp;6, 2029 if the last reported sale price of our common
stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the
trading day immediately preceding the date on which we provide notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. As
a result, we may choose to redeem some or all of the notes, including at times when prevailing interest rates are relatively low. As a result, you may not be able to reinvest the proceeds you receive from the redemption in a comparable security at
an effective interest rate as high as the interest rate on your notes being redeemed. In addition, despite the partial redemption limitation, a redemption of less than all of the outstanding notes will likely harm the liquidity of the market for the
unredeemed notes following the redemption. Accordingly, if your notes are not redeemed in a partial redemption, then you may be unable to sell your notes at the times you desire or at favorable prices, if at all, and the trading price of your notes
may decline. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you convert your notes, the consideration we deliver may not fully compensate you for any future interest
payments that you would have otherwise received or any other lost time value of your notes. See the caption &#8220;Description of Notes&#8212;Optional Redemption.&#8221; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our management has broad discretion over the use of proceeds from this offering and the proceeds from the Concurrent Stock Offering, if
consummated, and we may use the proceeds in ways that may not generate a favorable return for us or improve our operating results. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our management has significant flexibility in applying the net proceeds that we receive from this offering. We expect to use
the net proceeds from this offering, together with the net proceeds from the Concurrent Stock </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Offering, if consummated: (i)&nbsp;to pay the approximately $246.3 million cost of repurchasing for cash approximately $216.0 million in aggregate principal amount at maturity of the Green
Convertible Notes in the Note Repurchase Transactions as described below under the caption &#8220;The Concurrent Transactions&#8221;; (ii)&nbsp;to repurchase additional Green Convertible Notes from time to time; and (iii)&nbsp;for working capital
and other general corporate purposes. See the caption &#8220;Use of Proceeds.&#8221; However, the net proceeds are not required to be allocated to any specific purpose, and you will be unable to determine in advance the value or propriety of our
management&#8217;s application of such net proceeds on our behalf. In addition, the net proceeds of this offering may not generate a favorable return for us or improve our operating results. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Conversion of the notes, the Green Convertible Notes and the Series&nbsp;B Convertible Preferred Stock (as defined below) may dilute the ownership
interest of our stockholders or may otherwise depress the price of our common stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The conversion of some or all
of the notes, the Green Convertible Notes or the Series&nbsp;B Convertible Perpetual Preferred Stock, par value $0.001 per share (the &#8220;Series&nbsp;B Convertible Preferred Stock&#8221;) issued to certain investors pursuant to binding
subscription agreements entered into on June&nbsp;16, 2025 may dilute the ownership interests of our stockholders. Upon conversion of the notes or the Green Convertible Notes, we have the option to pay or deliver, as the case may be, cash, shares of
our common stock, or a combination of cash and shares of our common stock. If we elect to settle our conversion obligation in shares of our common stock or a combination of cash and shares of our common stock with respect to conversions of the notes
or the Green Convertible Notes, any sales in the public market of our common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of the notes or the Green Convertible
Notes may encourage short selling by market participants because the conversion of the notes or the Green Convertible Notes could be used to satisfy short positions, or anticipated conversion of the notes or the Green Convertible Notes into shares
of our common stock could depress the price of our common stock. Holders of Series B Convertible Preferred Stock may elect to convert such shares into common stock at any time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, the shares of common stock to be issued in the Concurrent Stock Offering will dilute the ownership interests of
our stockholders. Because the price per share of our common stock being offered in the Concurrent Stock Offering may be higher than the book value per share of our common stock, our stockholders may suffer immediate and substantial dilution in the
net tangible book value of the common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The accounting method for the notes and the Green Convertible Notes could adversely
affect our reported financial condition and results. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The accounting method for reflecting the notes and the Green
Convertible Notes on our consolidated balance sheet, accruing interest expense for the notes and the Green Convertible Notes and reflecting the underlying shares of our common stock in our reported diluted earnings per share may adversely affect our
reported earnings and financial condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In August 2020, the Financial Accounting Standards Board published Accounting
Standards Update (&#8220;ASU&#8221;) <FONT STYLE="white-space:nowrap">2020-06</FONT> (&#8220;ASU <FONT STYLE="white-space:nowrap">2020-06&#8221;),</FONT> which simplified certain of the accounting standards that apply to convertible notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In accordance with ASU <FONT STYLE="white-space:nowrap">2020-06</FONT> and subject to our full accounting assessment with
respect to the notes, which is not complete as of the date of this prospectus supplement, we expect that the notes we are offering hereunder will be, consistent with the Green Convertible Notes, reflected as a liability on our consolidated balance
sheet, with the initial carrying amount equal to the principal amount of the notes, net of issuance costs. Issuance costs are treated as a debt discount for accounting purposes, which are amortized into interest expense over the term of such notes.
As a result of this amortization, the interest expense that we expect to recognize for the notes for accounting purposes will be greater than the cash interest payments we will pay on the notes, which will result in lower reported net income or
larger reported net loss. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, consistent with the Green Convertible Notes, we expect that the
shares of common stock underlying the notes will be reflected in our diluted earnings per share using the &#8220;if converted&#8221; method, in accordance with <FONT STYLE="white-space:nowrap">ASU&nbsp;2020-06,</FONT> for fiscal periods in which we
report net income. Under that method, diluted earnings per share would generally be calculated assuming that all the notes were converted solely into shares of common stock at the beginning of the reporting period, unless the result would be
anti-dilutive. The application of the <FONT STYLE="white-space:nowrap">if-converted</FONT> method may reduce our reported diluted earnings per share to the extent we are profitable in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We cannot be sure whether other changes may be made to the current accounting standards related to the notes or the Green
Convertible Notes, or otherwise, that could have a material effect on our reported financial results. We have not reached a final determination regarding the accounting treatment for the notes, and the description above is preliminary. In addition,
accounting standards may change in the future. Accordingly, we may account for the notes in a manner that is significantly different than described above. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The Concurrent Stock Offering, as well as other future sales of our common stock or equity-linked securities in the public market could
lower the market price for our common stock and adversely impact the trading price of the notes. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Concurrently with
this offering, we are offering 17,570,200 shares (or up to 19,854,000 shares of our common stock if the underwriters in the Concurrent Stock Offering exercise their option to purchase additional shares in full) at a price of $8.21 per share of our
common stock pursuant to a separate prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, in the future, we may sell additional shares of
our common stock or equity-linked securities to raise capital. In addition, a substantial number of shares of our common stock are reserved for issuance upon the exercise of stock options and upon conversion of the notes, the Green Convertible Notes
and the Series B Convertible Preferred Stock. We cannot predict the size of future issuances or the effect, if any, that the Concurrent Stock Offering or future issuances may have on the market price for our common stock. The issuance and sale of
substantial amounts of our common stock or equity-linked securities, or the perception that such issuances and sales may occur, could adversely affect the trading price of the notes and the market price of our common stock and impair our ability to
raise capital through the sale of additional equity or equity-linked securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The sale of the shares of common stock offered in
the Concurrent Stock Offering, the sale of the notes convertible into shares of common stock offered by this prospectus supplement and the conversion of the notes for shares of common stock, or the perception that such sales or conversions may
occur, could result in a significant decline in the price of our common stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Concurrently with this offering, we
are offering 17,570,200 shares (or up to 19,854,000 shares of our common stock if the underwriters in the Concurrent Stock Offering exercise their option to purchase additional shares in full) at a price of $8.21 per share of our common stock
pursuant to a separate prospectus supplement. If all of the shares of common stock offered in the Concurrent Stock Offering and issuable upon conversion of the notes offered by this prospectus supplement were issued and outstanding, they would
represent a significant percentage of our public float and of our outstanding shares of common stock. As of March 31, 2026, and after giving effect to this offering and the Concurrent Stock Offering (but without giving effect to the use of proceeds
therefrom, including any Note Repurchase Transactions), the shares of common stock offered in the Concurrent Stock Offering and issuable upon conversion of the notes offered by this prospectus supplement would represent approximately 22.2% of the
total number of outstanding shares of common stock (excluding (i) 5,634,313 shares of common stock issuable upon the settlement of outstanding restricted stock units (&#8220;RSUs&#8221;) and performance-based restricted stock awards
(&#8220;PSUs&#8221;) and the exercise of stock options as of March 31, 2026, (ii) 23,115,521 shares of common stock authorized and reserved for future issuance under our equity and other incentive-based plans as of March 31, 2026, (iii) 5,893,798
shares of common stock issuable upon exercise of the public warrants and private warrants (the &#8220;PCT Warrants&#8221;), (iv) 17,757,136 shares of common stock issuable upon exercise of Series A Warrants, (v)&nbsp;3,064,081 shares of common stock
issuable upon exercise of Series B Warrants, (vi) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
5,000,000 shares of common stock issuable upon exercise of Series C Warrants, (vii) 22,583,963 shares of common stock issuable upon conversion of Series B Convertible Preferred Stock and (viii)
23,237,440 shares of common stock issuable upon conversion of the Green Convertible Notes (assuming the maximum increase to the conversion rate in connection with a &#8220;make-whole fundamental change&#8221; or a notice of redemption). Accordingly,
the sale of the shares of common stock offered in the Concurrent Stock Offering, the sale of the notes convertible into shares of common stock offered by this prospectus supplement and the conversion of the notes for shares of common stock, or the
perception that such sales or conversions may occur, could result in a significant decline in the public trading price of our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Holders of notes will not be entitled to any rights with respect to our common stock, but they will be subject to all changes made with
respect to our common stock to the extent our conversion obligation includes shares of our common stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Holders
of notes will not be entitled to any rights with respect to our common stock (including, without limitation, voting rights and rights to receive any dividends or other distributions on our common stock) prior to the conversion date relating to such
notes (if we have elected to settle the relevant conversion by delivering solely shares of our common stock (other than paying cash in lieu of delivering any fractional share)) or the last trading day of the relevant observation period (if we elect
to pay and deliver, as the case may be, a combination of cash and shares of our common stock in respect of the relevant conversion), but holders of notes will be subject to all changes affecting our common stock. For example, if an amendment is
proposed to our amended and restated certificate of incorporation or second amended and restated bylaws requiring stockholder approval and the record date for determining the stockholders of record entitled to vote on the amendment occurs prior to
the conversion date related to a holder&#8217;s conversion of its notes (if we have elected to settle the relevant conversion by delivering solely shares of our common stock (other than paying cash in lieu of delivering any fractional share)) or the
last trading day of the relevant observation period (if we elect to pay and deliver, as the case may be, a combination of cash and shares of our common stock in respect of the relevant conversion), such holder will not be entitled to vote any shares
underlying the notes held by such holder on the amendment, although such holder will nevertheless be subject to any changes affecting our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Upon conversion of the notes, you may receive less valuable consideration than expected because the value of our common stock may
decline after you exercise your conversion right but before we settle our conversion obligation. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the notes,
a converting holder will be exposed to fluctuations in the value of our common stock during the period from the date such holder surrenders notes for conversion until the date we settle our conversion obligation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon conversion of the notes, we have the option to pay or deliver, as the case may be, cash, shares of our common stock, or a
combination of cash and shares of our common stock. If we elect to satisfy our conversion obligation in cash or a combination of cash and shares of our common stock, the amount of consideration that you will receive upon conversion of your notes
will be determined by reference to the volume-weighted average price of our common stock for each trading day in a 30 trading day observation period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the price of our common stock decreases during this period, the amount and/or value of consideration you receive will be
adversely affected. In addition, if the market price of our common stock at the end of such period is below the average volume-weighted average price of our common stock during such period, the value of any shares of our common stock that you will
receive in satisfaction of our conversion obligation will be less than the value used to determine the number of shares that you will receive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we elect to satisfy our conversion obligation solely in shares of our common stock upon conversion of the notes, we will be
required to deliver the shares of our common stock, together with cash for any fractional share, on the second business day following the relevant conversion date (provided that, with respect to any conversion
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
date following the regular record date immediately preceding the maturity date where physical settlement applies to the related conversion, we will settle any such conversion on the maturity
date). Accordingly, if the price of our common stock decreases during this period, the value of the shares that you receive will be adversely affected and would be less than the conversion value of the notes on the relevant conversion date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The notes are not protected by restrictive covenants. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The indenture that will govern the notes will not contain any financial or operating covenants or restrictions on the payments
of dividends, the incurrence of indebtedness or the issuance or repurchase of securities by us or any of our subsidiaries. The indenture that will govern the notes will not contain any covenants or other provisions to afford protection to holders of
the notes in the event of a fundamental change or other corporate transaction involving us except to the extent described under the captions &#8220;Description of Notes&#8212;Repurchase at the Option of Holders&#8212;Fundamental Change Permits
Holders to Require Us to Repurchase Notes,&#8221; &#8220;Description of Notes&#8212;Conversion Rights&#8212;Increase in Conversion Rate upon Conversion upon a Make-Whole Fundamental Change or Notice of Redemption&#8221; and &#8220;Description of
Notes&#8212;Consolidation, Merger and Sale of Assets.&#8221;&#8195; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The increase in the conversion rate for notes converted in
connection with a make-whole fundamental change or a notice of redemption may not adequately compensate you for any lost value of your notes as a result of such transaction or redemption. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a make-whole fundamental change occurs prior to the maturity date or if we deliver a notice of redemption, we will, under
certain circumstances, increase the conversion rate by a number of additional shares of our common stock for notes converted in connection with such make-whole fundamental change or notes called (or deemed called) for redemption that are converted
during the related redemption period. The increase in the conversion rate will be determined based on the date on which the make-whole fundamental change occurs or becomes effective, or the date we deliver the notice of redemption, as the case may
be, and the price paid (or deemed to be paid) per share of our common stock in the make-whole fundamental change or determined with respect to the notice of redemption, as the case may be and as described below under the caption &#8220;Description
of Notes&#8212;Conversion Rights&#8212;Increase in Conversion Rate upon Conversion upon a Make-Whole Fundamental Change or Notice of Redemption.&#8221; The increase in the conversion rate for notes converted in connection with a make-whole
fundamental change or notes called (or deemed called) for redemption that are converted during the related redemption period may not adequately compensate you for any lost value of your notes as a result of such transaction or redemption.
Furthermore, if we call only a portion of the outstanding notes for redemption, only those notes called (or deemed called) for redemption will become convertible as a result of such call for redemption and only the conversion rate of notes converted
in connection with such notice of redemption will be increased. Accordingly, notes not called (or not deemed called) for redemption will not become convertible if not otherwise convertible at such time and will remain outstanding, and may have
reduced liquidity and a resulting reduced trading price. In addition, if the &#8220;stock price&#8221; (as defined under the caption &#8220;Description of Notes&#8212;Conversion Rights&#8212;Increase in Conversion Rate upon Conversion upon a
Make-Whole Fundamental Change or Notice of Redemption&#8221;) is greater than $40.00 per share or less than $8.21 per share (in each case, subject to adjustment), no additional shares will be added to the conversion rate. Moreover, in no event will
the conversion rate per $1,000 principal amount of notes as a result of this adjustment exceed 121.8026 shares of our common stock, subject to adjustment in the same manner as the conversion rate as set forth under the caption &#8220;Description of
Notes&#8212;Conversion Rights&#8212;Conversion Rate Adjustments.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our obligation to increase the conversion rate
for notes converted in connection with a make-whole fundamental change or notes called (or deemed called) for redemption that are converted during the related redemption period could be considered a penalty, in which case the enforceability thereof
would be subject to general principles of reasonableness and equitable remedies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The conversion rate of the notes may not be adjusted for all dilutive events.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The conversion rate of the notes is subject to adjustment for certain events, including, but not limited to, the
issuance of certain stock dividends on our common stock, the issuance of certain rights or warrants, subdivisions, combinations, distributions of capital stock, indebtedness, or assets, cash dividends and certain issuer tender or exchange offers as
described under the caption &#8220;Description of Notes&#8212;Conversion Rights&#8212;Conversion Rate Adjustments.&#8221; However, the conversion rate will not be adjusted for other events, such as a third-party tender or exchange offer or an
issuance of common stock for cash, that may adversely affect the trading price of the notes or our common stock. An event that adversely affects the value of the notes may occur, and that event may not result in an adjustment to the conversion rate.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Some significant restructuring transactions may not constitute a fundamental change, in which case we would not be obligated to
offer to repurchase the notes. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon the occurrence of a fundamental change (as described under the caption titled
&#8220;Description of Notes&#8212;Repurchase at the Option of Holders&#8212;Fundamental Change Permits Holders to Require Us to Repurchase Notes&#8221;), you have the right to require us to repurchase all or any portion of your notes. However, the
fundamental change provisions will not afford protection to holders of notes in the event of other transactions that could adversely affect the notes. For example, transactions such as leveraged recapitalizations, refinancings, restructurings, or
acquisitions initiated by us may not constitute a fundamental change requiring us to offer to repurchase the notes. In the event of any such transaction, the holders would not have the right to require us to repurchase the notes, even though each of
these transactions could increase the amount of our indebtedness, or otherwise adversely affect our capital structure or any credit ratings, thereby adversely affecting the holders of notes. Furthermore, holders would not have the right to require
us to repurchase the notes in circumstances involving solely a significant change in the composition of our board. See the caption &#8220;Description of Notes&#8212;Repurchase at the Option of Holders&#8212;Fundamental Change Permits Holders to
Require Us to Repurchase Notes.&#8221; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Certain provisions in the indentures governing the notes and the Green Convertible Notes may
delay or prevent an otherwise beneficial takeover attempt of us. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Certain provisions in the indenture that will
govern the notes may make it more difficult or expensive for a third party to acquire us. For example, the indenture that will govern the notes will require us, except as described in this prospectus supplement, to repurchase the notes for cash upon
the occurrence of a fundamental change and, in certain circumstances, to increase the conversion rate for a holder that converts its notes in connection with a make-whole fundamental change. A takeover of us may trigger the requirement that we
repurchase the notes and/or increase the conversion rate, which could make it costlier for a potential acquirer to engage in such takeover. Such additional costs may have the effect of delaying or preventing a takeover of us that would otherwise be
beneficial to investors. The indenture governing the Green Convertible Notes contains similar provisions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We cannot assure you that
an active or liquid trading market will develop for the notes. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The notes are a new issue of securities for which
there is currently no public market, and no active trading<B><I> </I></B>market (public or otherwise) might ever develop. If the notes are traded after their initial issuance, they may trade at<B><I> </I></B>a discount from their initial offering
price, depending on prevailing interest rates, the market for similar securities,<B><I> </I></B>the price, and volatility in the price, of our common stock, our performance and other factors. We do not intend to apply to list the notes on any
securities exchange or to arrange for quotation on any automated dealer quotation system. We have been informed by certain of the underwriters that they intend to make a market in the notes after the offering is completed. However, such underwriters
may cease their market-making at any time without notice. In addition, the liquidity of the trading market in the notes, and the market price quoted for the notes, may be adversely affected by changes in the overall market for this type of security
and by changes in our financial performance or prospects or in the prospects for companies in our industry generally. As a result, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
we cannot assure you that an active trading market will develop for the notes. If an active trading market does not develop or is not maintained, the market price and liquidity of the notes may
be adversely affected. In that case you may not be able to sell your notes at a particular time or you may not be able to sell your notes at a favorable price or at all. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Any adverse rating of the notes may cause their trading price to fall. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We do not intend to seek a rating on the notes. However, if a rating service were to rate the notes and if such rating service
were to lower its rating on the notes below the rating initially assigned to the notes or otherwise announces its intention to put the notes on credit watch, the trading price of the notes could decline. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>You may be subject to tax if we make or fail to make certain adjustments to the conversion rate of the notes even though you do not
receive a corresponding cash distribution. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The conversion rate of the notes is subject to adjustment in certain
circumstances, including the payment of cash dividends. If the conversion rate is adjusted as a result of a distribution that is taxable to our stockholders, such as a distribution of money or other property, you generally will be deemed to have
received a distribution, which may be treated as a dividend subject to U.S. federal income tax, without the receipt of any cash. In addition, a failure to adjust (or to adjust properly) the conversion rate after an event that increases your
proportionate interest in us could be treated as a deemed taxable dividend to you. If a make-whole fundamental change occurs prior to the maturity date or if we deliver a notice of redemption, we will, under some circumstances, increase the
conversion rate for notes converted in connection with the make-whole fundamental change or notice of redemption, as the case may be. Such increase also may be treated as a distribution subject to U.S. federal income tax as a dividend. See the
caption &#8220;Material U.S. Federal Income Tax Considerations.&#8221; If you are a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder (as defined under the caption &#8220;Material U.S. Federal Income Tax Considerations&#8221;), any deemed
dividend generally would be subject to U.S. federal withholding tax at a 30% rate, or such lower rate as may be specified by an applicable treaty, which may be withheld from or set off against subsequent payments of cash or delivery of shares of our
common stock, if any, in respect of the notes (or, in some circumstances, any payments on our common stock) or sales proceeds payable to you or your other funds or assets. See the caption &#8220;Material U.S. Federal Income Tax
Considerations.&#8221; The Internal Revenue Service has proposed regulations addressing the amount and timing of deemed distributions, obligations of withholding agents and filing and notice obligations of issuers, which, if adopted, could affect
the U.S. federal income tax treatment of a holder of notes deemed to receive such a distribution. See the caption &#8220;Material U.S. Federal Income Tax Considerations.&#8221; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We may not be able to fully utilize our deferred tax assets. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are subject to income and other taxes in the United States. As of December&nbsp;31, 2025, we had U.S. federal net operating
loss carryforwards of $800.8&nbsp;million as described further in Note&nbsp;12 &#8220;Income Taxes&#8221; to the consolidated financial statements accompanying our Annual Report. At that date, we also had recorded a valuation allowance of
$214.6&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our ability to use our U.S. net operating loss carryforwards may be limited if we experience an
&#8220;ownership change&#8221; as defined in Section&nbsp;382 of the Code (as defined herein). An ownership change generally occurs if certain stockholders increase their aggregate percentage ownership of a corporation&#8217;s stock by more than
50&nbsp;percentage points over their lowest percentage ownership at any time during the testing period, which is generally the three-year period preceding any potential ownership change. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Although we may be able to utilize some or all of the U.S. net operating losses in the future if we have income of the
appropriate character (subject to certain limitation on the amount of taxable income that can be offset by a net operating loss carryforward in a given taxable year), there is no assurance that we will be able to do so. Further, we are presently
unable to record tax benefits on future losses until such time as sufficient income is generated by our operations to support the realization of the related net deferred tax asset positions. Our results of operations, financial condition and cash
flows may adversely be affected in future periods by these limitations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Because the notes will initially be issued in book-entry form, holders must rely on
DTC&#8217;s procedures to receive communications relating to the notes and exercise their rights and remedies. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We
will initially issue the notes in the form of one or more global notes registered in the name of Cede&nbsp;&amp; Co., as nominee of DTC. Beneficial interests in global notes will be shown on, and transfers of global notes will be effected only
through, the records maintained by DTC. Except in limited circumstances, we will not issue certificated notes. See the caption &#8220;Description of Notes&#8212;Book-Entry, Settlement and Clearance.&#8221; Accordingly, if you own a beneficial
interest in a global note, then you will not be considered an owner or holder of the notes. Instead, DTC or its nominee will be the sole holder of global notes. Unlike persons who have certificated notes registered in their names, owners of
beneficial interests in global notes will not have the direct right to act on our solicitations for consents or requests for waivers or other actions from holders. Instead, those beneficial owners will be permitted to act only to the extent that
they have received appropriate proxies to do so from DTC or, if applicable, a DTC participant. The applicable procedures for the granting of these proxies may not be sufficient to enable owners of beneficial interests in global notes to vote on any
requested actions on a timely basis. In addition, notices and other communications relating to the notes will be sent to DTC. We expect DTC to forward any such communications to DTC participants, which in turn would forward such communications to
indirect DTC participants. However, we can make no assurances that you will timely receive any such communications. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Any repurchases
of the Green Convertible Notes may affect the value of the notes and our common stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We expect to use a portion
of the net proceeds from this offering and the Concurrent Stock Offering, if consummated, to repurchase for cash approximately $216.0&nbsp;million in aggregate principal amount at maturity of the Green Convertible Notes, including $50.0 million in
aggregate principal amount at maturity of the Green Convertible Notes held by the affiliated investors, for cash in the Note Repurchase Transactions. No assurance can be given as to how much, if any, of the Green Convertible Notes will be
repurchased or the terms on which they will be repurchased. This prospectus supplement is not an offer to repurchase the Green Convertible Notes, and the offering of the notes is not contingent upon the Note Repurchase Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with any Note Repurchase Transaction, we expect that the hedged holders will unwind all or part of their hedge
positions by buying shares of our common stock, including pursuant to the Concurrent Stock Offering, and/or entering into or unwinding various derivative transactions with respect to our common stock. The amount of our common stock to be purchased
by the hedged holders or in connection with such derivative transactions may be substantial in relation to the historic average daily trading volume of our common stock. This activity by the hedged holders could increase (or reduce the size of any
decrease in) the market price of our common stock, including concurrently with the pricing of the notes, which could result in a higher effective conversion price for the notes. We cannot predict the magnitude of such market activity or the overall
effect it will have on the price of the notes offered hereby or our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>This offering is not contingent on the
consummation of the Concurrent Stock Offering, and vice versa, or the Note Repurchase Transactions. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Neither the
completion of this offering nor the Concurrent Stock Offering is contingent on the completion of the other or the Note Repurchase Transactions. No assurance can be given that the Concurrent Stock Offering will be completed on the terms described
herein or at all. This prospectus supplement does not constitute an offer to sell, or the solicitation of an offer to buy, any shares of our common stock in the Concurrent Stock Offering. See the caption &#8220;The Concurrent Transactions.&#8221;
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Risks Related to Our Common Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Certain of our current and former stockholders have the right to elect a certain number of directors to our board of directors.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to a letter agreement entered into between Pure Crown LLC (&#8220;Pure Crown&#8221;) and PCT, dated
October&nbsp;5, 2020, Pure Crown is entitled to select one director (the &#8220;Pure Crown Director&#8221;) to our Board of Directors (the &#8220;Board&#8221;), and Pure Crown designated Ms.&nbsp;Tanya Burnell as the current Pure Crown Director. For
so long as Pure Crown has this right to select one director to the Board, any vacancy with respect to the Pure Crown Director may only be filled by Pure Crown. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Furthermore, pursuant to the board representation agreement, dated March&nbsp;7, 2022 (the &#8220;Board Representation
Agreement&#8221;), between PCT and Sylebra Capital, Sylebra Capital has been granted the right to designate (i)&nbsp;one person to be nominated for election to the Board so long as Sylebra Capital together with its affiliates beneficially owns at
least 10.0% of the common stock, and (ii)&nbsp;two persons to be nominated for election to the Board so long as Sylebra Capital together with its affiliates beneficially owns at least 15.0% of the common stock, subject to certain exceptions,
including that Sylebra Capital together with its affiliates will not be entitled to designate more than two nominees. Accordingly, Sylebra Capital is currently entitled to designate two directors for nomination, and has designated Valerie Mars and
Dan Gibson to serve on the Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Future offerings of debt or offerings or issuances of equity securities by us may adversely
affect the market price of our common stock or otherwise dilute all other stockholders. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the future, we may
attempt to obtain financing or further increase our capital resources by issuing additional shares of our common stock or offering debt, including commercial paper, medium-term notes, senior or subordinated notes, debt securities convertible into
equity or shares of preferred stock. We also expect to grant equity awards to employees, directors, and consultants under our stock incentive plans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The implementation of our business strategy could require substantial additional capital in excess of cash generated from
operations. We would expect to obtain the capital required for the implementation of our business strategy through a combination of additional issuances of equity, corporate indebtedness and/or cash from operations, which may be effectuated through
private financings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Issuing additional shares of our common stock or other equity securities or securities convertible
into equity may dilute the economic and voting rights of our existing stockholders or reduce the market price of our common stock or both, and could be constrained by stock exchange rules that may require prior stockholder approval for certain large
or below market issuances. Upon liquidation, holders of such debt securities and preferred shares, if issued, and lenders with respect to other borrowings would receive a distribution of our available assets prior to the holders of our common stock.
Preferred shares, if issued, could have a preference with respect to liquidating distributions or a preference with respect to dividend payments that could limit our ability to pay dividends to the holders of our common stock. Our decision to issue
securities in any future offering will depend on market conditions and other factors beyond our control, which may adversely affect the amount, timing and nature of our future offerings. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Sales of a substantial number of shares of our common stock, or the perception that such sales may occur, may impair our future ability
to raise capital. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Sales of a substantial number of shares of our common stock in the public markets could impair
our ability to raise capital through the sale of additional equity securities or securities convertible into equity shares in the future. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The price of our common stock may be volatile. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The market price of our common stock may fluctuate substantially. For example, from January&nbsp;1, 2025 through June&nbsp;9,
2026, the closing price of our common stock fluctuated between $5.11 and $16.92. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
price of our common stock that will prevail in the market after this offering may be higher or lower than the price that you have paid, depending on many factors, some of which are beyond our
control and may not be related to our operating performance. Stock market volatility may also adversely affect the trading price of our common stock. In the past, following periods of volatility in the market price of a company&#8217;s securities,
stockholders have often instituted class action securities litigation against those companies. Such litigation, if instituted, could result in substantial costs and diversion of management attention and resources, which could significantly harm our
profitability and reputation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Future sales of shares of the common stock by existing stockholders may depress its stock price.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with the closing of the business combination (&#8220;Business Combination&#8221;) by and among Roth
CH Acquisition I Co., a Delaware corporation (&#8220;ROCH&#8221;), Roth CH Acquisition I Co. Parent Corp., a Delaware corporation and wholly-owned direct subsidiary of ROCH (&#8220;ParentCo&#8221;), Roth CH Merger Sub LLC, a Delaware limited
liability company and wholly-owned direct subsidiary of Parent Co, Roth CH Merger Sub Corp., a Delaware corporation and wholly-owned direct subsidiary of ParentCo and PureCycle Technologies LLC, a Delaware limited liability company and indirect
wholly-owned subsidiary of PCT (&#8220;PCT LLC&#8221;), holders of the Class&nbsp;A Units, Class&nbsp;B preferred Units, <FONT STYLE="white-space:nowrap">Class&nbsp;B-1</FONT> preferred Units and Class&nbsp;C Units of PCT LLC (collectively, the
&#8220;PCT Unitholders&#8221;) representing at least 70% of PCT LLC&#8217;s outstanding membership interests entered into the Investor Rights Agreement, whereby such PCT Unitholders agreed, with certain limited exceptions, to lock up the shares of
the common stock they received in the Business Combination (the &#8220;IRA <FONT STYLE="white-space:nowrap">Lock-up&#8221;).</FONT> On March&nbsp;17, 2026, the IRA <FONT STYLE="white-space:nowrap">Lock-up</FONT> expired pursuant to its terms, and
the PCT Unitholders are able to sell the final 33.33% of such PCT Unitholder&#8217;s shares of the common stock (or 50% of such PCT Unitholder&#8217;s shares of the common stock with respect to certain affiliates of PCT LLC at the time of the
Business Combination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Following the expiration of the IRA <FONT STYLE="white-space:nowrap">Lock-up,</FONT> the PCT
Unitholders are no longer restricted from selling their shares of the common stock, other than by applicable securities laws. The timing or volume of sales or possible sales of these shares could have the effect of increasing the volatility in
PCT&#8217;s share price or the market price of the shares of common stock could decline if a large amount of the shares of common stock are sold by the PCT Unitholders or if a large amount of the PCT Unitholders are perceived by the market as
intending to sell the shares of common stock held by them. These sales, or the possibility that these sales could occur, may make it more difficult for the Company or its stockholders to sell equity securities in the future at a time and at a price
that the Company or its stockholders deem appropriate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>PCT&#8217;s revenues, results of operations and cash utilization may
fluctuate significantly from period to period. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As PCT advances its commercial operations, its revenues, results of
operations and/or cash utilization may be subject to significant quarterly fluctuations. This variability can result from a number of factors that are difficult to predict and that are in many cases outside of PCT&#8217;s control, including:
customer qualification and sales cycle timing; order and shipment timing, which may be impacted by production schedules, logistics constraints, and customer-specific arrangements; production and operation constraints, due to mechanical challenges or
otherwise; and fixed cost structure relative to variable revenues. As a consequence of these factors, PCT&#8217;s revenues, operating results, and cash flows may vary materially from quarter to quarter. Such variability could make it difficult for
PCT to accurately forecast its revenues, meet financial obligations as they become due, and maintain compliance with financial covenants under its debt agreements, and could adversely affect PCT&#8217;s business, financial condition, results of
operations and prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, as PCT continues to ramp production at its first commercial-scale recycling
facility in Lawrence County, Ohio (the &#8220;Ironton Facility&#8221;) and expand commercial shipments to customers over the coming periods, PCT operating results and cash utilization could differ materially from analysts&#8217; and/or
investors&#8217; expectations. The Company believes the trading market for the common stock may be influenced by the research and reports that industry or securities analysts publish about PCT. If one or more of the analysts who cover PCT downgrade
the common stock or publish unfavorable research, or if PCT operating results or cash utilization do not meet their or investors&#8217; expectations, PCT&#8217;s stock price could decline. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Risks Related to PCT&#8217;s Status as a
<FONT STYLE="white-space:nowrap">Low-Revenue</FONT> Early Commercial-Stage Company </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>PCT is a
<FONT STYLE="white-space:nowrap">low-revenue</FONT> early commercial-stage company that has incurred operating losses since inception, and expects to continue to incur operating losses and PCT may never achieve or sustain operating profitability,
which depends on the successful commercialization and <FONT STYLE="white-space:nowrap">scale-up</FONT> of PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin products, and any other products PCT may develop in the future, to
scale in the U.S., Europe, Asia and other territories. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT has incurred operating losses since inception, and
expects to continue to incur operating losses as it continues to commercialize and scale up its PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin products. PCT relies principally on the commercialization of its PureFive<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin, and any other products PCT may develop in the future, to generate revenue growth. This includes establishing sales, marketing and distribution capabilities to effectively market and sell
PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin products in the U.S., Europe, Asia, and in other territories; expanding the number of Purification plants and Feed PreP facilities; and maintaining and growing relationships
with offtake partners, feedstock suppliers, customers, and other strategic partners. Achieving these objectives also requires procuring and maintaining all required regulatory approvals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Market uncertainties, particularly related to demand for PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>
resin, and any other products PCT may develop in the future, pricing dynamics and feedstock costs, make it difficult to predict the timing or amount of increased expenses or the timing, if ever, of achieving profitability. If demand for PureFive<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin products does not grow as anticipated, or if PCT cannot secure sufficient feedstock, offtake commitments or favorable pricing, revenue levels may not increase as expected. Even if adoption
improves, adverse market conditions, cost pressures or execution risks may prevent PCT from generating sufficient revenue to achieve or sustain profitability. PCT currently has no other material lines of business or sources of revenue beyond
PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin products, and this lack of diversification may limit its ability to adapt to changing business conditions and could adversely affect its business, financial condition, results
of operations and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>PCT&#8217;s operations are substantially dependent on intellectual property licensed from P&amp;G
under the License Agreement, and any termination, conversion or impairment of such license could have a material adverse effect on PCT&#8217;s business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT&#8217;s operations are substantially dependent on the continued validity and enforceability of the intellectual property
licensed from P&amp;G under the License Agreement. Pursuant to the License Agreement, P&amp;G has granted PCT a license to utilize certain P&amp;G intellectual property. The License Agreement sets forth certain construction and sales deadlines for
future facilities outside North America, which, if missed, could result in (i)&nbsp;a termination of the license granted under the License Agreement (if PCT is unable to make PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin
at certain production volumes and at certain prices within a certain time frame) or (ii)&nbsp;conversion of the license to a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license (if PCT is unable or unwilling to provide P&amp;G with
PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin at certain prices from the first plant). In the event the License Agreement is terminated or converted to a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license, this
could have a material adverse effect on PCT&#8217;s business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the P&amp;G license is converted to a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license following a failure to
comply with the terms of the License Agreement, PCT could face competition in the future from new market entrants or existing competitors expanding their business. If the License Agreement is terminated, PCT would not have the right to utilize the
P&amp;G intellectual property that underpins the Technology, and the production of PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin, and PCT&#8217;s business, would not be viable unless PCT is able to develop an alternative
technology. PCT has limited ability to control the prosecution, maintenance or enforcement of the underlying P&amp;G intellectual property, and P&amp;G may make decisions regarding such intellectual property that are adverse to PCT&#8217;s
interests. Any improvements to the licensed technology developed by PCT may be subject to ownership or licensing provisions that limit PCT&#8217;s ability to exploit such improvements independently. In addition, PCT&#8217;s compliance with the terms
of the License Agreement, including sublicensing limitations, quality standards and reporting obligations, is an ongoing obligation, and any breach, whether actual or alleged, could give rise to a termination right or other remedies in favor of
P&amp;G. PCT&#8217;s dependence on third-party-owned technology means that any challenge to, or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
invalidation of, the underlying P&amp;G intellectual property could materially impair PCT&#8217;s competitive position and its ability to operate its business, and could have a material adverse
effect on PCT&#8217;s business, financial condition, results of operations and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>PCT&#8217;s substantial indebtedness,
restrictive covenants, and potential inability to obtain additional financing could materially and adversely affect its business, financial condition, results of operations and prospects. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of March&nbsp;31, 2026, PCT had total consolidated indebtedness of $403.8&nbsp;million, including bonds payable to related
parties and does not yet have any sources of material recurring revenue. PCT&#8217;s existing and future debt service obligations, together with restrictions in its financing arrangements and the uncertainty of access to additional capital, could
have important consequences for the foreseeable future. A significant portion of cash flow from operating activities, if and when generated, will be required to service debt, which will reduce funds available for operations, capital expenditures,
strategic initiatives, and other corporate purposes. PCT&#8217;s leverage may exceed that of some competitors, potentially placing it at a competitive disadvantage and increasing its vulnerability to market conditions, operational challenges, and
changes in law or regulations. In addition, PCT&#8217;s ability to obtain additional financing for capital expenditures, and other needs may be impaired by its existing debt and related covenants, as well as by general market conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT&#8217;s debt agreements, including the Loan Agreement (as defined below), and certain other agreements to which PCT is a
party, contain operating, financial covenants and other restrictions that, among other things, limit PCT and its subsidiaries&#8217; ability to incur additional debt, certain liens or other encumbrances, sell assets, transfer ownership interests,
pay dividends, and enter into transactions with affiliates. These limitations could restrict activities that may be in PCT&#8217;s long-term interests and reduce its financial and operational flexibility. PCT has in the past obtained waivers or
amendments for <FONT STYLE="white-space:nowrap">non-compliance</FONT> with financial covenants; however, a failure to comply with covenants or obtain a waiver in the future could result in an event of default under one or more agreements, permitting
lenders to accelerate maturity, foreclose on collateral securing the debt, terminate commitments, or exercise other remedies. Cross-default provisions could compound these effects, and PCT might not have sufficient funds or resources to satisfy its
obligations or to refinance or restructure such indebtedness on favorable terms or at all. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Additionally, PCT&#8217;s
estimate of its operating expenses and capital expenditures requirements is based on assumptions that may prove to be wrong, and PCT could use its available capital resources sooner than it currently expects. Changing circumstances, some of which
may be beyond PCT&#8217;s control, could cause PCT to consume capital significantly faster than it currently anticipates, and PCT may need to seek additional funds sooner than planned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Until PCT can generate significant revenue from sales of its products, PCT will require additional financing to fund its
operations and growth. There can be no assurance that additional capital will be available when needed, on acceptable terms or at all. Any such financing, if available, may involve the issuance of equity or equity-linked securities that are dilutive
to existing stockholders, securities with preferences that are senior to the common stock, or additional indebtedness that imposes restrictive covenants, collateral requirements, or repayment obligations, each of which could further constrain
PCT&#8217;s operations and liquidity. PCT may also seek capital opportunistically due to favorable market conditions or strategic considerations even if it believes existing resources are adequate. If PCT cannot obtain financing when required or on
reasonable terms, it may be unable to execute its business strategy, meet obligations as they come due, or maintain compliance with financial covenants, any of which would adversely affect its business, financial condition, results of operations and
prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>PCT faces risks and uncertainties related to litigation, regulatory actions and investigations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">From time to time, PCT has and may continue to be involved in legal proceedings and investigations arising in the ordinary
course of business, including those relating to employment matters, product liability, relationships </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
with our feedstock suppliers and offtake partners as well as strategic partners, intellectual property disputes, additional volatility in the market price of our securities and other business
matters. Any such claims or investigations may be time-consuming, costly, divert management resources, or otherwise have a material adverse effect on PCT&#8217;s business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The results of litigation and other legal proceedings are inherently uncertain and adverse judgments or settlements may result
in materially adverse monetary damages or injunctive relief against PCT. Any claims or litigation, even if fully indemnified or insured, could damage PCT&#8217;s reputation and make it more difficult to compete effectively or obtain adequate
insurance in the future. The litigation and other legal and regulatory proceedings described in the notes to PCT&#8217;s audited consolidated financial statements included in its Annual Report are subject to future developments and
management&#8217;s view of these matters may change in the future. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Risks Related to PCT&#8217;s Operations </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>If PCT is unable to consistently execute capital investment projects to cost and schedule, and to achieve and sustain targeted
production volumes, yields, uptime, quality and economics at the Ironton Facility, the Company&#8217;s economic viability and ability to raise capital could be materially and adversely impacted, and construction of one or more additional PreP and
Purification facilities may be delayed or abandoned. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Ironton Facility is the foundation of PCT&#8217;s
commercial strategy. Failure to increase production rates that approach the plant&#8217;s full capacity and can meet expected current and future customer demand, as well as maintain sufficient uptime, product quality specifications and unit
economics at the Ironton Facility could undermine investor confidence and PCT&#8217;s ability to attract future capital, customers and strategic partners as it continues development of the other Planned Facilities. Operational challenges at the
Ironton Facility have included, but are not limited to: (i)&nbsp;filter fouling, including the accumulation of contaminants on filtration systems that can reduce throughput, increase maintenance requirements and cause unplanned downtime; <FONT
STYLE="white-space:nowrap">(ii)&nbsp;co-product</FONT> handling, including the potential monetization of <FONT STYLE="white-space:nowrap">non-polypropylene</FONT> materials and process residues; (iii)&nbsp;odor and color specification compliance,
which are among the most difficult quality parameters to achieve consistently at commercial scale; and (iv)&nbsp;maintenance downtime, including both planned and unplanned outages that reduce effective operating hours and output. Any one or more of
these operational challenges or failures, individually or in combination, could prevent PCT from achieving or sustaining the production volumes, yields, uptime, quality or economics required to demonstrate commercial viability, satisfy offtake
commitments and support the construction and financing of future Planned Facilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Additionally, the construction and
commissioning of any new project, including PreP and Purification facilities, is dependent on a number of contingencies, many of which are beyond PCT&#8217;s control. There is also a risk that significant unanticipated costs or delays could arise
due to, among other things, errors or omissions, unanticipated or concealed construction site conditions, including subsurface conditions, unforeseen technical issues or increases in plant and equipment costs, delays in delivery of certain long-lead
items, insufficiency of water supply and other utility infrastructure, inadequate contractual arrangements or unanticipated or unforeseen regulatory requirements, engineering, procurement, and construction contract delays or defaults, cost overruns
arising from changes in scope, labor or materials pricing, permitting delays or denials, and the inability to replicate at future facilities the operational learnings and process improvements achieved at the Ironton Facility. Should significant
unanticipated costs arise, this could have a material adverse impact on PCT&#8217;s business, financial performance, cash utilization and operations. No assurance can be given that construction will commence or be completed, or will be completed
without further delay. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Delays in commissioning and obtaining an independent engineer&#8217;s certificate of operational performance
at the Ironton Facility or any new project could severely impact PCT&#8217;s business, financial condition, results of operations and prospects. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT may not be able to achieve full commissioning and the certification of operational performance required by an independent
engineer of the Ironton Facility due to a variety of factors including, but not limited </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
to, the rates at which other plastics and additives can currently be removed from the Purification process, as well as challenges with sustaining continuous operations at full capacity over a
number of consecutive days. Failure to achieve full commissioning, obtain the certification or sustain continuous operations at the Ironton Facility could severely impact PCT&#8217;s business, financial condition, results of operations and
prospects, and impact PCT&#8217;s ability to comply with certain covenants under its debt agreements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>PCT currently relies on a
single facility for all of its operations, and its business is not diversified. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT currently relies solely on the
operations at the Ironton Facility, and there is no guarantee that the Planned Facilities will be constructed on the expected timeline, or at all. Adverse changes or developments affecting the Ironton Facility could impair PCT&#8217;s ability to
produce PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin and impact its business, prospects, financial condition and results of operations. Any shutdown or period of reduced production at the Ironton Facility, which may be
caused by regulatory noncompliance or other issues, as well as other factors beyond its control, such as severe weather conditions, natural disaster, fire, power interruption or outages, work stoppage, disease outbreaks or pandemics, equipment
failure, delay in supply delivery, or shortages of material, equipment, or labor, has in the past, and would in the future, significantly disrupt PCT&#8217;s ability to grow and produce
PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin products in a timely manner, or at all, meet its contractual obligations and operate its business. PCT has historically experienced periodic equipment failures, some of which
have caused extended interruptions to plant operations, and other interruptions or plant shutdowns could occur in the future. Some of PCT&#8217;s equipment is costly to repair, and PCT&#8217;s equipment supply chains may be disrupted in connection
with pandemics, trade wars or other factors. If any material amount of PCT&#8217;s machinery were damaged, it would be unable to predict when, if at all, it could replace or repair such machinery or find
<FONT STYLE="white-space:nowrap">co-manufacturers</FONT> with suitable alternative machinery, which could adversely affect PCT&#8217;s business, financial condition, results of operations and prospects. Performance guarantees may not be sufficient
to cover damages or losses, or the guarantors under such guarantees may not have the ability to pay. Any insurance coverage PCT has may not be sufficient to cover all of its potential losses and may not continue to be available to PCT on acceptable
terms, or at all. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">There are also currently no other lines of business or other material sources of revenue to support the
Company&#8217;s future. Such lack of diversification may limit PCT&#8217;s ability to adapt to changing business conditions and could have an adverse effect on PCT&#8217;s business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Cybersecurity incidents and the failure to maintain the integrity of PCT&#8217;s systems or infrastructure, or those of third parties
with which PCT does business, could have a material adverse effect on PCT&#8217;s business, financial condition, results of operations and prospects. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT is subject to an increasing number of information technology vulnerabilities, threats and targeted computer crimes that
pose a risk to the security of its systems and networks and the confidentiality, availability and integrity of data. Disruptions or failures in the physical infrastructure or operating systems that support PCT&#8217;s businesses, offtake partners,
feedstock suppliers and customers, or cyber-attacks or security breaches of PCT&#8217;s networks or systems or of third party suppliers and service providers, could result in the loss of customers and business opportunities, lawsuits, regulatory
fines, penalties or intervention, reputational damage, loss of stakeholder confidence, reimbursement or other compensatory costs, and additional compliance costs, any of which could materially adversely affect PCT&#8217;s business, financial
condition, results of operations and prospects. In addition, recently enhanced cybersecurity disclosure requirements increase the risk of regulatory scrutiny enforcement actions and securities litigation in the wake of a material cyber incident.
Emerging artificial intelligence (&#8220;AI&#8221;) technologies may intensify these cybersecurity risks and introduce new governance and compliance obligations under evolving <FONT STYLE="white-space:nowrap">AI-related</FONT> laws and guidance in
the U.S. and abroad. In addition, PCT relies on third party <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">software-as-a</FONT></FONT> service and cloud providers for critical business functions, and any disruptions,
misconfiguration or breach in these services could materially impact the Company&#8217;s business. Increasing costs associated with cybersecurity protections may be costly and may also adversely affect the financial condition of PCT. While PCT
attempts to mitigate these risks, PCT&#8217;s systems, data, networks, products, solutions and services remain potentially vulnerable to advanced and persistent cybersecurity threats. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT also maintains and has access to sensitive, confidential or personal
data or information in its business that is subject to privacy and security laws, regulations and customer controls. Despite PCT&#8217;s efforts to protect such personal data or information, PCT&#8217;s facilities and systems and those of its
customers, offtake partners, feedstock suppliers and third-party service providers may be vulnerable to cybersecurity incidents, theft, misplaced or loss of data, insider threats, supply chain risks, natural disasters,
<FONT STYLE="white-space:nowrap">zero-day</FONT> vulnerabilities, programming and/or human errors that could lead to the compromise of sensitive, confidential or personal data or information or unauthorized use or disruption of PCT&#8217;s systems
and software. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>PCT may be unable to sufficiently protect its proprietary rights and may encounter disputes from time to time
relating to its use of the intellectual property of third parties. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT relies on its proprietary intellectual
property, including registered trademarks and certain licensed intellectual property under the License Agreement and other documents to market, promote and sell PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin products. PCT
monitors and protects against activities that might infringe, dilute, or otherwise harm its trademarks and other intellectual property and relies on the relevant patent, trademark and other laws of the U.S. and other countries. However, PCT may be
unable to prevent third parties from using its intellectual property without authorization. In addition, the laws of some <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions, particularly those of certain emerging markets, provide less
protection for PCT&#8217;s proprietary rights than the laws of the U.S. and present greater risks of counterfeiting and other infringement. To the extent PCT cannot protect its intellectual property, unauthorized use and misuse of PCT&#8217;s
intellectual property could harm its competitive position and have a material adverse effect on PCT&#8217;s business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Despite PCT&#8217;s efforts to protect these rights, unauthorized third parties may attempt to duplicate or copy the
proprietary aspects of its technology and processes. PCT&#8217;s competitors and other third parties independently may design around or develop similar technology or otherwise duplicate PCT&#8217;s services or products such that PCT could not assert
its intellectual property rights against them. In addition, PCT&#8217;s contractual arrangements may not effectively prevent disclosure of its intellectual property and confidential and proprietary information or provide an adequate remedy in the
event of an unauthorized disclosure. Measures in place may not prevent misappropriation or infringement of PCT&#8217;s intellectual property or proprietary information and the resulting loss of competitive advantage, and PCT may be required to
litigate to protect its intellectual property and proprietary information from misappropriation or infringement by others, which is time consuming, expensive, could cause a diversion of resources and may not be successful. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT also may encounter disputes from time to time concerning intellectual property rights of others, and it may not prevail in
these disputes. Third parties may raise claims against PCT alleging that PCT, or consultants or other third parties retained or indemnified by PCT, infringe on their intellectual property rights. Some third-party intellectual property rights may be
extremely broad, and it may not be possible for PCT to conduct its operations in such a way as to avoid all alleged violations of such intellectual property rights. Given the complex, rapidly changing and competitive technological and business
environment in which PCT operates, and the potential risks and uncertainties of intellectual property-related litigation, an assertion of an infringement claim against PCT may cause PCT to spend significant amounts to defend the claim, even if PCT
ultimately prevails, pay significant money damages, lose significant revenues, be prohibited from using the relevant systems, processes, technologies or other intellectual property (temporarily or permanently), cease offering certain products or
services, or incur significant license, royalty or technology development expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Moreover, it has become common in
recent years for individuals and groups to purchase intellectual property assets for the sole purpose of making claims of infringement and attempting to extract settlements from companies such as PCT. Even in instances where PCT believes that claims
and allegations of intellectual property infringement against it are without merit, defending against such claims is time consuming and expensive and could result in the diversion of time and attention of PCT&#8217;s management and employees. In
addition, although in some cases a third party may have agreed to indemnify PCT for such costs, such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
indemnifying party may refuse or be unable to uphold its contractual obligations. In other cases, insurance may not cover potential claims of this type adequately or at all, and PCT may be
required to pay monetary damages, which may be significant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Climate change, or legal, regulatory or market measures to address
climate change may materially adversely affect the Company&#8217;s financial condition and business operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Climate change resulting from increased concentrations of carbon dioxide and other greenhouse gases in the atmosphere could
present risks to PCT&#8217;s future operations from natural disasters and extreme weather conditions, such as hurricanes, tornadoes, wildfires or flooding. Such extreme weather conditions could pose physical risks to PCT&#8217;s facilities and
disrupt operation of PCT&#8217;s supply chain and may impact operational costs. The impacts of climate change on global resources may result in scarcity, which could in the future impact PCT&#8217;s ability to access sufficient equipment and
materials in certain locations and result in increased costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Additionally, concern over climate change could result in
new legal or regulatory requirements designed to mitigate the effects of climate change on the environment. If such laws or regulations are more stringent than current legal or regulatory requirements, PCT may experience increased compliance burdens
and costs to meet the regulatory obligations and may adversely affect raw material sourcing, manufacturing operations and the distribution of PCT&#8217;s products. Likewise, a failure to comply with any current or future sustainability-related
reporting requirements, as established by regulators in the U.S., Europe, and beyond, may result in loss of business, regulatory penalties, litigation, and/or reputational damage. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>PCT may be negatively impacted by volatility in the political and economic environment, which could have an adverse impact on
PCT&#8217;s business, financial condition, results of operations and prospects. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Trade, monetary and fiscal
policies, and political and economic conditions may substantially change, and credit markets may experience periods of constriction and variability. These conditions may impact PCT&#8217;s business. Further, rising or prolonged high inflation may
negatively impact PCT&#8217;s business and raise its costs, specifically with respect to the construction of the Planned Facilities and other future Purification and Feed PreP facilities. In the case of sustained inflation, it could become
increasingly difficult to effectively mitigate the increases to PCT&#8217;s costs. If PCT is unable to take actions to effectively mitigate the effect of the resulting higher costs, PCT&#8217;s business, financial condition, results of operations
and prospects could be adversely impacted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Although the Federal Reserve began to reduce interest rates in late 2024
through 2025, they continue to remain higher than <FONT STYLE="white-space:nowrap">pre-pandemic</FONT> levels. The Federal Reserve may continue to hold them at their currently high rates longer than expected. Higher interest rates, coupled with
reduced government spending and volatility in financial markets, may increase economic uncertainty and affect PCT&#8217;s offtake partners, feedstock suppliers and potential customers. Similarly, the ongoing military conflict between Russia and
Ukraine and the current instability in the Middle East has created volatility in various markets and could have further global economic consequences, including disruptions of the global supply chain, increased costs and energy markets. Furthermore,
actual events involving limited liquidity, defaults, <FONT STYLE="white-space:nowrap">non-performance</FONT> or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services
industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity concerns. Any such volatility, disruptions or
market-wide liquidity concerns may adversely affect PCT&#8217;s business or the third parties on whom it relies. If the equity and credit markets deteriorate, including as a result of political or economic unrest or war, it may make necessary debt
or equity financing, such as the financing necessary to fully fund the construction of the Planned Facilities, future Purification facilities and currently contemplated and future Feed PreP facilities and otherwise finance PCT&#8217;s expansion,
more difficult to obtain in a timely manner or on favorable terms, more costly or more dilutive. Increased or sustained inflation can adversely affect PCT by increasing its costs, including labor and employee benefit costs. In addition, higher or
sustained inflation, macro turmoil, uncertainty and market-wide </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
liquidity concerns could also adversely affect PCT&#8217;s offtake partners, feedstock suppliers and potential customers, which could have an adverse impact on PCT&#8217;s business, financial
condition, results of operations and prospects. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Risks Related to PCT&#8217;s Production of PureFive<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Resin </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>There is no guarantee the Technology is scalable to
commercial-scale profitability. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Technology is based upon generally-available commercial equipment to process
contaminated polypropylene into clean recycled polypropylene product. While PCT has constructed the Feedstock Evaluation Unit (the &#8220;FEU&#8221;) to demonstrate the process using the same or similar equipment (except at a smaller scale) as the
Ironton Facility, and, for the most part, the Planned Facilities, the FEU does not operate at a commercial scale. The FEU test data was used to design the Ironton Facility equipment for commercial scale and testing under the intended operating
conditions and configuration for the commercial-scale operation to verify reproducibility of results including color, melt flow index, moldability (tensile modulus and other measures) and the odor of the final
<FONT STYLE="white-space:nowrap">PCT-produced</FONT> polypropylene product. While that testing indicated that the FEU can generate recycled polypropylene product that, on average, meets all of its key parameter targets, PCT cannot guarantee these
results will be achieved if or when the Ironton Facility, or any of the Planned Facilities, are operating at full capacity. PCT&#8217;s ability to achieve commercial-scale profitability relies on its ability to commercially scale its operations.
Further, of the four quality parameters for PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin, odor is the most difficult to characterize and measure. PCT&#8217;s goal is to generate product that will significantly reduce the
odor of the offtake and be comparable or nearly comparable to virgin polypropylene with respect to level of odor, but PCT cannot guarantee that the Ironton Facility, or any of the Planned Facilities, will be capable of achieving the quality
parameters of PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin on a consistent basis to achieve profitability on a commercial scale. The Ironton Facility&#8217;s, or any of the Planned Facilities&#8217;, failure to
consistently achieve the quality parameters for PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin at higher rates could impact PCT&#8217;s business, financial condition, results of operations and prospects if the possible
shortfalls versus specification are not effectively remedied per contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Furthermore, each of the Thailand Facility and
PCT&#8217;s first commercial-scale European plant at its Antwerp, Belgium site (the &#8220;Belgium Facility&#8221;) are expected to be larger 130 million-pound per year Purification facilities and the Purification facility to be built in Augusta,
Georgia (the &#8220;Augusta Facility&#8221; and together with the Thailand Facility and the Belgium Facility, the &#8220;Planned Facilities&#8221;) is planned to be PCT&#8217;s first <FONT STYLE="white-space:nowrap">scaled-up</FONT> facility model,
with an expected capacity of 300&nbsp;million pounds per year. PCT is currently working on engineering for the Thailand Facility and Belgium Facility, and <FONT STYLE="white-space:nowrap">pre-engineering</FONT> for the design and installation of the
<FONT STYLE="white-space:nowrap">scaled-up</FONT> Purification facility at the Augusta Facility, and there is no guarantee that these efforts will be successful. If the Thailand Facility and Belgium Facility are not completed and operational, and
the Augusta Facility fails to achieve the expected efficiencies, including across the construction and permitting processes, as well as fails to reduce average capital expenditures per plant and reduce overall operating costs, PCT&#8217;s business,
financial condition, results of operations and prospects could be materially adversely impacted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>PCT may not be successful in
consummating strategic endeavors for the sale of PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin products. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT may not be successful in efforts to establish or consummate strategic endeavors, or other alternative arrangements for the
sale of PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin products because PCT&#8217;s products may be deemed to be at too early of a stage of development for collaborative effort or third parties may not view PCT&#8217;s
product as having the requisite potential to demonstrate commercial success. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If PCT is unable to reach agreements with
existing or future customers on a timely basis, on acceptable terms or at all, PCT may have to curtail the development of PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin products, reduce or delay the development program,
delay potential commercialization, reduce the scope of any sales or marketing activities or increase expenditures and undertake development or commercialization activities at PCT&#8217;s own expense. If PCT
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
elects to fund development or commercialization activities on its own, PCT may need to obtain additional expertise and additional capital, which may not be available on acceptable terms or at
all. If PCT fails to enter into collaborations and does not have sufficient funds or expertise to undertake the necessary development and commercialization activities, PCT may not be able to further develop product candidates and PCT&#8217;s
business, financial condition, results of operations and prospects may be materially and adversely affected. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>PCT&#8217;s failure to
secure sufficient quantities of waste polypropylene could have a negative impact on PCT&#8217;s business, financial condition, results of operations and prospects. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT&#8217;s ability to procure a sufficient quantity and quality of post-industrial and post-consumer waste that contains high
levels of polypropylene as feedstock is dependent upon certain factors outside of PCT&#8217;s control, including, but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes to pricing levels for waste polypropylene, recycled polypropylene and
<FONT STYLE="white-space:nowrap">non-recycled</FONT> polypropylene; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">shortages in supply or reductions in available volumes due to seasonal, regional or market-driven factors;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">logistics and transportation constraints, including the cost and availability of transportation infrastructure
necessary to move feedstock from collection points to PCT&#8217;s facilities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">competition from other buyers of waste polypropylene, including mechanical recyclers, other advanced recyclers
and virgin resin producers seeking to meet recycled-content commitments, which may reduce the volume available to PCT or increase procurement costs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regional availability and collection infrastructure limitations, particularly in Asia where post-consumer
polypropylene collection rates are low or collection infrastructure is underdeveloped; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interruptions affecting suppliers, including those due to operational restraints, industrial relations,
transportation difficulties, accidents or natural disasters; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the introduction of new laws or regulations that may make access to waste polypropylene more difficult or
expensive. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Additionally, while PCT believes it has sourced sufficient feedstock of desirable quality
and with high levels of polypropylene, and that it has the ability to increase polypropylene content at its <FONT STYLE="white-space:nowrap">pre-processing</FONT> facilities, it cannot guarantee that feedstock suppliers will have sufficient
quantities available and at the appropriate specifications in accordance with their respective agreements with PCT. If feedstock is not available to PCT in sufficient quantity and of requisite quality and with high levels of polypropylene,
PCT&#8217;s business, financial condition, results of operations and prospects could be materially adversely impacted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Because
PCT&#8217;s global expansion requires sourcing feedstock and supplies and shipping product around the world (including Asia and Europe), changes to international trade agreements, tariffs, import and excise duties, taxes or other governmental rules
and regulations could adversely affect PCT&#8217;s business, financial condition, results of operations and prospects. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT&#8217;s global expansion model, which includes the construction of the Planned Facilities, will require sourcing additional
feedstock in the U.S. and from suppliers around the world. The U.S. federal government, the Belgian government, the Thai government and other governmental bodies may propose changes to international trade agreements, tariffs, taxes and other
government rules and regulations that would affect PCT&#8217;s global expansion model. For example, the U.S. government has imposed and expanded tariffs and other trade measures on certain foreign imports into the U.S., particularly from China,
Canada, and Mexico. If any restrictions or significant increases in costs or tariffs are imposed related to feedstock sourced from Asia, Europe, or elsewhere, as a result of amendments to existing trade agreements, and PCT&#8217;s supply costs
consequently increase, PCT may </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
be required to raise PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin product prices, which may result in decreased margins, the loss of customers, and a material adverse
effect on PCT&#8217;s financial results. The extent to which PCT&#8217;s margins could decrease in response to any future tariffs is uncertain. PCT continues to evaluate the impact of effective trade agreements, as well as other recent changes in
foreign trade policy on its supply chain, costs, sales and profitability, which could negatively impact PCT&#8217;s business, financial condition, results of operations and prospects. Any such impact could be material. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>There is no guarantee the Feed PreP facilities will be viable or achieve the expected efficiencies. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In conjunction with future Purification facilities, PCT expects to build and operate Feed PreP facilities in locations
geographically near the feed sources in an effort to optimize PCT&#8217;s supply chain economics. These Feed PreP facilities are expected to employ feedstock processing systems with advanced sorting capabilities that can handle various types of
plastics in addition to polypropylene (designated as no. 5 plastic), such as plastic bales between #1 and #7. There is no guarantee that the Feed PreP facilities will be successful. If the feedstock processing systems don&#8217;t operate as
expected, or in a commercially viable manner or are constrained from receiving permits necessary to operate the facilities by city, country or state regulations; the Feed PreP facilities fail to achieve the expected efficiencies, including due to
increased shipping costs; as well as fail to reduce average expenditures on feedstock and reduce overall operating costs, PCT&#8217;s business, financial condition, results of operations, and prospects could be materially adversely impacted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>There is no guarantee the &#8220;Feedstock+&#8221; pricing model will be successful or adopted broadly across PCT&#8217;s offtake
agreements. For those agreements where selling prices remain linked to virgin polypropylene price indices, PCT&#8217;s feedstock, PreP, energy, logistics and plant costs may not move commensurately, which may result in margin compression or
elimination in low oil price environments. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT&#8217;s Feedstock+ pricing model for offtake agreements uses a
formula based on: (i)&nbsp;a secondary materials per pound pricing index for curbside bales divided by a fixed polypropylene yield loss modifier, plus (ii)&nbsp;a fixed base price per pound covering PCT&#8217;s operating and conversion costs. The
Feedstock+ pricing model is designed to mitigate the impact on PCT&#8217;s operating margins by incorporating the feedstock market price fluctuations, upside and downside, into the PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>
price. There is no guarantee that the Feedstock+ pricing model will be successful and that most of or all of the counterparties will enter into offtake agreements with PCT using this pricing model in sufficient numbers, or at all. Additionally,
counterparties may attempt to reduce or eliminate the fixed base price, which would reduce and potentially eliminate the effort to <FONT STYLE="white-space:nowrap">de-risk</FONT> PCT&#8217;s operating margins. If PCT is unable to incorporate its
Feedstock+ pricing model into its future offtake agreements, in part or at all, or unable to negotiate a sufficiently high fixed base price or procure feedstock above the secondary materials markets pricing index, PCT&#8217;s business, financial
condition, and results of operations and prospects could be materially adversely impacted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT&#8217;s legacy strategic
partnership agreements and certain offtake arrangements use pricing formulas that reference the price of virgin polypropylene resin, which is itself correlated to the price of crude oil and natural gas feedstocks. In periods of low or declining
crude oil prices, the price of virgin polypropylene may fall significantly, which would reduce the index-linked selling price of PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin under such agreements. However, PCT&#8217;s
costs, including feedstock procurement costs, PreP operating costs, energy costs, logistics costs and fixed plant operating costs, may not decline commensurately with the price of virgin polypropylene, as these costs are driven by different market
dynamics. As a result, in low oil price environments, PCT may face a significant mismatch between its selling prices and its cost of production, which could compress or eliminate its operating margins, impair its ability to service its debt
obligations and have a material adverse effect on PCT&#8217;s business, financial condition, results of operations and prospects. Conversely, in high feedstock cost environments, PCT&#8217;s Feedstock+ pricing model is designed to pass through
feedstock cost increases to customers, but there is no guarantee that customers will accept such pass-throughs or that the model will function as intended across all market conditions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>PCT is subject to many hazards and operational risks at its manufacturing facility
that can result in potential injury to individuals, disrupt its business, and subject PCT to liability and increased costs, any of which could have a material adverse effect on PCT&#8217;s business, financial condition and results of operations.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT&#8217;s processes involve the controlled use of chemicals, including flammable and combustible solvents
operated under elevated pressures and temperatures that are potentially hazardous. As a result, PCT&#8217;s operations are subject to various industrial risks including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fires and explosions arising from the handling, storage or release of flammable solvents or other combustible
materials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">uncontrolled releases or discharges of solvents, or process gases, including emissions to air, discharges to
water and releases to soil; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">wastewater generation and disposal challenges, including the management of liquid waste streams; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">dangers resulting from confined operating spaces, equipment failures and maintenance activities.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">These risks can result in personal injury, loss of life, catastrophic damage to or destruction of
property and equipment or environmental damage, and related legal proceedings, including those commenced by regulators, neighbors, or others. Additionally, PCT may not be able to timely source and install replacement parts for damaged or broken
equipment, which could result in an unanticipated interruption or suspension of operations having both financial and customer supply impacts, along with reputational damage and the imposition of liability. Notwithstanding PCT&#8217;s extensive
safety procedures and training, relief and depressurization systems, emergency shutdown systems, safety instrumented systems and interlocks, fire and gas detection, and fire suppression systems, the risk of injury or property damage cannot be
completely eliminated. While PCT believes that it maintains adequate insurance coverage, PCT cannot guarantee that it will be able to maintain adequate insurance at reasonable rates or that its insurance coverage will be adequate to cover future
claims that may arise. In the event of an incident or accident, PCT&#8217;s business could be disrupted and PCT could be liable for damages, and any such liability could exceed PCT&#8217;s resources, and have a negative impact on its financial
condition and results of operations. The loss or shutdown over an extended period of operations at any of PCT&#8217;s facilities or any losses relating to these risks could also have a material adverse impact on its business, financial condition,
results of operations and prospects. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Risks Related to the Market for PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>
Resin </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The market for PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin is still in the development phase
and the acceptance of PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin by manufacturers and potential customers is not guaranteed. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT has agreed to one or more strategic partnership term sheets to enter into offtake agreements with a term of 20 years,
whereby PCT guarantees the PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin products to meet specific criteria for color and opacity. There is no odor specification in the offtake agreements. Any modifications to the
strategic partnership term sheets may require corresponding amendments to PCT&#8217;s executed offtake agreements for the Ironton Facility and the Planned Facilities. Pursuant to the strategic partnership term sheets and PCT&#8217;s executed offtake
agreements, PCT must provide samples of the product to each customer so that the customer may determine if the product meets specifications, regulatory and legal requirements, the customer&#8217;s internal policies, and technical, safety, and other
qualifications for PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin use in the customer&#8217;s products. The inability of PCT to provide product of sufficient quantity and quality for sale pursuant to the offtake agreements
is likely to materially adversely affect PCT&#8217;s business, financial condition, results of operations and prospects. The premium pricing depicted in recent offtake agreements may also adversely affect the acquisition of new customers.
Furthermore, future market trends for recycled product, changes in brand owner strategies and changes in consumer preferences for circular or low carbon footprint products could reduce PCT&#8217;s customers&#8217; demand for PureFive<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin, which would be likely to materially adversely affect PCT&#8217;s business, financial condition, results of operations and prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Certain of PCT&#8217;s offtake agreements are subject to index pricing, and
fluctuation in index prices may adversely impact PCT&#8217;s financial results. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT expects the price of its
PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin will command a premium over the price of virgin resin and generally not be subject to fluctuations in the price of virgin polypropylene, but there is no guarantee of this
result. While most offtake agreements have been executed using the Feedstock + pricing model, certain of PCT&#8217;s legacy strategic partnership agreements&#8217; pricing formulas for
PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin use a pricing formula based on fixed and index pricing using historical and forecast pricing for virgin resin produced from fossil fuels. If PCT is unable to modify the legacy
terms to a Feedstock+ pricing, or should the modeled index price for virgin resin be materially lower than the cost to produce PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin from waste polypropylene feedstock, PCT would
have to absorb the cost difference between virgin resin and PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin production for those customers, and PCT&#8217;s business, financial condition, liquidity, results of operations and
prospects may be materially adversely impacted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Competition could reduce demand for PCT&#8217;s products or negatively affect
PCT&#8217;s sales mix or price realization, and failure to compete effectively could materially and adversely affect PCT&#8217;s business, financial condition, results of operations and prospects. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT operates in a competitive global market for polypropylene sources&#8212;both virgin and recycled polypropylene. PCT faces,
or may in the future face, competition from: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">integrated petrochemical producers and resin manufacturers, which have significant scale, established customer
relationships, extensive distribution networks and substantial financial and technical resources, and which may develop or acquire recycled polypropylene capabilities or offer virgin polypropylene at prices that make PureFive<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin less economically attractive; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">mechanical recyclers of polypropylene, which offer lower-cost recycled polypropylene that, while of lower
quality than PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin, may be sufficient for certain limited applications and may be preferred by cost-sensitive customers or in jurisdictions where recycled-content requirements do not
mandate chemically recycled material; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other advanced recyclers utilizing chemical depolymerization, dissolution, pyrolysis or other technologies to
produce recycled polypropylene or polypropylene substitutes, some of which may benefit from greater financial, technical or operational resources than PCT and are otherwise acceptable uses under current or future regulations; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">customers&#8217; internal circularity platforms, whereby brand owners and manufacturers develop or invest in
their own recycled polypropylene supply chains, potentially reducing their reliance on third-party suppliers such as PCT. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Competitors or new entrants might develop new products or technologies that compete with PCT and its proprietary Technology.
PCT cannot predict changes that might affect its competitiveness or whether existing competitors or new entrants might develop products that reduce demand for PCT&#8217;s PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin
products. Any of these competitive developments could reduce demand for PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin, exert downward pressure on pricing, impair PCT&#8217;s ability to attract and retain customers, and
have a material adverse effect on PCT&#8217;s business, financial condition, results of operations and prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In
addition, PCT has granted a sublicense of P&amp;G intellectual property back to P&amp;G under the terms of the License Agreement, with a limited right to sublicense by P&amp;G (the &#8220;Grant Back&#8221;). Under the Grant Back, for five years
after July&nbsp;28, 2020, the aggregate tonnage that was produced under the Grant Back was capped at a certain level per year worldwide. Since July&nbsp;28, 2025, the aggregate annual tonnage was expanded for each of the six regions worldwide.
P&amp;G has agreed that territory under the Grant Back excluded the start of construction of a plant within a certain radius of the Ironton Facility until July&nbsp;28, 2025, and that P&amp;G will not be bound by the tonnage limitations if certain
construction and sales deadlines are not met for future facilities in other regions. If P&amp;G is able to establish production, either on its own or through a sublicense agreement with another partner, in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
any territory, P&amp;G production will now be capped within that territory. If P&amp;G sublicenses the P&amp;G intellectual property under the Grant Back to other manufacturers, the aggregate
production of recycled polypropylene resin and supply to markets could increase, adversely impacting PCT&#8217;s business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Delays in direct customer commercial sales and customer qualification and application-conversion may adversely impact PCT&#8217;s
financial results. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition to sales through distributors, PCT&#8217;s current business model is reliant on
sales directly to companies that value sustainability. The process for obtaining customer acceptance of PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin as a substitute and/or replacement for traditional virgin or
mechanically recycled polypropylene, and the ability to sell into a customer&#8217;s supply chain, is typically dependent upon the successful trials from one or more samples of PCT&#8217;s
PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin. These trials could take an extended period of time, depending upon the application into which PCT&#8217;s PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>
resin will be used. The ability for PCT to fund its operations and service its debt requirements is highly dependent upon PCT&#8217;s ability to develop meaningful commercial sales directly to customers. The failure to obtain timely customer
approval and extended delays in customers&#8217; adoption of PCT&#8217;s PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin as a substitute for a customer&#8217;s existing polypropylene supplies may have a material adverse
effect on PCT&#8217;s business, financial condition, results of operations and prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Additionally, while PCT has
entered into offtake agreements and strategic partnerships with a number of brand owners and manufacturers, the realization of commercial sales volumes is dependent on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">customer-by-customer,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">application-by-application</FONT></FONT> qualification process that is distinct
from, and in addition to, the execution of an offtake agreement. Many customers independently evaluate and qualify PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin for use in each specific application, which typically
involves: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">laboratory and pilot-scale testing of PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin
against the customer&#8217;s internal material specifications; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory and compliance review, including assessment of applicable food-contact, product safety, chemical
substance and other regulatory requirements in the relevant jurisdiction; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">production trials and validation runs at the customer&#8217;s manufacturing facilities to confirm that
PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin performs as expected in the customer&#8217;s specific processing equipment and <FONT STYLE="white-space:nowrap">end-use</FONT> application. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This qualification process can be lengthy, resource-intensive and uncertain in outcome, and there is no guarantee that any
particular customer will successfully qualify PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin for any particular application, or that qualification for one application will result in qualification for other applications
within the same customer. Delays in, or failures to complete, customer qualification processes could result in offtake agreements generating little or no actual purchase volume, could delay PCT&#8217;s ability to generate meaningful commercial
revenues, and could have a material adverse effect on PCT&#8217;s business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Risks Related to Regulatory Developments </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>PCT may not be able to meet applicable regulatory requirements for the use of PCT&#8217;s PureFive<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin in food-grade applications, which are feedstock-specific, jurisdiction-specific and application-specific, and, even if the requirements are met, complying on an ongoing basis with the
numerous regulatory requirements applicable to the PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin and PCT&#8217;s facilities will be time-consuming and costly. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The use of PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin in food-grade applications is subject to
regulation by the U.S. Food and Drug Administration (&#8220;FDA&#8221;). In order for the PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin to be used in food-grade applications, PCT may request one or more Letters of No
Objection (&#8220;LNOs&#8221;) from the FDA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company has received LNOs from the FDA that allow the Company&#8217;s
purified product to be used for all food types per the FDA&#8217;s Conditions of Use listed and per all applicable authorizations in the food-contact regulations listed in the 21 CFR (Code of Federal Regulations, Title 21). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The process for obtaining further LNOs will include FDA evaluation of the PCT Purification process and the Technology. Each
LNO is feedstock-specific, jurisdiction-specific and application-specific, meaning that any change in the source, type, or composition of feedstock used in the PCT process, or any expansion into new food-contact applications will require separate
LNO submissions and independent FDA evaluation. All LNOs require that feedstock used in the PCT process should comply with all applicable authorizations, including 21 CFR 174.5&#8212;<I>General</I> provisions applicable to indirect food additives,
and may be impacted by evolving FDA expectations. The Company is conducting additional testing and plans to make further LNO submissions. In addition, as needed, individual surrogate challenge testing and migration studies will be conducted to
simulate articles in contact with food. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The process of obtaining FDA regulatory approval requires the expenditure of
substantial time and significant financial resources. The FDA could refuse to approve further LNO applications, a decision may be delayed if the FDA has questions about the data or other aspects of the filing, or the review schedule may be extended
if there are a significant number of LNO requests pending. LNOs are also FDA staff opinions rather than formal approvals, and continued reliance depends on consistency in responses. Material changes may require new submissions and could alter prior
conclusions. All of the above could have an adverse effect on PCT&#8217;s business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Furthermore, changes in regulatory requirements, laws and policies, or evolving interpretations of existing regulatory
requirements, laws and policies, may result in increased compliance costs, delays, capital expenditures and other financial obligations that could adversely affect PCT&#8217;s business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The use of PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin will also be subject to foreign regulatory
schemes in Europe and Asia, including, but not limited to, the European Commission (the &#8220;EC&#8221;), the European Food Safety Authority (the &#8220;EFSA&#8221;), the Federal Agency for the Safety of the Food Chain (the &#8220;FASFC&#8221;) in
Belgium, the Association of Southeast Asian Nations (the &#8220;ASEAN&#8221;), and the Thai Food and Drug Administration (the &#8220;TFDA&#8221;) in Thailand. The European Union (the &#8220;EU&#8221;) has a general framework of rules for clearing
and marketing food packaging materials through a positive list system as well as specific rules for recycled plastics. PCT is currently advancing the authorization process in Europe and hopes to receive the final authorizations in 2026. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT also expects to encounter regulations in most, if not all, of the countries in which PCT may seek to expand, and PCT
cannot be sure that it will be able to obtain necessary approvals in a timely manner or at all. If PCT&#8217;s PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin does not meet applicable regulatory requirements in a particular
country or at all, then PCT may face hindered or reduced market demand in those countries and PCT&#8217;s business, financial condition, results of operations and prospects may be adversely affected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The various regulatory schemes applicable to PCT&#8217;s PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>
resin will continue to apply following initial approval. Monitoring regulatory changes and ensuring the Company&#8217;s ongoing compliance with applicable requirements is time-consuming and may affect PCT&#8217;s business, financial condition,
results of operation and prospects. If PCT fails to comply with such requirements on an ongoing basis, PCT may be subject to fines or other penalties, or may be prevented from selling
PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin products, and PCT&#8217;s business, financial condition, results of operation and prospects may be harmed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Legislative, regulatory or judicial developments could affect PCT&#8217;s business, financial condition, results of operations and
prospects. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT&#8217;s activities and plants are subject to extensive air, water and other environmental and
workplace safety laws and regulations at the federal and state level. In addition, PCT will be subject to additional regulatory </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
regimes upon expanding to new regions, including foreign regulatory authorities in the EU, such as the EC, the EFSA, and the FASFC, foreign regulatory authorities in the ASEAN such as the TFDA,
and similar regulatory authorities. Some of these laws require or may require PCT to operate under a number of environmental permits. These laws, regulations and permits can often require pollution control equipment or operational changes to limit
actual or potential impacts to the environment. These laws, regulations and permit conditions evolve in time and may become more difficult to comply with. A violation of these laws, regulations or permit conditions could result in substantial fines,
damages, criminal sanctions, permit revocations and/or a plant shutdown. PCT has experienced, and may in the future experience, violations of applicable environmental laws, regulations or permit conditions, including with respect to wastewater
generation and disposal to the extent applicable. PCT cannot provide assurance that it will not face further regulatory scrutiny, additional citations, or enforcement action in connection with these or other violations, or that any such action will
not result in substantial fines, damages, criminal sanctions, permit revocations and/or a plant shutdown. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition,
proposals relating to recycling or recycling content and prohibitions on certain types of plastic products have been introduced and/or adopted in various jurisdictions, and it is anticipated that similar legislation or regulations may be proposed in
the future at federal, state, and local levels, both within the U.S. and elsewhere. There is a risk that PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin may not qualify as recycled content or post-consumer recycled content
under one or more applicable state laws, federal regulations, customer sustainability programs or third-party certification schemes, whether due to the nature of PCT&#8217;s purification process or evolving interpretations of applicable standards.
If PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin is determined not to qualify as recycled content or post-consumer recycled content under standards that are material to PCT&#8217;s customers, demand for PureFive<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin could be materially reduced, customers may seek alternative suppliers or materials, and PCT&#8217;s business, financial condition, results of operations and prospects could be materially
adversely affected. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Risks Related to Human Capital Management </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>PCT is dependent on management and key personnel, and PCT&#8217;s business would suffer if it fails to retain its key personnel and
attract additional highly skilled employees. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT&#8217;s success is dependent on the specialized skills of its
management team and key operating personnel. This may present particular challenges as PCT operates in a highly specialized industry sector, which may make replacement of its management team and key operating personnel difficult. A loss of the
management team members or key employees, or their failure to satisfactorily perform their responsibilities, could affect a variety of roles. Loss of key personnel may also heighten any operational exposures should staff be pulled into multiple
activities simultaneously due to challenges related to retention and recruitment, and may result in significant attrition of high caliber and high potential employees, loss of key skills and a noticeable decline in employee morale. Ultimately, the
loss of high caliber and high potential team members could have an adverse effect on PCT&#8217;s business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT&#8217;s future success will depend on its ability to identify, hire, develop, motivate and retain highly qualified
personnel for all areas of its organization, particularly research and development, recycling technology, operations and sales. Trained and experienced personnel are in high demand and may be in short supply, and tight labor markets, evolving
workplace expectations and immigration/work-authorization constraints could further limit availability and increase costs. Many of the companies with which PCT competes for experienced employees have greater resources than PCT does and may be able
to offer more attractive terms of employment. In addition, PCT invests significant time and expense in training employees, which increases their value to competitors that may seek to recruit them. PCT may not be able to attract, develop and maintain
the skilled workforce necessary to operate its business, and labor expenses may increase as a result of a shortage in the supply of qualified personnel, which may negatively impact PCT&#8217;s business, financial condition, results of operations and
prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_7"></A>CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus supplement and the accompanying prospectus contain and incorporate by reference forward-looking statements
within the meaning of Section&nbsp;27A of the Securities Act and Section&nbsp;21E of the Exchange Act, including statements about the financial condition, results of operations, earnings outlook and prospects of PCT. Forward-looking statements
generally relate to future events or PCT&#8217;s future financial or operating performance and may refer to projections and forecasts. Forward-looking statements are typically identified by words such as &#8220;plan,&#8221; &#8220;believe,&#8221;
&#8220;expect,&#8221; &#8220;aim,&#8221; &#8220;anticipate,&#8221; &#8220;drive,&#8221; &#8220;intend,&#8221; &#8220;outlook,&#8221; &#8220;estimate,&#8221; &#8220;forecast,&#8221; &#8220;future,&#8221; &#8220;goal,&#8221; &#8220;guidance,&#8221;
&#8220;project,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;should,&#8221; &#8220;would&#8221; and other similar words and
expressions (or the negative versions of such words or expressions), but the absence of these words does not mean that a statement is not forward-looking. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The forward-looking statements are based on the current expectations of the management of PCT and are inherently subject to
uncertainties and changes in circumstances and their potential effects and speak only as of the date they were made. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements
involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are
not limited to, those factors described under the caption &#8220;Risk Factors&#8221; in each of PCT&#8217;s Annual Report and PCT&#8217;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the period ended March&nbsp;31, 2026,
those discussed and identified in other public filings made with the SEC by PCT and the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to obtain funding for our operations, future capital requirements and future growth, and to
continue as a going concern; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to meet, continue to meet, and comply on an ongoing basis with the numerous regulatory
requirements applicable to our PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin both generally and in food-grade applications and, more broadly, the operations of our facilities (including in the United States, Europe, Asia
and other future international locations); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations and changes regarding our strategies and future financial performance, including future business
plans, expansion plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and our
ability to invest in growth initiatives, which could be impacted by significant changes to tariffs on foreign imports; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of the Ironton Facility to be appropriately certified by Leidos Engineering, LLC, following
certain performance and other tests, and commence full-scale commercial operations in a timely and cost-effective manner, or at all; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to meet, and to continue to meet, the requirements imposed upon us and our subsidiaries by the
funding for our operations, including the funding for the Ironton Facility, and the Planned Facilities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to minimize or eliminate the many hazards and operational risks at our manufacturing facilities
that can result in potential injury to individuals, disrupt our business, including interruptions or disruptions in operations at our facilities, and subject us to liability and increased costs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to complete the necessary funding with respect to, and complete the construction of the Planned
Facilities in a timely and cost-effective manner; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to procure, sort and process polypropylene plastic waste at our planned plastic waste prep
(&#8220;Feed PreP&#8221;) facilities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to maintain exclusivity under the P&amp;G license (as described above); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the implementation, market acceptance and success of our business model and growth strategy, which includes
our ability to bring a total of one billion pounds of installed polypropylene recycling capability online by 2030, and our ability to meet related construction, regulatory, and financing requirements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to negotiate multi-year offtake agreements at appropriate margins to fund ongoing operations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possibility that we may be adversely affected or potentially impacted by economic, business, and/or
competitive factors, including interest rates, availability of capital, economic cycles, and other macro-economic impacts (such as tariffs); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the prices and availability of materials (such as steel and other materials needed for the
construction of future Feed PreP and Purification facilities), including those changes caused by inflation, tariffs and supply chain conditions, such as increased transportation costs and global conflicts, and our ability to obtain such materials in
a timely and cost-effective manner; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to source feedstock with a high polypropylene content at a reasonable cost, and the temporary
spike in prices due to global conflicts such as the current conflict in the Middle East; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the development of direct competitors in the recycled polypropylene segment that could impact the demand for
our products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outcome of any legal or regulatory proceedings to which we are, or may become, a party;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">geopolitical risk and changes in applicable laws or regulations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the prices and availability of labor (including labor shortages), turnover in employees, and
increases in employee-related costs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any business disruptions due to political or economic instability, pandemics, or armed hostilities (including
the ongoing conflict between Russia and Ukraine and active military conflicts in the Middle East); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">operational risks associated with the ability to operate the Ironton Facility and the Planned Facilities, as
and when operative, at nameplate capacity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to consummate this offering and the Concurrent Stock Offering and the potential effects of this
offering and the Concurrent Stock Offering on the trading price of the common stock; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the anticipated use of the net proceeds from this offering and the net proceeds of the Concurrent Stock
Offering. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT undertakes no obligation to update any forward-looking statements made in this prospectus
supplement or the accompanying prospectus to reflect events or circumstances after the date of this prospectus supplement or to reflect new information or the occurrence of unanticipated events, except as required by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Should one or more of these risks or uncertainties materialize or should any of the assumptions made prove incorrect, actual
results may vary in material respects from those projected in these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_8"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We estimate that the net proceeds to us from this offering will be approximately $242.0&nbsp;million (or approximately
$278.3&nbsp;million if the underwriters exercise their over-allotment option in full), after deducting the underwriting discounts and commissions and estimated offering expenses payable by us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We expect to use the net proceeds from this offering, together with the net proceeds from the Concurrent Stock Offering, if
consummated: (i)&nbsp;to pay the approximately $246.3&nbsp;million cost of repurchasing for cash approximately $216.0&nbsp;million in aggregate principal amount at maturity of the Green Convertible Notes in the Note Repurchase Transactions as
described below under the caption &#8220;The Concurrent Transactions&#8221;; (ii)&nbsp;to repurchase additional Green Convertible Notes from time to time; and (iii)&nbsp;for working capital and other general corporate purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Neither the completion of this offering nor the Concurrent Stock Offering is contingent on the completion of the other or the
Note Repurchase Transactions. No assurance can be given that the Concurrent Stock Offering will be completed on the terms described herein or at all. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Green Convertible Notes bear interest at a rate of 7.25% per year and mature on August&nbsp;15, 2030. As of March&nbsp;31,
2026, $250.0&nbsp;million aggregate principal amount at maturity of the Green Convertible Notes remained outstanding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_9"></A>CAPITALIZATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth our cash and cash equivalents and capitalization as of March&nbsp;31, 2026, as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on an actual basis; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on an as adjusted basis to give effect to (i)&nbsp;the issuance and sale of the notes in this offering, after
deducting the underwriting discounts and estimated offering expenses payable by us (assuming no exercise of the underwriters&#8217; over-allotment option in this offering), and (ii)&nbsp;the sale of our common stock in the Concurrent Stock Offering,
after deducting the underwriting discounts and estimated offering expenses payable by us (assuming no exercise of the underwriters&#8217; option to purchase additional shares in the Concurrent Stock Offering), but without giving effect to the use of
proceeds from this offering and the Concurrent Stock Offering. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You should read the following
information in conjunction with the section titled &#8220;Use of Proceeds&#8221; included in this prospectus supplement and the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;
and our consolidated financial statements and related notes in our Annual Report and our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarterly period ended March&nbsp;31, 2026, which are incorporated by reference
herein. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of March&nbsp;31, 2026</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual<SUP STYLE="font-size:75%; vertical-align:top">(1) </SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;Adjusted</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands, except share<BR>amounts)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90,213</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">468,555</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt securities available for sale</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term indebtedness:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Green Convertible Notes<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue Bonds<SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150,210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150,210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revolving Credit Facility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8212;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8212;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other Debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notes offered hereby<SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8212;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">403,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">653,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock, $0.001 par value; 25,000,000 shares authorized; 54,000 shares of Series A
Preferred Stock issued and outstanding, actual and as adjusted; 300,000 shares of Series B Convertible Preferred Stock, issued and outstanding, actual and as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">370,630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">370,630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#8217; equity:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, $0.001 par value; 450,000,000 shares authorized, 180,841,199 shares issued and
outstanding; 198,411,399&nbsp;shares issued and outstanding, as adjusted<SUP STYLE="font-size:75%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">181</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">857,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">993,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(575</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(575</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(849,382</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(849,382</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#8217; equity<SUP STYLE="font-size:75%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,424</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 143,816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">781,889</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,168,281</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Excludes unamortized discount and issuance costs associated with debt and preferred stock.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">As adjusted, does not reflect the repurchase, exchange or retirement of any Green Convertible Notes, a
portion of which we expect to repurchase through the Note Repurchase Transactions. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Revenue Bonds are recorded within long-term debt (current and noncurrent) and related party debt
(current and noncurrent), including $114.4&nbsp;million that are held by affiliates of Daniel Gibson, a director of the Company. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amount shown in the table above for the notes offered hereby represents their aggregate principal
amount. However, we expect that the initial liability carrying amount of the notes for accounting purposes will be recorded net of issuance costs, which will be treated as a debt discount for accounting purposes and amortized into interest expense
over the term of the notes. See the caption &#8220;Risk Factors&#8212;Risks Related to the Notes and This Offering&#8212;The accounting method for the notes and the Green Convertible Notes could adversely affect our reported financial condition and
results.&#8221; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">As adjusted outstanding shares reflects the issuance and sale of shares in the Concurrent Stock Offering.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Based on 180,841,199 shares of our common stock outstanding as of March&nbsp;31, 2026, and excludes:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">5,893,798 shares of common stock issuable upon exercise of PCT Warrants outstanding as of March&nbsp;31, 2026,
with an exercise price of $11.50 per underlying share of common stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">17,757,136 shares of common stock issuable upon exercise of Series A Warrants to purchase the Company&#8217;s
common stock outstanding as of March&nbsp;31, 2026, with an exercise price of $11.50 per underlying share of common stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,064,081 shares of common stock issuable upon exercise of Series B Warrants to purchase the Company&#8217;s
common stock outstanding as of March&nbsp;31, 2026, with an exercise price of $11.50 per underlying share of common stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">5,000,000 shares of common stock issuable upon exercise of Series C Warrants to purchase the Company&#8217;s
common stock outstanding as of March&nbsp;31, 2026, with an exercise price of $11.50 per underlying share of common stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">23,237,440 shares of common stock issuable upon the conversion of Green Convertible Notes outstanding as of
March&nbsp;31, 2026 (assuming the maximum increase to the conversion rate in connection with a &#8220;make-whole fundamental change&#8221; or a notice of redemption); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">22,583,963 shares of common stock issuable upon the conversion of Series B Convertible Preferred Stock
outstanding as of March&nbsp;31, 2026 (assuming the maximum increase to the conversion rate in connection with a &#8220;make-whole fundamental change&#8221; or a notice of redemption); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">23,115,521 shares of common stock authorized and reserved for issuance under our equity and other
incentive-based plans as of March 31, 2026; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,686,028 shares of common stock issuable upon exercise of outstanding stock options outstanding as of
March&nbsp;31, 2026, 935,281 of which are fully vested, with a weighted average exercise price of $14.86 per share; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,948,285 shares of common stock issuable upon vesting of outstanding RSUs and PSUs assuming target
achievement of associated performance metrics for the PSUs. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The outstanding share information set forth above also does
not include up to an additional 2,000,000 shares of common stock to be issued upon the Ironton Facility becoming operational, as certified by Leidos Engineering, LLC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_10"></A>DESCRIPTION OF NOTES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will issue the 4.75% Convertible Senior Notes due 2032 (the &#8220;notes&#8221;) under a base indenture (the &#8220;base
indenture&#8221;), to be dated as of the date of initial issuance of the notes, between us and U.S. Bank Trust Company, National Association, as trustee (the &#8220;trustee&#8221;), as supplemented by a first supplemental indenture with respect to
the notes (the &#8220;supplemental indenture&#8221;), between us and the trustee. In this section, we refer to the base indenture, as supplemented by the supplemental indenture, collectively as the &#8220;indenture.&#8221; This description of the
notes supplements and, to the extent it is inconsistent, replaces the description of the general provisions of the notes and the base indenture in the accompanying prospectus. The terms of the notes include those expressly set forth in the indenture
and those made part of the indenture by reference to the Trust Indenture Act of 1939, as amended (the &#8220;Trust Indenture Act&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You may request a copy of the indenture from us as described under the caption &#8220;Where You Can Find More
Information.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following description is a summary of the material provisions of the notes and the indenture and
does not purport to be complete. This summary is subject to and is qualified by reference to all the provisions of the notes and the indenture, including the definitions of certain terms used in the indenture. We urge you to read these documents
because they, and not this description, define your rights as a holder of the notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of this description,
references to &#8220;we,&#8221; &#8220;our&#8221; and &#8220;us&#8221; refer only to PureCycle Technologies, Inc. and not to its subsidiaries. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The notes will: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be our general unsecured, senior obligations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">initially be limited to an aggregate principal amount of $250,000,000 (or $287,500,000 if the
underwriters&#8217; over-allotment option is exercised in full); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">bear cash interest from June 15, 2026 at an annual rate of 4.75% payable semi-annually in arrears on
January&nbsp;1 and July&nbsp;1 of each year, beginning on January&nbsp;1, 2027; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be subject to redemption at our option, in whole or in part (subject to the partial redemption limitation
described below), on a redemption date on or after July&nbsp;6, 2029 if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during
any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption, at a redemption price equal to 100% of the
principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date as described under the caption &#8220;&#8212;Optional Redemption;&#8221; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be subject to repurchase by us at the option of the holders of the notes on July&nbsp;8, 2030 (the
&#8220;specified repurchase date&#8221;), at a specified repurchase date repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the specified repurchase date;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be subject to repurchase by us at the option of the holders following a &#8220;fundamental change&#8221; (as
defined under the caption &#8220;&#8212;Repurchase at the Option of Holders&#8212;Fundamental Change Permits Holders to Require Us to Repurchase Notes&#8221;), subject to certain conditions and limited exceptions, at a fundamental change repurchase
price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">mature on July&nbsp;1, 2032, unless earlier converted, redeemed or repurchased; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be issued in minimum denominations of $1,000 and integral multiples of $1,000; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">initially be represented by one or more registered notes in global form, but in certain limited circumstances
may be represented by notes in definitive form (see the caption &#8220;&#8212;Book-Entry, Settlement and Clearance&#8221;). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to satisfaction of certain conditions and during the periods described below, the notes may be converted at an initial
conversion rate of 90.2242 shares of common stock per $1,000 principal amount of notes (equivalent to an initial conversion price of approximately $11.08 per share of common stock). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will settle conversions of notes by paying or delivering, as the case may be, cash, shares of our common stock or a
combination of cash and shares of our common stock, at our election, as described under the caption &#8220;&#8212;Conversion Rights&#8212;Settlement upon Conversion.&#8221; You will not receive any separate cash payment for interest, if any, accrued
and unpaid to the conversion date except under the limited circumstances described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The indenture will not limit
the amount of debt, including secured debt, that may be issued by us or our subsidiaries under the indenture or otherwise. The indenture will not contain any financial covenants and will not restrict us from paying dividends or issuing or repaying,
prepaying or repurchasing our other securities or indebtedness. Other than restrictions described under the caption &#8220;&#8212;Repurchase at the Option of Holders&#8212;Fundamental Change Permits Holders to Require Us to Repurchase Notes&#8221;
and &#8220;&#8212;Consolidation, Merger and Sale of Assets&#8221; below and except for the provisions set forth under the caption &#8220;&#8212;Conversion Rights&#8212;Increase in Conversion Rate upon Conversion upon a Make-Whole Fundamental Change
or Notice of Redemption,&#8221; the indenture will not contain any covenants or other provisions designed to afford holders of the notes protection in the event of a highly leveraged transaction involving us or in the event of a decline in our
credit rating as the result of a takeover, recapitalization, highly leveraged transaction or similar restructuring involving us that could adversely affect such holders. The notes will not be guaranteed by any of our subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We may, without the consent of, or notice to, the holders, reopen the indenture for the notes and issue additional notes under
the indenture with the same terms as the notes offered hereby (other than differences in the issue date, the issue price, interest accrued prior to the issue date of such additional notes and, if applicable, restrictions on transfer in respect of
such additional notes) in an unlimited aggregate principal amount; <I>provided</I> that if any such additional notes are not fungible with the notes initially offered hereby for U.S. federal income tax or securities law purposes, such additional
notes will have one or more separate CUSIP numbers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We do not intend to list the notes on any securities exchange or any
automated dealer quotation system. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except to the extent the context otherwise requires, we use the term
&#8220;notes&#8221; in this prospectus supplement to refer to each $1,000 principal amount of notes. In this prospectus supplement, we use the term &#8220;common stock&#8221; to refer to our common stock, par value $0.001 per share. References in
this prospectus supplement to a &#8220;holder&#8221; or &#8220;holders&#8221; of notes that are held through The Depository Trust Company (&#8220;DTC&#8221;) are references to owners of beneficial interests in such notes, unless the context
otherwise requires. However, we and the trustee will treat the person in whose name the notes are registered (Cede&nbsp;&amp; Co., in the case of notes held through DTC) as the owner of such notes for all purposes. References herein to the
&#8220;close of business&#8221; refer to 5:00 p.m., New York City time, and to the &#8220;open of business&#8221; refer to 9:00 a.m., New York City time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Purchase and Cancellation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of the notes, the description below under this section titled &#8220;&#8212;Purchase and Cancellation&#8221;
supersedes, in its entirety, the information in the accompanying prospectus under the caption &#8220;Description of Debt Securities&#8212;Purchase and Cancellation.&#8221; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will cause all notes surrendered for payment at maturity, repurchase on
the specified repurchase date or upon a fundamental change, redemption, registration of transfer or exchange or conversion, if surrendered to us or any of our agents or subsidiaries, to be delivered to the trustee for cancellation and they will no
longer be considered &#8220;outstanding&#8221; under the indenture upon such payment at maturity, repurchase on the specified repurchase date or upon a fundamental change, redemption, registration of transfer or exchange or conversion, as the case
may be. All notes delivered to the trustee shall be cancelled promptly by the trustee in accordance with its customary procedures upon our written request. Except for notes surrendered for registration of transfer or exchange, no notes shall be
authenticated in exchange for any notes cancelled as provided in the indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We may, to the extent permitted by law,
and directly or indirectly (regardless of whether such notes are surrendered to us), repurchase notes in the open market or otherwise, whether by us or our subsidiaries or through a privately negotiated transaction or public tender or exchange offer
or through counterparties to private agreements, including by cash-settled swaps or other derivatives, in each case, without the consent of or notice to the holders of the notes. We may, at our option and to the extent permitted by applicable law,
reissue, resell or surrender to the trustee for cancellation any notes that we may repurchase, in the case of a reissuance or resale, so long as such notes do not constitute restricted securities upon such reissuance or resale; <I>provided</I> that
if any such reissued or resold notes are not fungible with the notes initially offered hereby for U.S. federal income tax or securities law purposes, such reissued or resold notes will have one or more separate CUSIP numbers. Any notes that we may
repurchase will be considered outstanding for all purposes under the indenture (other than, at any time when such notes are held by us, any of our subsidiaries or affiliates or any subsidiary of any of our affiliates, for the purpose of determining
whether holders of the requisite aggregate principal amount of notes have concurred in any direction, consent, waiver or other action under the indenture) unless and until such time we surrender them to the trustee for cancellation and, upon receipt
of a written order from us, the trustee will cancel all notes so surrendered. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Payments on the Notes; Paying Agent and Registrar;
Transfer and Exchange </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will pay, or cause the paying agent to pay, the principal of, and interest on, notes in
global form registered in the name of or held by DTC or its nominee by wire transfer in immediately available funds to DTC or its nominee, as the case may be, as the registered holder of such global note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will pay, or cause the paying agent to pay, the principal of any certificated notes at the office or agency designated by
us for that purpose. We have initially designated the trustee as our paying agent and registrar and its agency in the continental United States of America as a place where notes may be presented for payment or for registration of transfer. We may,
however, change the paying agent or registrar without prior notice to the holders of the notes, and we may act as paying agent or registrar. Interest on certificated notes will be payable (i)&nbsp;to holders having an aggregate principal amount of
$5,000,000 or less, by check mailed to the holders of these notes and (ii)&nbsp;to holders having an aggregate principal amount of more than $5,000,000, either by check mailed to each holder or, upon application by such a holder to the registrar not
later than the relevant regular record date, by wire transfer in immediately available funds to that holder&#8217;s account within the United States if such holder has provided us, the trustee or the paying agent (if other than the trustee) with the
requisite information necessary to make such wire transfer, which application shall remain in effect until the holder notifies, in writing, the registrar to the contrary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A holder of notes may transfer or exchange notes at the office of the registrar in accordance with the indenture. The
registrar and the trustee may require a holder, among other things, to furnish appropriate endorsements and transfer documents. No service charge will be imposed by us, the trustee or the registrar for any registration of transfer or exchange of
notes, but we may require a holder to pay a sum sufficient to cover any transfer tax or other similar governmental charge required by law or permitted by the indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are not required to transfer or exchange any note selected for redemption or surrendered for conversion or required
repurchase on the specified repurchase date or on a fundamental change repurchase date. A holder of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
a beneficial interest in a note in global form may transfer or exchange such beneficial interest in accordance with the indenture and the applicable procedures of DTC. See the caption
&#8220;&#8212;Book-Entry, Settlement and Clearance.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The registered holder of a note will be treated as its owner
for all purposes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Interest </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The notes will bear cash interest at a rate of 4.75% per year until maturity. Interest on the notes will accrue from
June&nbsp;15, 2026 or from the most recent date on which interest has been paid or duly provided for. Interest will be payable semiannually in arrears on January&nbsp;1 and July&nbsp;1 of each year (each, an &#8220;interest payment date&#8221;),
beginning on January&nbsp;1, 2027. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Interest will be paid to the person in whose name a note is registered at the close of
business on May&nbsp;15 or November&nbsp;15 (whether or not a business day), as the case may be, immediately preceding the relevant interest payment date (each, a &#8220;regular record date&#8221;). Interest on the notes will be computed on the
basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year composed of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months and, for partial months, on the basis of the number of days actually elapsed in a
<FONT STYLE="white-space:nowrap">30-day</FONT> month. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If any interest payment date, the maturity date, any redemption
date, the specified repurchase date or any fundamental change repurchase date falls on a day that is not a business day, the required payment will be made on the next succeeding business day with the same force and effect as if made on such
scheduled payment date, and no interest on such payment will accrue in respect of the delay. The term &#8220;business day&#8221; means, with respect to any note, any day other than a Saturday, a Sunday or a day on which the Federal Reserve Bank of
New York is authorized or required by law or executive order to close or be closed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless the context otherwise
requires, all references to interest in this prospectus supplement include additional interest, if any, payable at our election as the sole remedy relating to the failure to comply with our reporting obligations as described under the caption
&#8220;&#8212;Events of Default.&#8221; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Ranking </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The notes will be our general unsecured obligations that will rank senior in right of payment to all of our indebtedness that
is expressly subordinated in right of payment to the notes. The notes will rank equal in right of payment with all of our existing and future liabilities that are not so subordinated, including our existing 7.25% Convertible Senior Notes due 2030
(the &#8220;Green Convertible Notes&#8221;). The notes will effectively rank junior to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness, including any outstanding borrowings under our
$200&nbsp;million revolving credit facility with Sylebra Capital (the &#8220;Revolving Credit Facility&#8221;). In the event of our bankruptcy, liquidation, reorganization or other winding up, our assets that secure secured indebtedness will be
available to pay obligations on the notes only after all indebtedness under such secured indebtedness has been repaid in full from such assets. The notes will rank structurally junior to all indebtedness and other liabilities (including trade
payables) of our current or future subsidiaries, including the revenue bonds issued by or on behalf of certain of our subsidiaries (the &#8220;Revenue Bonds&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Substantially all of our consolidated assets are held by, and substantially all of our business is conducted through, our
subsidiaries. The notes will not be guaranteed by any of our subsidiaries. Any subsidiaries that we may form in the future will be separate and distinct legal entities and will have no obligation, contingent or otherwise, to pay amounts due with
respect to the notes or to make any funds available therefor, whether by dividends, loans or other payments. Our right to receive any assets of any of our subsidiaries upon such subsidiary&#8217;s bankruptcy, liquidation or reorganization, and,
therefore, the right of the holders of notes to participate in those assets, will be subject to prior claims of creditors of the subsidiary, including trade creditors, and such subsidiary may not have sufficient assets remaining to make any payments
to us as a stockholder or otherwise. We advise you that there may not be sufficient assets remaining to pay amounts due on any or all of the notes then outstanding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of March&nbsp;31, 2026, the outstanding principal amount of our total
consolidated indebtedness for borrowed money was approximately $403.8&nbsp;million, of which approximately $153.8&nbsp;million was secured indebtedness consisting of the Revenue Bonds and certain equipment financing. As of March&nbsp;31, 2026, our
subsidiaries had approximately $248.9&nbsp;million of liabilities (including trade payables, but excluding intercompany obligations and liabilities of a type not required to be reflected on a balance sheet of such subsidiaries in accordance with
GAAP) to which the notes would have been structurally subordinated. After giving effect to the issuance of the notes (assuming no exercise of the underwriters&#8217; over-allotment option and without giving effect to the use of the proceeds
therefrom), the outstanding principal amount of our total consolidated indebtedness for borrowed money as of March&nbsp;31, 2026 would have been $653.8 million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The ability of our subsidiaries to pay dividends and make other payments to us is restricted by the terms of the credit
agreement governing the Revolving Credit Facility and may be restricted by, among other things, applicable corporate and other laws and regulations, our future debt instruments as well as agreements to which our subsidiaries may become a party. We
may not be able to pay the cash portions of any settlement amount upon conversion of the notes, or to pay cash for the specified repurchase date repurchase price on the specified repurchase date or the fundamental change repurchase price upon a
fundamental change if a holder requires us to repurchase notes as described below. See the caption &#8220;Risk Factors&#8212;Risks Related to the Notes&#8212;We may not have the ability to raise the funds necessary to settle conversions of the notes
or the Green Convertible Notes in cash or to repurchase the notes on July&nbsp;8, 2030, the Green Convertible Notes on August&nbsp;15, 2027 or the notes or the Green Convertible Notes upon a fundamental change, and our future debt may contain
limitations on our ability to pay cash upon conversion or repurchase of the notes or the Green Convertible Notes.&#8221; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Optional
Redemption </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No &#8220;sinking fund&#8221; is provided for the notes, which means that we are not required to redeem or
retire the notes periodically. Prior to July&nbsp;6, 2029, the notes will not be redeemable. On a redemption date on or after July&nbsp;6, 2029, we may redeem for cash all or any portion of the notes (subject to the partial redemption limitation set
forth below), at our option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period
(including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption. In the case of any optional redemption, we will provide not less than 35 nor more than
55 scheduled trading days&#8217; written notice before the redemption date to the trustee, the paying agent (if other than the trustee), the conversion agent (if other than the trustee) and each holder of notes, and the redemption price will be
equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (unless the redemption date falls after a regular record date but on or prior to the immediately succeeding
interest payment date, in which case we will pay the full amount of accrued and unpaid interest to the holder of record as of the close of business on such regular record date on, or at our election, before, such interest payment date, and the
redemption price will be equal to 100% of the principal amount of the notes to be redeemed). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">However, if, in accordance
with the provisions described in the third paragraph under the caption &#8220;&#8212;Conversion Rights&#8212;Settlement upon Conversion,&#8221; we elect to settle all conversions of notes called for redemption (or deemed called for redemption as
described below under the caption &#8220;&#8212;Conversion Rights&#8212;General&#8221;) with a conversion date that occurs during the related &#8220;redemption period&#8221; (as defined under the caption &#8220;&#8212;Conversion
Rights&#8212;General&#8221;) by physical settlement, then we may instead elect to choose a redemption date that is a business day not less than 15 calendar days nor more than 55 scheduled trading days after the date we send such notice of
redemption. The redemption date set forth in the relevant notice of redemption must be a business day that is scheduled to be a business day as of the date of such notice of redemption, and we may not specify a redemption date that falls on or after
the 31st scheduled trading day immediately preceding the maturity date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The &#8220;last reported sale price&#8221; of our common stock (or other
security for which a closing sale price must be determined) on any date means the closing sale price per share (or if no closing sale price is reported, the average of the bid and ask prices or, if more than one in either case, the average of the
average bid and the average ask prices) on that date as reported in composite transactions for the principal U.S. national or regional securities exchange on which our common stock (or such other security) is traded. If our common stock (or such
other security) is not listed for trading on a U.S. national or regional securities exchange on the relevant date, the &#8220;last reported sale price&#8221; will be the last quoted bid price for our common stock (or such other security) in the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market on the relevant date as reported by OTC Markets Group Inc. or a similar organization. If our common stock (or such other security) is not so quoted,
the &#8220;last reported sale price&#8221; will be the average of the <FONT STYLE="white-space:nowrap">mid-point</FONT> of the last bid and ask prices for our common stock (or such other security) on the relevant date from each of at least three
nationally recognized independent investment banking firms selected by us for this purpose. The &#8220;last reported sale price&#8221; will be determined without regard to after-hours trading or any other trading outside of regular trading session
hours. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except for purposes of determining amounts due upon conversion, &#8220;trading day&#8221; means a day on which
(i)&nbsp;trading in our common stock (or other security for which a closing sale price must be determined) generally occurs on The Nasdaq Capital Market or, if our common stock (or such other security) is not then listed on The Nasdaq Capital
Market, on the principal other U.S. national or regional securities exchange on which our common stock (or such other security) is then listed or, if our common stock (or such other security) is not then listed on a U.S. national or regional
securities exchange, on the principal other market on which our common stock (or such other security) is then traded, and (ii)&nbsp;a last reported sale price for our common stock (or closing sale price for such other security) is available on such
securities exchange or market. If our common stock (or such other security) is not so listed or traded, &#8220;trading day&#8221; means a &#8220;business day.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">With respect to any notes that are called (or deemed called) for redemption and converted in connection with a notice of
redemption as described under the caption &#8220;&#8212;Conversion Rights&#8212;General,&#8221; we will, under certain circumstances, increase the conversion rate for the notes so surrendered for conversion by a number of additional shares as
described under the caption &#8220;&#8212;Conversion Rights&#8212;Increase in Conversion Rate upon Conversion upon a Make-Whole Fundamental Change or Notice of Redemption.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we elect to redeem less than all of the outstanding notes, at least $75,000,000 aggregate principal amount of notes must be
outstanding and not subject to redemption as of, and after giving effect to, delivery of the relevant notice of redemption (such requirement, the &#8220;partial redemption limitation&#8221;). If we decide to redeem less than all of the outstanding
notes and the notes to be redeemed are global notes, the notes to be redeemed will be selected by DTC in accordance with applicable DTC procedures. If we decide to redeem less than all of the outstanding notes and the notes to be redeemed are not
global notes then held by DTC, the trustee will select the notes to be redeemed (in principal amounts of $1,000 or multiples thereof) by lot, on a pro rata basis, or by another method the trustee considers to be fair and appropriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the trustee (or DTC, with respect to global notes) selects a portion of your notes for partial redemption and you convert a
portion of the same notes, the converted portion will be deemed to be from the portion selected for redemption, subject to the applicable procedures of DTC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event of any redemption in part, we will not be required to register the transfer of or exchange for other notes any
note so selected for redemption, in whole or in part, except the unredeemed portion of any note being redeemed in part. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No notes may be redeemed if the principal amount of the notes has been accelerated, and such acceleration has not been
rescinded, on or prior to the redemption date (except in the case of an acceleration resulting from a default by us in the payment of the redemption price with respect to such notes). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Conversion Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>General </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Holders may convert all or any portion of their notes, in integral multiples of $1,000 principal amount, at their option at any
time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
conversion rate for the notes will initially be 90.2242 shares of common stock per $1,000 principal amount of notes (equivalent to an initial conversion price of approximately $11.08 per share of common stock). Upon conversion of a note, we will
satisfy our conversion obligation by paying or delivering, as the case may be, cash, shares of our common stock or a combination of cash and shares of our common stock, at our election, all as set forth below under the caption
&#8220;&#8212;Settlement upon Conversion.&#8221; If we satisfy our conversion obligation solely in cash or through payment and delivery, as the case may be, of a combination of cash and shares of our common stock, the amount of cash and shares of
common stock, if any, due upon conversion will be based on a &#8220;daily conversion value&#8221; (as defined under the caption &#8220;&#8212;Settlement upon Conversion&#8221;) calculated on a proportionate basis for each trading day in a 30 trading
day &#8220;observation period&#8221; (as defined under the caption &#8220;&#8212;Settlement upon Conversion&#8221;). The trustee will initially act as the conversion agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A holder may convert fewer than all of such holder&#8217;s notes so long as the notes converted are an integral multiple of
$1,000 principal amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we call (or are deemed to have called) a note for redemption, a holder of such note called
(or deemed called) for redemption may convert its note called (or deemed called) for redemption from, and including, the date of issuance of a notice of redemption with respect to such note until the close of business on the second scheduled trading
day immediately preceding the applicable redemption date unless we fail to pay the redemption price (in which case a holder of a note called (or deemed called) for redemption may convert such note until the close of business on the scheduled trading
day immediately preceding the date on which the redemption price has been paid or duly provided for) (any such period, a &#8220;redemption period&#8221;). If a holder elects to convert a note called (or deemed called) for redemption during the
related redemption period, we will, under certain circumstances, increase the conversion rate for such note as described under the caption &#8220;&#8212;Increase in Conversion Rate upon Conversion upon a Make-Whole Fundamental Change or Notice of
Redemption.&#8221; Accordingly, if we elect to redeem less than all of the outstanding notes as described under the caption &#8220;&#8212;Optional Redemption,&#8221; holders of the notes not called (or deemed called) for redemption will not be
entitled to an increased conversion rate for conversions of such notes (on account of the notice of redemption) during the related redemption period, except in the limited circumstances set forth in the immediately succeeding paragraph. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we elect to redeem less than all of the outstanding notes as described under the caption &#8220;&#8212;Optional
Redemption,&#8221; and the holder of any note (or any owner of a beneficial interest in any global note) is reasonably not able to determine, before the close of business on the 29th scheduled trading day immediately before the relevant redemption
date (or if, as permitted under the caption &#8220;&#8212;Optional Redemption,&#8221; we deliver a notice of redemption not less than 15 calendar days nor more than 55 scheduled trading days prior to the related redemption date, then prior to close
of business on the 14th calendar day immediately before the relevant redemption date), whether such note or beneficial interest, as applicable, is to be redeemed pursuant to such redemption (and, as a result thereof, convertible on account of the
related notice of redemption in accordance with the provisions of the indenture), then the notes converted by such holder during the related redemption period will be deemed to be of a note called for redemption (and each such conversion will be
deemed &#8220;in connection with&#8221; the relevant notice of redemption). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon conversion, you will not receive any
separate cash payment for accrued and unpaid interest, if any, except as described below. We will not issue fractional shares of our common stock upon conversion of notes. Instead, we will pay cash in lieu of delivering any fractional share as
described under the caption &#8220;&#8212;Settlement upon Conversion.&#8221; Our payment and delivery, as the case may be, to you of the cash, shares of our common </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
stock or a combination thereof, as the case may be, into which a note is convertible will be deemed to satisfy in full our obligation to pay: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the principal amount of the note; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accrued and unpaid interest, if any, to, but not including, the relevant conversion date.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As a result, accrued and unpaid interest, if any, to, but not including, the relevant conversion date
will be deemed to be paid in full rather than cancelled, extinguished or forfeited. Upon a conversion of notes into a combination of cash and shares of our common stock, accrued and unpaid interest will be deemed to be paid first out of the cash
paid upon such conversion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding the immediately preceding paragraph, if notes are converted after the close of
business on a regular record date for the payment of interest and prior to the open of business on the corresponding interest payment date, holders of such notes at the close of business on such regular record date will receive the full amount of
interest payable on such notes on the corresponding interest payment date notwithstanding the conversion. Notes surrendered for conversion during the period from the close of business on any regular record date to the open of business on the
immediately following interest payment date must be accompanied by funds equal to the amount of interest payable on the notes so converted; provided that no such payment need be made: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for conversions following the close of business on the regular record date immediately preceding the maturity
date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if we have specified a redemption date that is after a regular record date and on or prior to the second
business day immediately following the corresponding interest payment date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if we have specified a fundamental change repurchase date that is after a regular record date and on or prior
to the business day immediately following the corresponding interest payment date; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to the extent of any overdue interest, if any overdue interest exists at the time of conversion with respect
to such note. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Therefore, for the avoidance of doubt, all record holders on the regular record date
immediately preceding the maturity date will receive the full interest payment due on the maturity date in cash regardless of whether their notes have been converted following such regular record date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a holder converts notes, we will pay any documentary, stamp or similar issue or transfer tax due on any issuance or
delivery of any shares of our common stock upon the conversion, unless the tax is due because the holder requests such shares to be issued in a name other than the holder&#8217;s name, in which case the holder will pay that tax. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Certain Distributions Notice </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If, prior to the close of business on the business day immediately preceding April&nbsp;1, 2032, we elect to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">distribute to all or substantially all holders of our common stock any rights, options or warrants (other than
in connection with a stockholder rights plan prior to separation of such rights from our common stock) entitling them, for a period of not more than 60 calendar days after the announcement date of such distribution, to subscribe for or purchase
shares of our common stock at a price per share that is less than the average of the last reported sale prices of our common stock for the 10 consecutive trading day period ending on, and including, the trading day immediately preceding the date of
announcement of such distribution; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">distribute to all or substantially all holders of our common stock our assets, securities or rights to
purchase our securities (other than in connection with a stockholder rights plan prior to separation of such rights from our common stock), which distribution has a per share value, as reasonably determined by us in good faith, exceeding 10% of the
last reported sale price of our common stock on the trading day preceding the date of announcement for such distribution, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">then, in either case, we must notify the holders of the notes, the trustee and the
conversion agent (if other than the trustee) at least 36 scheduled trading days prior to the <FONT STYLE="white-space:nowrap">ex-dividend</FONT> date for such distribution (or, if later in the case of any such separation of rights issued pursuant to
a stockholder rights plan, as soon as reasonably practicable after we become aware that such separation or triggering event has occurred or will occur); <I>provided</I>, <I>however</I>, that if we are then otherwise permitted to settle conversions
of notes by physical settlement (and, for the avoidance of doubt, have not irrevocably agreed to settle by some other method), then we may instead elect to provide such notice at least five scheduled trading days prior to such <FONT
STYLE="white-space:nowrap">ex-dividend</FONT> date, in which case we shall be required to settle all conversions of notes with a conversion date occurring during the period on or after the date we provide such notice and before such <FONT
STYLE="white-space:nowrap">ex-dividend</FONT> date (or, if earlier, the date we announce that such issuance or distribution will not take place) by physical settlement, and we shall describe the same in such notice. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Conversion Procedures </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you hold a beneficial interest in a global note, to convert you must comply with DTC&#8217;s procedures for converting a
beneficial interest in a global note and, if required, pay funds equal to interest payable on the next interest payment date to which you are not entitled. As such, if you are a beneficial owner of the notes, you must allow for sufficient time to
comply with DTC&#8217;s procedures if you wish to exercise your conversion rights. If you hold a certificated note, to convert you must: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">complete and manually sign the conversion notice on the back of the note, or a facsimile of the conversion
notice; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver the conversion notice, which is irrevocable, and the note to the conversion agent;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if required, furnish appropriate endorsements and transfer documents; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if required, pay funds equal to interest payable on the next interest payment date to which you are not
entitled. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will pay any documentary, stamp or similar issue or transfer tax on the issuance or
delivery of any shares of our common stock upon conversion of the notes, unless the tax is due because the holder requests such shares to be issued in a name other than the holder&#8217;s name, in which case the holder will pay the tax. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We refer to the date you comply with the relevant procedures for conversion described above as the &#8220;conversion
date.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a holder has already delivered a repurchase notice as described under the caption
&#8220;&#8212;Repurchase at the Option of Holders&#8221; with respect to a note, the holder may not surrender that note for conversion until the holder has validly withdrawn the repurchase notice in accordance with the relevant provisions of the
indenture. If a holder submits its notes for required repurchase, the holder&#8217;s right to withdraw the repurchase notice and convert the notes that are subject to repurchase will terminate at the close of business on the business day immediately
preceding the specified repurchase date or the relevant fundamental change repurchase date, as applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Settlement upon
Conversion </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon conversion, we may choose to pay or deliver, as the case may be, either cash (&#8220;cash
settlement&#8221;), shares of our common stock (&#8220;physical settlement&#8221;) or a combination of cash and shares of our common stock (&#8220;combination settlement&#8221;), as described below. We refer to each of these settlement methods as a
&#8220;settlement method.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">All conversions of notes called for redemption (or deemed called for redemption) for
which the relevant conversion date occurs during the related redemption period, and all conversions for which the relevant conversion date occurs on or after April&nbsp;1, 2032, will be settled using the same settlement method. Except for any such
conversions for which the relevant conversion date occurs during a redemption period, and any conversions </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
for which the relevant conversion date occurs on or after April&nbsp;1, 2032, and except to the extent we have irrevocably elected physical settlement as described under the caption
&#8220;&#8212;Certain Distributions Notice,&#8221; in the related notice described therein or we have previously made an irrevocable election with respect to all subsequent conversions of notes as described below, we will use the same settlement
method for all conversions with the same conversion date, but we will not have any obligation to use the same settlement method with respect to conversions with different conversion dates. That is, prior to April&nbsp;1, 2032, subject to the
immediately preceding sentence, we may choose for notes converted on one conversion date to settle conversions using one settlement method (for example, physical settlement), and choose for notes converted on another conversion date to use a
different settlement method (for example, cash settlement or combination settlement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we elect a settlement method, we
will inform holders so converting, the trustee and the conversion agent (if other than the trustee), in writing, of the settlement method we have selected no later than the close of business on the trading day immediately following the related
conversion date (or in the case of any conversions (x)&nbsp;of notes called for redemption (or deemed called for redemption) for which the relevant conversion date occurs during the related redemption period, in the related notice of redemption,
(y)&nbsp;of notes for which the relevant conversion date occurs on or after April&nbsp;1, 2032, no later than April&nbsp;1, 2032, or (z)&nbsp;of notes for which we have irrevocably elected physical settlement as described under the caption
&#8220;&#8212;Certain Distributions Notice,&#8221; in the related notice described therein or for which we have previously made an irrevocable election with respect to all subsequent conversions of notes, as described below). If we do not timely
elect a settlement method, we will no longer have the right to elect a settlement method with respect to any conversion on such conversion date or during such period, and we will be deemed to have elected the &#8220;default settlement method&#8221;
(as defined below) with respect to such conversion. If we elect (or are deemed to have elected) combination settlement, but we do not timely notify converting holders of the specified dollar amount per $1,000 principal amount of notes to be
converted, such specified dollar amount will be deemed to be $1,000. For the avoidance of doubt, our failure to timely elect a settlement method or specify as applicable a specified dollar amount will not constitute a default under the indenture.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The &#8220;default settlement method&#8221; will initially be physical settlement. By written notice to holders of the
notes, the trustee and the conversion agent (if other than the trustee), we may, from time to time, change the default settlement method prior to April&nbsp;1, 2032. In addition, by written notice to holders of the notes, we may, prior to
April&nbsp;1, 2032, at our option, irrevocably elect to fix the settlement method to any settlement method that we are then permitted to elect, including combination settlement with a specified dollar amount per $1,000 principal amount of notes of
$1,000 or with an ability to continue to set the specified dollar amount per $1,000 principal amount of notes at or above a specific amount set forth in such election notice (any such election, an &#8220;irrevocable election&#8221;). If we change
the default settlement method or we irrevocably elect to fix the settlement method, in either case, to combination settlement with an ability to continue to set the specified dollar amount per $1,000 principal amount of notes at or above a specific
amount, we will, after the date of such change or election, as the case may be, inform holders converting their notes, the trustee and the conversion agent (if other than the trustee), in writing, of such specified dollar amount no later than the
relevant deadline for election of a settlement method as described in the immediately preceding paragraph, or, if we do not timely notify holders, such specified dollar amount will be the specific amount set forth in the change or election notice
or, if no specific amount was set forth in the change or election notice, such specified dollar amount will be $1,000 per $1,000 principal amount of notes. A change in the default settlement method or an irrevocable election will apply to all note
conversions on conversion dates occurring subsequent to delivery of such notice; <I>provided</I>, <I>however</I>, that no such change or election will affect any settlement method theretofore elected (or deemed to be elected) with respect to any
note. For the avoidance of doubt, such an irrevocable election, if made, will be effective without the need to amend the indenture or the notes, including pursuant to the provisions described in clause (13)&nbsp;of the third paragraph under the
caption &#8220;&#8212;Modification and Amendment&#8221; below. However, we may nonetheless choose to execute such an amendment at our option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we change the default settlement method or we irrevocably fix the settlement method pursuant to the provisions described in
the preceding paragraph, then, concurrently with providing notice to holders of notes, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
trustee and the conversion agent (if other than the trustee) of such change or election, we will either post the default settlement method or fixed settlement method, as the case may be, on our
website or disclose the same in a current report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (or any successor form) that is filed with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Settlement amounts will be computed as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if we elect (or are deemed to have elected) physical settlement, we will deliver to the converting holder in
respect of each $1,000 principal amount of notes being converted a number of shares of common stock equal to the conversion rate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if we elect (or are deemed to have elected) cash settlement, we will pay to the converting holder in respect
of each $1,000 principal amount of notes being converted cash in an amount equal to the sum of the daily conversion values for each of the 30 consecutive trading days during the related observation period; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if we elect (or are deemed to have elected) combination settlement, we will pay or deliver, as the case may
be, to the converting holder in respect of each $1,000 principal amount of notes being converted a &#8220;settlement amount&#8221; equal to the sum of the daily settlement amounts for each of the 30 consecutive trading days during the related
observation period. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If more than one note is surrendered for conversion at any one time by the same
holder, the conversion obligation with respect to such notes shall be computed on the basis of the aggregate principal amount of the notes surrendered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The &#8220;daily settlement amount,&#8221; for each of the 30 consecutive trading days during the relevant observation period,
shall consist of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cash equal to the lesser of (i)&nbsp;the maximum cash amount per $1,000 principal amount of notes to be
received upon conversion as specified in the notice specifying our chosen settlement method (or deemed specified as set forth above) (the &#8220;specified dollar amount&#8221;), if any, divided by 30 (such quotient, the &#8220;daily measurement
value&#8221;) and (ii)&nbsp;the daily conversion value; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the daily conversion value exceeds the daily measurement value, a number of shares of common stock equal to
(i)&nbsp;the difference between the daily conversion value and the daily measurement value, divided by (ii)&nbsp;the daily VWAP for such trading day. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The &#8220;daily conversion value&#8221; means, for each of the 30 consecutive trading days during the relevant observation
period, <FONT STYLE="white-space:nowrap">one-thirtieth</FONT> (1/30th) of the product of (1)&nbsp;the conversion rate on such trading day and (2)&nbsp;the daily VWAP for such trading day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The &#8220;daily VWAP&#8221; means, for each of the 30 consecutive trading days during the relevant observation period, the
per share volume-weighted average price as displayed under the heading &#8220;Bloomberg VWAP&#8221; on Bloomberg page &#8220;PCT &lt;equity&gt; AQR&#8221; (or its equivalent successor if such page is not available) in respect of the period from the
scheduled open of trading until the scheduled close of trading of the primary trading session on such trading day (or if such volume-weighted average price is unavailable, the market value of one share of our common stock on such trading day
determined, using a volume-weighted average method, by a nationally recognized independent investment banking firm retained for this purpose by us). The &#8220;daily VWAP&#8221; will be determined without regard to after-hours trading or any other
trading outside of the regular trading session trading hours. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The &#8220;observation period&#8221; with respect to any
note surrendered for conversion means: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to the immediately succeeding bullet point, if the relevant conversion date occurs prior to
April&nbsp;1, 2032, the 30 consecutive trading day period beginning on, and including, the second trading day immediately succeeding such conversion date; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">with respect to any notes called for redemption (or deemed called for redemption) as described above under the
caption &#8220;&#8212;General,&#8221; if the relevant conversion date occurs during the related redemption period, the 30 consecutive trading days beginning on, and including, the 31st scheduled trading day immediately preceding such redemption
date; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to the immediately preceding bullet point, if the relevant conversion date occurs on or after
April&nbsp;1, 2032, the 30 consecutive trading days beginning on, and including, the 31st scheduled trading day immediately preceding the maturity date. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For the purposes of determining amounts due upon conversion only, &#8220;trading day&#8221; means a day on which
(i)&nbsp;there is no &#8220;market disruption event&#8221; (as defined below) and (ii)&nbsp;trading in our common stock generally occurs on the Nasdaq Capital Market or, if our common stock is not then listed on the Nasdaq Capital Market, on the
principal other U.S. national or regional securities exchange on which our common stock is then listed or, if our common stock is not then listed on a U.S. national or regional securities exchange, on the principal other market on which our common
stock is then listed or admitted for trading. If our common stock is not so listed or admitted for trading, &#8220;trading day&#8221; means a &#8220;business day.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#8220;Scheduled trading day&#8221; means a day that is scheduled to be a trading day on the principal U.S. national or
regional securities exchange or market on which our common stock is listed or admitted for trading. If our common stock is not so listed or admitted for trading, &#8220;scheduled trading day&#8221; means a &#8220;business day.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For the purposes of determining amounts due upon conversion, &#8220;market disruption event&#8221; means (i)&nbsp;a failure by
the primary U.S. national or regional securities exchange or market on which our common stock is listed or admitted for trading to open for trading during its regular trading session or (ii)&nbsp;the occurrence or existence prior to 1:00 p.m., New
York City time, on any scheduled trading day for our common stock for more than one half-hour period in the aggregate during regular trading hours of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits
permitted by the relevant stock exchange or otherwise) in our common stock or in any options contracts or futures contracts relating to our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as described under the captions &#8220;&#8212;Increase in Conversion Rate upon Conversion upon a Make-Whole Fundamental
Change or Notice of Redemption&#8221; and &#8220;&#8212;Recapitalizations, Reclassifications and Changes of Our Common Stock,&#8221; we will deliver the consideration due in respect of conversion on the second business day immediately following the
relevant conversion date, if we elect physical settlement (provided that, with respect to any conversion date following the regular record date immediately preceding the maturity date where physical settlement applies to the related conversion, we
will settle any such conversion on the maturity date), or on the second business day immediately following the last trading day of the relevant observation period, in the case of any other settlement method. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will pay cash in lieu of delivering any fractional share of common stock issuable upon conversion based on the daily VWAP
for the relevant conversion date (in the case of physical settlement) or based on the daily VWAP for the last trading day of the relevant observation period (in the case of combination settlement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each conversion will be deemed to have been effected as to any notes surrendered for conversion on the conversion date;
<I>provided, however</I>, that the person in whose name any shares of our common stock shall be issuable upon such conversion will be treated as the holder of record of such shares as of the close of business on the conversion date (in the case of
physical settlement) or the last trading day of the relevant observation period (in the case of combination settlement). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Exchange
in Lieu of Conversion </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">When a holder surrenders its notes for conversion, we may, at our election (an
&#8220;exchange election&#8221;), direct the conversion agent to deliver, on or prior to the trading day immediately following the conversion date, such notes to one or more financial institutions designated by us for exchange in lieu of conversion.
In order to accept </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
any notes surrendered for conversion, the designated financial institution(s) must agree to timely pay or deliver, as the case may be, in exchange for such notes, cash, shares of our common
stock, or a combination of cash and shares of our common stock, at our election, that would otherwise be due upon conversion as described above under the caption &#8220;&#8212;Conversion Rights&#8212;Settlement upon Conversion&#8221; or such other
amount agreed to by the holder and the designated financial institution(s) (the &#8220;conversion consideration&#8221;). If we make an exchange election, we will, by the close of business on the trading day following the relevant conversion date,
notify in writing the trustee, the conversion agent (if other than the trustee) and the holder surrendering its notes for conversion that we have made the exchange election, and we will notify the designated financial institution(s) of the relevant
deadline for delivery of the consideration due upon conversion and the type of conversion consideration to be paid and/or delivered, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any notes delivered to the designated financial institution(s) will remain outstanding, subject to applicable DTC procedures.
If the financial institution(s) agree(s) to accept any notes for exchange but does not timely pay and/or deliver, as the case may be, the related conversion consideration, or if such designated financial institution does not accept the notes for
exchange, we will pay and/or deliver, as the case may be, the relevant conversion consideration, as, and at the time, required pursuant to the indenture as if we had not made the exchange election. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our designation of any financial institution(s) to which the notes may be submitted for exchange does not require such
financial institution(s) to accept any notes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Conversion Rate Adjustments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The conversion rate will be adjusted as described below, except that we will not make any adjustments to the conversion rate if
holders of the notes participate (other than in the case of (x)&nbsp;a share split or share combination or (y) a tender or exchange offer), at the same time and upon the same terms as holders of our common stock and solely as a result of holding the
notes, in any of the transactions described below without having to convert their notes as if they held a number of shares of common stock equal to the conversion rate, <I>multiplied by</I> the principal amount (expressed in thousands) of notes held
by such holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(1) If we exclusively issue shares of our common stock as a dividend or distribution on shares of our common stock, or if
we effect a share split or share combination, the conversion rate will be adjusted based on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g113098g59k01.jpg" ALT="LOGO" STYLE="width:1.11584in;height:0.356669in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">CR<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the conversion rate in effect immediately prior to the open of business on the <FONT
STYLE="white-space:nowrap">ex-dividend</FONT> date of such dividend or distribution, or immediately prior to the open of business on the effective date of such share split or share combination, as applicable; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">CR<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB>&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the conversion rate in effect immediately after the open of business on such
<FONT STYLE="white-space:nowrap">ex-dividend</FONT> date or effective date; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the number of shares of our common stock outstanding immediately prior to the open of business on such <FONT
STYLE="white-space:nowrap">ex-dividend</FONT> date or effective date (before giving effect to any such dividend, distribution, split or combination); and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">OS<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB>&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the number of shares of our common stock outstanding immediately after giving effect to such dividend,
distribution, share split or share combination. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any adjustment made under this clause (1)&nbsp;shall
become effective immediately after the open of business on the <FONT STYLE="white-space:nowrap">ex-dividend</FONT> date for such dividend or distribution, or immediately after the open of business on the effective
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
date for such share split or share combination, as applicable. If any dividend or distribution of the type described in this clause (1)&nbsp;is declared but not so paid or made, the conversion
rate shall be immediately readjusted, effective as of the date our board of directors or a committee thereof determines not to pay such dividend or distribution, to the conversion rate that would then be in effect if such dividend or distribution
had not been declared. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(2) If we distribute to all or substantially all holders of our common stock any rights, options or warrants
(other than pursuant to a stockholder rights plan) entitling them, for a period of not more than 60 calendar days after the announcement date of such distribution, to subscribe for or purchase shares of our common stock at a price per share that is
less than the average of the last reported sale prices of our common stock for the 10 consecutive trading day period ending on, and including, the trading day immediately preceding the date of announcement of such distribution, the conversion rate
will be increased based on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g113098g59k02.jpg" ALT="LOGO" STYLE="width:1.36084in;height:0.356662in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">CR<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the conversion rate in effect immediately prior to the open of business on the <FONT
STYLE="white-space:nowrap">ex-dividend</FONT> date for such distribution; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">CR<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB>&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the conversion rate in effect immediately after the open of business on such
<FONT STYLE="white-space:nowrap">ex-dividend</FONT> date; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the number of shares of our common stock outstanding immediately prior to the open of business on such <FONT
STYLE="white-space:nowrap">ex-dividend</FONT> date; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">X&#8199;&#8196;&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the total number of shares of our common stock distributable pursuant to such rights, options or warrants;
and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">Y&#8199;&#8196;&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the number of shares of our common stock equal to the aggregate price payable to exercise such rights,
options or warrants, divided by the average of the last reported sale prices of our common stock over the 10 consecutive trading day period ending on, and including, the trading day immediately preceding the date of announcement of the distribution
of such rights, options or warrants. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any increase made under this clause (2)&nbsp;will be made
successively whenever any such rights, options or warrants are distributed and shall become effective immediately after the open of business on the <FONT STYLE="white-space:nowrap">ex-dividend</FONT> date for such distribution. To the extent that
shares of common stock are not delivered after the expiration of such rights, options or warrants, the conversion rate shall be decreased to the conversion rate that would then be in effect had the increase with respect to the distribution of such
rights, options or warrants been made on the basis of delivery of only the number of shares of common stock actually delivered. If such rights, options or warrants are not so distributed, the conversion rate shall be decreased to the conversion rate
that would then be in effect if such <FONT STYLE="white-space:nowrap">ex-dividend</FONT> date for such distribution had not occurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For the purpose of this clause (2), and for the purpose of the first bullet point under the caption &#8220;&#8212;Certain
Distributions Notice,&#8221; in determining whether any rights, options or warrants entitle the holders of our common stock to subscribe for or purchase shares of our common stock at a price per share that is less than such average of the last
reported sale prices for the 10 consecutive trading day period ending on, and including, the trading day immediately preceding the date of announcement of such distribution, and in determining the aggregate offering price of such shares of common
stock, there shall be taken into account any consideration received by us for such rights, options or warrants and any amount payable on exercise or conversion thereof, the value of such consideration, if other than cash, to be determined by us in
good faith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(3) If we distribute shares of our capital stock, evidences of our indebtedness, other
assets or property of ours or rights, options or warrants to acquire our capital stock or other securities, to all or substantially all holders of our common stock, excluding: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">dividends, distributions or issuances (including share splits) as to which an adjustment was effected (or
would have been effected but for the 1% exception (as defined below)) pursuant to clause (1)&nbsp;or (2) above; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">except as otherwise described below, rights issued pursuant to any stockholder rights plan of ours then in
effect; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">distributions of reference property issued in exchange for, or upon conversion of, our common stock as
described under the caption &#8220;&#8212;Recapitalizations, Reclassifications and Changes of Our Common Stock&#8221;; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">dividends or distributions paid exclusively in cash as to which the provisions set forth in
clause&nbsp;(4)&nbsp;below shall apply; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">spin-offs as to which the provisions set forth below in this clause (3)&nbsp;shall apply; then the conversion
rate will be increased based on the following formula: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g113098g60k60.jpg" ALT="LOGO" STYLE="width:1.58331in;height:0.356662in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">CR<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#8199;&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the conversion rate in effect immediately prior to the open of business on the <FONT
STYLE="white-space:nowrap">ex-dividend</FONT> date for such distribution; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">CR<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB>&#8199;&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the conversion rate in effect immediately after the open of business on such
<FONT STYLE="white-space:nowrap">ex-dividend</FONT> date; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#8201;&#8199;&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the average of the last reported sale prices of our common stock over the 10 consecutive trading day period
ending on, and including, the trading day immediately preceding the <FONT STYLE="white-space:nowrap">ex-dividend</FONT> date for such distribution; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">FMV&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the fair market value (as determined by us in good faith) of the shares of capital stock, evidences of
indebtedness, assets, property, rights, options or warrants distributed with respect to each outstanding share of our common stock on the <FONT STYLE="white-space:nowrap">ex-dividend</FONT> date for such distribution. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any increase made under the portion of this clause (3)&nbsp;above will become effective immediately after the open of business
on the <FONT STYLE="white-space:nowrap">ex-dividend</FONT> date for such distribution. If such distribution is not so paid or made, the conversion rate shall be decreased to be the conversion rate that would then be in effect if such distribution
had not been declared. Notwithstanding the foregoing, if &#8220;FMV&#8221; (as defined above) is equal to or greater than &#8220;SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#8221; (as defined above), in lieu of the foregoing
increase, each holder of a note shall receive, in respect of each $1,000 principal amount thereof, at the same time and upon the same terms as holders of our common stock, the amount and kind of our capital stock, evidences of our indebtedness,
other assets or property of ours or rights, options or warrants to acquire our capital stock or other securities that such holder would have received if such holder owned a number of shares of common stock equal to the conversion rate in effect on
the <FONT STYLE="white-space:nowrap">ex-dividend</FONT> date for the distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">With respect to an adjustment pursuant
to this clause (3)&nbsp;where there has been a payment of a dividend or other distribution on our common stock of shares of capital stock of any class or series, or similar equity interest, of or relating to a subsidiary or other business unit, that
are, or, when issued, will be, listed or admitted for trading on a U.S. national securities exchange, which we refer to as a <FONT STYLE="white-space:nowrap">&#8220;spin-off,&#8221;</FONT> the conversion rate will be increased based on the following
formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g113098g61k61.jpg" ALT="LOGO" STYLE="width:1.64667in;height:0.356662in;">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">CR<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#8199;&#8196;&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the conversion rate in effect immediately prior to the end of the &#8220;valuation period&#8221; (as defined
below); </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">CR<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB>&#8199;&#8196;&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the conversion rate in effect immediately after the end of the valuation period; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">FMV<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the average of the last reported sale prices of the capital stock or similar equity interest distributed to
holders of our common stock applicable to one share of our common stock (determined by reference to the definition of last reported sale price set forth under the caption &#8220;&#8212;Optional Redemption&#8221; as if references therein to our
common stock were to such capital stock or similar equity interest) over the first 10 consecutive trading day period after, and including, the <FONT STYLE="white-space:nowrap">ex-dividend</FONT> date of the
<FONT STYLE="white-space:nowrap">spin-off</FONT> (the &#8220;valuation period&#8221;); and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">MP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#8199;&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the average of the last reported sale prices of our common stock over the valuation period.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The increase to the conversion rate under the preceding paragraph will occur at the close of business
on the last trading day of the valuation period; <I>provided</I> that (x)&nbsp;in respect of any conversion of notes for which physical settlement is applicable, if the relevant conversion date occurs during the valuation period, the reference to
&#8220;10&#8221; in the preceding paragraph shall be deemed replaced with such lesser number of trading days as have elapsed from, and including, the <FONT STYLE="white-space:nowrap">ex-dividend</FONT> date for such
<FONT STYLE="white-space:nowrap">spin-off</FONT> to, and including, such conversion date in determining the conversion rate and (y)&nbsp;in respect of any conversion of notes for which cash settlement or combination settlement is applicable, for any
trading day that falls within the relevant observation period for such conversion and within the valuation period, the reference to &#8220;10&#8221; in the preceding paragraph shall be deemed replaced with such lesser number of trading days as have
elapsed from, and including, the <FONT STYLE="white-space:nowrap">ex-dividend</FONT> date for such <FONT STYLE="white-space:nowrap">spin-off</FONT> to, and including, such trading day in determining the conversion rate as of such trading day of such
observation period. If any dividend or distribution that constitutes a <FONT STYLE="white-space:nowrap">spin-off</FONT> is declared but not so paid or made, the conversion rate shall be immediately decreased, effective as of the date our board of
directors or a committee thereof determines not to pay or make such dividend or distribution, to the conversion rate that would then be in effect if such dividend or distribution had not been declared or announced. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(4) If we make any cash dividend or distribution to all or substantially all holders of our common stock, the conversion rate
will be adjusted based on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g113098g62k01.jpg" ALT="LOGO" STYLE="width:1.37449in;height:0.356669in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">CR<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the conversion rate in effect immediately prior to the open of business on the <FONT
STYLE="white-space:nowrap">ex-dividend</FONT> date for such dividend or distribution; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">CR<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB>&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the conversion rate in effect immediately after the open of business on the
<FONT STYLE="white-space:nowrap">ex-dividend</FONT> date for such dividend or distribution; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">SP<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the last reported sale price of our common stock on the trading day immediately preceding the <FONT
STYLE="white-space:nowrap">ex-dividend</FONT> date for such dividend or distribution; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">C&#8199;&#8201;&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the amount in cash per share we distribute to all or substantially all holders of our common stock.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any increase made under this clause (4)&nbsp;shall become effective immediately after the open of
business on the <FONT STYLE="white-space:nowrap">ex-dividend</FONT> date for such dividend or distribution. If such dividend or distribution is not so paid, the conversion rate shall be decreased, effective as of the date our board of directors or a
committee thereof determines not to make or pay such dividend or distribution, to be the conversion rate that would then be in effect </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
if such dividend or distribution had not been declared. Notwithstanding the foregoing, if &#8220;C&#8221; (as defined above) is equal to or greater than &#8220;SP<SUB
STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#8221; (as defined above), in lieu of the foregoing increase, each holder of a note shall receive, for each $1,000 principal amount of the notes it holds, at the same time and upon the same terms
as holders of shares of our common stock, the amount of cash that such holder would have received if such holder owned a number of shares of our common stock equal to the conversion rate on the <FONT STYLE="white-space:nowrap">ex-dividend</FONT>
date for such cash dividend or distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(5) If we or any of our subsidiaries make a payment in respect of a tender
or exchange offer for our common stock that is subject to the then applicable tender offer rules under the Exchange Act (other than any odd lot tender offer), to the extent that the cash and value of any other consideration included in the payment
per share of common stock exceeds the average of the last reported sale prices of our common stock over the 10 consecutive trading day period commencing on, and including, the trading day next succeeding the last date on which tenders or exchanges
may be made pursuant to such tender or exchange offer, the conversion rate will be increased based on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g113098g62k02.jpg" ALT="LOGO" STYLE="width:1.90749in;height:0.356662in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">CR<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the conversion rate in effect immediately prior to the close of business on the 10th trading day immediately
following, and including, the trading day next succeeding the date such tender or exchange offer expires; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">CR<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB>&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the conversion rate in effect immediately after the close of business on the 10th trading day immediately
following, and including, the trading day next succeeding the date such tender or exchange offer expires; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">AC&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the aggregate value of all cash and any other consideration (as determined by us in good faith) paid or
payable for shares purchased in such tender or exchange offer; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB>&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the number of shares of our common stock outstanding immediately prior to the date such tender or exchange
offer expires (prior to giving effect to the purchase of all shares accepted for purchase or exchange in such tender or exchange offer); </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">OS<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB>&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the number of shares of our common stock outstanding immediately after the date such tender or exchange
offer expires (after giving effect to the purchase of all shares accepted for purchase or exchange in such tender or exchange offer); and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left">SP<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB>&#8199;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the average of the last reported sale prices of our common stock over the 10 consecutive trading day period
commencing on, and including, the trading day next succeeding the date such tender or exchange offer expires. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The increase to the conversion rate under the preceding paragraph will occur at the close of business on the 10th trading day
immediately following, and including, the trading day next succeeding the date such tender or exchange offer expires; <I>provided</I> that (x)&nbsp;in respect of any conversion of notes for which physical settlement is applicable, if the relevant
conversion date occurs during the 10 trading days immediately following, and including, the trading day next succeeding the expiration date of any tender or exchange offer, references to &#8220;10&#8221; or &#8220;10th&#8221; in the preceding
paragraph shall be deemed replaced with such lesser number of trading days as have elapsed from, and including, the trading day next succeeding such expiration date of such tender or exchange offer to, and including, such conversion date in
determining the conversion rate and (y)&nbsp;in respect of any conversion of notes for which cash settlement or combination settlement is applicable, for any trading day that falls within the relevant observation period for such conversion and
within the 10 trading days immediately following, and including, the trading day next succeeding the expiration date of any tender or exchange offer, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
references to &#8220;10&#8221; or &#8220;10th&#8221; in the preceding paragraph shall be deemed replaced with such lesser number of trading days as have elapsed from, and including, the trading
day next succeeding such expiration date of such tender or exchange offer to, and including, such trading day in determining the conversion rate as of such trading day of such observation period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we are or one of our subsidiaries is obligated to purchase shares of our common stock pursuant to any such tender or
exchange offer described in clause (5)&nbsp;but we are, or such subsidiary is, permanently prevented by applicable law from effecting any such purchase or all such purchases are rescinded, the conversion rate will be readjusted to be the conversion
rate that would then be in effect if such tender or exchange offer had not been made or had been made only in respect of the purchases that have been made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding the foregoing, if a conversion rate adjustment becomes effective on any
<FONT STYLE="white-space:nowrap">ex-dividend</FONT> date as described above, and a holder that has converted its notes on or after such <FONT STYLE="white-space:nowrap">ex-dividend</FONT> date and on or prior to the related record date would be
treated as the record holder of shares of our common stock as of the related conversion date as described under the caption &#8220;&#8212;Settlement upon Conversion&#8221; based on an adjusted conversion rate for such
<FONT STYLE="white-space:nowrap">ex-dividend</FONT> date, then, notwithstanding the foregoing conversion rate adjustment provisions, the conversion rate adjustment relating to such <FONT STYLE="white-space:nowrap">ex-dividend</FONT> date will not be
made for such converting holder. Instead, such holder will be treated as if such holder were the record owner of the shares of our common stock on an unadjusted basis and participate in the related dividend, distribution or other event giving rise
to such adjustment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as stated herein, we will not adjust the conversion rate for the issuance of shares of our
common stock or any securities convertible into or exchangeable for shares of our common stock or the right to purchase shares of our common stock or such convertible or exchangeable securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As used in this section, <FONT STYLE="white-space:nowrap">&#8220;ex-dividend</FONT> date&#8221; means the first date on which
the shares of our common stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive the issuance, dividend or distribution in question, from us or, if applicable, from the seller of our common stock
on such exchange or market (in the form of due bills or otherwise) as determined by such exchange or market, and &#8220;effective date&#8221; means the first date on which the shares of our common stock trade on the applicable exchange or in the
applicable market, regular way, reflecting the relevant share split or share combination, as applicable. For the avoidance of doubt, any alternative trading convention on the applicable exchange or market in respect of shares of our common stock
under a separate ticker symbol or CUSIP number will not be considered &#8220;regular way&#8221; for this purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As used
in this section, &#8220;record date&#8221; means, with respect to any dividend, distribution or other transaction or event in which the holders of our common stock (or other applicable security) have the right to receive any cash, securities or
other property or in which our common stock (or such other security) is exchanged for or converted into any combination of cash, securities or other property, the date fixed for determination of holders of our common stock (or such other security)
entitled to receive such cash, securities or other property (whether such date is fixed by our board of directors or a duly authorized committee thereof, statute, contract or otherwise). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to applicable exchange listing rules, we are permitted to increase the conversion rate of the notes by any amount for
a period of at least 20 business days if we determine that such increase would be in our best interest. Subject to applicable exchange listing rules, we may also (but are not required to) increase the conversion rate to avoid or diminish income tax
to holders of our common stock or rights to purchase shares of our common stock in connection with a dividend or distribution of shares (or rights to acquire shares) or similar event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A beneficial owner of a note may, in some circumstances, including a distribution of cash dividends to holders of shares of
our common stock, be deemed to have received a distribution subject to U.S. federal income tax as a result of an adjustment or the nonoccurrence of an adjustment to the conversion rate. Any applicable withholding taxes (including backup withholding)
may be withheld from interest and payments upon conversion, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
repurchase, redemption or maturity of the notes, or if any withholding taxes (including backup withholding) are paid on behalf of a holder or beneficial owner of the notes, those withholding
taxes may be withheld from or set off against payments of cash or delivery of shares of common stock, if any, in respect of the notes (or, in some circumstances, any payments on our common stock) or sales proceeds payable to, or other funds or
assets of, such holder or beneficial owner. For a discussion of the U.S. federal income tax treatment of an adjustment to the conversion rate, see the caption &#8220;Material U.S. Federal Income Tax Considerations.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we have a rights plan in effect upon conversion of the notes into common stock, you will receive, in addition to any shares
of common stock received in connection with such conversion, the rights under the rights plan. However, if, prior to any conversion, the rights have separated from the shares of common stock in accordance with the provisions of the applicable rights
plan, the conversion rate will be adjusted at the time of separation as if we distributed to all or substantially all holders of our common stock, shares of our capital stock, evidences of indebtedness, assets, property, rights, options or warrants
as described in clause (3)&nbsp;above, subject to readjustment in the event of the expiration, termination or redemption of such rights. We do not currently have a rights plan in effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding any of the foregoing, the conversion rate will not be adjusted: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon the issuance of shares of our common stock at a price below the conversion price or otherwise, other than
any such issuance described in clause (1), (2) or (3)&nbsp;above; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon the issuance of any shares of our common stock pursuant to any present or future plan providing for the
reinvestment of dividends or interest payable on our securities and the investment of additional optional amounts in shares of our common stock under any plan; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon the issuance of any shares of our common stock or options or rights to purchase those shares pursuant to
any present or future employee, director or consultant benefit or incentive plan or program (including pursuant to any evergreen plan) of or assumed by us or any of our subsidiaries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon the issuance of any shares of our common stock pursuant to any option, warrant, right or exercisable,
exchangeable or convertible security (including any adjustment to the conversion rate thereof), including the issuance of any shares of our common stock upon the redemption, conversion or settlement of any shares of preferred stock (or any
securities issued in connection with the redemption or settlement of any such shares of preferred stock or similar securities), in each case, not described in the preceding bullet point and outstanding as of the date the notes were first issued;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for a third-party tender offer by any party other than a tender offer by one or more of our subsidiaries as
described in clause (5)&nbsp;above; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon the repurchase of any shares of our common stock pursuant to an open market share purchase program or
other <FONT STYLE="white-space:nowrap">buy-back</FONT> transaction, including structured or derivative transactions such as accelerated share repurchase transactions or similar forward derivatives, or other
<FONT STYLE="white-space:nowrap">buy-back</FONT> transaction, that is not a tender offer or exchange offer of the kind described under clause (5)&nbsp;above; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">solely for a change in the par value (or lack of par value) of our common stock; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for accrued and unpaid interest, if any. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Adjustments to the conversion rate will be calculated to the nearest 1/10,000th of a share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If an adjustment to the conversion rate otherwise required by the provisions described above would result in a change of less
than 1% to the conversion rate, then, notwithstanding the foregoing, we may, at our election, defer and carry forward such adjustment, except that all such deferred adjustments must be given effect immediately upon the earliest to occur of the
following: (i)&nbsp;when all such deferred adjustments would result in an aggregate change of at least 1% to the conversion rate; (ii)&nbsp;on the conversion date for any notes (in the case of physical settlement); (iii) on each trading day of any
observation period related to any conversion of notes (in the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
case of cash settlement or combination settlement); (iv)&nbsp;April&nbsp;1, 2032; (v)&nbsp;on any date on which we deliver a notice of redemption; and (vi)&nbsp;on the effective date of any
fundamental change and/or make-whole fundamental change, in each case, unless the adjustment has already been made. We refer to the provisions described in the preceding sentence as the &#8220;1% exception.&#8221; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Recapitalizations, Reclassifications and Changes of Our Common Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the case of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any recapitalization, reclassification or change of our common stock (other than a change to par value, or
from par value to no par value, or changes resulting from a subdivision or combination), </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any consolidation, merger, combination or similar transaction involving us, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any sale, lease or other transfer to a third party of the consolidated assets of ours and our subsidiaries
substantially as an entirety, or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any statutory share exchange, </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">in each case, as a result of which our common stock would be converted into, or exchanged for, stock, other securities, other
property or assets (including cash or any combination thereof) (any such event, a &#8220;share exchange event&#8221;), then, at and after the effective time of the share exchange event, the right to convert each $1,000 principal amount of notes will
be changed into a right to convert such principal amount of notes into the kind and amount of shares of stock, other securities or other property or assets (including cash or any combination thereof) that a holder of a number of shares of common
stock equal to the conversion rate immediately prior to such share exchange event would have owned or been entitled to receive (the &#8220;reference property&#8221;) upon such share exchange event and, prior to or at the effective time of such share
exchange event, we or the successor or acquiring company, as the case may be, shall execute with the trustee a supplemental indenture providing for such change in the right to convert each $1,000 principal amount of notes. However, at and after the
effective time of the share exchange event, (i)&nbsp;we or the successor or acquiring company, as the case may be, will continue to have the right to determine the form of consideration to be paid or delivered, as the case may be, upon conversion of
notes, as set forth under the caption &#8220;&#8212;Settlement upon Conversion&#8221; and (ii)(x) any amount payable in cash upon conversion of the notes as set forth under the caption &#8220;&#8212;Settlement upon Conversion&#8221; will continue to
be payable in cash, (y)&nbsp;any shares of our common stock that we would have been required to deliver upon conversion of the notes as set forth under the caption &#8220;&#8212;Settlement upon Conversion&#8221; will instead be deliverable in the
amount and type of reference property that a holder of that number of shares of our common stock would have received in such share exchange event and (z)&nbsp;the daily VWAP will be calculated based on the value of a unit of reference property that
a holder of one share of our common stock would have received in such share exchange event. If the share exchange event causes our common stock to be converted into, or exchanged for, the right to receive more than a single type of consideration
(determined based in part upon any form of stockholder election), the reference property into which the notes will be convertible will be deemed to be the weighted average of the types and amounts of consideration actually received by the holders of
our common stock. If the holders of our common stock receive only cash in such share exchange event, then for all conversions that occur after the effective date of such share exchange event (i)&nbsp;the consideration due upon conversion of each
$1,000 principal amount of notes shall be solely cash in an amount equal to the conversion rate in effect on the conversion date (as may be increased as described under the caption &#8220;&#8212;Increase in Conversion Rate upon Conversion upon a
Make-Whole Fundamental Change or Notice of Redemption&#8221;), <I>multiplied by</I> the price paid per share of common stock in such share exchange event and (ii)&nbsp;we will satisfy our conversion obligation by paying cash to converting holders on
the second business day immediately following the conversion date. We will notify holders, the trustee and the conversion agent (if other than the trustee) in writing of the weighted average as soon as practicable after such determination is made.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the reference property in respect of any such share exchange event includes, in whole or in part, shares of common
equity or American depositary receipts (or other interests) in respect thereof, the supplemental indenture </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
providing that the notes will be convertible into reference property will also provide for anti-dilution and other adjustments that are as nearly equivalent as possible to the adjustments
described under the caption &#8220;&#8212;Conversion Rate Adjustments&#8221; above with respect to the portion of the reference property consisting of such common equity or American depositary receipts (or other interests) in respect thereof. If the
reference property in respect of any such share exchange event includes shares of stock, securities or other property or assets (other than cash and/or cash equivalents) of a company other than us or the successor or acquiring company, as the case
may be, in such share exchange event, such other company, if an affiliate of us or the successor or acquiring company, will also execute such supplemental indenture, and such supplemental indenture will contain such additional provisions to protect
the interests of the holders, including the right of holders to require us to repurchase their notes upon a fundamental change as described under the caption &#8220;&#8212;Repurchase at the Option of Holders&#8212;Fundamental Change Permits Holders
to Require Us to Repurchase Notes&#8221; below, as we in good faith reasonably consider necessary by reason of the foregoing. We will agree in the indenture not to become a party to any such share exchange event unless its terms are consistent with
the foregoing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Adjustments of Prices </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Whenever any provision of the indenture requires us to calculate the last reported sale prices, the daily VWAPs, the daily
conversion values or the daily settlement amounts over a span of multiple days (including, without limitation, an observation period and the period, if any, for determining the &#8220;stock price&#8221; for purposes of a make-whole fundamental
change or a notice of redemption), we will, in good faith, make appropriate adjustments (without duplication in respect of any adjustment made pursuant to the provisions described under the caption &#8220;&#8212;Conversion Rate Adjustments&#8221;
above) to each to account for any adjustment to the conversion rate that becomes effective, or any event requiring an adjustment to the conversion rate where the <FONT STYLE="white-space:nowrap">ex-dividend</FONT> date, effective date or expiration
date of the event occurs, at any time during the period when the last reported sale prices, the daily VWAPs, the daily conversion values or the daily settlement amounts are to be calculated. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Increase in Conversion Rate upon Conversion upon a Make-Whole Fundamental Change or Notice of Redemption </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If (i)&nbsp;(a) the &#8220;effective date&#8221; (as defined below) of a &#8220;fundamental change&#8221; (as defined below and
determined after giving effect to any exceptions to or exclusions from such definition, but without regard to the <I>proviso</I> in clause (2)&nbsp;of the definition thereof, a &#8220;make-whole fundamental change&#8221;) occurs prior to the
maturity date of the notes or (b)&nbsp;we deliver a notice of redemption as provided under the caption &#8220;&#8212;Optional Redemption&#8221; and (ii)&nbsp;a holder elects to convert its notes (or any portion thereof) in connection with such
make-whole fundamental change or notice of redemption, as the case may be, we will, under certain circumstances, increase the conversion rate for the notes so surrendered for conversion by a number of additional shares of common stock (the
&#8220;additional shares&#8221;), as described below. A conversion of notes will be deemed for these purposes to be &#8220;in connection with&#8221; a make-whole fundamental change if the relevant conversion date occurs during the period from, and
including, the effective date of the <FONT STYLE="white-space:nowrap">make-whole</FONT> fundamental change up to, and including, the business day immediately prior to the related fundamental change repurchase date (or, in the case of an exempted
fundamental change or a <FONT STYLE="white-space:nowrap">make-whole</FONT> fundamental change that would have been a fundamental change but for the proviso in clause (2)&nbsp;of the definition thereof, the 35th trading day immediately following the
effective date of such make-whole fundamental change) (such period, the &#8220;make-whole fundamental change period&#8221;). A conversion of notes will be deemed for these purposes to be &#8220;in connection with&#8221; a notice of redemption if
such notes have been called (or deemed called) for redemption and the relevant conversion date occurs during the related redemption period. Accordingly, if we elect to redeem less than all of the outstanding notes as described under the caption
&#8220;&#8212;Optional Redemption,&#8221; holders of the notes not called for redemption will not be entitled to convert such notes on account of the notice of redemption and will not be entitled to an increased conversion rate for conversions of
such notes (on account of the notice of redemption) during the applicable redemption period if such notes are otherwise convertible, except in the limited circumstances set forth under the caption &#8220;&#8212;Conversion
Rights&#8212;General.&#8221; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon surrender of notes for conversion in connection with a make-whole
fundamental change or a notice of redemption, we will, at our option, satisfy our conversion obligation by physical settlement, cash settlement or combination settlement, as described under the caption &#8220;&#8212;Conversion
Rights&#8212;Settlement upon Conversion.&#8221; However, if the consideration for our common stock in any make-whole fundamental change described in clause (2)&nbsp;of the definition of fundamental change is composed entirely of cash, for any
conversion of notes following the effective date of such make-whole fundamental change, the conversion obligation will be calculated based solely on the &#8220;stock price&#8221; (as defined below) for the transaction and will be deemed to be an
amount of cash per $1,000 principal amount of converted notes equal to the conversion rate (including any increase to reflect the additional shares as described in this section), <I>multiplied by</I> such stock price. In such event, the conversion
obligation will be determined and paid to holders in cash on the second business day following the conversion date. We will notify holders, the trustee and the conversion agent (if other than the trustee) of the effective date of any make-whole
fundamental change no later than five business days after such effective date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The number of additional shares, if any,
by which the conversion rate will be increased will be determined by reference to the table below, based on the date on which the make-whole fundamental change occurs or becomes effective, or the date we deliver the notice of redemption, as the case
may be (in each case, the &#8220;effective date&#8221;), and the price (the &#8220;stock price&#8221;) paid (or deemed to be paid) per share of our common stock in the make-whole fundamental change or determined with respect to the notice of
redemption, as the case may be. If the holders of our common stock receive in exchange for their common stock only cash in a make-whole fundamental change described in clause (2)&nbsp;of the definition of fundamental change, the stock price will be
the cash amount paid per share. Otherwise, the stock price will be the average of the last reported sale prices of our common stock over the five consecutive trading day period ending on, and including, the trading day immediately preceding the
effective date. If a conversion in connection with a notice of redemption would also be deemed to be in connection with a make-whole fundamental change, a holder of the notes to be converted will be entitled to a single increase to the conversion
rate with respect to the first to occur of the effective date of the notice of redemption or the make-whole fundamental change, as applicable, and the later event will be deemed not to have occurred for purposes of such conversion for purposes of
this section. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The stock prices set forth in the column headings of the table below will be adjusted as of any date on
which the conversion rate of the notes is otherwise adjusted. The adjusted stock prices will equal the stock prices immediately prior to such adjustment, <I>multiplied by</I> a fraction, the numerator of which is the conversion rate immediately
prior to the adjustment giving rise to the stock price adjustment and the denominator of which is the conversion rate as so adjusted. The number of additional shares as set forth in the table below will be adjusted in the same manner and at the same
time as the conversion rate as set forth under the caption &#8220;&#8212;Conversion Rate Adjustments.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
following table sets forth the number of additional shares by which the conversion rate will be increased per $1,000 principal amount of notes for each stock price and effective date set forth below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="46" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Effective Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$8.21</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$9.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$10.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$11.08</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$12.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$13.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$14.41</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$15.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$16.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$20.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$30.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$40.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;15,&nbsp;2026</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31.5784</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28.9156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23.7820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19.4513</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.4958</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.8615</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.9181</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.8960</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.3900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.3355</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.5457</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;1,&nbsp;2027</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31.5784</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28.9156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23.7820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19.4513</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.4958</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.8469</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.7876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.7347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.1925</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.1120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.4583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;1,&nbsp;2028</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31.5784</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28.9156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23.7820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19.4513</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.2933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.4108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.2748</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.2100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.6650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.6800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.3390</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;1,&nbsp;2029</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31.5784</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28.9156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23.6900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.4594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15.0658</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.1731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.1027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.0793</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.6144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.9610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.1647</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;1,&nbsp;2030</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31.5784</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26.4767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20.5470</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15.7825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.6883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.0608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.2991</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.3900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.1025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.0200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;1,&nbsp;2031</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31.5784</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24.7322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17.9740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.7996</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.6258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.0900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.6315</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.8780</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.8681</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.7845</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;1,&nbsp;2032</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31.5784</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20.8869</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.7758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The exact stock prices and effective dates may not be set forth in the table above, in which
case: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If the stock price is between two stock prices in the table or the effective date is between two effective
dates in the table, the number of additional shares by which the conversion rate will be increased will </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
be determined by a straight-line interpolation between the number of additional shares set forth for the higher and lower stock prices and the earlier and later effective dates, as applicable,
based on a <FONT STYLE="white-space:nowrap">365-day</FONT> year. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If the stock price is greater than $40.00 per share (subject to adjustment in the same manner as the stock
prices set forth in the column headings of the table above), no additional shares will be added to the conversion rate. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If the stock price is less than $8.21 per share (subject to adjustment in the same manner as the stock prices
set forth in the column headings of the table above), no additional shares will be added to the conversion rate. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding the foregoing, in no event will the conversion rate per $1,000 principal amount of notes exceed 121.8026
shares of common stock, subject to adjustment in the same manner as the conversion rate as set forth under the caption &#8220;&#8212;Conversion Rate Adjustments.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our obligation to increase the conversion rate for notes converted in connection with a make-whole fundamental change or a
notice of redemption could be considered a penalty, in which case the enforceability thereof would be subject to general principles of reasonableness and equitable remedies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Repurchase at the Option of Holders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Repurchase on July&nbsp;8, 2030 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Holders have the right, at their option, to require us to repurchase for cash all of their notes, or any portion of the principal thereof that
is equal to $1,000 or a multiple of $1,000, on the specified repurchase date. The repurchase price we are required to pay on the specified repurchase date will be equal to 100% of the principal amount of the notes to be repurchased, plus any accrued
and unpaid interest to, but excluding, the specified repurchase date (the &#8220;specified repurchase date repurchase price&#8221;). On or before the 20th business day prior to the specified repurchase date, we will provide to all holders, the
trustee, the paying agent (if other than the trustee) and the conversion agent (if other than the trustee) a written notice stating, among other things (such notice, the &#8220;specified repurchase date right notice&#8221;): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the last date on which a holder may exercise the repurchase right; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the specified repurchase date repurchase price; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the specified repurchase date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the name and address of the conversion and paying agents; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the procedures that holders must follow to require us to repurchase their notes. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Fundamental Change Permits Holders to Require Us to Repurchase Notes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a &#8220;fundamental change&#8221; (other than an &#8220;exempted fundamental change,&#8221; each as defined below in this
section) occurs at any time, holders will have the right, at their option, to require us to repurchase for cash all of their notes, or any portion of the principal amount thereof that is equal to $1,000 or an integral multiple of $1,000. The
fundamental change repurchase date will be a date specified by us that is not less than 20 or more than 35 business days following the date of our fundamental change notice as described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The fundamental change repurchase price we are required to pay will be equal to 100% of the principal amount of the notes to
be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date (unless the fundamental change repurchase date falls after a regular record date but on or prior to the interest payment date to which such
regular record date relates, in which case we will instead pay the full amount of accrued and unpaid interest to the holder of record as of the close of business on such regular </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
record date on, or at our election, before, such interest payment date, and the fundamental change repurchase price will be equal to 100% of the principal amount of the notes to be repurchased).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A &#8220;fundamental change&#8221; will be deemed to have occurred at the time after the notes are originally issued if
any of the following occurs: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">except in connection with transactions described in clause (2)&nbsp;below, a &#8220;person&#8221; or
&#8220;group&#8221; within the meaning of Section&nbsp;13(d) of the Exchange Act, other than us, our direct or indirect wholly owned subsidiaries and our and their employee benefit plans, has become and files a Schedule TO (or any successor
schedule, form or report) or any schedule, form or report under the Exchange Act that discloses that such person or group has become the direct or indirect &#8220;beneficial owner,&#8221; as defined in Rule
<FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act, of shares of our common stock representing more than 50% of the voting power of our common stock, unless such beneficial ownership arises solely as a result of a revocable proxy
delivered in response to a public proxy or consent solicitation made pursuant to the applicable rules and regulations under the Exchange Act and is not also then reportable on Schedule 13D or Schedule 13G (or any successor schedule) under the
Exchange Act regardless of whether such a filing has actually been made; provided that no person or group shall be deemed to be the beneficial owner of any securities tendered pursuant to a tender or exchange offer made by or on behalf of such
&#8220;person&#8221; or &#8220;group&#8221; until such tendered securities are accepted for purchase or exchange under such offer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the consummation of (A)&nbsp;any recapitalization, reclassification or change of our common stock (other
than a change to par value, or from par value to no par value, or changes resulting from a subdivision or combination) as a result of which our common stock would be converted into, or exchanged for, stock, other securities, other property or
assets; (B)&nbsp;any share exchange, consolidation or merger of us pursuant to which our common stock will be converted into cash, securities or other property or assets; or (C)&nbsp;any sale, lease or other transfer in one transaction or a series
of transactions of all or substantially all of the consolidated assets of us and our subsidiaries, taken as a whole, to any person other than one or more of our direct or indirect wholly owned subsidiaries; provided, however, that a transaction
described in clause (A)&nbsp;or (B) in which the holders of all classes of our common equity immediately prior to such transaction own, directly or indirectly, more than 50% of all classes of common equity of the continuing or surviving corporation
or transferee or the parent thereof immediately after such transaction in substantially the same proportions (relative to each other) as such ownership immediately prior to such transaction shall not be a fundamental change pursuant to this clause
(2); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">our stockholders approve any plan or proposal for the liquidation or dissolution of us; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">our common stock (or other common stock underlying the notes) ceases to be listed or quoted on any of The
New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market or the Nasdaq Capital Market (or any of their respective successors). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A transaction or transactions described in clause (2)&nbsp;above will not constitute a fundamental change, however, if at
least 90% of the consideration received or to be received by our common stockholders, excluding cash payments for fractional shares and cash payments made in respect of dissenters&#8217; appraisal rights, in connection with such transaction or
transactions consists of shares of common stock that are listed or quoted on any of The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market or the Nasdaq Capital Market (or any of their respective
successors) or will be so listed or quoted when issued or exchanged in connection with such transaction or transactions and as a result of such transaction or transactions the notes become convertible into such consideration, excluding cash payments
for fractional shares and cash payments made in respect of dissenters&#8217; appraisal rights (subject to the provisions set forth above under the caption &#8220;&#8212;Conversion Rights&#8212;Settlement upon Conversion&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If any transaction in which our common stock is replaced by the common stock or other common equity of another entity occurs,
following completion of any related make-whole fundamental change period (or, in the case of a transaction that would have been a fundamental change or a make-whole fundamental change but for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the immediately preceding paragraph, following the effective date of such transaction), references to us in the definition of &#8220;fundamental change&#8221; above shall instead be references to
such other entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On or before the 20th business day after the occurrence of a fundamental change, we will provide to
all holders of the notes and the trustee, the conversion agent (if other than the trustee) and the paying agent (if other than the trustee) a notice of the occurrence of the fundamental change and of the resulting repurchase right. Such notice shall
state, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the events causing a fundamental change; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effective date of the fundamental change; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the last date on which a holder may exercise the repurchase right; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fundamental change repurchase price; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fundamental change repurchase date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the name and address of the paying agent and the conversion agent, if applicable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, the conversion rate and any adjustments to the conversion rate as a result of the fundamental
change (or related make-whole fundamental change); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">that the notes with respect to which a fundamental change repurchase notice has been delivered by a holder may
be converted only if the holder validly withdraws the fundamental change repurchase notice in accordance with the terms of the indenture; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the procedures that holders must follow to require us to repurchase their notes. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Simultaneously with providing such notice, we will publish the information on our website or through such other public medium
as we may use at that time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding the foregoing, we will not be required to repurchase, or to make an offer to
repurchase, the notes upon a fundamental change if a third party makes such an offer in the same manner, at the same time and otherwise in compliance with the requirements for an offer made by us as set forth above and such third party purchases all
notes properly surrendered and not validly withdrawn under its offer in the same manner, at the same time and otherwise in compliance with the requirements for an offer made by us as set forth above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding anything to the contrary, we will not be required to send a fundamental change notice, or offer to repurchase
or repurchase any notes, as described above, in connection with a fundamental change occurring pursuant to clause (2)(A) or (B)&nbsp;of the definition thereof, if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such fundamental change constitutes a share exchange event referred to under the caption
&#8220;&#8212;Conversion Rights&#8212;Recapitalizations, Reclassifications and Changes of Our Common Stock,&#8221; whose reference property consists entirely of cash in U.S. dollars; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">immediately after such fundamental change, the notes become convertible (pursuant to the provisions described
above under the captions &#8220;&#8212;Conversion Rights&#8212;Recapitalizations, Reclassifications and Changes of Our Common Stock&#8221; and, if applicable, &#8220;&#8212;Conversion Rights&#8212;Increase in Conversion Rate upon Conversion upon a
Make-Whole Fundamental Change or Notice of Redemption&#8221;) into consideration that consists solely of U.S. dollars in an amount per $1,000 principal amount of notes that equals or exceeds the fundamental change repurchase price per $1,000
principal amount of notes (calculated assuming that the same includes the maximum amount of accrued but unpaid interest payable as part of the fundamental change repurchase price for such fundamental change); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we timely send the notice relating to such fundamental change required pursuant to the provisions described
above under the caption &#8220;&#8212;Conversion Rights&#8212;Increase in Conversion Rate upon Conversion upon a Make-Whole Fundamental Change or Notice of Redemption.&#8221; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We refer to any fundamental change with respect to which, in accordance with
the provisions described above, we do not offer to repurchase any notes as an &#8220;exempted fundamental change.&#8221; For the avoidance of doubt, the maximum amount of accrued interest referred to in the second bullet point in the immediately
preceding paragraph above will be determined (i)&nbsp;by assuming that the fundamental change repurchase date occurs on the latest possible date permitted for the applicable fundamental change pursuant to the provisions described under this caption
&#8220;&#8212;Fundamental Change Permits Holders to Require Us to Repurchase Notes&#8221;; and (ii)&nbsp;without regard to the parenthetical in the second paragraph under this caption &#8220;&#8212;Fundamental Change Permits Holders to Require Us to
Repurchase Notes.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The fundamental change repurchase rights of the holders could discourage a potential acquirer of
us. The fundamental change repurchase feature, however, is not the result of management&#8217;s knowledge of any specific effort to obtain control of us by any means or part of a plan by management to adopt a series of anti-takeover provisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The term fundamental change is limited to specified transactions and may not include other events that might adversely affect
our financial condition. In addition, the requirement that we offer to repurchase the notes upon a fundamental change may not protect holders in the event of a highly leveraged transaction, reorganization, merger or similar transaction involving us.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Furthermore, holders may not be entitled to require us to repurchase their notes or be entitled to an increase in the
conversion rate upon conversion as described under &#8220;&#8212;Increase in Conversion Rate upon Conversion upon a Make-Whole Fundamental Change or Notice of Redemption&#8221; in circumstances involving a significant change in the composition of
our board unless such change is in connection with a fundamental change or make-whole fundamental change as described herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The definition of fundamental change includes a phrase relating to the sale, lease or other transfer of &#8220;all or
substantially all&#8221; of the consolidated assets of us and our subsidiaries, taken as a whole. There is no precise, established definition of the phrase &#8220;substantially all&#8221; under applicable law. Accordingly, the ability of a holder of
the notes to require us to repurchase its notes as a result of the sale, lease or other transfer of less than all of the consolidated assets of us and our subsidiaries may be uncertain. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Repurchase Procedures </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To exercise a repurchase right, holders of certificated notes must deliver, on or before the business day immediately preceding
the specified repurchase date or the fundamental change repurchase date, as applicable, the notes to be repurchased, duly endorsed for transfer, together with a written repurchase notice, to the paying agent. Each repurchase notice must state: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the certificate numbers of your notes to be delivered for repurchase; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the portion of the principal amount of notes to be repurchased, which must be $1,000 or an integral multiple
thereof; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">that the notes are to be repurchased by us pursuant to the applicable provisions of the notes and the
indenture. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the notes are not in certificated form, to exercise the specified repurchase date right
or the fundamental change repurchase right, as applicable, holders must surrender their notes in accordance with applicable DTC procedures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Holders of certificated notes may withdraw any repurchase notice (in whole
or in part) by a written notice of withdrawal delivered to the paying agent prior to the close of business on the business day immediately preceding the fundamental change repurchase date. The notice of withdrawal shall state: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the principal amount of the withdrawn notes, which must be $1,000 or an integral multiple thereof;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the certificate numbers of the withdrawn notes; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the principal amount, if any, which remains subject to the repurchase notice, which must be $1,000 or an
integral multiple thereof. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the notes are not in certificated form, holders must withdraw their notes
subject to repurchase in accordance with applicable DTC procedures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will be required to repurchase the notes on the
specified repurchase date or the fundamental change repurchase date, as applicable. Holders who have exercised the repurchase right will receive payment of the specified repurchase date repurchase price or the fundamental change repurchase price, as
applicable, on the later of (i)&nbsp;the specified repurchase date or the fundamental change repurchase date, as applicable, and (ii)&nbsp;the time of book-entry transfer or the delivery of the notes. If the paying agent holds money sufficient to
pay the specified repurchase date repurchase price or the fundamental change repurchase price, as applicable, of the notes on the specified repurchase date or the fundamental change repurchase date, as applicable, then, with respect to the notes
that have been properly surrendered for repurchase and have not been validly withdrawn: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the notes will cease to be outstanding and interest will cease to accrue (whether or not book-entry transfer
of the notes is made or whether or not the notes are delivered to the paying agent); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all other rights of the holder will terminate (other than the right to receive the specified repurchase date
repurchase price or the fundamental change repurchase price, as applicable). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with any
repurchase offer pursuant to a specified repurchase date right notice or a fundamental change repurchase notice, we will, if required: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">comply with the tender offer rules under the Exchange Act that may then be applicable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">file a Schedule TO or any other required schedule under the Exchange Act; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">otherwise comply in all material respects with all federal and state securities laws in connection with any
offer by us to repurchase the notes; in each case, so as to permit the rights and obligations under this caption &#8220;&#8212;Repurchase at the Option of Holders&#8221; to be exercised in the time and in the manner specified in the indenture.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To the extent that the provisions of any securities laws or regulations enacted or adopted after the
date on which the notes are first issued conflict with the provisions of the indenture relating to our obligations to purchase the notes upon a fundamental change, we will comply with such securities laws and regulations and will not be deemed to
have breached our obligations under such provisions of the indenture by virtue of such conflict. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No notes may be
repurchased on any date at the option of holders on the specified repurchase date or upon a fundamental change if the principal amount of the notes has been accelerated, and such acceleration has not been rescinded, on or prior to such date (except
in the case of an acceleration resulting from a default by us in the payment of the specified repurchase date repurchase price or the fundamental change repurchase price, as applicable, with respect to such notes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On the specified repurchase date or if a fundamental change were to occur, we may not have enough funds to pay the specified
repurchase date repurchase price or the fundamental change repurchase price. Our ability to repurchase the notes for cash may be limited by restrictions on our ability to obtain funds for such repurchase through dividends from our subsidiaries, the
terms of our then existing borrowing arrangements or otherwise. See </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the caption &#8220;Risk Factors&#8212;Risks Related to the Notes&#8212;We may not have the ability to raise the funds necessary to settle conversions of the notes or the Green Convertible Notes
in cash or to repurchase the notes on July&nbsp;8, 2030, the Green Convertible Notes on August&nbsp;15, 2027 or the notes or the Green Convertible Notes upon a fundamental change, and our future debt may contain limitations on our ability to pay
cash upon conversion or repurchase of the notes or the Green Convertible Notes.&#8221; If we fail to repurchase the notes when required on the specified repurchase date or a fundamental change repurchase date, we will be in default under the
indenture. In addition, we have incurred, and may in the future incur, other indebtedness with similar change in control provisions permitting our holders to accelerate or to require us to repurchase our indebtedness upon the occurrence of similar
events or on some specific dates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Consolidation, Merger and Sale of Assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of the notes, the description below under this section titled &#8220;&#8212;Consolidation, Merger and Sale of
Assets&#8221; supersedes, in its entirety, the information in the accompanying prospectus under the caption &#8220;Description of Debt Securities&#8212;Consolidation, Merger and Sale of Assets.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The indenture will provide that we shall not consolidate with or merge with or into, or sell, convey, transfer or lease all or
substantially all of the consolidated properties and assets of us and our subsidiaries, taken as a whole, to, another person (other than any such sale, conveyance, transfer or lease to one or more of our direct or indirect wholly owned subsidiaries)
(each, a &#8220;business combination event&#8221;), unless (i)&nbsp;the resulting, surviving or transferee person (if not us) is a &#8220;qualified successor entity&#8221; (as defined below) (such qualified successor entity, the &#8220;successor
entity&#8221;) organized and existing under the laws of the United States of America, any state thereof or the District of Columbia, and such successor entity (if not us) expressly assumes by supplemental indenture all of our obligations under the
notes and the indenture; and (ii)&nbsp;immediately after giving effect to such business combination event, no default or event of default has occurred and is continuing under the indenture. Upon any business combination event, the successor entity
(if not us) shall succeed to, and may exercise every right and power of, ours under the indenture, and we shall be discharged from our obligations under the notes and the indenture except in the case of any such lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of the provision described in the preceding paragraph, the sale, conveyance, transfer or lease of all or
substantially all of the properties and assets of one or more of our subsidiaries to another person, which properties and assets, if held by us instead of such subsidiaries, would constitute all or substantially all of our properties and assets on a
consolidated basis, will be deemed to be the sale, conveyance, transfer or lease of all or substantially all of our properties and assets to another person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Although these types of transactions will be permitted under the indenture, certain of the foregoing transactions could
constitute a fundamental change permitting each holder to require us to repurchase the notes of such holder as described above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#8220;Qualified successor entity&#8221; means, with respect to a business combination event, a corporation; <I>provided</I>,
<I>however</I>, that (i)&nbsp;if such business combination event is an exempted fundamental change, then a limited liability company, limited partnership or other similar entity will also constitute a qualified successor entity with respect to such
business combination event; and (ii)&nbsp;a limited liability company or limited partnership that is the resulting, surviving or transferee person of such business combination event will also constitute a qualified successor entity with respect to
such business combination event, if each of the following clauses (1), (2), (3) and (4)&nbsp;is satisfied: (1)&nbsp;either (x) such limited liability company or limited partnership is treated as a corporation or an entity disregarded as separate
from a corporation, in each case, for U.S. federal income tax purposes, or (y)&nbsp;we have received an opinion of a nationally recognized tax counsel to the effect that such business combination event will not be treated as an exchange under
Section&nbsp;1001 of the U.S. Internal Revenue Code of 1986, as amended, for holders or beneficial owners of the notes, (2)&nbsp;such limited liability company or limited partnership is a direct or indirect, wholly owned subsidiary of a corporation
(or other entity treated as a corporation for U.S. federal income tax purposes) duly organized and existing under the laws of the United States of America, any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
state thereof or the District of Columbia; (3)&nbsp;such business combination event constitutes a share exchange event whose reference property consists solely of any combination of U.S. dollars
and shares of common stock or other corporate common equity interests of a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) described in clause (2); and (4)&nbsp;if such limited liability company or limited
partnership is disregarded as separate from its owner for U.S. federal income tax purposes, its regarded owner for those purposes is a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) described in clause
(2). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Events of Default </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of the notes, the description below under this section titled &#8220;&#8212;Events of Default&#8221; supersedes,
in its entirety, the information in the accompanying prospectus under the caption &#8220;Description of Debt Securities&#8212;Events of Default, Notice and Waiver.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each of the following is an event of default with respect to the notes: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">default in any payment of interest on any note when due and payable and the default continues for a period
of 30&nbsp;days; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">default in the payment of principal of any note when due and payable at its stated maturity, upon any
optional redemption, upon any required repurchase, upon declaration of acceleration or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">our failure to comply with our obligation to convert the notes in accordance with the indenture upon
exercise of a holder&#8217;s conversion right and such failure continues for three business days; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">our failure to give (i)&nbsp;a fundamental change notice as described under the caption
&#8220;&#8212;Repurchase at the Option of Holders&#8212;Fundamental Change Permits Holders to Require Us to Repurchase Notes&#8221; or notice of a make-whole fundamental change as described under the caption &#8220;&#8212;Conversion
Rights&#8212;Increase in Conversion Rate upon Conversion upon a Make-Whole Fundamental Change or Notice of Redemption,&#8221; in&nbsp;either case when due and such failure continues for five business days, (ii)&nbsp;a specified repurchase date right
notice as described under &#8220;&#8212;Repurchase at the Option of Holders&#8212;Repurchase on July&nbsp;8, 2030,&#8221; when due or (iii)&nbsp;notice of a specified corporate transaction as described under the caption &#8220;&#8212;Conversion
Rights&#8212;Certain Distributions Notice&#8221; when due and such failure continues for three business days; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">our failure to comply with our obligations under the caption &#8220;&#8212;Consolidation, Merger and Sale of
Assets&#8221;; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">our failure for 60&nbsp;days after written notice from the trustee or the holders of at least 25% in
principal amount of the notes then outstanding has been received to comply with any of our other agreements contained in the notes or the indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">default by us or any of our significant subsidiaries with respect to any mortgage, agreement or other
instrument under which there may be outstanding, or by which there may be secured or evidenced, any indebtedness for money borrowed with a principal amount in excess of $25,000,000 (or its foreign currency equivalent) in the aggregate of us and/or
any such significant subsidiary, whether such indebtedness now exists or shall hereafter be created (i)&nbsp;resulting in such indebtedness becoming or being declared due and payable prior to its stated maturity date or (ii)&nbsp;constituting a
failure to pay the principal of any such debt when due and payable (after the expiration of all applicable grace periods) at its stated maturity, upon required repurchase, upon declaration of acceleration or otherwise, and in the cases of clauses
(i)&nbsp;and (ii), such acceleration shall not have been rescinded or annulled or such failure to pay or default shall not have been cured or waived, or such indebtedness is not paid or discharged, as the case may be, within 30 days after written
notice to us by the trustee or to us and the trustee by holders of at least 25% in aggregate principal amount of notes then outstanding in accordance with the indenture; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">a final judgment or judgments for the payment of $25,000,000 (or its foreign currency equivalent) or more
(in each case, excluding any amounts covered by insurance) in the aggregate rendered against us or any of our significant subsidiaries, which judgment is not discharged, bonded, paid, waived or stayed within 60 days after (i)&nbsp;the date on which
the right to appeal thereof has expired if no such appeal has commenced, or (ii)&nbsp;the date on which all rights to appeal have been extinguished; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">certain events of bankruptcy, insolvency, or reorganization of us or any of our &#8220;significant
subsidiaries,&#8221; as defined below. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A &#8220;significant subsidiary,&#8221; for purposes of clauses
(7), (8) and (9) above, is a subsidiary that is a &#8220;significant subsidiary&#8221; as defined in Article 1, Rule <FONT STYLE="white-space:nowrap">1-02(w)(1)</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> promulgated by the SEC
(or any successor rule); provided that, in the case of a subsidiary that meets the criteria of clause (1)(iii) of the definition thereof but not clause (1)(i) or (1)(ii) thereof, in each case as such rule is in effect on the issue date, such
subsidiary shall be deemed not to be a significant subsidiary unless the subsidiary&#8217;s income from continuing operations before income taxes (after intercompany eliminations), exclusive of amounts attributable to any noncontrolling interests
for the last completed fiscal year prior to the date of such determination exceeds $5,000,000. For the avoidance of doubt, to the extent any such subsidiary would not be deemed to be a &#8220;significant subsidiary&#8221; under the relevant
definition set forth in Article 1, Rule <FONT STYLE="white-space:nowrap">1-02(w)</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> (or any successor rule) as in effect on the relevant date of determination, such subsidiary shall not
be deemed to be a &#8220;significant subsidiary&#8221; under the indenture irrespective of whether such subsidiary has greater than $5,000,000 in income from continuing operations as described in the immediately preceding sentence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If an event of default (other than an event of default described in clause (9)&nbsp;above with respect to us) occurs and is
continuing, the trustee by notice to us, or the holders of at least 25% in principal amount of the outstanding notes by notice to us and the trustee, may declare 100% of the principal of and accrued and unpaid interest, if any, on all the
outstanding notes to be due and payable. In case of certain events of bankruptcy, insolvency or reorganization, described in clause (9)&nbsp;above with respect to us, 100% of the principal of and accrued and unpaid interest on the notes will
automatically become due and payable. Upon such a declaration of acceleration, such principal and accrued and unpaid interest, if any, will be due and payable immediately. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding the foregoing, the indenture will provide that, to the extent we elect, the sole remedy for an event of
default under the indenture relating to our failure to comply with our obligations as set forth under the caption &#8220;&#8212;Reports&#8221; below (including our obligations under Section&nbsp;314(a)(1) of the Trust Indenture Act) (such default, a
&#8220;reporting event of default&#8221;), will, for the first 365 days after the occurrence of such an event of default consist exclusively of the right to receive additional interest on the notes at a rate equal to 0.25% per annum of the principal
amount of the notes outstanding for each day that such event of default is continuing during the first 180 days after the occurrence of such an event of default and 0.50% per annum of the principal amount of the notes outstanding from the 181st day
to, and including, the 365th day following the occurrence of such event of default, as long as such event of default is continuing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we so elect, such additional interest will be payable in the same manner and on the same dates as the stated interest
payable on the notes. On the 366th day after such event of default (if the event of default relating to the reporting obligations is not cured or waived prior to such 366th day), the notes will be subject to acceleration as provided above. The
provisions of the indenture described in this paragraph will not affect the rights of holders of notes in the event of the occurrence of any other event of default. In the event we do not elect to pay the additional interest following an event of
default in accordance with this paragraph or we elected to make such payment but do not pay the additional interest when due, the notes will be immediately subject to acceleration as provided above as a result of the event of default pursuant to
clause (6)&nbsp;of the definition thereof if such event of default is then continuing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In order to elect to pay the
additional interest as the sole remedy during the first 365 days after the occurrence of an event of default relating to the failure to comply with the reporting obligations in accordance </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
with the two immediately preceding paragraphs, we must notify all holders of notes, the trustee and the paying agent (if other than the trustee) in writing of such election prior to the beginning
of such <FONT STYLE="white-space:nowrap">365-day</FONT> period. Upon our failure to timely give such notice, the notes will be immediately subject to acceleration as provided above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If any portion of the amount payable on the notes upon acceleration is considered by a court to be unearned interest (through
the allocation of the value of the instrument to the embedded warrant or otherwise), the court could disallow recovery of any such portion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The holders of a majority in principal amount of the outstanding notes may waive all past defaults (except with respect to any
continuing defaults relating to nonpayment of principal or interest or with respect to the failure to deliver the consideration due upon conversion) and rescind any such acceleration with respect to the notes and its consequences if
(i)&nbsp;rescission would not conflict with any judgment or decree of a court of competent jurisdiction and (ii)&nbsp;all existing events of default, other than the nonpayment of the principal of and interest on the notes that have become due solely
by such declaration of acceleration, have been cured or waived. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For the avoidance of doubt, and without limiting the
manner in which any default or event of default can be cured: (a)&nbsp;a failure by us to send a notice in accordance with the indenture and any related default (or event of default) shall be deemed cured and shall cease to continue upon delivery of
such notice to the applicable recipient; (b)&nbsp;if we fail to make any payment of principal of or interest on the notes (or delivery of any other consideration in respect thereof) when due, such default (or event of default) shall be deemed cured
and shall cease to continue upon the making of such payment or delivery, as applicable, together with any accrued interest thereon, if applicable; and (c)&nbsp;a reporting event of default shall be deemed cured and shall cease to continue at such
time as we file the applicable report or reports that gave rise to such reporting event of default (it being understood that any report that we file with the SEC through the EDGAR system (or any successor thereto) will be deemed to be filed with the
trustee at the time such report is so filed via the EDGAR system (or such successor)); provided that, for the avoidance of doubt, (x)&nbsp;the cure of any event of default shall not invalidate any acceleration of the notes on account of such event
of default that was properly effected prior to such time as such event of default was cured and (y)&nbsp;the cure of any reporting event of default shall not affect our obligation to pay any additional interest that accrues prior to the time of such
cure. In addition, if an event of default is cured or waived before any related notice of acceleration is delivered, such event of default shall be deemed cured and the notes shall not be subject to acceleration on account of such event of default.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each holder shall have the right to receive payment or delivery, as the case may be, of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the principal (including the redemption price, the specified repurchase date repurchase price and the
fundamental change repurchase price, if applicable) of; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accrued and unpaid interest, if any, on; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the consideration due upon conversion of, </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">its notes, on or after the respective due dates expressed or provided for in the indenture, or to institute suit for the enforcement of any
such payment or delivery, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If an event of default occurs and is continuing, the trustee will be under
no obligation to exercise any of the rights or powers under the indenture at the request or direction of any of the holders unless such holders have offered, and if requested, provided, to the trustee indemnity or security satisfactory to it against
any loss, liability or expense. Except to enforce the right to receive payment of principal or interest when due, or the right to receive payment or delivery of the consideration due upon conversion, no holder may pursue any remedy with respect to
the indenture or the notes unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">such holder has previously given the trustee written notice that an event of default is continuing;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">holders of at least 25% in principal amount of the outstanding notes have requested the trustee to pursue
the remedy; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">such holders have offered, and if requested, provided, the trustee security or indemnity reasonably
satisfactory to it against any loss, liability or expense; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the trustee has not complied with such request within 60 days after the receipt of the request and the
offer, or provision, of such security or indemnity; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the holders of a majority in principal amount of the outstanding notes have not given the trustee a
direction that, in the opinion of the trustee, is inconsistent with such request within such <FONT STYLE="white-space:nowrap">60-day</FONT> period. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to certain restrictions, the holders of a majority in principal amount of the outstanding notes are given the right to direct the
time, method and place of conducting any proceeding for any remedy available to the trustee or of exercising any trust or power conferred on the trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The indenture will provide that in the event an event of default has occurred and is continuing, the trustee will be required
in the exercise of its powers to use the degree of care that a prudent person would use in the conduct of its own affairs. The trustee, however, may refuse to follow any direction that conflicts with law or the indenture or that the trustee
determines is unduly prejudicial to the rights of any other holder or that would involve the trustee in personal liability (it being understood that the trustee does not have an affirmative duty to determine whether any action is prejudicial to any
holders). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Prior to taking any action under the indenture, the trustee shall receive indemnification or security
satisfactory to it against any loss, liability or expense caused by taking or not taking such action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The indenture will
provide that if a default occurs and is continuing and is actually known to a responsible officer of the trustee, the trustee must deliver to each holder notice of the default within the later of 90 days after the date on which such default
occurred, if known, and promptly after a responsible officer of the trustee obtains knowledge of such default. Except in the case of a default in the payment of principal of or interest on any note or a default in the payment or delivery of the
consideration due upon conversion, the trustee may withhold notice if and so long as it determines that withholding notice is in the interests of the holders. In addition, we are required to deliver to the trustee, within 120 days after the end of
each fiscal year, a certificate indicating whether the signers thereof know of any event of default under the indenture that occurred during the previous year. We are also required to deliver to the trustee, within 30 days after obtaining knowledge
of the occurrence thereof, written notice of any events which would constitute certain defaults, their status and what action we are taking or proposing to take in respect thereof; <I>provided</I> that we are not required to deliver such notice if
such default has been cured or is no longer continuing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Payments of the redemption price, the fundamental change
repurchase price, principal and interest that are not made when due will accrue interest per annum at the then-applicable interest rate from the required payment date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Modification and Amendment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of the notes, the description below under this section titled &#8220;&#8212;Modification and Amendment&#8221;
supersedes, in its entirety, the information in the accompanying prospectus under the caption &#8220;Description of Debt Securities&#8212;Modification and Waiver.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to certain exceptions, the indenture or the notes may be amended or supplemented with the consent of the holders of at
least a majority in principal amount of the notes then outstanding (including without limitation, consents obtained in connection with a repurchase of, or tender or exchange offer for, notes) and, subject to certain exceptions, any past default or
compliance with any provisions may be waived with the consent of the holders of a majority in principal amount of the notes then outstanding (including, without limitation, consents obtained in connection with a repurchase of, or tender or exchange
offer for, notes). However, without </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the consent of each holder of an outstanding note affected, no amendment or supplement may, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">reduce the principal amount of notes whose holders must consent to an amendment, supplement or waiver;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">reduce the rate of or extend the stated time for payment of interest on any note; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">reduce the principal amount of or change the stated maturity of any note; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">except as required by the indenture, make any change that adversely affects the conversion rights of any
notes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">reduce the redemption price, the specified repurchase date repurchase price on the specified repurchase date
or the fundamental change repurchase price for any note or change the times at which, or the circumstances under which, the notes may or will be redeemed or repurchased by us; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">make any note payable in money, or at a place of payment, other than that stated in the note;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">modify the ranking provisions of the indenture in a manner that is adverse to the rights of the holders of
the notes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">impair the absolute rights of any holder of a note to receive payment or delivery, as applicable, of the
principal of, or the redemption price, specified repurchase date repurchase price or fundamental change repurchase price for, or any interest on, or the consideration due upon conversion of, such note on or after the respective due dates therefor,
or to bring suit for the enforcement of any such payment or delivery on or after such respective due dates; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">make any change in the amendment provisions that require each holder&#8217;s consent or in the waiver
provisions. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Without the consent of, or prior notice to, any holder, we and the trustee may amend or
supplement the indenture or the notes to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">cure any ambiguity, omission, defect or inconsistency; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">provide for the assumption by a successor entity of our obligations under the indenture;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">add guarantees with respect to the notes; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">secure the notes; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">add to our covenants or events of default for the benefit of the holders or surrender any right or power
conferred upon us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">make any change that does not adversely affect the rights of any holder in any material respect, as
certified by us in an officer&#8217;s certificate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">in connection with any transaction described under the caption &#8220;&#8212;Conversion
Rights&#8212;Recapitalizations, Reclassifications and Changes of Our Common Stock&#8221; above, provide that the notes are convertible into reference property, subject to the provisions described under the caption &#8220;&#8212;Conversion
Rights&#8212;Settlement upon Conversion&#8221; above, and make certain related changes to the terms of the notes to the extent expressly required by the indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">conform the provisions of the indenture to the &#8220;Description of Notes&#8221; section in the preliminary
prospectus supplement, as supplemented by the related pricing term sheet and as evidenced in an officer&#8217;s certificate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">comply with the rules of any applicable securities depositary, including DTC, so long as such amendment does
not adversely affect the rights of any holder in any material respect; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">appoint a successor trustee with respect to the notes; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">increase the conversion rate as provided in the indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">provide for the acceptance of appointment by a successor trustee, security registrar, paying agent, bid
solicitation agent or conversion agent to facilitate the administration of the trusts under the indenture by more than one trustee; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">comply with any requirement of the SEC in connection with the qualification of the indenture under the Trust
Indenture Act; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">irrevocably elect a settlement method or a specified dollar amount, or eliminate our right to elect a
settlement method (including, at our option, upon an irrevocable election as provided under the caption &#8220;&#8212;Conversion Rights&#8212;Settlement upon Conversion&#8221;); provided, however, that no such election or elimination will affect any
settlement method theretofore elected (or deemed to be elected) with respect to any note pursuant to the provisions described above under the caption &#8220;&#8212;Conversion Rights.&#8221; </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Holders do not need to approve the particular form of any proposed amendment. It will be sufficient if such holders approve
the substance of the proposed amendment. After an amendment under the indenture becomes effective, we are required to deliver to the holders a notice briefly describing such amendment. However, the failure to give such notice to all the holders, or
any defect in the notice, will not impair or affect the validity of the amendment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Discharge </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of the notes, the description below under this section titled &#8220;&#8212;Discharge&#8221; supersedes, in its
entirety, the information in the accompanying prospectus under the caption &#8220;Description of Debt Securities&#8212;Defeasance&#8221; and &#8220;&#8212;Satisfaction and Discharge.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We may satisfy and discharge our obligations under the indenture and the notes by delivering to the trustee for cancellation
all outstanding notes or by depositing with the trustee or delivering to the holders, as applicable, after the notes have become due and payable, whether at maturity, at any redemption date, at the specified repurchase date, at any fundamental
change repurchase date, upon conversion or otherwise, cash or cash and/or shares of common stock, solely to satisfy outstanding conversions, as applicable, sufficient to pay all of the outstanding notes and paying all other sums payable under the
indenture by us. Such discharge is subject to terms contained in the indenture. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Calculations in Respect of Notes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as otherwise provided above, we will be responsible for making all calculations called for under the indenture and the
notes. These calculations include, but are not limited to, determinations of the stock price, the last reported sale prices of our common stock, the trading price of the notes (for purposes of determining whether the notes are convertible as
described herein), the daily VWAPs, the daily conversion values, the daily settlement amounts, accrued interest payable on the notes, additional interest, if any, payable on the notes, the redemption price and the conversion rate of the notes. We
will make all these calculations in good faith and, absent manifest error, our calculations will be final and binding on holders of notes. We will provide a schedule of our calculations to each of the trustee, the paying agent (if other than the
trustee) and the conversion agent (if other than the trustee), and each of the trustee, the paying agent and the conversion agent is entitled to rely conclusively upon the accuracy of our calculations without independent verification. The trustee
will forward our calculations to any holder of notes upon the request of that holder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Reports </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of the notes, the description below under this section titled &#8220;&#8212;Reports&#8221; supersedes, in its
entirety, the information in the accompanying prospectus under the caption &#8220;Description of Debt Securities&#8212;<FONT STYLE="font-family:Times New Roman; font-size:0.5pt">
</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">Reporting.&#8221; </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The indenture will provide that any annual or quarterly reports (on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> or Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or any respective successor form) that we are required to file with the SEC pursuant to Section&nbsp;13 or 15(d) of the Exchange Act (excluding any such
information, documents or reports, or portions thereof, subject to confidential treatment and any correspondence with the SEC) must be filed by us with the trustee within 15 days after the same are required to be filed with the SEC (after giving
effect to any grace period provided by Rule <FONT STYLE="white-space:nowrap">12b-25</FONT> under the Exchange Act (or any successor rule), which grace period, for the avoidance of doubt, shall be deemed applicable whether or not we check the box in
the relevant Rule <FONT STYLE="white-space:nowrap">12b-25</FONT> filing indicating that we expect to file such report within the applicable Rule <FONT STYLE="white-space:nowrap">12b-25</FONT> grace period). Documents filed by us with the SEC via the
EDGAR system (or any successor system) will be deemed to be filed with the trustee as of the time such documents are filed via EDGAR (or any successor thereto), it being understood that the trustee shall not be responsible for determining whether
such filings have been made. We will also comply with our other obligations under Section&nbsp;314(a)(1) of the Trust Indenture Act. Delivery of reports, information and documents to the trustee under the indenture is for informational purposes only
and the information and the trustee&#8217;s receipt of the foregoing shall not constitute actual or constructive notice of any information contained therein, or determinable from information contained therein including our compliance with any of our
covenants thereunder (as to which the trustee is entitled to rely exclusively on an officer&#8217;s certificate). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Trustee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">U.S. Bank Trust Company, National Association is the trustee, security registrar, paying agent and conversion agent under the
notes and the indenture. U.S. Bank Trust Company, National Association, in each of its capacities, including without limitation as trustee, security registrar, paying agent and conversion agent, assumes no responsibility for the accuracy or
completeness of the information concerning us or our affiliates or any other party contained in this document or the related documents or for any failure by us or any other party to disclose events that may have occurred and may affect the
significance or accuracy of such information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The trustee is also the trustee, security registrar, paying agent and
conversion agent for the Green Convertible Notes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Governing Law; Waiver of Jury Trial </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of the notes, the description below under this section titled &#8220;&#8212;Governing Law; Waiver of Jury
Trial&#8221; supersedes, in its entirety, the information in the accompanying prospectus under the caption &#8220;Description of Debt Securities&#8212;Governing Law.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The indenture will provide that it and the notes, and any claim, controversy or dispute arising under or related to the
indenture or the notes, will be governed by and construed in accordance with the laws of the State of New&nbsp;York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">EACH OF US, THE
HOLDERS OF THE NOTES, BY THEIR ACCEPTANCE THEREOF, AND THE TRUSTEE IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE, THE
NOTES OR THE TRANSACTIONS CONTEMPLATED THEREBY. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Book-Entry, Settlement and Clearance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The Global Notes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The notes will be initially issued in the form of one or more registered notes in global form, without interest coupons (the
&#8220;global notes&#8221;). Upon issuance, each of the global notes will be deposited with the trustee as custodian for DTC and registered in the name of Cede&nbsp;&amp; Co., as nominee of DTC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Ownership of beneficial interests in a global note will be limited to
persons who have accounts with DTC (&#8220;DTC participants&#8221;) or persons who hold interests through DTC participants. We expect that under procedures established by DTC: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon deposit of a global note with DTC&#8217;s custodian, DTC will credit portions of the principal amount of
the global note to the accounts of the DTC participants designated by the underwriters; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ownership of beneficial interests in a global note will be shown on, and transfer of ownership of those
interests will be effected only through, records maintained by DTC (with respect to interests of DTC participants) and the records of DTC participants (with respect to other owners of beneficial interests in the global note). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Beneficial interests in global notes may not be exchanged for notes in physical, certificated form except in the limited
circumstances described below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Book-Entry Procedures for the Global Notes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">All interests in the global notes will be subject to the operations and procedures of DTC and, therefore, you must allow for
sufficient time in order to comply with these procedures if you wish to exercise any of your rights with respect to the notes. We provide the following summary of those operations and procedures solely for the convenience of investors. The
operations and procedures of DTC are controlled by that settlement system and may be changed at any time. Neither we nor the underwriters, the trustee or any agent of the foregoing are responsible for those operations or procedures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">DTC has advised us that it is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a limited-purpose trust company organized under the New York Banking Law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#8220;banking organization&#8221; within the meaning of the New York State Banking Law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a member of the Federal Reserve System; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#8220;clearing corporation&#8221; within the meaning of the New York Uniform Commercial Code; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#8220;clearing agency&#8221; registered pursuant to the provisions of Section&nbsp;17A of the Exchange Act.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">DTC was created to hold securities for its participants and to facilitate the clearance and settlement
of securities transactions between its participants through electronic book-entry changes to the accounts of its participants. DTC&#8217;s participants include both U.S. and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> securities brokers and
dealers, including the underwriters; banks and trust companies; clearing corporations and certain other organizations. Indirect access to DTC&#8217;s system is also available to others such as both U.S. and
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> securities brokers and dealers, banks, trust companies, and clearing corporations that clear through or maintain a custodial relationship with a DTC participant, either directly or indirectly.
Investors who are not DTC participants may beneficially own securities held by or on behalf of DTC only through DTC participants or indirect participants in DTC. The DTC rules applicable to its participants are on file with the SEC. More information
about DTC can be found at www.dtcc.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">So long as DTC&#8217;s nominee is the registered owner of a global note, that
nominee will be considered the sole owner or holder of the notes represented by that global note for all purposes under the indenture. Except as provided below, owners of beneficial interests in a global note: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will not be entitled to have notes represented by the global note registered in their names;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will not receive or be entitled to receive physical, certificated notes; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will not be considered the owners or holders of the notes under the indenture for any purpose, including with
respect to the giving of any direction, instruction or approval to the trustee under the indenture. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As a result, each investor who owns a beneficial interest in a global note
must rely on the procedures of DTC to exercise any rights of a holder of notes under the indenture (and, if the investor is not a participant or an indirect participant in DTC, on the procedures of the DTC participant through which the investor owns
its interest). Neither we nor the trustee, paying agent or conversion agent has any responsibility or liability for any act or omission of DTC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Payments of principal and interest with respect to the notes represented by a global note will be made by the trustee to
DTC&#8217;s nominee as the registered holder of the global note. Neither we nor the trustee (including in its capacity as paying agent) will have any responsibility or liability for the payment of amounts to owners of beneficial interests in a
global note, for any aspect of the records relating to or payments made on account of those interests by DTC, or for maintaining, supervising or reviewing any records of DTC relating to those interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Payments by participants and indirect participants in DTC to the owners of beneficial interests in a global note will be
governed by standing instructions and customary practices, as is the case with securities held for the accounts of customers in bearer form or registered in &#8220;street name,&#8221; and will be the responsibility of those participants or indirect
participants and not of DTC, the trustee, or the Company, subject to any statutory or regulatory requirements as may be in effect from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Transfers between participants in DTC will be effected under DTC&#8217;s procedures and will be settled in <FONT
STYLE="white-space:nowrap">same-day</FONT> funds. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Certificated Notes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notes in physical, certificated form will be issued and delivered to each person that DTC identifies as a beneficial owner of
the related notes only if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">DTC notifies us at any time that it is unwilling or unable to continue as depositary for the global notes and
a successor depositary is not appointed within 90 days; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">DTC ceases to be registered as a clearing agency under the Exchange Act and a successor depositary is not
appointed within 90 days; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an event of default with respect to the notes has occurred and is continuing and such beneficial owner
requests that its notes be issued in physical, certificated form. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_11"></A>DESCRIPTION OF OTHER INDEBTEDNESS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following is a summary of certain provisions of the documents evidencing our material indebtedness. This summary does not
purport to be complete and is subject to, and is qualified in its entirety by reference to, all of the provisions of the agreements governing such indebtedness, including the definitions of certain terms referred to herein. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Description of Revenue Bonds </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On October&nbsp;7, 2020, the Southern Ohio Port Authority (&#8220;SOPA&#8221;) issued certain revenue bonds (&#8220;Revenue
Bonds&#8221;) pursuant to an Indenture of Trust dated as of October&nbsp;1, 2020 (as amended, restated, supplemented or otherwise modified from time to time, the &#8220;Revenue Bonds Indenture&#8221;), between SOPA and UMB Bank, N.A., as Trustee
(&#8220;Revenue Bonds Trustee&#8221;), and loaned the proceeds from their sale to PureCycle: Ohio LLC (&#8220;PCO&#8221;), an Ohio limited liability company and indirect wholly-owned subsidiary of PCT, pursuant to a Loan Agreement dated as of
October&nbsp;1, 2020, between SOPA and PCO (as amended, restated, supplemented or otherwise modified from time to time, the &#8220;Loan Agreement&#8221;), to (i)&nbsp;acquire, construct and equip the Ironton Facility (referred to within the Loan
Agreement as the &#8220;Ohio Phase II Facility&#8221; and, together with the Feedstock Evaluation Unit (referred to within the Loan Agreement as the &#8220;Phase I Facility&#8221;), the &#8220;Project&#8221;); (ii) fund a debt service reserve fund
for the Series 2020A Bonds (defined below); (iii) finance capitalized interest; and (iv)&nbsp;pay the costs of issuing the Revenue Bonds. The Revenue Bonds were issued in three series, including (i)&nbsp;Exempt Facility Revenue Bonds (PureCycle
Project), <FONT STYLE="white-space:nowrap">Tax-Exempt</FONT> Series 2020A (&#8220;Series 2020A Bonds&#8221; or &#8220;Senior Bonds&#8221;); (ii) Subordinate Exempt Facility Revenue Bonds (PureCycle Project),
<FONT STYLE="white-space:nowrap">Tax-Exempt</FONT> Series 2020B (&#8220;Series 2020B Bonds&#8221;); and (iii)&nbsp;Subordinate Exempt Facility Revenue Bonds (PureCycle Project), Taxable Series 2020C (&#8220;Series 2020C Bonds&#8221;), each series
issued in the aggregate principal amount, bearing interest and maturing, and with the aggregate principal amount Outstanding as of December&nbsp;31, 2025, as shown in the table below. PCT is not a direct obligor on the Revenue Bonds and is not a
party to the Loan Agreement or the Revenue Bonds Indenture pursuant to which the Revenue Bonds have been issued. PCT LLC has executed a guaranty of completion dated as of October&nbsp;7, 2020 (as amended, restated, supplemented or otherwise modified
from time to time, the &#8220;Guaranty&#8221;), with respect to the full and complete performance by PCO of PCO&#8217;s obligations with respect to construction and completion of the Project, including construction by the Completion Date, free and
clear of any liens (other than permitted liens), and the payment of all Project costs incurred prior to completion of the Project, and all claims, liabilities, losses and damages owed by PCO to each counterparty under the Project Documents (as such
terms are defined in the Revenue Bonds Indenture). In addition, pursuant to the Guaranty, PCT LLC was obligated to fund and maintain and did fund a liquidity reserve for the Project during the term of the Guaranty in the amount of $50.0&nbsp;million
(&#8220;Liquidity Reserve&#8221;) to be held in an escrow account with U.S. Bank National Association, as escrow agent (&#8220;Escrow Agent&#8221;). Pursuant to the terms of the Loan Agreement, PCO executed promissory notes in the principal amounts
of each maturity (or interest rate within a maturity), aggregating the principal amount of each series of Revenue Bonds, in favor of SOPA, which were assigned to the Revenue Bonds Trustee on October&nbsp;7, 2020. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><I>(in thousands)</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Bond Series</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Term</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Principal<BR>Amount</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Interest&nbsp;Rate</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Maturity Date</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2020A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.50</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">December&nbsp;1,&nbsp;2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2020A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">168,480</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">December&nbsp;1, 2042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2020B</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">December&nbsp;1, 2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2020C</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">C1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">December&nbsp;1, 2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The proceeds of the Revenue Bonds and certain equity contributions were placed in various
trust funds and <FONT STYLE="white-space:nowrap">non-interest-bearing</FONT> accounts established and administered by the Revenue Bonds Trustee under the Revenue Bonds Indenture. Before each disbursement of amounts in the Project Fund (funded with
equity and proceeds from the issuance of the Revenue Bonds) held by the Revenue Bonds Trustee, the Revenue Bonds Indenture </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
requires PCO to submit to the Revenue Bonds Trustee a requisition for funds to be disbursed outlining the specified purpose of the disbursement and substantiating the expenditure. All proceeds
from the sale of the Revenue Bonds that were deposited to the Project Fund held by the Revenue Bonds Trustee under the Revenue Bonds Indenture have been spent pursuant to the terms of the Loan Agreement and the Revenue Bonds Indenture. Funds
remaining in the trust accounts will be disbursed by the Revenue Bonds Trustee when certain conditions are met, and will be used to pay costs and expenditures related to the development and operation of the Ironton Facility, make required interest
and principal payments (including sinking fund redemption amounts) and pay any premium, in certain circumstances required under the Revenue Bonds Indenture, to redeem the Revenue Bonds. A Mechanical Completion Certificate for the Phase II Facility
was issued by the Denham-Blythe Company certifying that the requirements for Mechanical Completion under the Construction Contract had been achieved on April&nbsp;24, 2023, which certification was accepted by PCO. While Phase II Facility has been
deemed to be &#8220;mechanically complete&#8221; pursuant to the transaction documents, completion of the Project, as contemplated in the Guaranty, means the expiration of the twelfth month following the completion of thirty (30)&nbsp;consecutive
days of full name plate operations of the Project following completion. Full nameplate operations on an annual basis is 107&nbsp;million pounds per year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with its obligations under that certain Security Agreement dated as of October&nbsp;7, 2020, between PCO, as
debtor, and the Revenue Bonds Trustee, as secured party, entered into when the Revenue Bonds were issued (the &#8220;Security Agreement&#8221;), PCO must deliver consent and agreements (&#8220;Consents&#8221;) to the Revenue Bonds Trustee with
respect to each agreement entered into in connection with the Project, each of which agreements is required under the Loan Agreement to be assigned to the Revenue Bonds Trustee. The forms of the Consents relating to a certain feedstock supply
agreement from one supplier of feedstock to the Project (the &#8220;Supplier&#8221;) and from two purchasers of offtake from the Project (&#8220;Offtaker 2&#8221; and &#8220;Offtaker 3&#8221; and together with the Supplier, the
&#8220;Counterparties&#8221;) delivered to the Revenue Bonds Trustee contained terms inconsistent with the form of the Consent required under the Security Agreement. On May&nbsp;11, 2021, the Guaranty was amended and restated, executed by PCT LLC
and delivered to the Revenue Bonds Trustee, which broadens the purposes for which draws by the Revenue Bonds Trustee on the Liquidity Reserve may be utilized, extends the period during which the Liquidity Reserve must be maintained, includes
conditions that would permit a reduction in the amount of the Liquidity Reserve required to be maintained by PCT, and includes conditions precedent to the elimination of the requirement that PCT LLC replenish the Liquidity Reserve and to the
termination of the Guaranty and the escrow agreement under which the Liquidity Reserve is held by the escrow agent (the &#8220;Escrow Agreement&#8221;), upon which termination, the balance of the Liquidity Reserve will be returned to PCT LLC. So
long as there are any Series 2020A Bonds outstanding under the Revenue Bonds Indenture, the Guaranty and the Escrow Agreement will remain in place upon the conditions stated in the Guaranty. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The terms of the Guaranty are summarized as follows: The Liquidity Reserve shall be maintained in the amount of
$50.0&nbsp;million, subject to replenishment by PCT LLC until certain conditions stated in the Guaranty relating to the following have been met: (i)&nbsp;the completion of construction and acquisition of the Project (as set forth in the Guaranty),
(ii) the payment of all Project costs, and (iii)&nbsp;the replacement of the assigned agreements of the Counterparties underlying the Consents which have expired or terminated, with one or more agreements between counterparties and PCO upon terms at
least as favorable to PCO as the expired or terminated agreements of the Counterparties, (a)&nbsp;for which a Consent that conforms to the form of Consent required by the Security Agreement is executed by the counterparties and provided to the
Revenue Bonds Trustee, (b)&nbsp;which, in the case of supply of feedstock to the Project, provide in the aggregate for the supply of at least the minimum and maximum volumes of feedstock meeting substantially similar feedstock specifications as the
Supplier had committed to supply, and (c)&nbsp;which, in the case of purchase of offtake from the Project, provide in the aggregate for the purchase of the minimum and maximum volumes of offtake from the Project meeting substantially similar
specifications as Offtaker 2 and Offtaker 3 had committed to purchase from PCO. When the conditions stated in (i), (ii) and (iii)&nbsp;above have been satisfied but so long as there are Series 2020A Bonds outstanding under the Revenue Bonds
Indenture, the Escrow Agreement shall remain in place but the Liquidity Reserve amount shall be reduced to $25.0&nbsp;million and PCT shall no longer be required to replenish the amount of the reduced Liquidity Reserve if and when disbursements are
made therefrom. If the conditions of (i)&nbsp;and (ii) have been met but only a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
portion of the feedstock and offtake contracted for by the Counterparties, respectively, has been replaced under replacement agreements as aforesaid in (iii)&nbsp;above, then the Liquidity
Reserve amount may be reduced only by the applicable proportion of the amounts stated in the Guaranty which evidence the intent of the parties of the amount of value representing the supply or offtake of the agreements of the Counterparties. When
the conditions precedent of (i), (ii), and (iii)&nbsp;have been satisfied and there are no longer any Series 2020A Bonds then outstanding, then PCT LLC shall have no obligation to maintain the reduced Liquidity Reserve, the Guaranty and the Escrow
Agreement shall terminate and the balance on deposit in the Liquidity Reserve escrow fund held by the escrow agent shall be returned to PCT LLC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As long as any Series 2020A Bonds remain outstanding under the Revenue Bonds Indenture, upon the occurrence of an event of
default under the Loan Agreement or Revenue Bonds Indenture, if the Revenue Bonds Trustee takes control of the Liquidity Reserve held by the escrow agent, such funds may be used for any purpose, including the payment of debt service on the Series
2020A Bonds, as may be determined by the Revenue Bonds Trustee or directed by a majority of the holders of the Series 2020A Bonds then outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Revenue Bonds Indenture has been supplemented by seven supplemental indentures, which have amended, supplemented or
otherwise modified certain terms of, among others, the Loan Agreement, the Revenue Bonds Indenture, the Guaranty, the Security Agreement and the Escrow Agreement, with the effect that the Completion Date for the Project has been extended to
December&nbsp;31, 2029, certain financial covenants have been amended or eliminated, the definition of Majority Holders, who hold Senior Bonds and have certain consent rights, has been amended, deposit balance requirements for certain funds held by
the Revenue Bonds Trustee have been amended, funds on deposit in the Liquidity Reserve under the Escrow Agreement have been and may be disbursed to PCT LLC for the purpose of purchasing Revenue Bonds from Holders, the minimum amount of funds on
deposit in the Liquidity Reserve has been reduced, and earnings on the Liquidity Reserve may be distributed to PCT LLC on a periodic basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On March&nbsp;5, 2024, PCT LLC purchased $246,750,000 in aggregate principal amount of the Revenue Bonds Outstanding, of which
$216,750,000 in aggregate principal amount were Senior Bonds, leaving only $2.8&nbsp;million of the Senior Bonds held by other Holders. Selling Holders of those Revenue Bonds agreed to certain amendments to the transaction documents. Thereafter, PCT
LLC has sold Revenue Bonds held by it in the aggregate principal amount of $158,745,000 to Qualified Institutional Buyers or Accredited Investors, resulting in sale proceeds of $130,350,800 to PCT LLC. One such purchaser of Revenue Bonds held by PCT
LLC is Pure Plastic LLC (&#8220;Pure Plastic&#8221;). Together, Pure Plastic and PCT LLC hold $170,595,000 in aggregate principal amount of Senior Bonds, comprising 82.341% of the aggregate principal amount of Outstanding Senior Bonds and,
therefore, Pure Plastic and PCT LLC are Majority Holders with certain consent rights. Pursuant to supplemental indentures consented to by Majority Holders since March&nbsp;15, 2023, the Outside Completion Date for the Project has been extended to
December&nbsp;31, 2029; &#8220;Majority Holders&#8221; means (i)&nbsp;so long as any Senior Bonds are Outstanding, the Holders of not less than a majority in aggregate principal amount of the Senior Bonds then Outstanding, and (ii)&nbsp;if no Senior
Bonds are Outstanding, the Holders of not less than a majority in aggregate principal amount of Revenue Bonds then Outstanding; additional supplemental indentures will require the consent of Holders of a majority in aggregate principal amount of
Senior Bonds Outstanding; the Fiscal Year with respect to which certain financial covenants will first apply has been extended to Fiscal Year 2030; investment earnings and profits relating to the Liquidity Reserve may be distributed to PCT LLC
periodically; the obligation of PCT LLC under the Guaranty to replenish the Liquidity Reserve has been eliminated; Liquidity Reserve deposits have been distributed to PCT LLC to pay a portion of the purchase price of Revenue Bonds from Holders; and
the following financial covenants have been amended: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">amending the definition of &#8220;Overall Coverage Requirement&#8221; to mean a ratio of at least 105% of
(a)&nbsp;Net Income Available for Debt Service to (b)&nbsp;all obligations of PCO which are charges, liens, Indebtedness or encumbrances upon or payable from Gross Revenues, including but not limited to Senior Bonds, Parity Indebtedness and
Subordinate Bonds, calculated at the end of each Fiscal Year, based upon Audited Financial Statements of PCT LLC; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">amending the definition of &#8220;Senior Parity Coverage Requirement&#8221; to mean a Senior Debt Service
Coverage Ratio equal to at least 125% for such Fiscal Year, calculated at the end of each Fiscal Year, based upon Audited Financial Statements of PCT LLC (Senior Debt Service Coverage Ratio means for any given period of time, the ratio of
(a)&nbsp;Net Income Available for Debt Service to (b)&nbsp;the total of Maximum Annual Debt Service of the Senior Bonds and any Senior Parity Indebtedness, all as determined in accordance with GAAP.); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">amending the &#8220;Days Cash on Hand Requirement&#8221; to mean not less than 60 Days Cash on Hand for such
Fiscal Year, to be tested commencing with the Fiscal Year ended December&nbsp;31, 2030, and annually thereafter; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">requiring PCO to produce sufficient annual Gross Revenues in order to meet the Senior Parity Coverage
Requirement, the Overall Coverage Requirement, and the Days Cash on Hand Requirement for each Fiscal Year, beginning with the Fiscal Year ended December&nbsp;31, 2030; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">providing that an event of default shall not be deemed to have occurred should PCO fail to comply with the
Senior Parity Coverage Requirement, the Overall Coverage Requirement, or the Days Cash on Hand Requirement, beginning with the Fiscal Year ended December 31, 2030, so long as PCO engages an Independent Consultant to make recommendations to PCO to
meet those requirements and the Independent Consultant confirms that PCO has substantially complied with such recommendations; provided, however, an event of default will exist if (a)&nbsp;the Senior Parity Coverage Ratio is less than 115% or if the
Overall Coverage Requirement ratio is less than 100% for any Fiscal Year commencing with the Fiscal Year ended December&nbsp;31, 2030, or (b)&nbsp;if PCO&#8217;s Days Cash on Hand is less than 30 Days Cash on Hand; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibiting PureCycle from making any distributions to its members prior to January&nbsp;1, 2030, other than
amounts due to PCT, its parent, pursuant to the Shared Services Agreement, by and among PCT, PCT Managed Services LLC (a subsidiary of PCT, and PCO, and then made only if, among other things, the Senior Parity Coverage Requirement, the Overall
Coverage Requirement and the Days Cash on Hand Requirement are each satisfied with respect to the Fiscal Year prior to the date on which the distribution is made, and there shall remain after such distribution no less than 60 Days Cash on Hand;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">including certain other customary default&nbsp;provisions; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">providing that the Senior Bonds Debt Service Reserve Requirement, the Subordinate Bonds Debt Service Reserve
Requirement, and the Repair and Replacement Fund Requirement are <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">$-0-,</FONT></FONT> and providing that certain provisions in the Revenue Bonds Indenture and/or Loan Agreement, as
applicable, relating to the funding and maintenance of the Senior Bonds Debt Service Reserve Fund, the Subordinate Bonds Debt Service Reserve Fund, and the repair and Replacement Fund are suspended until the effectiveness of an amendment to the
Revenue Bonds Indenture, the Loan Agreement and/or any other applicable Financing Documents providing otherwise in accordance with the terms of the Revenue Bonds Indenture, the Loan Agreement, and such other applicable Financings Documents.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Description of Green Convertible Notes </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On August&nbsp;24, 2023, PCT completed a private offering of $250.0&nbsp;million in aggregate principal amount at maturity of
the Green Convertible Notes with a maturity of August&nbsp;15, 2030. Interest is payable semi-annually in arrears on February&nbsp;15 and August&nbsp;15 of each year, and commenced on February&nbsp;13, 2024. Each $1,000 principal amount at maturity
of the Green Convertible Notes was issued at a price of $900. An amount equal to the difference between the issue price and the principal amount at maturity will accrete from the original issue date through August&nbsp;15, 2027. The Green
Convertible Notes are senior unsecured obligations of PCT. Entities affiliated with a greater than 5% beneficial owner of PCT purchased $50.0&nbsp;million aggregate principal amount of the Green Convertible Notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with the issuance of the Green Convertible Notes, PCT entered
into an Indenture, dated August&nbsp;24, 2023 (the &#8220;Green Convertible Notes Indenture&#8221;), with U.S. Bank Trust Company, National Association, as trustee. The Green Convertible Notes Indenture includes customary covenants and events of
default, after which the Green Convertible Notes may be declared immediately due and payable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Holders of the Green
Convertible Notes may convert their notes at any time prior to the maturity date. PCT may choose to settle conversions in cash, shares of its common stock, or a combination of both. The initial conversion rate is 67.4764 shares of its common stock
per $1,000 principal amount (equivalent to approximately $14.82 per share of its common stock). The conversion rate is subject to adjustment for certain events, and in specified circumstances before August&nbsp;15, 2027, PCT may increase the
conversion rate for holders who convert in connection with such events. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Holders of the Green Convertible Notes may
require PCT to repurchase their notes on August&nbsp;15, 2027 for cash at 100% of the principal amount at maturity, plus accrued and unpaid interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, if PCT undergoes a fundamental change (as defined in the Green Convertible Notes Indenture), holders of the Green
Convertible Notes may require PCT to repurchase their notes at a cash repurchase price equal to 100% of the accreted principal amount at maturity of the notes, plus accrued and unpaid interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT may redeem the Green Convertible Notes on or after August&nbsp;20, 2025 for cash at 100% of the accreted principal amount
at maturity, plus accrued and unpaid interest, if certain stock-price conditions are met. No sinking fund is provided for the Green Convertible Notes. The fair value of the Green Convertible Notes is classified within Level&nbsp;3 of the fair value
hierarchy due to the use of significant unobservable inputs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The net proceeds from the Green Convertible Notes, excluding
any offering expenses, were approximately $218.5&nbsp;million, after deducting the initial purchaser&#8217;s discounts and fees paid to PCT&#8217;s financial advisor. PCT allocated a portion of the net proceeds to the financing and refinancing of
recently completed and future Eligible Green Projects in the U.S. &#8220;Eligible Green Projects&#8221; means: investments in (i)&nbsp;acquisitions of buildings; (ii)&nbsp;building developments or redevelopments; (iii)&nbsp;renovations in existing
buildings; and (iv)&nbsp;tenant improvement projects, in each case, that have received, or are expected to receive, in the three years prior to the issuance of the notes or during the term of the notes, a Leadership in Energy and Environmental
Design (&#8220;LEED&#8221;) Silver, Gold or Platinum certification (or environmentally equivalent successor standards). Prior to issuing the Green Convertible Notes and as part of its overall business plan, PCT has focused on the value of the
sustainability opportunities PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin offers to support expanding a circular economy. To pursue those opportunities, PCT purchased equipment and commissioned design services for PreP
facilities that will enable it to advance circular economy adapted products, production technologies and processes, and/or research and development related to recycling waste polypropylene. PCT believes those legacy purchases and designs should
complement PCT&#8217;s Eligible Green Projects development. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Description of Revolving Credit Facility </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On March&nbsp;15, 2023, we entered into the Revolving Credit Facility pursuant to the Revolving Credit Agreement, which matures
on September&nbsp;30, 2027. The Lenders and their affiliates are greater than 5% beneficial owners of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Borrowings under the Revolving Credit Agreement may be used for working capital, capital expenditures and other general
corporate purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Amounts outstanding under the Revolving Credit Agreement bear interest at a variable annual rate
equal to Term SOFR (as defined in the Revolving Credit Agreement) in effect for such period plus an applicable margin. The applicable margin currently in effect is equal to 17.50%. The Company is also required to pay a commitment fee equal to 0.25%
per annum based on the actual daily unused amount of the Revolving Credit Facility, payable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
quarterly. Subject to timely prior written notice and payment of breakage fees, if any, the Company may at any time and from time to time (i)&nbsp;terminate all or any portion of the commitments
under the Revolving Credit Agreement and/or (ii)&nbsp;prepay all or any portion of any outstanding borrowings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
Revolving Credit Agreement contains representations, covenants and events of default that are customary for financing transactions of this nature. Events of default in the Revolving Credit Agreement include, among others: <FONT
STYLE="white-space:nowrap">(a)&nbsp;non-payment</FONT> of principal, interest, fees or other amounts; (b)&nbsp;default of specific covenants; (c)&nbsp;breach of representations and warranties; (d)&nbsp;cross-defaults to other indebtedness in an
amount greater than $1&nbsp;million, subject to certain exceptions; (e)&nbsp;bankruptcy and insolvency proceedings; (f)&nbsp;inability to pay debts or attachment; (g)&nbsp;judgments; and (h)&nbsp;change of control. Upon the occurrence of an event of
default, the Administrative Agent shall, at the request of, or may, with the consent of, the Required Lenders (as defined in the Revolving Credit Agreement) terminate the loan commitments, accelerate all loans and exercise on behalf of itself and
the Lenders all rights and remedies available to it and the Lenders under the Revolving Credit Agreement and the other loan documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Amounts outstanding under the Revolving Credit Agreement are guaranteed by the Revolving Credit Facility Guarantors, and are
secured by a security interest in substantially all of the assets of the Company and PureCycle Augusta, LLC. Any majority- owned direct or indirect subsidiaries of the Company formed after the closing date of the Revolving Credit Facility will also
be required to guaranty the obligations under the Revolving Credit Agreement and grant security interests in substantially all of their respective assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On June&nbsp;10, 2026, we further amended the Revolving Credit Agreement to, among other things, (i)&nbsp;permit this offering
and the Concurrent Stock Offering and (ii)&nbsp;remove as secured obligations certain obligations in respect of the Company&#8217;s Series A Preferred Stock, Series C Warrants and Pre-Funded Warrants, in each case, owed by the affiliated investors.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Description of Financial Assurance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PCT holds a surety bond in the amount of $8.0&nbsp;million as of March&nbsp;31, 2026 to provide financial assurance related to
its performance under a certain vendor contract, which expires at the earlier of satisfaction of the obligation, termination of the related vendor contract, or December&nbsp;31, 2026 (subject to renewal within one year). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_12"></A>THE CONCURRENT TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Concurrently with this offering, we are conducting an underwritten public offering of 17,570,200 shares of our common stock
(or up to 19,854,000 of our common stock if the underwriters in the Concurrent Stock Offering exercise their option to purchase additional shares in full) at a price of $8.21 per share pursuant to a separate prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, concurrently with the pricing of the notes in this offering, we entered into privately negotiated transactions to
repurchase for cash approximately $216.0 million in aggregate principal amount at maturity of the Green Convertible Notes (including $50.0 million in aggregate principal amount at maturity of the Green Convertible Notes held by the affiliated
investors) for approximately $246.3 million (including approximately $57.0&nbsp;million payable to the affiliated investors). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No assurance can be given as to how much, if any, of the Green Convertible Notes will be repurchased or the terms on which
they will be repurchased. Neither the completion of this offering nor the Concurrent Stock Offering is contingent on the completion of the other or the Note Repurchase Transactions. No assurance can be given that the Concurrent Stock Offering will
be completed on the terms described herein or at all. This prospectus supplement does not constitute an offer to sell, or the solicitation of an offer to buy, any shares of our common stock in the Concurrent Stock Offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">After giving effect to the Note Repurchase Transactions, approximately $34.0 million aggregate principal amount at maturity of
the Green Convertible Notes are expected to remain outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with any Note Repurchase Transaction, we
expect that the hedged holders will unwind all or part of their hedge positions by buying shares of our common stock, including pursuant to the Concurrent Stock Offering, and/or entering into or unwinding various derivative transactions with respect
to our common stock. The amount of our common stock to be purchased by the hedged holders or in connection with such derivative transactions may be substantial in relation to the historic average daily trading volume of our common stock. This
activity by the hedged holders could increase (or reduce the size of any decrease in) the market price of our common stock, including concurrently with the pricing of the notes, which could result in a higher effective conversion price for the
notes. We cannot predict the magnitude of such market activity or the overall effect it will have on the price of the notes offered hereby or our common stock. See the caption &#8220;Risk Factors&#8212;Risks Related to the Notes and This
Offering&#8212;Any repurchases of the Green Convertible Notes may affect the value of the notes and our common stock.&#8221; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_13"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following is a summary of certain U.S. federal income tax considerations of the purchase, ownership, disposition and
conversion of notes and ownership and disposition of the common stock into which the notes may be converted. This summary is based upon the current provisions of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), applicable U.S.
Treasury Regulations, administrative rulings and judicial decisions, all in effect as of the date hereof, any of which may subsequently be changed, possibly retroactively, so as to result in U.S. federal income tax consequences different from those
discussed below. We have not sought, and will not seek, any ruling from the Internal Revenue Service (the &#8220;IRS&#8221;) or any opinion of counsel with respect to the tax consequences discussed herein, and there can be no assurance that the IRS
will not take a position contrary to the tax consequences discussed herein or that any position taken by the IRS would not be sustained by a court. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except where noted, this summary addresses only a note or common stock held as a capital asset by a beneficial owner who
purchased the note on original issuance at its &#8220;issue price&#8221; (generally, the first price at which a substantial portion of the notes is sold for cash to persons other than bond houses, brokers, or similar persons or organizations acting
in the capacity of underwriters, placement agents or wholesalers). This summary does not address the effects of any state, local, estate, gift or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws or the potential application of the income
accrual rules set forth in Section&nbsp;451(b) of the Code. This summary does not address all aspects of U.S. federal income taxes relevant to investors, nor does it address all tax consequences that may be relevant to such investors in light of
their personal circumstances or particular situations, such as tax consequences to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">investors who may be subject to special tax treatment, including dealers in securities, banks, financial
institutions, regulated investment companies, real estate investment trusts, <FONT STYLE="white-space:nowrap">tax-exempt</FONT> entities, insurance companies, <FONT STYLE="white-space:nowrap">tax-deferred</FONT> or other retirement accounts,
controlled foreign corporations, passive foreign investment companies, subchapter S corporations or traders in securities that elect to use a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-</FONT></FONT> market method of
tax accounting for their securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons holding notes or common stock as a part of an integrated or conversion transaction or a straddle, or
persons deemed to sell notes or common stock under the constructive sale provisions of the Code; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">investors who are former citizens or long-term residents of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">investors subject to any alternative minimum tax provisions of the Code; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">U.S. holders (as defined below) whose &#8220;functional currency&#8221; is not the U.S. dollar;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">investors that participate in the Concurrent Stock Offering, and holders or beneficial owners of the Green
Convertible Notes that are exchanged, repurchased or redeemed with the proceeds from this offering or the Concurrent Stock Offering; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">investors that are entities or arrangements treated as partnerships or other pass-through entities for U.S.
federal income tax purposes and the partners or owners thereof. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If an entity or arrangement that is
treated as a partnership for U.S. federal income tax purposes holds notes or common stock, the tax treatment of a partner or member generally will depend upon the status of the partner or member and the activities of the entity or arrangement. If
you are a partner or member in such an entity or arrangement holding the notes or common stock, you should consult your tax advisors regarding the U.S. federal income tax considerations applicable to you. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>If you are considering the purchase of notes, you should consult your tax advisor concerning the U.S. federal income tax
consequences to you in light of your specific situation, as well as consequences arising under the laws of any other taxing jurisdiction. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As used herein, a &#8220;U.S. holder&#8221; is a beneficial owner of a note
or common stock received upon conversion of a note that is, for U.S. federal income tax purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is a citizen or resident of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation (or any other entity treated as a corporation for U.S. federal income tax purposes) created or
organized in or under the laws of the United States, any state thereof or the District of Columbia; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate the income of which is subject to U.S. federal income taxation regardless of its source; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust, if it (i)&nbsp;is subject to the primary supervision of a court within the United States and one or
more U.S. persons have the authority to control all substantial decisions of the trust, or (ii)&nbsp;has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a U.S. person. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A <FONT STYLE="white-space:nowrap">&#8220;non-U.S.</FONT> holder&#8221; is a beneficial owner of a note or common stock
received upon conversion of a note that is (i)&nbsp;a foreign corporation, (ii)&nbsp;a nonresident alien individual, or (iii)&nbsp;a foreign estate or trust that in each case is not subject to U.S. federal income tax on a <FONT
STYLE="white-space:nowrap">net-income</FONT> basis on income or gain from a note or share of common stock. Special rules may apply to certain <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders such as corporations that accumulate earnings to
avoid U.S. federal income tax. Consequently, <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders should consult their tax advisors to determine the U.S. federal, state, local, <FONT STYLE="white-space:nowrap">non-U.S.</FONT> and other tax
consequences that may be relevant to them in light of their particular circumstances. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Consequences to U.S. Holders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Interest on the Notes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The stated interest on the notes will be taxed as ordinary interest income that is included in a U.S. holder&#8217;s gross
income in accordance with the U.S. holder&#8217;s regular method of accounting for U.S. federal income tax purposes. It is anticipated, and this discussion assumes, that the notes will be issued with less than a <I>de minimis</I> amount of original
issue discount for U.S. federal income tax purposes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Additional Payments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In certain circumstances, we may pay additional interest on the notes in excess of the stated interest on the notes. See the
caption &#8220;Description of Notes&#8212;Events of Default.&#8221; According to the applicable U.S. Treasury Regulations, certain contingencies will not cause a debt instrument to be treated as a contingent payment debt instrument if such
contingencies, as of the date of issuance, are &#8220;remote or incidental&#8221; or certain other circumstances apply. We believe that there is only a remote possibility that we would be required to pay additional interest, or that if such
additional interest were required to be paid, it would be an incidental amount, We believe, and intend to take the position that, the possibility of such additional payments will not cause the notes to be treated as contingent payment debt
instruments under the applicable U.S. Treasury Regulations. However, there is no authority that directly addresses notes with terms identical to these notes. Assuming such position is respected, a U.S. holder would be required to include in income
the amount of any such additional payments at the time such payments are received or accrued, in accordance with such U.S. holder&#8217;s method of accounting for U.S. federal income tax purposes. Our position is binding on a U.S. holder, unless the
U.S. holder discloses in the proper manner to the IRS that it is taking a different position. If the IRS successfully challenged our position, and the notes were treated as contingent payment debt instruments, U.S. holders would be required to
accrue interest income at a rate higher than the notes&#8217; stated interest rate, regardless of the U.S. holder&#8217;s method of accounting, and to treat as ordinary income, rather than capital gain, any gain recognized on a sale, exchange,
redemption, repurchase or other taxable disposition of a note (including all gain realized upon conversion, even if the U.S. holder receives shares of our common stock). This discussion assumes that the notes will not be considered contingent
payment debt instruments. U.S. holders are urged to consult their tax advisors regarding the potential application to the notes of the contingent payment debt instrument rules and the consequences thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Sale, Exchange, Redemption, Repurchase or Other Taxable Disposition of Notes
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as provided below under &#8220;&#8212;Conversion of Notes,&#8221; a U.S. holder generally will recognize
gain or loss upon the sale, exchange, redemption, repurchase or other taxable disposition of a note (including an exchange with a designated financial institution in lieu of conversion, as described under &#8220;Description of Notes&#8212;Conversion
Rights&#8212; Exchange in Lieu of Conversion&#8221;) equal to the difference between the amount realized (less accrued but unpaid interest, which will be treated as described above under &#8220;&#8212;Interest on the Notes&#8221;) and such U.S.
holder&#8217;s adjusted tax basis in the note. A U.S. holder&#8217;s adjusted tax basis in a note generally will be: (i)&nbsp;the amount that the U.S. holder paid for the note, plus (ii)&nbsp;the amount, if any, included in income by the U.S. holder
on an adjustment to the conversion rate of the note, as described below under &#8220;&#8212;Constructive Distributions,&#8221; reduced by (iii)&nbsp;any cash payments received on the notes other than stated interest. Any gain or loss recognized on a
taxable disposition of a note will generally be capital gain or loss. If, at the time of the sale, exchange, redemption, repurchase or other taxable disposition of a note, a U.S. holder held the note for more than one year, such gain or loss
generally will be long-term capital gain or loss. Otherwise, such gain or loss will be short-term capital gain or loss. In the case of certain <FONT STYLE="white-space:nowrap">non-corporate</FONT> U.S. holders (including individuals), long-term
capital gains are generally eligible for a reduced rate of U.S. federal income tax. A U.S. holder&#8217;s ability to deduct capital losses may be limited. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Conversion of Notes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a U.S. holder presents a note for conversion, the U.S. holder may receive solely cash, solely common stock, or a combination
of cash and common stock in exchange for the note, depending upon our chosen settlement method. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a U.S. holder receives
solely cash in exchange for a note upon conversion, the U.S. holder&#8217;s gain or loss will be determined in the same manner as if the U.S. holder disposed of the notes in a taxable disposition (as described above under &#8220;&#8212;Sale,
Exchange, Redemption, Repurchase or Other Taxable Disposition of Notes&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a U.S. holder receives solely common
stock (and cash in lieu of any fractional share) in exchange for a note upon conversion, the U.S. holder generally will not recognize any income, gain or loss on the conversion, except with respect to cash received in lieu of a fractional share of
common stock (which could give rise to capital gain or loss, as described below) and any common stock attributable to accrued but unpaid interest not yet included in gross income (which will be treated as described above under &#8220;&#8212;Interest
on the Notes&#8221;), and subject to the discussion in the section titled &#8220;&#8212;Constructive Distributions&#8221; below regarding the possibility that an adjustment to the conversion rate of a note converted in connection with a make-whole
fundamental change or during a redemption period may be treated as a taxable stock dividend. The U.S. holder&#8217;s aggregate tax basis in the common stock (including any fractional share for which cash is paid, but excluding shares attributable to
accrued but unpaid interest not yet included in gross income) will equal the U.S. holder&#8217;s adjusted tax basis in the note. A U.S. holder&#8217;s tax basis in a fractional share of our common stock will be determined by allocating such
holder&#8217;s tax basis in the shares of our common stock, as determined in accordance with the previous sentence, between the shares of our common stock actually received and the fractional share of our common stock deemed received upon
conversion, in accordance with their respective fair market values. The U.S. holder&#8217;s holding period in the common stock (other than shares attributable to accrued but unpaid interest not yet included in gross income) will include the holding
period in the note. A U.S. holder&#8217;s tax basis in common stock attributable to such accrued interest will equal its fair market value on the date of receipt and the holding period for such stock will commence on the day after the date of
receipt. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As described below under &#8220;&#8212;Treatment as a Recapitalization,&#8221; the tax treatment of a conversion
of a note into cash and common stock is uncertain and subject to different characterizations, and U.S. holders should consult their tax advisors regarding the consequences of such a conversion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Treatment as a Recapitalization </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the note constitutes a &#8220;security&#8221; for U.S. federal income tax purposes, common stock and cash received by a U.S.
holder in exchange for a note upon conversion (subject to the discussion in &#8220;&#8212;Exchange in Lieu of Conversion&#8221; below) generally will be treated as received in a recapitalization for U.S. federal income tax purposes. The term
&#8220;security&#8221; is not defined in the Code or in the Treasury Regulations and has not been clearly defined by judicial decisions. An instrument is a &#8220;security&#8221; for these purposes if, based on all the facts and circumstances, the
instrument constitutes a meaningful investment in the issuer of the instrument. Although there are a number of factors that may affect the determination of whether a debt instrument is a &#8220;security,&#8221; one of the most important factors is
the original term of the instrument, or the length of time between the issuance of the instrument and its maturity. In general, instruments with an original term of more than ten years are likely to be treated as &#8220;securities,&#8221; and
instruments with an original term of less than five years generally have not been treated as &#8220;securities.&#8221; However, the convertibility of a debt instrument into stock of the issuer may support treatment as a &#8220;security&#8221;
because of the possible equity participation in the issuer. For purposes of this discussion, we assume that the notes are securities for U.S. federal income tax purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the note is a &#8220;security&#8221; and the conversion of the note into cash and common stock is a recapitalization, gain,
but not loss (other than in the case of receipt of cash in lieu of fractional shares), would be recognized by the U.S. holder equal to the excess of the fair market value of our common stock and cash received (other than amounts attributable to
accrued but unpaid interest not yet included in gross income, which will be treated as described above under &#8220;&#8212;Interest on the Notes&#8221;) over the U.S. holder&#8217;s adjusted tax basis in the note, but in no event would the gain
recognized exceed the amount of cash received (excluding any cash received in lieu of a fractional share or attributable to accrued but unpaid interest not yet included in gross income). Any gain recognized by a U.S. holder on conversion of a note
generally would be capital gain and generally would be long-term capital gain if, at the time of the conversion, the note has been held for more than one year. The amount of gain or loss recognized on the receipt of cash in lieu of a fractional
share would be equal to the difference between the amount of cash received in lieu of a fractional share and the portion of the U.S. holder&#8217;s tax basis in our common stock received that is allocable to the fractional share, as described in the
prior paragraph. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The tax basis of our common stock received upon such a conversion (including any fractional share deemed
to be received by the U.S. holder, but excluding any common stock attributable to accrued but unpaid interest not yet included in gross income, the tax basis of which would equal its fair market value) would be equal to the adjusted tax basis of the
note that was converted, reduced by the amount of any cash received (excluding cash received in lieu of a fractional share or attributable to accrued but unpaid interest not yet included in gross income), and increased by the amount of gain, if any,
recognized (other than gain recognized on any cash received with respect to a fractional share). A U.S. holder&#8217;s holding period for common stock would include the period during which the U.S. holder held the note, except that the holding
period of any common stock received with respect to accrued but unpaid interest not yet included in gross income would commence on the day after receipt. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Alternative Treatment as Part Conversion and Part Redemption. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under an alternative characterization, upon the conversion of a note into part cash and part common stock (excluding an
exchange with a designated financial institution in lieu of conversion, as described under &#8220;Description of Notes&#8212;Conversion Rights&#8212;Exchange in Lieu of Conversion,&#8221; which would be taxable as described above under
&#8220;&#8212;Sale, Exchange, Redemption, Repurchase or Other Taxable Disposition of Notes&#8221;), the cash payment received may be treated as proceeds from the sale of a portion of the note and taxed in the manner described above under
&#8220;&#8212;Sale, Exchange, Redemption, Repurchase or Other Taxable Disposition of Notes,&#8221; in which case our common stock received on such a conversion would be treated as received upon a conversion of the other portion of the note, which
generally would not be taxable to a U.S. holder, except to the extent of any common stock received with respect to accrued but unpaid interest not yet included in gross income, subject to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the discussion in the section titled &#8220;&#8212;Constructive Distributions&#8221; below regarding the possibility that an adjustment to the conversion rate of a note converted in connection
with a make-whole fundamental change or during a redemption period may be treated as a taxable stock dividend. In that case, the U.S. holder&#8217;s adjusted tax basis in the note would generally be allocated <I>pro rata</I> between the portion of
the note surrendered in exchange for common stock and the portion of the note surrendered in exchange for cash received based on the relative fair market value of our common stock and the cash received. The U.S. holder&#8217;s tax basis in the
common stock will be equal to the tax basis of that portion of the note surrendered in exchange for such common stock, except that a U.S. holder&#8217;s tax basis in common stock attributable to such accrued interest will equal its fair market value
on the date of receipt. The holding period for our common stock received in the conversion would include the holding period for the portion of the note surrendered in exchange for such common stock, except that the holding period for any common
stock received with respect to accrued but unpaid interest not yet included in gross income would commence on the day after receipt. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Exchange in Lieu of Conversion </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As described under &#8220;Description of Notes&#8212;Conversion Rights&#8212;Exchange in Lieu of Conversion,&#8221; we may
direct the notes to be offered to a financial institution for exchange in lieu of conversion. In this case, if a U.S. holder surrenders its notes for conversion, and the designated financial institution accepts the notes and delivers common stock
and/or cash in exchange for the notes, the U.S. holder will be taxed on the transfer as if it were a sale or exchange of the notes, as described above under &#8220;&#8212;Sale, Exchange, Redemption, Repurchase or Other Taxable Disposition of
Notes.&#8221; In such case, the U.S. holder&#8217;s tax basis in any shares of our common stock it receives will equal their fair market value on the date of the exchange, and the U.S. holder&#8217;s holding period in the shares of our common stock
it receives will begin the day after the date of the exchange. U.S. holders are urged to consult their tax advisors regarding the tax treatment of an exchange in lieu of conversion. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Constructive Distributions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The conversion rate of the notes is subject to adjustment in certain circumstances. Under Section&nbsp;305(c) of the Code,
certain adjustments (or failures to make adjustments) in the conversion rate of the notes that have the effect of increasing a U.S. holder&#8217;s proportionate interest in our assets or earnings and profits may result in a constructive distribution
to the U.S. holder for U.S. federal income tax purposes equal to the value of such increase even though the U.S. holder has not received any cash or property as a result of such adjustments. However, adjustments to the conversion rate made pursuant
to a <I>bona fide</I> reasonable adjustment formula that has the effect of preventing the dilution of the interest of the U.S. holders of the notes generally will not be deemed to result in a constructive distribution. Certain of the possible
conversion rate adjustments provided in the notes (including, without limitation, upon the payments of cash distributions to holders of common stock or in connection with a make-whole fundamental change or notice of redemption) will not qualify as
being pursuant to a bona fide reasonable adjustment formula. If such adjustments are made, depending on the facts at the time, including whether we have paid in the past or will pay in the future distributions on our stock or interest on other
convertible debt (including the Green Convertible Notes), a U.S. holder may be deemed to have received a distribution even though it has not received any cash or property because of such adjustments. Any constructive distribution would be taxable as
a dividend, return of capital, or capital gain in accordance with rules regarding distributions on stock described in &#8220;Distributions&#8221; below. It is not clear whether a constructive dividend deemed paid would be eligible for the
preferential rates of U.S. federal income tax applicable to certain dividends paid to <FONT STYLE="white-space:nowrap">non-corporate</FONT> U.S. holders. It is also not clear whether corporate U.S. holders would be entitled to claim the
dividends-received deduction with respect to any such constructive dividends. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are currently required to report the
amount of any deemed distributions on our website or to the IRS and to holders of notes not exempt from information reporting. The proposed U.S. Treasury Regulations addressing the amount and timing of deemed distributions, obligations of
withholding agents and filing and notice obligations of issuers, if adopted as proposed, generally would provide that (i)&nbsp;the amount of a deemed distribution is the excess of the fair market value of the right to acquire stock immediately after
the conversion </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
adjustment over the fair market value of the right to acquire stock without the adjustment, (ii)&nbsp;the deemed distribution occurs at the earlier of the date the adjustment occurs under the
terms of the note and the date of the actual distribution of cash or property that results in the deemed distribution, (iii)&nbsp;subject to certain limited exceptions, a withholding agent is required to impose any applicable withholding on deemed
distributions and, if there is no associated cash payment, may withhold the required amounts from payments on the notes (or, in some circumstances, any payments on our common stock) or sales proceeds received by or other funds or assets of an
investor, and (iv)&nbsp;we are required to report the amount of any deemed distributions on our website or to the IRS and to all holders of notes (including holders of notes that would otherwise be exempt from information reporting). The final U.S.
Treasury Regulations will be effective for deemed distributions occurring on or after the date of adoption, but holders of notes and withholding agents may rely on the proposed U.S. Treasury Regulations prior to that date under certain
circumstances. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Distributions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Distributions, if any, made on our common stock received upon conversion of a note, other than certain <I>pro rata
</I>distributions of common shares, generally will be included in a U.S. holder&#8217;s income as ordinary dividend income to the extent of our current or accumulated earnings and profits. Distributions in excess of our current and accumulated
earnings and profits will be treated as a <FONT STYLE="white-space:nowrap">tax-free</FONT> return of capital to the extent of a U.S. holder&#8217;s tax basis in our common stock and thereafter as capital gain from the sale or exchange of such common
stock. Dividends received by a corporate U.S. holder may be eligible for a dividends-received deduction, subject to applicable limitations. Dividends received by certain <FONT STYLE="white-space:nowrap">non-corporate</FONT> U.S. holders (including
individuals) are generally taxed at the lower applicable long-term capital gains rates, provided certain holding period and other requirements are satisfied. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Sales or Other Taxable Dispositions of Common Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon sales or other taxable dispositions of our common stock, a U.S. holder generally will recognize gain or loss equal to the
difference between the amount realized and the U.S. holder&#8217;s tax basis in our common stock. Any gain or loss recognized on a taxable disposition of common stock generally will be capital gain or loss. Such capital gain or loss will be
long-term capital gain or loss if a U.S. holder&#8217;s holding period at the time of the sale or other taxable disposition of our common stock is more than one year. Long-term capital gains recognized by certain
<FONT STYLE="white-space:nowrap">non-corporate</FONT> U.S. holders (including individuals) are generally eligible for a reduced rate of U.S. federal income tax. The deductibility of capital losses is subject to limitations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Possible Effect of the Change in Conversion Consideration after a Change in Control </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event we undergo certain of the events described above under the captions &#8220;Description of Notes&#8212;Conversion
Rights&#8212;Recapitalizations, Reclassifications and Changes of our Common Stock,&#8221; and &#8220;Description of Notes&#8212;Consolidation, Merger and Sale of Assets,&#8221; the conversion rate and the related conversion consideration may be
adjusted such that a U.S. holder would be entitled to convert its notes into the shares, property or assets other than our common stock described in such sections. Depending on the circumstances, such an adjustment could result in a deemed taxable
exchange of the notes to a U.S. holder, and the modified notes could be treated as newly issued at that time, potentially resulting in the recognition of taxable gain or loss. Furthermore, depending on the circumstances, the U.S. federal income tax
consequences of the exchange or conversion of the notes and of the ownership of the notes and the shares of our common stock may be different from the U.S. federal income tax consequences addressed in this discussion. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Medicare Tax </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Certain U.S. holders who are individuals, estates or trusts and whose income exceeds certain thresholds are subject to an
additional 3.8% unearned income Medicare contribution tax on an amount up to their &#8220;net investment income&#8221; (undistributed &#8220;net investment income&#8221; in the case of an estate or trust). A U.S. holder&#8217;s net
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
investment income generally will include interest received with respect to the notes, net gains from the disposition of the notes, dividends with respect to the shares of common stock into which
the notes are converted or net gains from the disposition of such shares. U.S. holders are urged to consult their tax advisors regarding the applicability of the unearned income Medicare contribution tax to their income and gains in respect of their
investment in the notes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Consequences to <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Interest on the Notes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to the discussions below under &#8220;&#8212;Information Reporting and Backup
<FONT STYLE="white-space:nowrap">Withholding&#8212;Non-U.S.</FONT> Holders,&#8221; and &#8220;&#8212;Information Reporting and Backup Withholding&#8212;Foreign Account Tax Compliance Act or FATCA,&#8221; the 30% U.S. federal withholding tax will not
be applied to any payment of interest on a note to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is not effectively connected with the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#8217;s conduct of a trade or business
within the United States, provided that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder does not actually or constructively (pursuant to
the conversion feature or otherwise) own 10% or more of the total combined voting power of all classes of our stock that are entitled to vote (including our common stock into which the notes are convertible); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is not a controlled foreign corporation that is
related to us (actually or constructively) through stock ownership; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder (a)&nbsp;provides its name and address, and
certifies, under penalties of perjury, that it is not a U.S. person (which certification may be made on an IRS Form <FONT STYLE="white-space:nowrap">W-8BEN,</FONT> IRS Form
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or other applicable Form <FONT STYLE="white-space:nowrap">W-8)</FONT> or (b)&nbsp;holds the notes through certain foreign intermediaries and the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder and the foreign intermediaries satisfy the certification requirements of applicable U.S. Treasury Regulations. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder cannot satisfy the requirements described above, payments of
interest will be subject to the 30% U.S. federal withholding tax, unless the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder provides the applicable withholding agent with a properly executed (i)&nbsp;IRS Form
<FONT STYLE="white-space:nowrap">W-8BEN</FONT> or IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> (or other applicable Form <FONT STYLE="white-space:nowrap">W-8)</FONT> claiming an exemption from or
reduction in withholding under an applicable income tax treaty or (ii)&nbsp;other applicable IRS Form <FONT STYLE="white-space:nowrap">W-8</FONT> providing that payments of interest with respect to the notes is not subject to withholding tax. If a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder is engaged in a trade or business in the United States and interest on a note is effectively connected with the conduct of that trade or business and, if required by an applicable income tax treaty,
is attributable to a U.S. permanent establishment or fixed base, then (although the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will be exempt from the 30% withholding tax (or lesser rate under an applicable income tax treaty) provided
the certification requirements discussed above are satisfied) the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will be subject to U.S. federal income tax on payments of that interest on a net income basis generally in the same manner as
if the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder were a U.S. holder (see the caption &#8220;&#8212;Consequences to U.S. Holders&#8212;Interest on the Notes&#8221; above). In addition, if the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a foreign corporation, it may be subject to a branch profits tax equal to 30% (or lesser rate under an applicable income tax treaty) of its earnings and profits for the taxable year, subject
to adjustments, that are effectively connected with its conduct of a trade or business in the United States. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Dividends and
Constructive Distributions </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any dividends paid to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder with
respect to common stock (and any deemed dividends resulting from certain adjustments, or failures to make adjustments, to the conversion rate of the notes, as described above under &#8220;&#8212;Consequences to U.S. Holders&#8212;Constructive
Distributions&#8221;) will be subject to U.S. withholding tax at a 30% rate or such lower rate as may be specified by an applicable income tax treaty. However, dividends that are effectively connected with the conduct of a trade or business in the
United States and, if required by an applicable income tax treaty, are attributable to a U.S. permanent establishment or fixed base, are not subject to the withholding tax, but instead are subject to U.S. federal income tax on a net income basis at
applicable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
graduated individual or corporate tax rates (see the caption &#8220;&#8212;Consequences to U.S. Holders&#8212;Distributions&#8221; above). Certain certification and disclosure requirements must
be complied with in order for effectively connected income to be exempt from withholding. Any such effectively connected income received by a foreign corporation may, under certain circumstances, be subject to a branch profits tax at a 30% rate or
such lower rate as may be specified by an applicable income tax treaty. Any applicable withholding taxes (including backup withholding) with respect to deemed dividends may be withheld from interest and payments upon conversion, repurchase or
maturity of the notes, or, if any withholding taxes (including backup withholding) are paid on behalf of a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder, those withholding taxes may be withheld from payments of cash or delivery of shares
of common stock, if any, in respect of the notes (or, in some circumstances, any payments on our common stock) or sales proceeds payable to, or other funds or assets of, such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder of common stock that wishes to claim the benefit of an applicable
income tax treaty is required to satisfy applicable certification and other requirements. If a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is eligible for an exemption from or a reduced rate of U.S. federal withholding tax pursuant to an
income tax treaty, it may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Sale, Exchange, Conversion or Other Taxable Dispositions of Notes or Common Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to the discussion below under &#8220;&#8212;Information Reporting and Backup
<FONT STYLE="white-space:nowrap">Withholding&#8212;Non-U.S.</FONT> Holders,&#8221; and &#8220;&#8212;Information Reporting and Backup Withholding&#8212;Foreign Account Tax Compliance or FATCA,&#8221; any gain recognized by a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder on the sale, exchange (including an exchange with a designated financial institution in lieu of conversion, as described under &#8220;Description of Notes&#8212;Conversion Rights&#8212;Exchange in
Lieu of Conversion&#8221;), conversion of a note into cash, common stock, or into a combination of cash and stock or other taxable disposition of a note or common stock will not be subject to U.S. federal income tax unless: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the gain is effectively connected with the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#8217;s
conduct of a trade or business in the United States (and, if required by an applicable income tax treaty, is attributable to a U.S. permanent establishment); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is an individual who is present in the United
States for 183 days or more in the taxable year of disposition, and certain other conditions are met; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are or have been a &#8220;U.S. real property holding corporation&#8221; (a &#8220;USRPHC&#8221;) for U.S.
federal income tax purposes during the shorter of the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#8217;s holding period or the <FONT STYLE="white-space:nowrap">5-year</FONT> period ending on the date of disposition of the note or common
stock, as the case may be, and certain other conditions are met. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you are a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder and you realize gain described in the first bullet point above, you will be subject to tax at regular graduated U.S. federal income tax rates on the net gain derived from the sale, exchange,
conversion or other taxable disposition of a note or common stock, generally in the same manner as if you were a U.S. holder (see the caption &#8220;&#8212;Consequences to U.S. Holders&#8212;Sale, Exchange, Redemption, Repurchase or Other Taxable
Disposition of Notes&#8221; and &#8220;&#8212;Consequences to U.S. Holders&#8212;Sales or Other Taxable Dispositions of Common Stock&#8221; above), and, if you are a foreign corporation, you additionally may be subject to a branch profits tax equal
to 30% of your effectively connected earnings and profits, or at such lower rate as may be specified by an applicable income tax treaty. If you are described in the second bullet point above, you will be subject to a flat 30% tax (or lower
applicable income tax treaty rate) on the gain recognized on the sale, exchange, conversion or other taxable disposition of a note or common stock (which gain may be offset by certain U.S.-source capital losses), even though you are not otherwise
considered a resident of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">With respect to the third bullet point above, a U.S. corporation generally is
a USRPHC if the fair market value of its U.S. real property interests equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests and its other assets used or held for use in a trade or business. We believe
that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
we are not currently and will not become a USRPHC. However, no assurance can be given that we are not or will not become a USRPHC in the future, because the determination of whether we are a
USRPHC depends on the fair market value of our United States real property interests relative to the fair market value of our other business assets. If we are or become a USRPHC, subject to the next two paragraphs, a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will be taxed on gain recognized on the sale, exchange or other taxable disposition of the notes (including a conversion of the notes into shares of our common stock) or shares of our
common stock in the same manner as if such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder were a United States person (subject to an applicable income tax treaty providing otherwise) and/or a 15% withholding tax will apply to the gross
proceeds from the sale, exchange or other taxable disposition of the notes (including a conversion of notes into shares of our common stock) or shares of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Even if we are or become a USRPHC, in the case of a disposition of the notes, a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will not be subject to U.S. federal income tax with respect to such gain as a result of us being or having been a USRPHC if either (i)&nbsp;our common stock continues to be
&#8220;regularly traded on an established securities market,&#8221; as defined by applicable Treasury Regulations, the notes are not regularly traded on an established securities market, and the fair market value of the notes owned, directly or
constructively (by application of certain attribution rules), by the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder on any date the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder acquired the notes did not exceed the fair market
value of 5% of our outstanding common stock, or (ii)&nbsp;our common stock continues to be regularly traded on an established securities market, the notes are considered regularly traded on an established securities market, and, at all times during
the shorter of (a)&nbsp;the five-year period preceding the disposition date and (b)&nbsp;the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#8217;s holding period for such notes, the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder
owns, directly or constructively (by application of certain attribution rules), no more than 5% of the outstanding notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Even if we are or become an USRPHC, in the case of a disposition of our common stock, if and so long as our common stock
continues to be regularly traded on an established securities market, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will not be subject to U.S. federal income tax with respect to such gain as a result of us being or having been
a USRPHC if such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder held, directly or constructively (by application of certain attribution rules), at all times during the shorter of the five-year period ending on the date of disposition or the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#8217;s holding period for the common stock, 5% or less of our outstanding common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our common shares are currently listed on the Nasdaq and we believe that, for as long as our common shares continue to be so
listed, our common shares will be treated as &#8220;regularly traded on an established securities market.&#8221; <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax advisors regarding the possibility that a sale,
exchange or other taxable disposition of the notes (including a conversion of the notes into shares of our common stock) or shares of our common stock may be subject to U.S. federal income taxation and withholding if we are or become a USRPHC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any amounts (including common stock) that a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder receives on a sale,
exchange, conversion or other taxable disposition of a note that are attributable to accrued but unpaid interest will be subject to U.S. federal income tax in accordance with the rules described above under &#8220;&#8212;Interest on the
Notes.&#8221; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Information Reporting and Backup Withholding </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>U.S. Holders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Information reporting requirements generally will apply to payments of interest (including additional interest, if any), deemed
dividends on the notes, dividends on our common stock, and the proceeds of a sale of a note or common stock paid to a U.S. holder, unless the U.S. holder is an exempt recipient and, if requested, certifies as to that status. Backup withholding
generally will apply to those payments if the U.S. holder fails to provide an appropriate certification with its correct taxpayer identification number or certification of exempt status. Backup withholding is not an additional tax. Any amounts
withheld under the backup withholding rules will be allowed as a refund or a credit against a U.S. holder&#8217;s U.S. federal income tax liability, provided the required information is timely furnished to the IRS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Generally, the amount of interest (including additional interest, if any) and deemed dividends on the notes, if any, and
dividends on our common stock paid to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders and the amount of tax, if any, withheld with respect to those payments must be reported annually to the IRS and to the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders. Copies of the information returns reporting such interest, deemed dividends, dividends and withholding may also be made available to the tax authorities in a country in which the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder resides under the provisions of an applicable income tax treaty. In general, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will not be subject to backup withholding with respect to
payments of interest or deemed dividends on a note or dividends on our common stock, provided the statement described above in the last bullet point under &#8220;&#8212;Consequences to <FONT STYLE="white-space:nowrap">Non-U.S.</FONT>
Holders&#8212;Interest on the Notes&#8221; has been received or the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder otherwise establishes an exemption. In addition, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will be subject to
information reporting and, depending on the circumstances, backup withholding with respect to payments of the proceeds of the sale of a note or common stock conducted within the United States or through certain U.S.-related financial intermediaries,
unless the statement described above has been received or the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder otherwise establishes an exemption. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding
rules will be allowed as a refund or a credit against a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#8217;s U.S. federal income tax liability, if any, provided the required information is timely furnished to the IRS. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Foreign Account Tax Compliance Act or FATCA </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Legislation incorporating provisions commonly referred to as FATCA imposes a withholding tax on certain types of payments made
to &#8220;foreign financial institutions&#8221; and certain other <FONT STYLE="white-space:nowrap">&#8220;non-financial</FONT> foreign entities&#8221; as defined in the Code and applicable Treasury Regulations. The legislation, together with
Treasury Regulations issued thereunder, generally imposes a 30% withholding tax on certain payments made to a foreign financial institution or to a <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity (whether as beneficial owner or
intermediary), unless (1)&nbsp;the foreign financial institution undertakes certain diligence and reporting obligations, (2)&nbsp;the <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity either certifies it does not have any
substantial U.S. owners or furnishes identifying information regarding each substantial U.S. owner and such entity meets certain other specified requirements, or (3)&nbsp;an exemption applies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to the following sentence, if the payee is a foreign financial institution and an exemption does not apply, it must
enter into an agreement with the U.S. Treasury requiring, among other things, that it undertake to identify accounts held by certain U.S. persons or U.S.-owned foreign entities, annually report certain information about such accounts, and withhold
30% on payments to account holders whose actions prevent it from complying with these reporting and other requirements. Foreign financial institutions and such other foreign entities located in jurisdictions that have entered into an
&#8220;intergovernmental agreement&#8221; with the United States regarding FATCA may be subject to different rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
Code generally provides that FATCA withholding applies to payments of interest, deemed dividends on our notes, dividends on our common stock and gross proceeds from the sale or other disposition of our notes or common stock. However, currently
proposed Treasury Regulations provide that FATCA withholding does not apply to gross proceeds from the disposition of the notes or our common stock. Pursuant to the preamble to the proposed Treasury Regulations, we and any other applicable
withholding agent may (but are not required to) rely on this proposed change to FATCA withholding until final regulations are issued or the proposed regulations are withdrawn. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will not pay any additional amounts to holders in respect of any amounts withheld, including pursuant to FATCA. Holders
should consult their tax advisors regarding the application of FATCA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_14"></A>CERTAIN ERISA CONSIDERATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following is a summary of certain considerations associated with the purchase and holding of the notes and any common
stock received upon conversion by (i) &#8220;employee benefit plans&#8221; (as defined in Section&nbsp;3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;)) that are subject to Part 4 of Title&nbsp;I of
ERISA, (ii)&nbsp;plans, including individual retirement accounts (&#8220;IRAs&#8221;) and other arrangements that are subject to the prohibited transaction provisions of Section&nbsp;4975 of the Code, or provisions under any other U.S. or <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> federal, state, local or other laws or regulations that are similar to such provisions of ERISA or the Code (collectively, &#8220;Similar Laws&#8221;), and (iii)&nbsp;entities whose underlying assets are
considered to include the assets of any of the foregoing described in clauses (i)&nbsp;and (ii), pursuant to ERISA or otherwise (each of the foregoing described in clauses (i), (ii) and (iii)&nbsp;referred to herein as a &#8220;Plan&#8221;). This
summary is based on provisions of ERISA and the Code, each as amended through the date of this prospectus supplement, and the relevant regulations, opinions and other authority issued by the U.S. Department of Labor and the IRS. We cannot assure you
that there will not be adverse tax or labor decisions or legislative, regulatory or administrative changes that would significantly modify the statements expressed herein. Any such changes may apply to transactions entered into prior to the date of
their enactment or issuance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>General Fiduciary Matters </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">ERISA and the Code impose certain duties on persons who are fiduciaries of a Plan subject to Title I of ERISA or
Section&nbsp;4975 of the Code (a &#8220;Covered Plan&#8221;) and prohibit certain transactions involving the assets of a Covered Plan and its fiduciaries or other interested parties. Under ERISA and the Code, any person who exercises any
discretionary authority or control over the administration of such a Covered Plan or the management or disposition of the assets of such a Covered Plan, or who renders investment advice for a fee or other compensation to such a Covered Plan, is
generally considered to be a fiduciary of the Covered Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In considering an investment in the notes or any common stock
received upon the conversion of the notes of a portion of the assets of any Plan, a fiduciary should determine whether the investment is in accordance with the documents and instruments governing the Plan and the applicable provisions of ERISA, the
Code or any Similar Law relating to a fiduciary&#8217;s duties to the Plan including, without limitation, the prudence, diversification, delegation of control and prohibited transaction provisions of ERISA, the Code and any other applicable Similar
Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Each Plan should consider the fact that none of the Company, U.S. Bank Trust Company, National Association, as
trustee, or the underwriter, or any of their respective affiliates will act as a fiduciary to any Plan with respect to the decision to acquire or hold the notes and that no such party is undertaking to provide impartial investment advice, or to give
advice in a fiduciary capacity with respect to such decision. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Prohibited Transaction Issues </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;406 of ERISA and Section&nbsp;4975 of the Code prohibit Covered Plans from engaging in specified transactions
involving plan assets with persons or entities who are &#8220;parties in interest,&#8221; within the meaning of ERISA, or &#8220;disqualified persons,&#8221; within the meaning of Section&nbsp;4975 of the Code, unless an exemption is available. A
party in interest or disqualified person who engaged in a <FONT STYLE="white-space:nowrap">non-exempt</FONT> prohibited transaction may be subject to excise taxes and other penalties and liabilities under ERISA and/or the Code and, with respect to a
Covered Plan that is an IRA, may result in the disqualification of the IRA. In addition, the fiduciary of the Covered Plan that engaged in such a <FONT STYLE="white-space:nowrap">non-exempt</FONT> prohibited transaction may be subject to penalties
and liabilities under ERISA and the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The acquisition and/or holding of the notes or any common stock received upon
the conversion of the notes by a Covered Plan with respect to which we, U.S. Bank Trust Company, National Association, as trustee, an underwriter or any of our or their respective affiliates is considered a party in interest or a disqualified person
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
may constitute or result in a direct or indirect prohibited transaction under Section&nbsp;406 of ERISA and/or Section&nbsp;4975 of the Code, unless the investment is acquired and is held in
accordance with an applicable statutory, class or individual prohibited transaction exemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In this regard, the U.S.
Department of Labor has issued prohibited transaction class exemptions, or &#8220;PTCEs,&#8221; each as amended, that may provide exemptive relief for direct or indirect prohibited transactions resulting from the sale, purchase or holding of the
notes or any common stock received upon the conversion of the notes. These class exemptions include, without limitation, PTCE <FONT STYLE="white-space:nowrap">84-14</FONT> respecting transactions determined by independent qualified professional
asset managers, PTCE <FONT STYLE="white-space:nowrap">90-1</FONT> respecting insurance company pooled separate accounts, PTCE <FONT STYLE="white-space:nowrap">91-38</FONT> respecting bank collective investment funds, PTCE <FONT
STYLE="white-space:nowrap">95-60</FONT> respecting life insurance company general accounts, and PTCE <FONT STYLE="white-space:nowrap">96-23</FONT> respecting transactions determined by <FONT STYLE="white-space:nowrap">in-house</FONT> asset managers.
In addition, Section&nbsp;408(b)(17) of ERISA and Section&nbsp;4975(d)(20) of the Code provide relief from the prohibited transaction provisions of ERISA and Section&nbsp;4975 of the Code for certain transactions, provided that neither the issuer of
the securities nor any of its affiliates (directly or indirectly) have or exercise any discretionary authority or control or render any investment advice with respect to the assets of any Covered Plan involved in the transaction and provided further
that the Covered Plan pays no more than adequate consideration in connection with the transaction. Each of the above-noted exemptions contains conditions and limitations on its application. Fiduciaries of Covered Plans considering acquiring and/or
holding the notes or any common stock received upon the conversion of the notes in reliance on these or any other exemption should carefully review the exemption to assure it is applicable. There can be no assurance that all of the conditions of any
such exemptions will be satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Plans that are governmental plans, <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
plans and certain church plans, while not necessarily subject to the prohibited transaction provisions of Title I of ERISA or Section&nbsp;4975 of the Code, may nevertheless be subject to Similar Laws which may affect their investment in the notes
or any common stock received upon the conversion of the notes. Any fiduciary of such a Plan considering an investment in the notes or common stock received upon the conversion of the notes should consult with its counsel before acquiring any notes
(or common stock issuable upon conversion of the notes) to consider the applicable fiduciary standards and to determine the need for, and, if necessary, the availability of, any exemptive relief under any applicable Similar Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Because of the foregoing, the notes and any common stock received upon the conversion of the notes should not be acquired or
held by any person investing the assets of any Plan, unless such acquisition and holding will not constitute a <FONT STYLE="white-space:nowrap">non-exempt</FONT> prohibited transaction under ERISA or the Code or a similar violation of any applicable
Similar Laws. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Representation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Accordingly, by acquiring or holding any note (or common stock received upon the conversion of the notes) each purchaser and
each subsequent transferee will be deemed to have represented and warranted that either (i)&nbsp;no portion of the assets used by such purchaser or subsequent transferee to purchase or hold the notes (or any common stock received upon the conversion
of the notes) constitutes assets of any Plan or (ii)&nbsp;the acquisition and holding of the notes (and any common stock received upon the conversion of the notes), by such purchaser or transferee will not constitute or result in (a)&nbsp;a <FONT
STYLE="white-space:nowrap">non-exempt</FONT> prohibited transaction under Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code or (b)&nbsp;a similar violation under any applicable Similar Laws and none of the Company, U.S. Bank Trust Company,
National Association, as trustee, the underwriters or any of their respective affiliates, is acting or will act as a fiduciary of such purchaser or transferee in connection with such acquisition and holding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The foregoing discussion is general in nature and is not intended to be <FONT STYLE="white-space:nowrap">all-inclusive.</FONT>
Due to the complexity of these rules and the penalties that may be imposed upon persons involved in <FONT STYLE="white-space:nowrap">non-exempt</FONT> prohibited transactions, it is particularly important that fiduciaries, or other persons
considering purchasing the notes or any common stock received upon the conversion of the notes on behalf of, or with the assets of, any Plan, consult </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
with their counsel regarding the potential applicability of ERISA, Section&nbsp;4975 of the Code and any Similar Laws to such investment, whether an exemption would be applicable to the purchase
and holding of the notes and whether the notes (or common stock received upon the conversion of the notes) would be an appropriate investment for the Plan under ERISA, the Code and any applicable Similar Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Purchasers of the notes have the exclusive responsibility for ensuring that their acquisition and holding of the notes and any
common stock received upon the conversion of the notes complies with the fiduciary responsibility rules of ERISA and does not violate the prohibited transaction rules of ERISA, the Code or applicable Similar Laws. We make no representation as to
whether an investment in the notes or any common stock received upon the conversion of the notes is appropriate for any Plan in general or whether such investment is appropriate for any particular Plan or arrangement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_15"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the terms and subject to the conditions in an underwriting agreement dated the date of this prospectus supplement, the
underwriters named below, for whom Morgan Stanley&nbsp;&amp; Co. LLC is acting as representative, have severally agreed to purchase, and we have agreed to sell to them, severally, the principal amount of notes indicated below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center"><B>Name</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Principal<BR>Amount&nbsp;of&nbsp;Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">225,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cantor Fitzgerald &amp; Co.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The underwriters and the representative are collectively referred to as the
&#8220;underwriters&#8221; and the &#8220;representative,&#8221; respectively. The underwriters are offering the notes subject to their acceptance of the notes from us and subject to prior sale. The underwriting agreement provides that the
obligations of the several underwriters to pay for and accept delivery of the notes offered by this prospectus supplement are subject to the approval of certain legal matters by their counsel and to certain other conditions. The underwriters are
obligated to take and pay for all of the notes offered by this prospectus supplement if any such notes are taken. However, the underwriters are not required to take or pay for the notes covered by the underwriters&#8217; over-allotment option
described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The underwriters initially propose to offer part of the notes directly to the public at the offering
price listed on the cover page of this prospectus supplement and part to certain dealers at a price that represents a concession not in excess of 3.0% of the principal amount of notes. After the initial offering of the notes, the offering price and
other selling terms may from time to time be varied by the representative. The notes are a new issue of securities, and there is currently no established trading market for such notes. We do not intend to apply for the notes to be listed on any
securities exchange or to arrange for the notes to be quoted on any quotation system. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have granted to the underwriters
an option, exercisable for 30 days from the date of this prospectus supplement, to purchase up to $37,500,000 additional aggregate principal amount of notes at the public offering price listed on the cover page of this prospectus supplement, less
underwriting discounts and commissions, solely to cover over-allotments. To the extent the option is exercised, each underwriter will become obligated, subject to certain conditions, to purchase about the same percentage of the additional notes as
the principal amount listed next to the underwriter&#8217;s name in the preceding table bears to the total aggregate principal amount of notes listed next to the names of all underwriters in the preceding table. Any notes issued or sold under the
over-allotment option will be issued and sold on the same terms and conditions as the other notes that are the subject of this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table shows the price per $1,000 principal amount of notes and total public offering price, underwriting
discounts and commissions, and proceeds before expenses to us. These amounts are shown assuming both no exercise and full exercise of the underwriters&#8217; over-allotment option. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD ROWSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;$1,000<BR>Principal<BR>Amount&nbsp;of<BR>Notes</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>No<BR>Exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Full<BR>Exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">287,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discounts and commissions to be paid by us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,625,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">242,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">278,875,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The estimated offering expenses payable by us in connection with this offering, exclusive of
the underwriting discounts and commissions, are approximately $550,000. We have agreed to reimburse the underwriters for expenses relating to clearance of this offering and the Concurrent Stock Offering with the Financial Industry Regulatory
Authority for up to $35,000. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our common stock is listed on Nasdaq under the symbol &#8220;PCT.&#8221;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have agreed that, during the period ending 60 days after the date of this prospectus supplement, which we refer to as
the &#8220;restricted period&#8221;, without the prior written consent of Morgan Stanley&nbsp;&amp; Co. LLC, we will not (i)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to
sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of our common stock or any securities convertible into or exercisable or exchangeable for shares of our common stock,
(ii)&nbsp;enter into any swap, loan or other arrangement (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward or any other derivative transaction or
instrument, however described or defined) that transfers to another, in whole or in part, directly or indirectly, any of the economic consequences of ownership of the shares of common stock, whether any such transaction described in clause
(i)&nbsp;or (ii) above is to be settled by delivery of shares of common stock or such other securities, in cash or otherwise, or (iii)&nbsp;confidentially submit any draft registration statement or file any registration statement with the SEC
relating to the offering of any shares of common stock or any securities convertible into or exercisable or exchangeable for common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The restrictions on our actions described in the immediately preceding paragraph do not apply to (A)&nbsp;the securities to be
sold pursuant to this prospectus supplement and any shares of common stock issued upon conversion of the securities, (B) the shares of common stock to be issued and sold in the Concurrent Stock Offering, (C) grants of equity-based awards pursuant to
our equity incentive plan, (D) any shares of common stock issued upon the exercise of an option, the vesting of any restricted stock or restricted class of similar units, or other equity award outstanding on the date hereof, (E) any shares of common
stock issued in connection with the exercise of the our Series A warrants or public warrants, whether in connection with a redemption of such warrants by us or otherwise, (F) the filing of any registration statement on Form S-8 with the SEC relating
to securities granted or to be granted pursuant to any plan in effect on the date hereof or any assumed benefit plan pursuant to an acquisition or similar strategic transaction, (G) facilitating the establishment of a trading plan on behalf of a
shareholder, officer or director pursuant to Rule 10b5-1 under the Exchange Act, for the transfer of shares of common stock, provided that (i) such plan does not provide for the transfer of common stock during the restricted period and (ii) to the
extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by us regarding the establishment of such plan, such announcement or filing shall include a statement to the effect that no transfer of common
stock may be made under such plan during the restricted period, or (H) the issuance of shares of common stock or any securities convertible into or exercisable or exchangeable for common stock in connection with our acquisition of the securities,
businesses, property or other assets of another person or entity or in connection with strategic partnering transactions; provided that, in the case of subclause (H), (i) the aggregate number of shares of common stock does not exceed 10% of the
outstanding shares of our common stock immediately following the issuance and sale of the securities to be sold pursuant to this prospectus supplement and the shares of common stock to be sold pursuant to the Concurrent Stock Offering prospectus
supplement and (ii) the recipient of such shares of common stock or securities convertible into or exercisable or exchangeable for common stock shall enter into a &#8220;lock up&#8221; agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our directors, executive officers and specified affiliates of such directors, as applicable, each of whom we refer to as a <FONT
STYLE="white-space:nowrap">&#8220;lock-up</FONT> party,&#8221; have agreed that, without the prior written consent of Morgan Stanley&nbsp;&amp; Co. LLC on behalf of the underwriters, they will not, during the restricted period: (i)&nbsp;offer,
pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of our
common stock or any securities convertible into or exercisable or exchangeable for shares of our common stock owned or hereafter acquired by the <FONT STYLE="white-space:nowrap">lock-up</FONT> party or with respect to which the <FONT
STYLE="white-space:nowrap">lock-up</FONT> party has or hereafter acquires the power of disposition (including, without limitation, common stock or such other securities which may be deemed to be beneficially owned by the <FONT
STYLE="white-space:nowrap">lock-up</FONT> party (as such term is used in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> of the Exchange Act)) and securities which may be issued upon exercise of a stock option or warrant by the <FONT
STYLE="white-space:nowrap">lock-up</FONT> party or any other securities so owned convertible into or exercisable or exchangeable for common stock (collectively, the <FONT STYLE="white-space:nowrap">&#8220;lock-up</FONT> securities&#8221;) or
(ii)&nbsp;enter into any hedging, swap, loan or other arrangement (including, without limitation, any short sale or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the purchase or sale of, or entry into, any put or call option, or combination thereof, forward or any other derivative transaction or instrument, however described or defined) that transfers to
another, in whole or in part, directly or indirectly, any of the economic consequences of ownership of the <FONT STYLE="white-space:nowrap">lock-up</FONT> securities, whether any such transaction described in clause (i)&nbsp;or (ii) is to be settled
by delivery of common stock or such other <FONT STYLE="white-space:nowrap">lock-up</FONT> securities, in cash or otherwise; (iii)&nbsp;make any demand for or exercise any right with respect to the registration of any
<FONT STYLE="white-space:nowrap">lock-up</FONT> securities, or (iv)&nbsp;publicly disclose the intention to do any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The restrictions described in the immediately preceding paragraph do not apply to the transfer of securities: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">pursuant to the exercise and issuance of an option or the vesting of any restricted stock, restricted class
of similar units or other equity awards outstanding on the date hereof or granted under equity incentive plans in effect as of the date hereof or described in this prospectus supplement, provided that any securities underlying such options continue
to be subject to the terms of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement (other than as provided under clause (ix)&nbsp;below); </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">by will or under the laws of descent, provided that the transferee agrees to be bound in writing by the
restrictions set forth in the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">transfers as a bona fide gift or gifts, including to charitable organizations or charitable trusts, provided
that the donee or donees thereof agree to be bound in writing by the restrictions set forth in the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">transfers to an immediate family member of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party or to a
trust, the beneficiaries of which are exclusively the <FONT STYLE="white-space:nowrap">lock-up</FONT> party or a member or members of his or her immediate family, provided that the trustee of the trust agrees to be bound in writing by the
restrictions set forth in the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">transfers to a partnership, limited liability company or other entity of which the <FONT
STYLE="white-space:nowrap">lock-up</FONT> party and the immediate family of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party are the legal and beneficial owner of all of the outstanding equity securities or similar interest, provided that
the transferee agrees to be bound in writing by the restrictions set forth in the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">transfers to a nominee or custodian of a person or entity to whom a disposition or transfer would be
permissible under clauses (ii)&nbsp;through (v) above, provided that the transferee agrees to be bound in writing by the restrictions set forth in the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">transfers by operation of law, such as pursuant to a qualified domestic order, divorce settlement, divorce
decree or separation agreement, provided that the transferee agrees to be bound in writing by the restrictions set forth in the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">transfers to us from an employee upon death, disability or termination of employment, in each case, of such
employee; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(ix)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">(a) transfers or sales of common stock pursuant to any contract, instruction or plan complying with Rule <FONT
STYLE="white-space:nowrap">10b5-1</FONT> of the Exchange Act, that has been entered into by the <FONT STYLE="white-space:nowrap">lock-up</FONT> party prior to the date hereof, or (b)&nbsp;the entry into any contract, instruction or plan complying
with Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> of the Exchange Act, provided that sales under any such new trading plan do not occur during the restricted period, any required public disclosure, announcement or filing under the Exchange
Act made by us or any person regarding the establishment of such plan during the restricted period shall include a statement that the <FONT STYLE="white-space:nowrap">lock-up</FONT> party is not permitted to transfer, sell or otherwise dispose of
securities under such plan during the restricted period in contravention of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement, and no public announcement, report or filing under the Exchange Act, or any other public filing, report or
announcement, shall be voluntarily made regarding the establishment of such plan during the restricted period; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(x)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">transfers made as a distribution to stockholders, partners or members of the
<FONT STYLE="white-space:nowrap">lock-up</FONT> party, provided that such stockholders, partners or members agree to be bound in writing by the restrictions set forth in the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(xi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">transfers required under any of our benefit plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(xii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">transfers to us in connection with the vesting, settlement or exercise of restricted stock units,
performance stock units, options, warrants or other rights to purchase shares of common stock (including, in each case, by way of &#8220;net&#8221; or &#8220;cashless&#8221; exercise), including for the payment of exercise price and tax and
remittance payments due as a result of the vesting, settlement, or exercise of such restricted stock units, performance stock units, options, warrants or rights, provided that any such shares of common stock received upon such exercise, vesting or
settlement shall be subject to the terms of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(xiii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">transactions in any securities acquired by the <FONT STYLE="white-space:nowrap">lock-up</FONT> party after
the closing date in the open market; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(xiv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">transfers made pursuant to a bona fide third-party tender offer, merger, consolidation or other similar
transaction that is approved by our board of directors and made to all holders of our capital stock involving a change of control; provided that in the event that such tender offer, merger, consolidation or other similar transaction is not
completed, the <FONT STYLE="white-space:nowrap">lock-up</FONT> securities owned by the <FONT STYLE="white-space:nowrap">lock-up</FONT> party shall remain subject to the provisions of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(xv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">with the prior written consent of Morgan Stanley&nbsp;&amp; Co. LLC; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(xvi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the exercise by the <FONT STYLE="white-space:nowrap">lock-up</FONT> party of any Series A Warrants or Public
Warrants (including by way of &#8220;net&#8221; or &#8220;cashless&#8221; exercise), in connection with a redemption of such warrants by us; provided that any shares of common stock received upon such exercise shall remain subject to the provisions
of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">provided, however, that, in each case, no filing
under Section&nbsp;16 of the Exchange Act, or other public announcement is required or otherwise made (other than a filing on Form 5 made after the expiration of the restricted period or, with respect to clauses (i), (iii) and (x)-(xvi), a filing on
Form 4 required to be filed under the Exchange Act; provided, however, that if such Form 4 is filed during the restricted period, such Form 4 shall indicate by footnote disclosure or otherwise the nature of such transfer, that no shares of common
stock are being sold or otherwise disposed of by the <FONT STYLE="white-space:nowrap">lock-up</FONT> party in connection therewith and/or that such shares of common stock received by any transferee are subject to the terms of the <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreement; provided further, that the <FONT STYLE="white-space:nowrap">lock-up</FONT> party shall notify Morgan Stanley&nbsp;&amp; Co. LLC at least one (1)&nbsp;business day prior to such required filing
under the Exchange Act), and in the case of any such transfer contemplated by clauses (ii)-(vii), (x), (xi) and (xiv), a copy of the required agreement of the transferee or transferees is furnished promptly to Morgan Stanley&nbsp;&amp; Co. LLC;
provided further, that in the case of any transfer or distribution pursuant to clauses (ii)-(viii) and (x), any such transfer shall not involve a disposition for value. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Morgan Stanley&nbsp;&amp; Co. LLC, in its sole discretion, may release the common stock and other securities subject to the <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements described above in whole or in part at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In order to
facilitate the offering of the notes, the underwriters may engage in transactions that stabilize, maintain or otherwise affect the price of the notes. Specifically, the underwriters may sell more notes than they are obligated to purchase under the
underwriting agreement, creating a short position. A short sale is covered if the short position is no greater than the aggregate principal amount of notes available for purchase by the underwriters under the option. The underwriters can close out a
covered short sale by exercising the option or purchasing notes in the open market. In determining the source of notes to close out a covered short sale, the underwriters will consider, among other things, the open market price of notes compared to
the price available under the option. The underwriters may also sell notes in excess of the option, creating a naked short position. The underwriters must close out any naked short position by purchasing notes in the open market. A naked short
position is more likely to be created if the underwriters are concerned that there may be downward pressure on </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the price of the notes in the open market after pricing that could adversely affect investors who purchase in this offering. As an additional means of facilitating this offering, the underwriters
may bid for, and purchase, notes in the open market to stabilize the price of the notes. These activities may raise or maintain the market price of the notes above independent market levels or prevent or retard a decline in the market price of the
notes. The underwriters are not required to engage in these activities and may end any of these activities at any time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We and the underwriters have agreed to indemnify each other against certain liabilities, including liabilities under the
Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A prospectus supplement in electronic format may be made available on websites maintained by one or more
underwriters, or selling group members, if any, participating in this offering. The representative may agree to allocate a portion of the notes to underwriters for sale to their online brokerage account holders. Internet distributions will be
allocated by the representative to underwriters that may make Internet distributions on the same basis as other allocations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which
may include securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. Certain of the underwriters and their respective
affiliates have, from time to time, performed, and may in the future perform, various financial advisory and investment banking services for us, for which they received or will receive customary fees and expenses. For example, Morgan
Stanley&nbsp;&amp; Co. LLC is also acting as underwriter in the Concurrent Stock Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, in the ordinary
course of their various business activities, the underwriters and their respective affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments
(including bank loans) for their own account and for the accounts of their customers and may at any time hold long and short positions in such securities and instruments. Such investment and securities activities may involve our securities and
instruments. The underwriters and their respective affiliates may also make investment recommendations or publish or express independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients
that they acquire, long or short positions in such securities and instruments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Settlement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We expect to deliver the notes to investors in book-entry form through the facilities of The Depository Trust Company on or
about June&nbsp;15, 2026, which will be the second business day following the initial trade date for the notes offered pursuant to this prospectus supplement (this settlement cycle being referred to as &#8220;T+2&#8221;). Under <FONT
STYLE="white-space:nowrap">Rule&nbsp;15c6-1</FONT> under the Exchange Act, trades in the secondary market generally are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers
who wish to trade the notes being offered hereby prior to the business day preceding the settlement date will be required, by virtue of the fact that the notes initially will settle&nbsp;T+2, to specify an alternate settlement cycle at the time of
any such trade to prevent a failed settlement. Purchasers of the notes who wish to trade the notes prior to the business day preceding the settlement date should consult their own advisors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Concurrent Stock Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Concurrently with this offering, we are conducting the Concurrent Stock Offering of 17,570,200 shares of our common stock (or
up to 19,854,000 shares of our common stock if the underwriters in the Concurrent Stock Offering exercise their option to purchase additional shares in full) at a price of $8.21 per share pursuant to a separate prospectus supplement. Neither the
completion of this offering nor the Concurrent Stock Offering is contingent on the completion of the other or the Note Repurchase Transactions. No assurance can be given that the Concurrent Stock Offering will be completed on the terms described
herein or at all. This prospectus </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
supplement does not constitute an offer to sell, or the solicitation of an offer to buy, any shares of our common stock in the Concurrent Stock Offering and does not constitute an offer to buy,
or the solicitation of an offer to sell, any of the Green Convertible Notes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Selling Restrictions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Canada </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The securities may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited
investors, as defined in National <FONT STYLE="white-space:nowrap">Instrument&nbsp;45-106</FONT><I></I><I>&nbsp;Prospectus Exemptions</I>&nbsp;or subsection 73.3(1) of the<I></I><I>&nbsp;Securities Act</I>&nbsp;(Ontario), and are permitted clients,
as defined in National <FONT STYLE="white-space:nowrap">Instrument&nbsp;31-103</FONT><I></I><I>&nbsp;Registration Requirements, Exemptions and Ongoing Registrant Obligations</I>. Any resale of the securities must be made in accordance with an
exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Securities
legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus supplement (including any amendment thereto) contains a misrepresentation, provided that the remedies for
rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#8217;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation
of the purchaser&#8217;s province or territory for particulars of these rights or consult with a legal advisor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant
to section 3A.3 of National <FONT STYLE="white-space:nowrap">Instrument&nbsp;33-105</FONT><I></I><I>&nbsp;Underwriting Conflicts</I><FONT STYLE="white-space:nowrap">&nbsp;(NI&nbsp;33-105),&nbsp;the</FONT> underwriters are not required to comply with
the disclosure requirements of <FONT STYLE="white-space:nowrap">NI&nbsp;33-105&nbsp;regarding</FONT> underwriter conflicts of interest in connection with this offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>European Economic Area </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In relation to each Member State of the European Economic Area (each, a Relevant State), no securities have been offered or
will be offered to the public in that Relevant State prior to the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Relevant State or, where appropriate, approved in another Relevant
State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation, except that offers of securities may be made to the public in that Relevant State at any time under the following exemptions
under the Prospectus Regulation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">to any legal entity which is a qualified investor as defined under the Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus
Regulation), subject to obtaining the prior consent of the representatives; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">in any other circumstances falling within Article 1(4) of the Prospectus Regulation; </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">provided that no such offer of the securities shall require us or any of the representatives to publish a prospectus pursuant to Article 3 of
the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For the
purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to the securities in any Relevant State means the communication in any form and by any means of sufficient information on the terms of the offer and any
securities to be offered so as to enable an investor to decide to purchase any securities, and the expression &#8220;Prospectus Regulation&#8221; means Regulation (EU) 2017/1129 (as amended). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>United Kingdom </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each underwriter has represented and agreed that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">it has only communicated or caused to be communicated and will only communicate or cause to be communicated
an invitation or inducement to engage in investment activity (within the meaning of Section&nbsp;21 of the Financial Services and Markets Act 2000, or the FSMA) received by it in connection with the issue or sale of the securities in circumstances
in which Section&nbsp;21(1) of the FSMA does not apply to us; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by
it in relation to the securities in, from or otherwise involving the United Kingdom. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No securities have
been offered or will be offered pursuant to the offering to the public in the United&nbsp;Kingdom prior to the publication of a prospectus in relation to the securities which has been approved by the Financial Conduct Authority, except that the
securities may be offered to the public in the United Kingdom at any time: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">to any legal entity which is a qualified investor as defined paragraph 15 of Schedule 1 to the POAT
Regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">to fewer than 150 natural or legal persons (other than qualified investors as defined paragraph 15 of
Schedule 1 to the POAT Regulations), subject to obtaining the prior consent of the representatives for any such offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">in any other circumstances falling within Part 1 of Schedule 1 to the POAT Regulations;
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">provided that no such offer of the securities shall require us or any of the representatives to publish a prospectus
pursuant to the POAT Regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For the purposes of this provision, the expression an &#8220;offer to the public&#8221;
in relation to the securities in the United Kingdom means the communication in any form and by any means of sufficient information on the terms of the offer and any securities to be offered so as to enable an investor to decide to purchase or
subscribe for any securities and the expression &#8220;POAT Regulations&#8221; means the Public Offers and Admissions to Trading Regulations 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus supplement is only for distribution to and directed at: (i)&nbsp;in the United Kingdom, persons having
professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended, or the Order, and high net worth entities falling within Article
49(2)(a) to (d)&nbsp;of the Order; (ii)&nbsp;persons who are outside the United Kingdom; and (iii)&nbsp;any other person to whom it can otherwise be lawfully distributed, or all such persons together, Relevant Persons. Any investment or investment
activity to which this prospectus supplement relates is available only to and will be engaged in only with Relevant Persons, and any person who is not a Relevant Person should not rely on it. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Hong Kong </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The securities have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document, other than
(a)&nbsp;to &#8220;professional investors&#8221; as defined in the Securities and Futures Ordinance (Cap. 571 of the laws of Hong Kong) and any rules made or (b)&nbsp;in other circumstances which do not result in the document being a
&#8220;prospectus&#8221; as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap.&nbsp;32 of the laws of Hong Kong) and which do not constitute an offer to the public within the meaning thereunder. No advertisement,
invitation or document relating to the securities has been or may be issued or has been or may be in the possession of any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the contents of which are likely
to be accessed or read by, the public of Hong Kong </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
(except if permitted to do so under the securities laws of Hong Kong) other than with respect to securities which are or are intended to be disposed of only to persons outside Hong Kong or only
to &#8220;professional investors&#8221; as defined in the Securities and Futures Ordinance and any rules made thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The contents of this prospectus supplement have not been reviewed, endorsed or approved by any Hong&nbsp;Kong regulatory
authority, including the Securities and Futures Commission and the Companies Registry of Hong Kong and neither has it been nor will it be registered with the Registrar of Companies in Hong Kong. You are advised to exercise caution in relation to the
offer. If you are in doubt about any contents of this document, you should obtain independent professional advice. This prospectus supplement may not be issued, circulated or distributed (in whole or in part) in Hong Kong, and the notes may not be
offered for subscription to members of the public in Hong Kong. Each person acquiring the securities will be required, and is deemed by the acquisition of the securities, to confirm that such person is aware of the restriction on offers of the
securities described in this prospectus supplement and that such person is not acquiring, and has not been offered any securities in circumstances that contravene any such restrictions and that such person has complied with all relevant laws, rules
and regulations applicable to him/her/it and the jurisdiction(s) where such person or his/her/its assets are located. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Japan
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The securities have not been and will not be registered pursuant to Article 4, Paragraph 1 of the Financial
Instruments and Exchange Act of Japan (Act No.&nbsp;25 of 1948, as amended, the &#8220;FIEA&#8221;) and, accordingly, will not be offered or sold, directly or indirectly, in Japan, or for the account of or the benefit of, any Japanese Person or to
others for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale, directly or indirectly, in Japan or to, or for the account of or the benefit of, any Japanese Person, except in compliance with the FIEA and other applicable laws, regulations
and ministerial guidelines promulgated by relevant Japanese governmental or regulatory authorities in effect at the relevant time. For the purposes of this paragraph, &#8220;Japanese Person&#8221; means any person resident in Japan, including any
corporation or other entity organized under the laws of Japan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Singapore </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus supplement has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, the
securities were not offered or sold or caused to be made the subject of an invitation for subscription or purchase and will not be offered or sold or caused to be made the subject of an invitation for subscription or purchase, and this prospectus
supplement or any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the securities, has not been circulated or distributed, nor will it be circulated or distributed, whether directly or
indirectly, to any person in Singapore other than (i)&nbsp;to an institutional investor (as defined in Section&nbsp;4A of the Securities and Futures Act 2001 of Singapore, as modified or amended from time to time (the &#8220;SFA&#8221;)) pursuant to
Section&nbsp;274 of the SFA, (ii)&nbsp;to a relevant person (as defined in Section&nbsp;275(2) of the SFA) pursuant to Section&nbsp;275(1) of the SFA, or any person pursuant to Section&nbsp;275(1A) of the SFA, and in accordance with the conditions
specified in Section&nbsp;275 of the SFA and (where applicable) Regulation&nbsp;3 of the Securities and Futures (Classes of Investors) Regulation 2018, or (iii)&nbsp;otherwise pursuant to, and in accordance with the conditions of, any other
applicable exemption or provision of the SFA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Where the securities are subscribed or purchased under Section&nbsp;275 of
the SFA by a relevant person which is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole
business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each
beneficiary of the trust is an individual who is an accredited investor; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">securities or securities-based derivatives
contracts (each term as defined in Section&nbsp;2(1) of the SFA) of that corporation or the beneficiaries&#8217; rights and interest (howsoever described) in that trust shall not be transferred </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
within six months after that corporation or that trust has acquired the securities pursuant to an offer made under Section&nbsp;275 of the SFA except: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">to an institutional investor or to a relevant person, or to any person arising from an offer referred to in
Section&nbsp;275(1A) or Section&nbsp;276(4)(c)(ii) of the SFA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">where no consideration is or will be given for the transfer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">where the transfer is by operation of law; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">as specified in Section&nbsp;276(7) of the SFA. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Singapore Securities and Futures Act Product Classification&#8212;Solely for the purposes of its obligations pursuant to sections 309B(1)(a)
and 309B(1)(c) of the SFA, the Company has determined, and hereby notifies all relevant persons (as defined in Section&nbsp;309A of the SFA) that the notes are &#8220;prescribed capital markets products&#8221; (as defined in the Securities and
Futures (Capital Markets Products) Regulations 2018) and Excluded Investment Products (as defined in MAS Notice SFA <FONT STYLE="white-space:nowrap">04-N12:</FONT> Notice on the Sale of Investment Products and MAS
<FONT STYLE="white-space:nowrap">Notice&nbsp;FAA-N16:</FONT> Notice on Recommendations on Investment Products). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Switzerland
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The securities may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange, or the
SIX, or on any other stock exchange or regulated trading facility in Switzerland. This prospectus supplement has been prepared without regard to the disclosure standards for issuance prospectuses under art.&nbsp;652a or art. 1156 of the Swiss Code
of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this prospectus supplement nor any
other offering or marketing material relating to the securities or the offering may be publicly distributed or otherwise made publicly available in Switzerland. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Neither this prospectus supplement nor any other offering or marketing material relating to us, the offering, or the
securities have been or will be filed with or approved by any Swiss regulatory authority. In particular, this prospectus supplement will not be filed with, and the offering of securities will not be supervised by, the Swiss Financial Market
Supervisory Authority FINMA, or the FINMA, and the offering of securities has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes, or the CISA. The investor protection afforded to acquirers of interests
in collective investment schemes under the CISA does not extend to acquirers of the securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Dubai International Financial
Centre </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus supplement relates to an Exempt Offer in accordance with the Markets Rules of the Dubai
Financial Services Authority (the &#8220;DFSA&#8221;). This prospectus supplement is intended for distribution only to persons of a type specified in the Markets Rules of the DFSA. It must not be delivered to, or relied on by, any other person. The
DFSA has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus supplement nor taken steps to verify the information set forth herein and has no responsibility for the
prospectus supplement. The securities to which this prospectus supplement relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the securities offered should conduct their own due diligence on the
securities. If you do not understand the contents of this prospectus supplement you should consult an authorized financial advisor. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Abu Dhabi Global Market </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus supplement relates to an Exempt Offer in accordance with the Markets Rules of the Financial Services Regulatory
Authority (&#8220;FSRA&#8221;). This prospectus supplement is intended for distribution only to persons of a type specified in the Markets Rules of the FSRA. It must not be delivered to, or relied on by, any
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-107 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
other person. The FSRA has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The FSRA has not approved this prospectus supplement nor taken steps to
verify the information set forth herein and has no responsibility for the prospectus supplement. The securities to which this prospectus supplement relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the
securities offered should conduct their own due diligence on the securities. If you do not understand the contents of this prospectus supplement you should consult an authorized financial advisor. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>United Arab Emirates </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The securities have not been, and are not being, publicly offered, sold, promoted or advertised in the United&nbsp;Arab
Emirates (including the Abu Dhabi Global Market and the Dubai International Financial Centre) other than in compliance with the laws of the United Arab Emirates (and the Abu Dhabi Global Market and the Dubai International Financial Centre) governing
the issue, offering and sale of securities. Further, this prospectus supplement does not constitute a public offer of securities in the United Arab Emirates (including the Abu Dhabi Global Market and the Dubai International Financial Centre) and is
not intended to be a public offer. This prospectus supplement has not been approved by or filed with the Central Bank of the United Arab Emirates, the Securities and Commodities Authority, Financial Services Regulatory Authority, the Dubai Financial
Services Authority, or any other relevant licensing authority in the United Arab Emirates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Australia </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No placement document, prospectus, product disclosure statement or other disclosure document has been lodged with the
Australian Securities and Investments Commission, in relation to the offering. This prospectus supplement does not constitute a prospectus, product disclosure statement or other disclosure document under the Corporations Act 2001, or the
Corporations Act, and does not purport to include the information required for a prospectus, product disclosure statement or other disclosure document under the Corporations Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any offer in Australia of the securities may only be made to persons, or Exempt Investors, who are &#8220;sophisticated
investors&#8221; (within the meaning of section 708(8) of the Corporations Act), &#8220;professional investors&#8221; (within the meaning of section 708(11) of the Corporations Act) or otherwise pursuant to one or more exemptions contained in
section 708 of the Corporations Act so that it is lawful to offer the securities without disclosure to investors under Chapter 6D of the Corporations Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The securities applied for by Exempt Investors in Australia must not be offered for sale in Australia in the period of 12
months after the date of allotment under the offering, except in circumstances where disclosure to investors under Chapter 6D of the Corporations Act would not be required pursuant to an exemption under section 708 of the Corporations Act or
otherwise. Any person acquiring the securities must observe such Australian <FONT STYLE="white-space:nowrap">on-sale</FONT> restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus supplement contains general information only and does not take account of the investment objectives, financial
situation or particular needs of any particular person. It does not contain any securities recommendations or financial product advice. Before making an investment decision, investors need to consider whether the information in this prospectus
supplement is appropriate to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Israel </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the State of Israel this prospectus supplement shall not be regarded as an offer to the public to purchase securities under
the Israeli Securities Law, 5728&#8212;1968, which requires a prospectus to be published and authorized by the Israel Securities Authority, if it complies with certain provisions of Section&nbsp;15 of the Israeli Securities Law, 5728&#8212;1968,
including, inter alia, if: (i)&nbsp;the offer is made, distributed or directed to not more than 35 investors, subject to certain conditions, or the Addressed Investors; or (ii)&nbsp;the offer is made, distributed or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-108 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
directed to certain qualified investors defined in the First Addendum of the Israeli Securities Law, 5728&#8212;1968, subject to certain conditions, or the Qualified Investors. The Qualified
Investors shall not be taken into account in the count of the Addressed Investors and may be offered to purchase securities in addition to the 35 Addressed Investors. The company has not and will not take any action that would require it to publish
a prospectus in accordance with and subject to the Israeli Securities Law, 5728&#8212;1968. We have not and will not distribute this prospectus supplement or make, distribute or direct an offer to subscribe for securities to any person within the
State of Israel, other than to Qualified Investors and up to 35 Addressed Investors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Qualified Investors may have to
submit written evidence that they meet the definitions set out in of the First Addendum to the Israeli Securities Law, 5728&#8212;1968. In particular, we may request, as a condition to be offered securities, that Qualified Investors will each
represent, warrant and certify to us and/or to anyone acting on our behalf: (i)&nbsp;that it is an investor falling within one of the categories listed in the First Addendum to the Israeli Securities Law, 5728&#8212;1968; (ii)&nbsp;which of the
categories listed in the First Addendum to the Israeli Securities Law, 5728&#8212;1968 regarding Qualified Investors is applicable to it; (iii)&nbsp;that it will abide by all provisions set forth in the Israeli Securities Law, 5728&#8212;1968 and
the regulations promulgated thereunder in connection with the offer to be issued securities; (iv)&nbsp;that the securities that it will be issued are, subject to exemptions available under the Israeli Securities Law, 5728&#8212;1968: (a)&nbsp;for
its own account; (b)&nbsp;for investment purposes only; and (c)&nbsp;not issued with a view to resale within the State of Israel, other than in accordance with the provisions of the Israeli Securities Law, 5728&#8212;1968; and (v)&nbsp;that it is
willing to provide further evidence of its Qualified Investor status. Addressed Investors may have to submit written evidence in respect of their identity and may have to sign and submit a declaration containing, inter alia, the Addressed
Investor&#8217;s name, address and passport number or Israeli identification number. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-109 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_16"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The validity of the securities offered by this prospectus supplement will be passed upon for us by Jones Day. The underwriters
are being represented in connection with this offering by Cooley LLP. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc113098_17"></A>EXPERTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The audited financial statements and management&#8217;s assessment of the effectiveness of internal control over financial
reporting incorporated by reference in this prospectus and elsewhere in the registration statement have been so incorporated by reference in reliance upon the reports of Grant Thornton LLP, independent registered public accountants, upon the
authority of said firm as experts in accounting and auditing. </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-110 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g137529g03x03.jpg" ALT="LOGO" STYLE="width:6.49463in;height:1.05972in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>PURECYCLE TECHNOLOGIES, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Preferred
Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Warrants </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Rights </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Stock Purchase
Contracts </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Stock Purchase Units </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Debt Securities </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Units
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or selling securityholders to be named in a prospectus supplement may from time to time issue, in one or more offerings, any combination of
the securities described in this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each time we or selling securityholders offer and sell securities registered under this
prospectus, we will provide the specific terms of the offering in a supplement to this prospectus. We may also authorize one or more free writing prospectuses to be provided to you in connection with such offerings. The prospectus supplement and any
related free writing prospectus may add, update or change information contained in this prospectus.&nbsp;You should carefully read this prospectus, the applicable prospectus supplement and any related free writing prospectus before you invest in any
of our securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or selling securityholders may offer and sell securities registered under this prospectus and any prospectus
supplement directly or to or through underwriters or dealers, and also to other purchasers or through agents. The names of any underwriters or agents that are included in a sale of any of our securities to you, and any applicable commissions or
discounts, will be stated in a prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock, publicly traded warrants and publicly traded units are listed on
the Nasdaq Capital Market under the symbols &#8220;PCT,&#8221; &#8220;PCTTW&#8221; and &#8220;PCTTU,&#8221; respectively.</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing in our securities involves risks. Please read carefully the section entitled &#8220;<A HREF="#tx137529_6">Risk Factors</A>&#8221;
beginning on page 5 of this prospectus. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has
approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is June&nbsp;10, 2026. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_2">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_3">INFORMATION WE INCORPORATE BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_4">PURECYCLE TECHNOLOGIES, INC.</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_5">CORPORATE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_6">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_7">CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_8">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_9">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_10">DESCRIPTION OF WARRANTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_11">DESCRIPTION OF RIGHTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_12">DESCRIPTION OF STOCK PURCHASE CONTRACTS AND STOCK PURCHASE
UNITS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_13">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_14">DESCRIPTION OF UNITS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_15">MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_16">FORMS OF SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_17">SELLING SECURITYHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_18">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_19">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx137529_20">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement that we are filing with the Securities and Exchange Commission, or the &#8220;SEC,&#8221;
using a &#8220;shelf&#8221; registration process. Under this shelf process, we or selling securityholders may sell at any time and from time to time, in one or more offerings, any combination of the securities registered under this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus provides you with a general description of the securities that may be offered. Each time we or selling securityholders sell
securities registered under this process, we will provide a prospectus supplement that will contain specific information about the terms of the offering of such securities. We may also authorize one or more free writing prospectuses to be provided
to you in connection with such offerings. For a more complete understanding of the offering of our securities, you should refer to the registration statement, including its exhibits. The prospectus supplement and any related free writing prospectus
may also add, update or change information contained in this prospectus. You should carefully read this prospectus and any prospectus supplement, including the additional information under the headings &#8220;Where You Can Find More
Information&#8221; and &#8220;Information We Incorporate By Reference,&#8221; and any related free writing prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not
authorized anyone to provide you with different information from the information contained in, or incorporated by reference into, this prospectus and in any prospectus supplement or in any free writing prospectus that we may provide to you. You
should not assume that the information contained in this prospectus, any prospectus supplement, any document incorporated by reference or any free writing prospectus is accurate as of any date, other than the date mentioned on the cover page of
these documents. We are not making offers to sell any of our securities in any jurisdiction in which an offer or solicitation is not authorized or in which the person making such offer or solicitation is not qualified to do so or to anyone to whom
it is unlawful to make an offer or solicitation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">References in this prospectus to the terms &#8220;we,&#8221; &#8220;us,&#8221;
&#8220;our,&#8221; &#8220;PCT&#8221; or &#8220;the Company&#8221; or other similar terms mean PureCycle Technologies, Inc. and its consolidated subsidiaries, unless we state otherwise or the context indicates otherwise. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_2"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to the informational reporting requirements of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange
Act&#8221;). We file reports, proxy statements and other information with the SEC. Our SEC filings are available at the SEC&#8217;s website at http://www.sec.gov. We make available, free of charge, on our website at http://www.purecycle.com, our
Annual Reports on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> and amendments to those reports and
statements as soon as reasonably practicable after they are filed with the SEC. The contents of our website are not part of this prospectus, and the reference to our website does not constitute incorporation by reference into this prospectus any of
the information contained at that site, other than documents we otherwise file with the SEC that are incorporated by reference into this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_3"></A>INFORMATION WE INCORPORATE BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#8220;incorporate by reference&#8221; into this prospectus the information in documents we file with it, which means
that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be a part of this prospectus, and information that we file later with the SEC will automatically update
and supersede this information. Any statement contained in any document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement
contained in or omitted from this prospectus or any prospectus supplement, any free writing prospectus, or in any other subsequently filed document that also is or is deemed to be incorporated by reference herein, modifies or supersedes such
statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We incorporate by reference the documents listed below and any future documents that we file with the SEC under Section&nbsp;13(a), 13(c), 14
or 15(d) of the Exchange Act (1)&nbsp;after the date of the initial filing of the registration statement of which this prospectus forms a part prior to the effectiveness of the registration statement and (2)&nbsp;after the date of this prospectus
until the offering of the shares of our Common Stock (as defined below) is terminated: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2025
filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001830033/000119312526076801/pct-20251231.htm">February&nbsp;26, 2026</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Definitive Proxy Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001830033/000119312526127753/d68127ddef14a.htm">Schedule
 14A</A>, filed with the SEC on March&nbsp;27, 2026 (solely with respect to those portions specifically incorporated by reference into our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2025);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarterly period ended
March&nbsp;31, 2026 filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001830033/000183003326000014/pct-20260331.htm">May<U></U>&nbsp;6, 2026</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001830033/000119312526011168/pct-20251229.htm">January
<U></U>&nbsp;13, 2026</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001830033/000119312526076587/pct-20260225.htm">February<U></U>&nbsp;
26, 2026</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001830033/000183003326000007/pct-20260416.htm">April<U></U>&nbsp;
17, 2026</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001830033/000183003326000017/pct-20260507.htm">May<U></U>&nbsp;11, 2026</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the description of our Common Stock contained in our Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1830033/000110465921037623/tm219633d1_8a12b.htm">Form
 <FONT STYLE="white-space:nowrap">8-A</FONT></A>, registering our Common Stock under Section&nbsp;12(b) under the Exchange Act, filed with the SEC on March&nbsp;
17, 2021, as updated by the description of our Common Stock contained in <A HREF="http://www.sec.gov/Archives/edgar/data/1830033/000119312524262591/d849012dex41.htm">Exhibit 4.1</A> to our Registration Statement on Form
<FONT STYLE="white-space:nowrap">S-3</FONT> filed with the SEC on November&nbsp;20, 2024, and all subsequently filed amendments and reports updating that description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not, however, incorporate by reference in this prospectus any documents or portions thereof that are not deemed &#8220;filed&#8221;
with the SEC, including any information furnished pursuant to Item 2.02 or Item 7.01 of our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> unless, and except to the extent, specified in such Current Reports. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will provide you with a copy of any of these filings (other than an exhibit to these filings, unless the exhibit is specifically
incorporated by reference into the filing requested) at no cost, if you submit a request to us by writing or telephoning us at the following address and telephone number: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PureCycle Technologies, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20
North Orange Ave. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Suite 106 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Orlando, Florida 32801 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Phone:
(877) <FONT STYLE="white-space:nowrap">648-3565</FONT><B> </B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_4"></A>PURECYCLE TECHNOLOGIES, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Company </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a Florida-based
corporation focused on commercializing a patented dissolution recycling technology for polypropylene that physically separates the polymer from other plastics, colors, odors and impurities (the &#8220;Technology&#8221;). The Technology was
originally developed by The Procter&nbsp;&amp; Gamble Company (&#8220;P&amp;G&#8221;) and is designed to restore recycled polypropylene waste into <FONT STYLE="white-space:nowrap">like-new</FONT> resin, called PureFive<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin. Our PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin has similar properties and applicability for reuse as virgin polypropylene. We have a global license for the
Technology from P&amp;G, which was amended during 2025 to permanently waive the possible clawback of our exclusivity for plants located in North America. The amendment also extends the time that our plants must begin construction and commence sales
in other regions to avoid a clawback of the exclusivity under the license agreement. We have introduced an important new product to the global polypropylene market that will assist corporations in meeting their sustainability goals, as well as
federal and state regulations and mandates, providing consumers with polypropylene-based products that are sustainable, and reducing overall polypropylene waste in the world&#8217;s landfills and oceans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our process includes the following steps: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Feed <FONT STYLE="white-space:nowrap">Pre-Processing</FONT> (&#8220;Feed PreP&#8221;) collects, sorts, and
prepares polypropylene waste (&#8220;feedstock&#8221;) for the dissolution recycling process (&#8220;Purification&#8221;). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Purification is a dissolution recycling process that uses a combination of solvent, temperature, and pressure to
return the feedstock to near-virgin condition through a novel configuration of commercially-available equipment and unit operations. The Purification process puts the plastic through a physical extraction process using supercritical fluids that both
extract and filter out other plastics and additives to purify the color, opacity and odor of the polypropylene without changing the bonds of the polymer. By not altering the chemical makeup of the polymer, we are able to use significantly less
energy and reduce production costs compared to the production of virgin resin. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Compounding, which involves blending our resin with either virgin resin or additives, allows for the modification
of the resin to meet the <FONT STYLE="white-space:nowrap">end-user&#8217;s</FONT> specifications including melt flow, flexibility, clarity, color and strength. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2023, we achieved mechanical completion of the Ironton Facility, which is our first commercial-scale recycling facility located in Lawrence
County, Ohio. We designed the Ironton Facility to have a production capacity of approximately 107&nbsp;million pounds per year when fully operational; however, the Ironton Facility is not yet operating at its expected full capacity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2024, we began operating a Feed PreP facility in Denver, Pennsylvania, which currently provides the required mix necessary to meet the
offtake requirements at the Ironton Facility. With future expansion, we believe we will be able to source sufficient amounts of feedstock to support future operations in the U.S., Europe, and Asia. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Technology has been evaluated by third parties with a focus on the Technology&#8217;s efficacy and commercial scalability. Certain of our
strategic partners have conducted testing on our PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin. In these evaluations, our PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin performed comparably to
virgin polypropylene in common food and beverage industry benchmarks for melt flow and mechanical properties, purity, odor and function (lift decay, hinge break, and impact resistance). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an early commercial-stage company and have reported minimal revenues to date. We have limited operations and measure our performance on
a consolidated basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Common Stock, units and Public Warrants are listed on the Nasdaq Capital Market (&#8220;NASDAQ&#8221;) under
the symbols &#8220;PCT,&#8221; &#8220;PCTTU&#8221; and &#8220;PCTTW,&#8221; respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_5"></A>CORPORATE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal executive offices are located at 20 North Orange Avenue, Suite 106, Orlando, Florida 32801. Our telephone number is (877) <FONT
STYLE="white-space:nowrap">648-3565.</FONT> Our website is http://www.purecycle.com. The information contained on or accessible through our website is not part of this prospectus, other than the documents that we file with the SEC that are
specifically incorporated by reference into this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_6"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investing in our securities involves risk. Prior to making a decision about investing in our securities, you should carefully consider the
specific factors discussed under the heading &#8220;Risk Factors&#8221; in our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> which is incorporated by reference in this prospectus and any prospectus supplement and
may be amended, supplemented or superseded from time to time by our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and other reports we file with the SEC in the future. The risks and uncertainties we have described are not
the only risks to which we are exposed. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our operations. If any of these risks actually occur, our business, results of operations and
financial condition could suffer. In that case, the trading price of our securities could decline, and you could lose all or a part of your investment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_7"></A>CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus and any prospectus supplement contains and incorporates by reference statements within the meaning of Section&nbsp;27A of the
Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), including statements about the financial condition, results of
operations, earnings outlook and prospects of PCT. Forward-looking statements generally relate to future events or future financial or operating performance and may refer to projections and forecasts. Forward-looking statements are typically
identified by words such as &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;aim,&#8221; &#8220;anticipate,&#8221; &#8220;drive,&#8221; &#8220;intend,&#8221; &#8220;outlook,&#8221; &#8220;estimate,&#8221;
&#8220;forecast,&#8221; &#8220;future,&#8221; &#8220;goal,&#8221; &#8220;guidance,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221;
&#8220;predict,&#8221; &#8220;should,&#8221; &#8220;would&#8221; and other similar words and expressions (or the negative versions of such words or expressions), but the absence of these words does not mean that a statement is not forward-looking.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The forward-looking statements are based on the current expectations of the management of PCT and are inherently subject to uncertainties
and changes in circumstances and their potential effects and speak only as of the date of this prospectus. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number
of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to,
those factors described in the section of PCT&#8217;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2025 entitled &#8220;Risk Factors,&#8221; those discussed and identified in other
public filings made with the SEC by PCT and the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our ability to obtain funding for our operations, future capital requirements and future growth, and to continue
as a going concern; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our ability to meet, continue to meet, and comply on an ongoing basis with the numerous regulatory requirements
applicable to our PureFive<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> resin both generally and in food-grade applications and, more broadly, the operations of our facilities (including in the United States, Europe, Asia and other
future international locations); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Expectations and changes regarding our strategies and future financial performance, including future business
plans, expansion plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and our
ability to invest in growth initiatives, which could be impacted by significant changes to tariffs on foreign imports; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The ability of the Ironton Facility to be appropriately certified by Leidos Engineering, LLC, following certain
performance and other tests, and commence full-scale commercial operations in a timely and cost-effective manner, or at all; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our ability to meet, and to continue to meet, the requirements imposed upon us and our subsidiaries by the
funding for our operations, including the funding for the Ironton Facility, and the Planned Facilities (as defined below); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our ability to minimize or eliminate the many hazards and operational risks at our manufacturing facilities that
can result in potential injury to individuals, disrupt our business, including interruptions or disruptions in operations at our facilities, and subject us to liability and increased costs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our ability to complete the necessary funding with respect to, and complete the construction of the new
polypropylene recycling facility in Rayong, Thailand (the &#8220;Thailand Facility&#8221;), our first commercial-scale European plant located at its Antwerp, Belgium site (the &#8220;Belgium Facility&#8221;), and the Purification facility to be
built in Augusta, Georgia (the &#8220;Augusta Facility&#8221; and, together with the Thailand Facility and the Belgium Facility, the &#8220;Planned Facilities&#8221;) in a timely and cost-effective manner; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our ability to procure, sort and process polypropylene plastic waste at our planned plastic waste Feed PreP
facilities; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our ability to maintain exclusivity under the P&amp;G license; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The implementation, market acceptance and success of our business model and growth strategy, which includes our
ability to bring a total of one billion pounds of installed polypropylene recycling capability online by 2030, and our ability to meet related construction, regulatory, and financing requirements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The ability to negotiate multi-year offtake agreements at appropriate margins to fund ongoing operations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The possibility that we may be adversely affected or potentially impacted by economic, business, and/or
competitive factors, including interest rates, availability of capital, economic cycles, and other macro-economic impacts (such as tariffs); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in the prices and availability of materials (such as steel and other materials needed for the
construction of future Feed PreP and Purification facilities), including those changes caused by inflation, tariffs and supply chain conditions, such as increased transportation costs and global conflicts, and our ability to obtain such materials in
a timely and cost-effective manner; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The ability to source feedstock with a high polypropylene content at a reasonable cost, and the temporary spike
in prices due to global conflicts such as the current conflict in the Middle East; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The development of direct competitors in the recycled polypropylene segment that could impact the demand for our
products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The outcome of any legal or regulatory proceedings to which we are, or may become, a party;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Geopolitical risk and changes in applicable laws or regulations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in the prices and availability of labor (including labor shortages), turnover in employees, and increases
in employee-related costs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Any business disruptions due to political or economic instability, pandemics, or armed hostilities (including the
ongoing conflict between Russia and Ukraine and active military conflicts in the Middle East); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Operational risks associated with the ability to operate the Ironton Facility and the Planned Facilities, as and
when operative, at nameplate capacity. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In light of the foregoing, we caution you not to place undue reliance on our
forward-looking statements. Any forward-looking statement that we make in this prospectus and any prospectus supplement speaks only as of the date of such statement, and we undertake no obligation to update any forward-looking statements made in
this prospectus to reflect events or circumstances after the date of this prospectus or to reflect new information or the occurrence of unanticipated events, except as required by law. Should one or more of these risks or uncertainties materialize
or should any of the assumptions made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_8"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless we inform you otherwise in the applicable prospectus supplement, we expect to use the net proceeds from the sale of the securities
offered under this prospectus for general corporate purposes. These purposes may include, but are not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">financing acquisitions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduction or refinancing of outstanding indebtedness or other corporate obligations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additions to working capital; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">capital expenditures. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not allocated a specific portion of the net proceeds for any particular use at this time, and we will have discretion in the use of
any net proceeds. Specific information concerning the use of proceeds from the securities offered under this prospectus will be described in the prospectus supplement for such offering. Pending any specific application, we may initially invest funds
in short-term marketable securities or apply them to the reduction of short-term indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not receive any proceeds from the
resale of securities by selling securityholders under this prospectus or any prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_9"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following description of
the Company&#8217;s capital stock is intended as a summary only and is qualified in its entirety by reference to our Amended and Restated Certificate of Incorporation, as amended (&#8220;Amended and Restated Certificate of Incorporation&#8221;), the
applicable certificate of designations and our Second Amended and Restated Bylaws (&#8220;Amended and Restated Bylaws&#8221;). We encourage you to read these documents and the applicable portion of the Delaware General Corporation Law, as amended
(the &#8220;DGCL&#8221;) and the Company&#8217;s Amended and Restated Certificate of Incorporation, including the applicable certificate of designations, and Amended and Restated Bylaws carefully and in their entirety because they describe your
rights as a holder of shares of the Company&#8217;s securities. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our authorized capital stock consists of 450,000,000 shares of Common Stock, par value $0.001 per share, and 25,000,000 shares of undesignated
preferred stock, par value $0.001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of shares of Common Stock are entitled to one vote for each share held of record on
all matters submitted to a vote of stockholders. The holders of shares of Common Stock do not have cumulative voting rights in the election of directors. Upon the Company&#8217;s liquidation, dissolution or winding up and after payment in full of
all amounts required to be paid to creditors and to the holders of preferred stock having liquidation preferences, if any, the holders of shares of Common Stock will be entitled to receive pro rata the Company&#8217;s remaining assets available for
distribution. Holders of shares of Common Stock do not have preemptive, subscription, redemption or conversion rights. The Common Stock will not be subject to further calls or assessment by the Company. There will be no redemption or sinking fund
provisions applicable to the Common Stock. All shares of the Common Stock that are outstanding are fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> The rights, powers, preferences and privileges of holders of shares of Common
Stock will be subject to those of the holders of any shares of the Company&#8217;s preferred stock the Company may authorize and issue in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When a quorum is present at any meeting, any matter other than the election of directors to be voted upon by the stockholders at such meeting
will be decided by the affirmative vote of the holders of a majority of shares of stock present or represented at the meeting and entitled to vote (meaning that of the shares present or represented at the meeting and entitled to vote, a majority of
them must be voted &#8220;for&#8221; the proposal for it to be approved). Abstentions will have the same effect as a vote &#8220;against&#8221; the proposal, and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the
vote for the proposal. At all meetings of stockholders for the election of directors at which a quorum is present, directors shall be elected by the affirmative vote of the majority of the votes cast (meaning the number of shares voted
&#8220;for&#8221; a nominee must exceed the number of shares voted &#8220;against&#8221; such nominee). If any nominee for director in an uncontested election receives a greater number of votes &#8220;against&#8221; his or her election than votes
&#8220;for&#8221; such election, our bylaws require that such person must promptly tender his or her resignation to the Board following certification of the vote. If the number of nominees for election at any such meeting exceeds the number of
directors to be elected at such meeting, however, directors shall be elected by a plurality of the votes cast (meaning that the number of director nominees who receive the highest number of shares voted &#8220;for&#8221; their election are elected).
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Amended and
Restated Certificate of Incorporation authorizes the Board to establish one or more series of preferred stock. Unless required by law or by NASDAQ, the authorized shares of preferred stock will be available for issuance without further action by
you. The Board is authorized to fix from time to time before issuance the number of preferred shares to be included in any such series and the designation, powers, preferences and relative participating, optional or other rights, if any, and the
qualifications, limitations or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
restrictions thereof. The authority of the Board with respect to each such series will include, without limiting the generality of the foregoing, the determination of any or all of the following:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of shares of any series and the designation to distinguish the shares of such series from the shares
of all other series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the voting powers, if any, and whether such voting powers are full or limited in such series;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the redemption provisions, if any, applicable to such series, including the redemption price or prices to be
paid; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether dividends, if any, will be cumulative or noncumulative, the dividend rate of such series, and the dates
and preferences of dividends on such series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rights of such series upon the voluntary or involuntary dissolution of, or upon any distribution of the
assets of, the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the provisions, if any, pursuant to which the shares of such series are convertible into, or exchangeable for,
shares of any other class or classes or of any other series of the same or any other class or classes of stock, or any other security, of the Company or any other corporation or other entity, and the rates or other determinants of conversion or
exchange applicable thereto; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the right, if any, to subscribe for or to purchase any securities of the Company or any other corporation or
other entity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the provisions, if any, of a sinking fund applicable to such series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other relative, participating, optional, or other special powers, preferences or rights and qualifications,
limitations, or restrictions thereof; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all as may be determined from time to time by the Board and stated or expressed in the resolution or resolutions
providing for the issuance of such preferred stock (collectively, a &#8220;Preferred Stock Designation&#8221;). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company could issue a series of preferred stock that could, depending on the terms of the series, impede or discourage an acquisition attempt or other transaction that some, or a majority, of the holders of the Common Stock might believe to be in
their best interests or in which the holders of the Common Stock might receive a premium for their Common Stock over its market price. Additionally, the issuance of preferred stock may adversely affect the rights of holders of the Common Stock by
restricting dividends on the Common Stock, diluting the voting power of the Common Stock or subordinating the liquidation rights of the Common Stock. As a result of these or other factors, the issuance of preferred stock could have an adverse impact
on the market price of the Common Stock. The Company has no current plans to issue any new series of preferred stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series A Preferred
Stock</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;13, 2024, we filed the Certificate of Designations, as amended on September&nbsp;17, 2024, as described
below (together, the &#8220;Series A Certificate of Designations&#8221;) with the Secretary of State of the State of Delaware that established the preferences, limitations and relative rights of the Series A preferred stock, par value $0.001 per
share (&#8220;Series A Preferred Stock&#8221;), and authorized for issuance 100,000 shares of Series A Preferred Stock. The Amended and Restated Certificate of Incorporation was amended, effective immediately, upon the filing of the Series A
Certificate of Designations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Ranking</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Series A Preferred Stock ranks senior to shares of Common Stock with respect to rights on the distribution of assets on any voluntary or
involuntary liquidation, dissolution or winding up of the affairs of our Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Liquidation Preference</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each share of Series A Preferred Stock has a liquidation preference of the issue price of $1,000 per share (the &#8220;Series A Initial Issue
Price&#8221;) multiplied by 1.05 (the &#8220;Series A Liquidation Preference&#8221;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dividend and Return Rights </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Certificate of Designations, the shares of Series A Preferred Stock have a maturity date three years after the initial issue
date (the &#8220;Series A Maturity Date&#8221;) and accrue a return equal to 8% per annum (the &#8220;Series A Return&#8221;), payable quarterly in cash or <FONT STYLE="white-space:nowrap">in-kind</FONT> at the election of the holder. Pursuant to
the Waiver Agreements (defined below), investors holding all of the shares of Series A Preferred Stock elected to irrevocably and unconditionally waive (and consented to such waivers for purposes of Section&nbsp;12 of the Series A Certificate of
Designations) the right to receive Series A Return payments on the first three quarterly Series A Return payment dates within each <FONT STYLE="white-space:nowrap">one-year</FONT> period following the issue date and to instead receive such Series A
Return payments on the fourth quarterly Series A Return payment date within each <FONT STYLE="white-space:nowrap">one-year</FONT> period following the issue date, such that each holder of Series A Preferred Stock shall receive Series A Return
payments for the entire <FONT STYLE="white-space:nowrap">one-year</FONT> period on each such fourth quarterly Series A Return payment date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Maturity</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Series A Preferred Stock matures
three years after the original issuance date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Conversion and Redemption</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of Series A Preferred Stock are subject to (i)&nbsp;a mandatory redemption upon the occurrence of certain triggering events related to
the incurrence of additional indebtedness not otherwise permitted under our existing credit agreement, dated as of March&nbsp;15, 2023, (ii) a mandatory redemption on the Series A Maturity Date and (iii)&nbsp;an optional redemption, at our election,
at any time prior to the Series A Maturity Date. Each share of Series A Preferred Stock is redeemable for an amount equal to the Series A Initial Issue Price multiplied by 1.05, which amount shall be payable in (i)&nbsp;cash, (ii) a number of shares
of Common Stock equal to such amount divided by $4.69, or (iii)&nbsp;a combination of cash and shares of Common Stock, in each case including accrued but unpaid Series A Return to the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the holder elects upon redemption to receive Common Stock and such holder&#8217;s beneficial ownership would exceed 19.9% of the
outstanding shares of Common Stock (the &#8220;Stock Issuance Cap&#8221;), then in lieu of such shares, the holder will receive a number of <FONT STYLE="white-space:nowrap">pre-funded</FONT> warrants exercisable for an equivalent number of Common
Stock <FONT STYLE="white-space:nowrap">(&#8220;Pre-Funded</FONT> Warrants&#8221;). The <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants will expire seven years after issuance and will be immediately exercisable by the holder for shares of
Common Stock, provided that such exercise does not cause such holder&#8217;s beneficial ownership to exceed the Stock Issuance Cap. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
September&nbsp;17, 2024, the investors holding all of the shares of Series A Preferred Stock entered into waivers (the &#8220;Waiver Agreements&#8221;) to irrevocably and unconditionally waive (and consented to such waivers for purposes of
Section&nbsp;12 of the Series A Certificate of Designations) the rights of such holders of shares of Series A Preferred Stock, (i)&nbsp;to elect to receive shares of Common Stock or <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants in
connection with redemption events under the Series A Certificate of Designations and (ii)&nbsp;to elect to receive additional shares of Series A Preferred Stock on Return payment dates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Voting</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of shares of Series A
Preferred Stock shall have no voting rights with respect to such shares of Series A Preferred Stock except as from time to time required by law. Holders of shares of Series A Preferred Stock shall vote as a single class with respect to amendments to
the Certificate of Designations applicable to all shares of Series A Preferred Stock upon the vote or written consent of the holders of a majority of such shares of Series A Preferred Stock then outstanding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Change of Control</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon certain change of control events involving the Company, the holders of shares of Series A Preferred Stock will be entitled to receive in
full, out of the assets of the Company or proceeds thereof available for distribution to stockholders, a sum in cash equal to (i)&nbsp;the Series A Liquidation Preference of such share of Series A Preferred Stock, plus (ii) the accrued Series A
Return in respect of such share of Series A Preferred Stock as of the applicable change of control purchase date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Liquidation</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of any liquidation, bankruptcy, insolvency, dissolution or winding up of the affairs of the Company, whether voluntary or
involuntary, or upon the occurrence of certain change of control events involving the Company, the holders of shares of Series A Preferred Stock will be entitled to receive in full, out of the assets of the Company or proceeds thereof available for
distribution to stockholders, and after satisfaction of all liabilities and obligations to creditors of the Company, before any distribution of such assets and/or proceeds is made to or set aside for the holders of any other junior securities, a sum
in cash equal to (i)&nbsp;the Liquidation Preference of such share of Series A Preferred Stock, plus (ii)&nbsp;the accrued Series A Return in respect of such share of Series A Preferred Stock as of the applicable change of control purchase date.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Registration</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the
subscription agreements, dated September&nbsp;11, 2024, by and between the Company and certain investors, holders of the shares of Series A Preferred Stock have the right to demand registration of the shares of Series A Preferred Stock and the
Common Stock issuable upon conversion of such Series A Preferred Stock (including shares issuable upon exercise of any <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants). Pursuant to the Waiver Agreements, the investors holding all of the
shares of Series A Preferred Stock irrevocably and unconditionally waived the rights of such holders of shares of Series A Preferred Stock to require us to register the shares of Common Stock issuable upon redemption of the Series A Preferred Stock
(including shares issuable upon exercise of any <FONT STYLE="white-space:nowrap">Pre-Funded</FONT> Warrants) on a registration statement filed by the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Preemption</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of shares of Series A
Preferred Stock shall not have any preemptive rights with respect to the Company&#8217;s other securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>No Sinking Fund</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of Series A Preferred Stock shall not be subject to or entitled to the operation of a retirement or sinking fund. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series B Convertible Preferred Stock</I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&nbsp;18, 2025, we filed the Certificate of Designations (the &#8220;Series B Certificate of Designations&#8221;) with the Secretary of
State of the State of Delaware that established the preferences, limitations and relative rights of the Series B convertible perpetual preferred stock, par value $0.001 per share (&#8220;Series B Convertible Preferred Stock&#8221;), and authorized
for issuance 300,000 shares of Series B Convertible Preferred Stock. The Amended and Restated Certificate of Incorporation was amended, effective immediately, upon the filing of the Series B Certificate of Designations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Ranking</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Series B Convertible
Perpetual Preferred Stock ranks, with respect to dividend rights and rights upon any liquidation, dissolution or winding up of the Company (a &#8220;Series B Liquidation Event&#8221;): (a) senior to the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company&#8217;s Common Stock and other capital stock of the Company, the terms of which do not expressly provide that such class or series ranks senior to or on a parity with the Series B
Convertible Perpetual Preferred Stock other than the Company&#8217;s Series A Preferred Stock, as to dividend rights and rights upon Liquidation Events; (b)&nbsp;on a parity with any other class or series of capital stock of the Company, the terms
of which expressly provide that such class or series ranks on a parity with the Series B Convertible Preferred Stock as to dividend rights and rights upon Series B Liquidation Events; (c)&nbsp;junior to the Series A Preferred Stock and any other
class or series of capital stock of the Company, the terms of which expressly provide that such class or series ranks senior to the Series B Convertible Preferred Stock as to dividend rights and rights upon Series B Liquidation Events; and
(d)&nbsp;junior to all existing and future indebtedness of the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Liquidation Preference</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each share of Series B Convertible Preferred Stock has a liquidation preference of the issue price of $1,000 per share as adjusted for
dividends paid in kind and accreted pursuant to the terms of the Series B Certificate of Designations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dividend and Return Rights </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Series B Certificate of Designations, the shares of Series B Convertible Preferred Stock are entitled to receive cumulative
dividends at a rate equal to 7% per annum (the &#8220;Series B Return&#8221;), payable quarterly in cash or <FONT STYLE="white-space:nowrap">in-kind</FONT> at the election of the Company, which, if paid
<FONT STYLE="white-space:nowrap">in-kind</FONT> will be capitalized to the Series B Accrued Value (as defined below). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Maturity</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Series B Convertible Preferred Stock is perpetual and has no maturity date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Conversion and Redemption</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A holder of the
Series B Convertible Preferred Stock may elect to convert such holder&#8217;s shares of Series B Convertible Preferred Stock into shares of Common Stock, at any time. In addition, on or after the dividend payment date following June&nbsp;20, 2029,
if at any time the closing price of the Common Stock has been at least 175% of the applicable conversion price for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading days ending on the trading day immediately
preceding the trading day on which a conversion notice is given (a &#8220;Series B Conversion Notice&#8221;), the Company may elect to convert all of the shares of Series B Convertible Preferred Stock into a number of shares of Common Stock equal to
the Series B Accrued Value (as defined below) divided by the conversion price on the date of the Series B Conversion Notice, unless modified pursuant to a Make-Whole Change (as defined in the Series B Certificate of Designations). The shares of
Series B Convertible Preferred Stock are convertible into Common Stock at an initial conversion price equal to $14.02, which represents a 30% premium to the <FONT STYLE="white-space:nowrap">10-day</FONT> volume weighted average price of the Common
Stock on the trading day immediately prior to the execution of the subscription agreements for the Series B Convertible Preferred Stock. Except in the case of a change in control, the Series B Convertible Preferred Stock may not be redeemed or
repurchased upon the election of the holders of the Series B Convertible Preferred Stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Voting</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of shares of Series B Convertible Preferred Stock shall have no voting rights with respect to such shares of Series B Convertible
Preferred Stock except as from time to time required by law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Change of Control</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon certain change in control events involving the Company, (i)&nbsp;the holders of the Series B Convertible Preferred Stock will have the
right to require the Company to redeem any or all of their Series B Convertible </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Preferred Stock and (ii)&nbsp;the Company will have the option to redeem all (but not less than all) of the then-outstanding Series B Convertible Preferred Stock, in each case, for a cash amount
equal to the Series B Accrued Value (as defined below), on a per share basis. In connection with the Company delivering a Series B Conversion Notice or in connection with a change in control, the Company will, in certain circumstances, be required
to increase the conversion rate for shares of Series B Convertible Preferred Stock converting in connection therewith, which will be calculated using a make-whole table calculated over a <FONT STYLE="white-space:nowrap">10-year</FONT> period. In no
event will the conversion rate be increased to an amount that exceeds 87.5611 shares of Common Stock per $1,000 liquidation preference of Series B Convertible Preferred Stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Liquidation</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of any Series B
Liquidation Event, each holder of the Series B Convertible Preferred Stock will be entitled to receive a per share amount equal to the greater of (i)&nbsp;the per share purchase price of the Series B Convertible Preferred Stock (as adjusted for any <FONT
STYLE="white-space:nowrap">in-kind</FONT> dividends) plus all accrued and unpaid dividends thereon (the &#8220;Series B Accrued Value&#8221;) and (ii)&nbsp;the amount that such Series B Convertible Preferred Stock would have been entitled to receive
if it had converted into the Company&#8217;s Common Stock immediately prior to such Series B Liquidation Event. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Registration</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares of Common Stock issuable upon conversion of the Series B Convertible Preferred Stock have been registered under the Company&#8217;s registration
statement on Form <FONT STYLE="white-space:nowrap">S-3,</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-284634),</FONT> which was filed with the Securities and Exchange Commission on January&nbsp;31, 2025, as supplemented by a prospectus
supplement filed with the Securities and Exchange Commission on July&nbsp;18, 2025. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Preemption</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of shares of Series B Convertible Preferred Stock shall not have any preemptive rights with respect to the Company&#8217;s other
securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>No Sinking Fund</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares
of Series B Convertible Preferred Stock shall not be subject to or entitled to the operation of a retirement or sinking fund. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Public Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has outstanding public warrants (the &#8220;Public Warrants&#8221;) and private warrants (the &#8220;Private Warrants,&#8221; and
together with the Public Warrants, the &#8220;PCT Warrants&#8221;) that entitle each holder to exercise its PCT Warrants for a whole number of the Common Stock at a price of $11.50 per share. The Private Warrants are identical to the Public
Warrants, except that the Private Warrants are <FONT STYLE="white-space:nowrap">non-redeemable</FONT> so long as they are held by the initial holder or any of its permitted transferees. If the Private Warrants are held by someone other than the
initial holder or its permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as Public Warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2026, we had approximately 5.9&nbsp;million of our PCT Warrants issued and outstanding. Pursuant to the Warrant Agreement
(as defined below), a holder of a PCT Warrant may exercise its PCT Warrants only for a whole number of shares of Common Stock. This means that only a whole PCT Warrant may be exercised at any given time by a holder of a PCT Warrant. No fractional
PCT Warrants were issued upon separation of the Public Units (as defined below) and only whole PCT Warrants trade on NASDAQ. Each PCT Warrant became exercisable on May&nbsp;4, 2021 and will expire on March&nbsp;17, 2027, or earlier upon redemption.
The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shares of Common Stock issuable upon exercise of the PCT Warrants have been registered under the Company&#8217;s registration statement on Form <FONT STYLE="white-space:nowrap">S-1,</FONT> as
amended (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-251034),</FONT> which was declared effective by the Securities and Exchange Commission on July&nbsp;1, 2021 (the &#8220;Form <FONT STYLE="white-space:nowrap">S-1&#8221;),</FONT> and, on
April&nbsp;1, 2022, a Company registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File Nos. <FONT STYLE="white-space:nowrap">333-251034</FONT> and <FONT STYLE="white-space:nowrap">333-257423)</FONT> was declared effective by
the Securities and Exchange Commission and serves as a post-effective amendment to the Form <FONT STYLE="white-space:nowrap">S-1</FONT> pursuant to Rule 429 under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The outstanding PCT Warrants, other than the Private Warrants held by initial purchasers and affiliates or their permitted transferees, may be
called for redemption, in whole and not in part, at a price of $0.01 per PCT Warrant: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at any time after the PCT Warrants become exercisable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon not less than 30 days&#8217; prior written notice of redemption to each PCT Warrant holder;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, and only if, the reported last sale price of the shares of Common Stock equals or exceeds $14.38 per share,
for any 20 trading days within a <FONT STYLE="white-space:nowrap">30-day</FONT> trading period commencing after the PCT Warrants become exercisable and ending on the third business day prior to the notice of redemption to PCT Warrant holders; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, and only if, there is a current registration statement in effect with respect to the shares of Common Stock
underlying such PCT Warrants at the time of redemption and for the entire <FONT STYLE="white-space:nowrap">30-day</FONT> trading period referred to above and continuing each day thereafter until the date of redemption. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The right to exercise will be forfeited unless the PCT Warrants are exercised prior to the date specified in the notice of redemption. On and
after the redemption date, a record holder of a PCT Warrant will have no further rights except to receive the redemption price for such holder&#8217;s PCT Warrant upon surrender of such PCT Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The redemption criteria for the PCT Warrants have been established at a price which is intended to provide PCT Warrant holders a reasonable
premium to the initial exercise price and provide a sufficient differential between the then-prevailing share price and the PCT Warrant exercise price so that if the share price declines as a result of a redemption call, the redemption will not
cause the share price to drop below the exercise price of the PCT Warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the PCT Warrants are called for redemption as described
above, management will have the option to require all holders that wish to exercise PCT Warrants to do so on a &#8220;cashless basis.&#8221; In such event, each holder would pay the exercise price by surrendering the PCT Warrants for that number of
shares of Common Stock equal to the quotient obtained by dividing (x)&nbsp;the product of the number of shares of Common Stock underlying the PCT Warrants, multiplied by the difference between the exercise price of the Public Warrants and the
&#8220;fair market value&#8221; (defined below) by (y)&nbsp;the fair market value. The &#8220;fair market value&#8221; for this purpose shall mean the average reported last sale price of the Common Stock for the 10 trading days ending on the third
trading day prior to the date on which the notice of redemption is sent to the holders of PCT Warrants. Whether we will exercise our option to require all holders to exercise their Public Warrants on a &#8220;cashless basis&#8221; will depend on a
variety of factors including the price of the Common Stock at the time the PCT Warrants are called for redemption, ongoing cash needs at such time and concerns regarding dilutive share issuances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The PCT Warrants have been issued in registered form under a warrant agreement (as supplemented by First Supplemental Warrant Agreement and
the Second Supplemental Warrant Agreement, the &#8220;Warrant Agreement&#8221;) between Continental Stock Transfer&nbsp;&amp; Trust Company, as warrant agent, and an affiliate of the Company (f/k/a Roth CH Acquisition I Co. and now known as
PureCycle Technologies Holdings Corp., a wholly-owned direct subsidiary of the Company). The Warrant Agreement provides that the terms of the PCT Warrants may be amended without the consent of any holder to cure any ambiguity or correct any
defective provision, but requires the approval, by written consent or vote, of the holders of a majority of the then outstanding PCT Warrants in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
order to make any change that adversely affects the interests of the registered holders. On February&nbsp;25, 2026, the Company entered into a supplemental warrant agreement (the &#8220;First
Supplemental Warrant Agreement&#8221;) to the original warrant agreements, which, in part, extended the expiration date of the PCT Warrants to June&nbsp;17, 2026, or earlier upon redemption or liquidation. On April&nbsp;17, 2026, the Company entered
into a supplemental agreement (the &#8220;Second Supplemental Warrant Agreement&#8221;) to the original warrant agreements, which, in part, extended the expiration dates of the PCT Warrants to March&nbsp;17, 2027, or earlier upon redemption or
liquidation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exercise price and number of shares of Common Stock issuable on exercise of the PCT Warrants may be adjusted in certain
circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, the PCT Warrants will not be adjusted for issuances of shares of Common Stock at a price below
the applicable exercise price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The PCT Warrants may be exercised upon surrender of the PCT Warrant certificate on or prior to the
expiration date at the offices of the warrant agent, with the exercise form on the reverse side of the PCT Warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price, by certified or official bank
check, for the number of PCT Warrants being exercised. The PCT Warrant holders do not have the rights or privileges of holders of shares of Common Stock and any voting rights until they exercise their PCT Warrants and receive shares of Common Stock.
After the issuance of shares of Common Stock upon exercise of the PCT Warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PCT Warrant holders may elect to be subject to a restriction on the exercise of their PCT Warrants such that an electing PCT Warrant holder
would not be able to exercise their PCT Warrants to the extent that, after giving effect to such exercise, such holder would beneficially own in excess of 9.9% of the shares of Common Stock outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No fractional shares will be issued upon exercise of the PCT Warrants. If, upon exercise of the PCT Warrants, a holder would be entitled to
receive a fractional interest in a share, upon exercise, the number of shares of Common Stock to be issued to the PCT Warrant holder will be rounded down to the nearest whole number. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Public Units</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2026,
we had 47,596 Public Units issued and outstanding. All Public Units outstanding reflect a unit consisting of one share of Common Stock and three-quarters of one redeemable PCT Warrant to purchase Common Stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividends</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not declared or paid
any cash dividends on our Common Stock and do not presently intend to pay any cash dividends in the foreseeable future. The payment of dividends is subject to the discretion of the Company&#8217;s board of directors (the &#8220;Board&#8221;). Our
Board bases its decisions regarding dividends on, among other things, general business conditions, our financial results, contractual, legal and regulatory restrictions regarding dividend payments and any other factors that the Board may consider
relevant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Common Stock,
PCT Warrants and Public Units trade on NASDAQ under the symbols &#8220;PCT,&#8221; &#8220;PCTTW&#8221; and &#8220;PCTTU,&#8221; respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Annual
Stockholder Meetings</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Second Amended and Restated Bylaws provide that annual stockholder meetings will be held wholly or partially
by means of remote communication or at such place, within or without the State of Delaware, on such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
date and at such time as may be determined by the Board, the Chief Executive Officer of the Company (the &#8220;Chief Executive Officer&#8221;) or the chairman of the Board (the
&#8220;Chairman&#8221;) and as will be designated in the notice of the annual meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Effects of the Company&#8217;s Amended and
Restated Certificate of Incorporation and Second Amended and Restated Bylaws and Certain Provisions of Delaware Law</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Amended and
Restated Certificate of Incorporation, Certificate of Designations and the Second Amended and Restated Bylaws contain and the DGCL contains provisions, which are summarized in the following paragraphs, that are intended to enhance the likelihood of
continuity and stability in the composition of the Board. These provisions are intended to avoid costly takeover battles, reduce the Company&#8217;s vulnerability to a hostile change of control and enhance the ability of the Board to maximize
stockholder value in connection with any unsolicited offer to acquire the Company. However, these provisions may have an anti-takeover effect and may delay, deter or prevent a merger or acquisition of the Company by means of a tender offer, a proxy
contest or other takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the prevailing market price for the shares of the Common Stock held by stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Authorized but Unissued Capital Stock</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Delaware law does not require stockholder approval for any issuance of authorized shares. However, the listing requirements of NASDAQ, which
would apply if and so long as the Common Stock remains listed on NASDAQ, require stockholder approval of certain issuances equal to or exceeding 20% of the then outstanding voting power or then outstanding number of shares of Common Stock.
Additional shares that may be used in the future may be issued for a variety of corporate purposes, including future public offerings, to raise additional capital or to facilitate acquisitions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may generally issue preferred stock on terms calculated to discourage, delay or prevent a change of control of the Company or the
removal of the Company&#8217;s management. Moreover, the Company&#8217;s authorized but unissued shares of preferred stock will be available for future issuances without stockholder approval and could be utilized for a variety of corporate purposes,
including future offerings to raise additional capital, to facilitate acquisitions and employee benefit plans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One of the effects of the
existence of unissued and unreserved Common Stock or preferred stock may be to enable the Board to issue shares to persons friendly to current management, which issuance could render more difficult or discourage an attempt to obtain control of the
Company by means of a merger, tender offer, proxy contest or otherwise, and thereby protect the continuity of the Company&#8217;s management and possibly deprive the Company&#8217;s stockholders of opportunities to sell their shares of the Common
Stock at prices higher than prevailing market prices. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Removal of Directors; Vacancies</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the rights, if any, of the holders of any series of preferred stock under circumstances specified in a Preferred Stock Designation,
newly created directorships resulting from any increase in the number of directors and any vacancies on the Board resulting from death, disability, resignation, disqualification, removal, or other cause will be filled solely by the affirmative vote
of a majority of the remaining directors then in office, even though less than a quorum of the Board, or by a sole remaining director; provided, that, (i)&nbsp;for so long as Pure Crown has a right to nominate the Pure Crown Director, any vacancy
resulting from the death, disability, resignation, disqualification, removal, or other cause with respect to the Pure Crown Director, will be filled only by Pure Crown and (ii)&nbsp;for so long as Sylebra Capital has a right to nominate one or more
directors for nomination to the Board, any vacancy resulting from the death, disability, disqualification, resignation, or removal with respect to such nominee shall be filled by a successor nominee of Sylebra Capital, subject to certain
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
exceptions described in the Board Representation Agreement. Sylebra Capital is currently entitled to designate two directors for nomination. Any director elected in accordance with the preceding
sentence will hold office until the next annual election and until their successors are duly elected and qualified or until their earlier death, disability, resignation, disqualification or removal. No decrease in the number of directors
constituting the Board may shorten the term of any incumbent director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the rights, if any, of the holders of any series of
preferred stock to elect additional directors under circumstances specified in a Preferred Stock Designation, any director may be removed from office by the stockholders at any time, with or without cause. At any annual meeting or special meeting of
the stockholders, the notice of which states that the removal of a director or directors is among the purposes of the meeting and identifies the director or directors proposed to be removed, the affirmative vote of the holders of a majority of the
voting power of the outstanding Voting Stock, voting together as a single class, may remove such director or directors. &#8220;Voting Stock&#8221; means stock of the Company of any class or series entitled to vote generally in the election of
directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Special Stockholder Meetings</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the rights of the holders of any future series of preferred stock, special meetings of stockholders may be called only (i)&nbsp;by
the Chairman, (ii)&nbsp;by the Chief Executive Officer, or (iii)&nbsp;by the Secretary of the Company (the &#8220;Secretary&#8221;) acting at the request of the Chairman, the Chief Executive Officer or a majority of the total number of directors
that the Company would have if there were no vacancies on its Board. At any annual meeting or special meeting of stockholders, only such business will be conducted or considered as has been brought before such meeting in the manner provided in the
Second Amended and Restated Bylaws. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Requirements for Advance Notification of Director Nominations and Stockholder Proposals</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Second Amended and Restated Bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of
candidates for election as directors, other than nominations made by or at the direction of the Board or a committee of the Board. In order for any matter to be properly brought before a meeting, a stockholder will have to comply with advance notice
requirements and provide the Company with certain information, including, for stockholders who intend, or are part of a group who intends, to solicit proxies in support of director nominees other than the nominees of the Board or a committee of the
Board, reasonable documentary evidence that the requirements of Rule <FONT STYLE="white-space:nowrap">14a-19</FONT> under the Exchange Act have been satisfied. Generally, to be timely, a stockholder&#8217;s notice relating to any nomination or other
business to be brought before an annual meeting must be delivered to the Secretary at the Company&#8217;s principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary date of the immediately preceding
annual meeting of stockholders. Notwithstanding the foregoing, in the event that the number of directors to be elected to the Board at the annual meeting is increased effective after the time period for which nominations would otherwise be due and
there is no public announcement by the Company naming the nominees for the additional directorships at least 100 days prior to the first anniversary of the preceding year&#8217;s annual meeting, a stockholder&#8217;s notice will also be considered
timely, but only with respect to nominees for the additional directorships, if it will be delivered to the Secretary at the principal executive offices of the Company not later than the close of business on the 10th day following the day on which
such public announcement is first made by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To be timely, a stockholder&#8217;s notice relating to the nomination of a
director to Board to be brought before a special meeting, if permitted, will be delivered to the Secretary at the principal executive offices of the Company not earlier than the close of business on the 120th day prior to such special meeting and
not later than the close of business on the later of the 90th day prior to such special meeting or the 10th day following the day on which public announcement is first made of the date of the special meeting and of the nominees proposed by the Board
to be elected at such meeting. The Second Amended and Restated Bylaws also specify requirements as to the form and content of a stockholder&#8217;s notice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing notice requirements, the notice requirements will not apply to
director nominations pursuant to the Pure Crown Side Letter (as defined in the Second Amended and Restated Bylaws). These notice provisions may defer, delay or discourage a potential acquirer from conducting a solicitation of proxies to elect the
acquirer&#8217;s own slate of directors or otherwise attempting to influence or obtain control of the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Consent of Stockholders in Lieu of
Meeting</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the rights of the holders of any series of preferred stock, any action required or permitted to be taken by the
stockholders may be taken only at a duly called annual or special meeting of stockholders and may not be taken without a meeting by means of any consent in writing of such stockholder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dissenters&#8217; Rights of Appraisal and Payment </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the DGCL, with certain exceptions, the Company&#8217;s stockholders will have appraisal rights in connection with a merger or
consolidation of the Company. Pursuant to the DGCL, stockholders who properly request and perfect appraisal rights in connection with such merger or consolidation will have the right to receive payment of the fair value of their shares as determined
by the Delaware Court of Chancery. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stockholders&#8217; Derivative Actions</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the DGCL, any of the Company&#8217;s stockholders may bring an action in the Company&#8217;s name to procure a judgment in the
Company&#8217;s favor, also known as a derivative action, provided that the stockholder bringing the action is a holder of the Company&#8217;s shares at the time of the transaction to which the action relates or such stockholder&#8217;s stock
thereafter devolved by operation of law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Amendment of the Amended and Restated Certificate of Incorporation</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Amended and Restated Certificate of Incorporation provides that the Company reserves the right at any time from time to time to amend,
alter, change or repeal any provision contained in the Amended and Restated Certificate of Incorporation. Notwithstanding any inconsistent provision of the Amended and Restated Certificate of Incorporation or any provision of law that might
otherwise permit a lesser vote or no vote, but in addition to any affirmative vote of the holders of any series of preferred stock required by law, the affirmative vote of the holders of a majority of the voting power of the outstanding capital
stock entitled to vote, voting together as a single class, is required to amend, alter, change or repeal, or adopt any provision inconsistent with, certain provisions, as noted in the Amended and Restated Certificate of Incorporation, or the
definition of any capitalized terms used therein or any successor provision. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Amendment of the Second Amended and Restated Bylaws</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Second Amended and Restated Bylaws may be amended in any respect or repealed at any time, either (a)&nbsp;at any meeting of stockholders,
provided that any amendment or supplement proposed to be acted upon at any such meeting has been properly described or referred to in the notice of such meeting, or (b)&nbsp;by the Board, provided that no amendment adopted by the board may vary or
conflict with any amendment adopted by the stockholders in accordance with the Amended and Restated Certificate of Incorporation and the Second Amended and Restated Bylaws. Notwithstanding the foregoing and anything contained in the Second Amended
and Restated Bylaws, certain provisions of the Second Amended and Restated Bylaws may not be amended or repealed by the stockholders, and no provision inconsistent therewith may be adopted by the stockholders, without the affirmative vote of the
holders of a majority of the Company&#8217;s outstanding capital stock entitled to vote, voting together as a single class. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Exclusive Forum Selection</I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Amended and Restated Certificate of Incorporation provides that, unless the Company consents in writing to the selection of an alternative
forum, (a)&nbsp;the Court of Chancery (the &#8220;Chancery Court&#8221;) of the State of Delaware (or, in the event that the Chancery Court does not have jurisdiction, the federal district court for the District of Delaware) will, to the fullest
extent permitted by law, be the sole and exclusive forum for (i)&nbsp;any derivative action, suit or proceeding brought on behalf of the Company, (ii)&nbsp;any action, suit or proceeding asserting a claim of breach of a fiduciary duty owed by any
director, officer, employee or stockholder of the Company to the Company or to the Company&#8217;s stockholders, (iii)&nbsp;any action, suit or proceeding arising pursuant to any provision of the DGCL or the Second Amended and Restated Bylaws or the
Amended and Restated Certificate of Incorporation (as either may be amended and/or restated from time to time) or as to which the DGCL confers jurisdiction on the Chancery Court, or (iv)&nbsp;any action, suit or proceeding asserting a claim against
the Company governed by the internal affairs doctrine; and (b)&nbsp;subject to the preceding provisions, the federal district courts of the United States will be the exclusive forum for the resolution of any complaint asserting a cause of action
arising under the Securities Act or the Exchange Act. If any action the subject matter of which is within the scope of clause (a)&nbsp;of the immediately preceding sentence is filed in a court other than the courts in the State of Delaware (a
&#8220;Foreign Action&#8221;) in the name of any stockholder, such stockholder will be deemed to have consented to (1)&nbsp;the personal jurisdiction of the state and federal courts in the State of Delaware in connection with any action brought in
any such court to enforce the provisions of clause (a)&nbsp;of the immediately preceding sentence and (2)&nbsp;having service of process made upon such stockholder in any such action by service upon such stockholder&#8217;s counsel in the Foreign
Action as agent for such stockholder. Any person or entity purchasing or otherwise acquiring or holding any interest in any security of the Company will be deemed to have notice of and consented to such provisions of the Amended and Restated
Certificate of Incorporation. Notwithstanding the foregoing, the exclusive forum provision will not apply to suits brought to enforce any liability or duty created by the Securities Act, the Exchange Act, or any other claim for which the federal
courts of the United States have exclusive jurisdiction. Unless the Company consents in writing to the selection of an alternative forum, the federal district courts of the United States of America shall, to the fullest extent permitted by
applicable law, be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations on Liability and Indemnification of Officers and Directors</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The DGCL authorizes corporations to limit or eliminate the personal liability of directors and certain officers to corporations and their
stockholders for monetary damages for breaches of directors&#8217; fiduciary duties, subject to certain exceptions. The Amended and Restated Certificate of Incorporation includes a provision that eliminates the personal liability of directors for
monetary damages for any breach of fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof is not permitted under the DGCL. The effect of these provisions is to eliminate the rights of the Company and
its stockholders, through stockholders&#8217; derivative suits on the Company&#8217;s behalf, to recover monetary damages from a director for breach of fiduciary duty as a director, including breaches resulting from grossly negligent behavior.
However, exculpation does not apply to any director for any breach of the director&#8217;s duty of loyalty to the Company or its stockholders, or if the director has acted in bad faith, knowingly or intentionally violated the law, authorized illegal
dividends or redemptions or derived an improper benefit from his or her actions as a director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Amended and Restated Certificate of
Incorporation provides that the Company must indemnify and advance expenses to the Company&#8217;s directors and officers to the fullest extent authorized by the DGCL. The Company also is expressly authorized to maintain insurance, at its expense,
to protect itself and any director, officer, employee or agent of the Company or another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Company would have the power to
indemnify such person against such expense, liability or loss under the DGCL. The Company believes that these indemnification and advancement provisions and insurance are useful to attract and retain qualified directors and executive officers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The limitation of liability, advancement and indemnification provisions in the Amended and
Restated Certificate of Incorporation may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against
directors and officers, even though such an action, if successful, might otherwise benefit the Company and its stockholders. In addition, your investment may be adversely affected to the extent the Company pays the costs of settlement and damage
awards against directors and officers pursuant to these indemnification provisions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_10"></A>DESCRIPTION OF WARRANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue warrants to purchase our debt or equity securities or securities of third parties or other rights, including rights to receive
payment in cash or securities based on the value, rate or price of one or more specified commodities, currencies, securities or indices, or any combination of the foregoing. Warrants may be issued independently or together with any other securities
and may be attached to, or separate from, such securities. Each series of warrants will be issued under a separate warrant agreement to be entered into between us and a warrant agent. The terms of any warrants to be issued and a description of the
material provisions of the applicable warrant agreement will be set forth in the applicable prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_11"></A>DESCRIPTION OF RIGHTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue rights to purchase Common Stock or other securities or any combination thereof. These rights may be issued independently or
together with any other security offered by us and may or may not be transferable by the securityholder receiving the rights in such offering. In connection with any offering of rights, we may enter into a standby arrangement with one or more
underwriters or other investors pursuant to which the underwriters or other investors may be required to purchase any securities remaining unsubscribed for after such offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent appropriate, the applicable prospectus supplement will describe the specific terms of the rights to purchase shares of our
securities offered thereby, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date of determining the securityholders entitled to the rights distribution; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price, if any, for the rights; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the exercise price payable for the Common Stock, depositary shares or other securities upon the exercise of the
right; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of rights issued to each securityholder; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount of Common Stock, depositary shares or other securities that may be purchased per each right;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any provisions for adjustment of the amount of securities receivable upon exercise of the rights or of the
exercise price of the rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent to which the rights are transferable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date on which the right to exercise the rights shall commence, and the date on which the rights shall expire;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent to which the rights may include an over-subscription privilege with respect to unsubscribed securities
or an over-allotment privilege to the extent the securities are fully subscribed; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the material terms of any standby underwriting or purchase arrangement entered into by us in connection with the
offering of rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any applicable U.S. federal income tax considerations; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other terms of the rights, including the terms, procedures and limitations relating to the transferability,
exchange and exercise of the rights. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The description in the applicable prospectus supplement of any rights we offer
will not necessarily be complete and will be qualified in its entirety by reference to the applicable rights certificate and/or rights agreement, which will be filed with the SEC if we offer rights. You are urged to read the applicable rights
certificate, rights agreement and any applicable prospectus supplement in their entirety. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_12"></A>DESCRIPTION OF STOCK PURCHASE CONTRACTS AND STOCK PURCHASE UNITS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue stock purchase contracts, including contracts obligating holders to purchase from us, and for us to sell to the holders,
a specified number of shares of Common Stock at a future date or dates. The price per share of Common Stock and the number of shares of Common Stock may be fixed at the time the stock purchase contracts are issued or may be determined by reference
to a specific formula stated in the stock purchase contracts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The stock purchase contracts may be issued separately or as part of units
that we call &#8220;stock purchase units.&#8221; Stock purchase units consist of a stock purchase contract and U.S. treasury securities securing the holders&#8217; obligations to purchase shares of Common Stock under the stock purchase contracts.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The stock purchase contracts may require us to make periodic payments to the holders of the stock purchase units or vice versa, and these
payments may be unsecured or prefunded on some basis. The stock purchase contracts may require holders to secure their obligations in a specified manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The applicable prospectus supplement will describe the terms of the stock purchase contracts or stock purchase units. The description in the
prospectus supplement will only be a summary, and you should read the stock purchase contracts, and, if applicable, collateral or depositary arrangements, relating to the stock purchase contracts or stock purchase units. Material U.S. federal income
tax considerations applicable to the stock purchase units and the stock purchase contracts will also be discussed in the applicable prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_13"></A>DESCRIPTION OF DEBT SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section describes the general terms that will apply to any debt securities that we may offer pursuant to this prospectus and an
applicable prospectus supplement. The specific terms of any offered debt securities, and the extent to which the general terms described in this section apply to these debt securities, will be described in the applicable prospectus supplement at the
time of the offering. The prospectus supplement, which we will file with the SEC, may or may not modify the general terms found in this prospectus. For a complete description of any series of debt securities, you should read both this prospectus and
the prospectus supplement that applies to that series of debt securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this prospectus, &#8220;debt securities&#8221; means
the debentures, notes, bonds and other evidences of indebtedness that we may offer pursuant to this prospectus and an applicable prospectus supplement and authenticated by the relevant trustee and delivered under the applicable indenture. We may
issue debt securities under an indenture (the &#8220;indenture&#8221;) to be entered into between us and U.S. Bank Trust Company, National Association, as trustee (the &#8220;trustee&#8221;), as supplemented from time to time, the form of which is
filed as an exhibit to the registration statement of which this prospectus is a part. If a different trustee or a different indenture for a series of debt securities is used, those details will be provided in a prospectus supplement and the forms of
any other indentures will be filed with the SEC at the time they are used. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have summarized below the material provisions of the
indenture and the debt securities, and indicated which material provisions will be described in an applicable prospectus supplement. For further information, you should read the indenture. The following summary is qualified in its entirety by the
provisions of the indenture, including the provisions made part thereof by reference to the Trust Indenture Act of 1939, as amended (the &#8220;Trust Indenture Act&#8221;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture will not limit the
aggregate principal amount of debt securities that may be issued under it. We may issue debt securities at one or more times in one or more series. Each series of debt securities may have different terms. The terms of any series of debt securities
will be described in, or determined by action taken pursuant to, a resolution of our Board or a committee appointed by our Board or in a supplement to the indenture relating to that series. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are not obligated to issue all debt securities of one series at the same time and, unless otherwise provided in the prospectus supplement,
we may reopen a series, without the consent of the holders of the debt securities of that series, for the issuance of additional debt securities of that series. Additional debt securities of a particular series will have the same terms and
conditions as outstanding debt securities of that series, except for the date of original issuance and the offering price, and will be consolidated with, and form a single series with, those outstanding debt securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospectus supplement relating to any series of debt securities that we may offer will state the price or prices at which the debt
securities will be offered and will contain the specific terms of that series. These terms may include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title of the series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any limit upon the aggregate principal amount of the series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date or dates on which each of the principal of and premium, if any, on the securities of the series is
payable and the method of determination thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the debt securities are senior or subordinated debt securities and, if subordinated, the terms of such
subordination; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rate or rates at which the securities of the series will bear interest, if any, or the method of calculating
such rate or rates of interest, the date or dates from which interest will accrue or the method by which the date or dates will be determined, the interest payment dates on which any interest will be payable and the record date, if any;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether debt securities are entitled to any guarantee of any subsidiary guarantors and the identity of any such
subsidiary guarantors for that series and the terms of such guarantee; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the place or places where the principal of (and premium, if any) and interest, if any, on securities of the
series will be payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the place or places where the securities may be exchanged or transferred; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the period or periods within which, the price or prices at which, the currency or currencies (including currency
unit or units) in which, and the other terms and conditions upon which, securities of the series may be redeemed, in whole or in part, at our option, if we are to have that option with respect to the applicable series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our obligation, if any, to redeem or purchase securities of the series in whole or in part pursuant to any
sinking fund or analogous provision or upon the happening of a specified event or at the option of a holder thereof and the period or periods within which, the price or prices at which, and the other terms and conditions upon which securities of the
series will be redeemed or purchased, in whole or in part, pursuant to such an obligation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if other than minimum denominations of $2,000 and multiples of $1,000 thereafter, the denominations in which
securities of the series are issuable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if other than U.S. dollars, the currency or currencies (including currency unit or units) in which payments of
principal of (and premium, if any) and interest, if any, on the securities of the series will or may be payable, or in which the securities of the series will be denominated, and the particular provisions applicable thereto; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the payments of principal (and premium, if any), or interest, if any, on the securities of the series are to
be made, at our or a holder&#8217;s election, in a currency or currencies (including currency unit or units) other than that in which the securities are denominated or designated to be payable, the currency or currencies (including currency unit or
units) in which the payments are to be made, the terms and conditions of the payments and the manner in which the exchange rate with respect to the payments will be determined, and the particular provisions applicable thereto; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the amount of payments of principal (and premium, if any) and interest, if any, on the securities of the
series will be determined with reference to an index, formula or other method (which index, formula or method may be based, without limitation, on a currency or currencies (including currency unit or units) other than that in which the securities of
the series are denominated or designated to be payable), the index, formula or other method by which those amounts will be determined; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether, and the terms and conditions upon which, the securities of the series may or must be converted into our
securities or exchanged for our securities or those of another enterprise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if other than the principal amount thereof, the portion of the principal amount of securities of the series which
will be payable upon declaration of acceleration of the maturity thereof pursuant to an event of default or the method by which that portion will be determined; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any modifications of or additions to (i)&nbsp;the events of default and any changes in the right of the trustee
or the holders to declare the principal, premium, if any, any interest, if any, with respect to the securities to be due and payable, (ii)&nbsp;covenants with respect to securities of the series or (iii)&nbsp;any modifications of or additions to
subordination provisions with respect to any debt securities that are subordinated; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the securities of the series will be subject to legal defeasance or covenant defeasance as provided in
the indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any modifications of or additions to provisions relating to satisfaction and discharge of the indenture;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if other than the trustee, the identity of the registrar and any paying agent and any other agent appointed in
connection with the securities of such series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the securities of the series will be issued in whole or in part in global form, (i)&nbsp;the depositary for
the global securities, (ii)&nbsp;the form of any legend that will be borne by the global securities, (iii)&nbsp;whether beneficial owners of interests in any securities of the series in global form may exchange those interests for certificated
securities of that series and of like tenor of any authorized form and denomination and (iv)&nbsp;the circumstances under which any such exchange may occur; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the securities of the series will be secured or unsecured and, if secured, the nature and priority of the
security interest and the identity of any collateral agent; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other terms of the series. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Interest </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in
the applicable prospectus supplement, if any payment date with respect to debt securities falls on a day that is not a business day, we will make the payment on the next business day. The payment made on the next business day will be treated as
though it had been made on the original payment date, and no interest will accrue on the payment for the additional period of time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Ranking </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in the applicable prospectus supplement, the debt securities, if senior debt securities, will be our direct,
unconditional, unsecured and unsubordinated obligations and will rank <I>pari passu </I>with all of our other unsecured senior obligations. However, such senior debt securities will be effectively junior to all of our secured obligations to the
extent of the value of the assets securing those obligations. Such debt securities will also be structurally subordinated to all liabilities, including trade payables and lease obligations, of our subsidiaries. The debt securities, if subordinated
debt securities, will be our direct, unconditional, unsecured and subordinated obligations and will be junior in right of payment to our existing and future senior obligations. The extent of subordination of such subordinated debt securities will be
described in an accompanying prospectus supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Covenants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as described below or in the prospectus supplement with respect to any series of debt securities, neither we nor any subsidiary
guarantors are restricted by the indenture from paying dividends or making distributions on our or their capital stock or purchasing or redeeming our or their capital stock. The indenture does not require the maintenance of any financial ratios or
specified levels of net worth or liquidity. In addition, with certain exceptions, the indenture does not contain any covenants or other provisions that would limit our or any subsidiary guarantor&#8217;s right to incur additional indebtedness or
limit the amount of additional indebtedness, including senior or secured indebtedness that we can create, incur, assume or guarantee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in the applicable prospectus supplement, covenants contained in the indenture will be applicable to the series of
debt securities to which the prospectus supplement relates so long as any of the debt securities of that series are outstanding. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reporting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture provides that we will file with the trustee and the SEC such information, documents and other reports as may be required pursuant
to the Trust Indenture Act at the times and in the manner provided in the Trust Indenture Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Guarantees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One or more of our direct or indirect wholly-owned subsidiaries may fully and unconditionally guarantee any series of debt securities offered
by this prospectus in the future. The term &#8220;subsidiary guarantors&#8221; with respect to a series of debt securities refers to those subsidiaries, if any, that guarantee that series of debt securities. We may file one or more post-effective
amendments to our registration statement to add such potential subsidiary guarantors. The applicable prospectus supplement will name the subsidiary guarantors, if any, for that series of debt securities and will describe the terms of the guarantee
by the subsidiary guarantors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidation, Merger and Sale of Assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture provides that neither we nor any subsidiary guarantor may consolidate or merge with or into, or sell or convey all or
substantially all of our assets in any one transaction or series of related transactions to another person, unless (other than a consolidation or merger of PCT and one or more subsidiary guarantors or two or more subsidiary guarantors, or a sale,
lease, conveyance, assignment, transfer or other disposition of all or substantially all of the assets of PCT to a subsidiary guarantor, a subsidiary guarantor to the Company or of a subsidiary guarantor to another subsidiary guarantor): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">either we or a subsidiary guarantor, as the case may be, are the resulting, surviving or transferee corporation,
or our successor is a corporation organized under the laws of the United States, any state or the District of Columbia and expressly assumes by supplemental indenture all of our obligations under the indenture and all the debt securities; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">immediately after giving effect to the transaction, no default or event of default has occurred and is
continuing. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The term &#8220;default&#8221; for the purpose of this provision means any event that is, or with the
passage of time or the giving of notice or both would become, an event of default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the provisions of this
covenant shall not apply to (i)&nbsp;any sale, transfer, lease, conveyance or other disposition of assets between or among the Company and its wholly owned subsidiaries or between or among wholly owned subsidiaries of the Company, or (ii)&nbsp;any
merger or consolidation of the Company with a wholly owned subsidiary of the Company solely for the purpose of reincorporating the Company in another jurisdiction. Except in the case of a lease of all or substantially all of our assets or a
subsidiary guarantor&#8217;s assets, the successor will be substituted for us or the subsidiary guarantor, as the case may be, in the indenture with the same effect as if it had been an original party to such indenture. Thereafter, the successor may
exercise the rights and powers of PCT or such subsidiary guarantor under the indenture. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Events of Default, Notice and Waiver </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the indenture, the term &#8220;event of default&#8221; with respect to debt securities of any series means any of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure by us to pay interest, if any, on the debt securities of that series for 30 days after the date payment
is due and payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure by us to pay principal of or premium, if any, on the debt securities of that series when due, at
maturity, upon any redemption, by declaration or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure by us or any subsidiary guarantor to comply with other covenants in the indenture or the debt securities
of that series for 90 days after notice that compliance was required; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain events of bankruptcy or insolvency of us or any subsidiary guarantor with respect to such series that is
a significant subsidiary; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, specified events involving the guarantees. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The term &#8220;significant subsidiary&#8221; for the purpose of this provision means any of
our subsidiaries that would be a &#8220;significant subsidiary&#8221; as defined in Rule <FONT STYLE="white-space:nowrap">1-02(w)</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an event of default (other than relating to certain events of bankruptcy or insolvency of us or breach of our reporting obligation) has
occurred and is continuing, the trustee or the holders of not less than 25% in aggregate principal amount of the debt securities of that series may declare the entire principal of all the debt securities of the affected series, and accrued interest
thereon, if any, to be due and payable immediately. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an event of default relating to certain events of bankruptcy or insolvency of us
or any subsidiary guarantor occurs and is continuing, then the principal amount of all of the outstanding debt securities and any accrued interest thereon will automatically become due and payable immediately, without any declaration or other act by
the trustee or any holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of not less than a majority in aggregate principal amount of the debt securities of any series
may, after satisfying conditions, rescind and annul any of the above-described declarations and consequences involving the debt securities of that series, except a continuing default or event of default in the payment of principal of, or interest or
premium, if any, on the debt securities of the affected series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture imposes limitations on suits brought by holders of debt
securities of any series against us or any subsidiary guarantor. Except for actions for payment of overdue principal or interest, no holder of a debt security of any series may institute any action against us under the indenture unless: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the holder has previously given to the trustee written notice of an event of default and the continuance of that
event of default; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the holder or holders of at least 25% in aggregate principal amount of the outstanding debt securities of that
series have requested that the trustee pursue the remedy; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such holder or holders have offered, and, if requested, provided to the trustee security or indemnity reasonably
satisfactory to the trustee against the costs, expenses and liabilities to be incurred in compliance with such request; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the trustee has not instituted the action within 60 days of the receipt of such notice, request and offer of
indemnity; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the trustee has not received inconsistent direction by the holders of a majority in principal amount of the
outstanding debt securities of that series. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will be required to file annually with the trustee a certificate, signed
by an officer of our Company, stating whether or not the officer knows of any default by us in the performance, observance or fulfillment of any condition or covenant of the indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the sole remedy for any breach of our obligation under the indenture to file or furnish reports or other
financial information pursuant to section 314(a)(1) of the Trust Indenture Act (or as otherwise required by the indenture) shall be the payment of liquidated damages, and the holders will not have any right under the indenture to accelerate the
maturity of the debt securities of the affected series as a result of any such breach. If any such breach continues for 180 days after notice thereof is given in accordance with the indenture, we will pay liquidated damages to the holders of the
debt securities of that series at a rate per annum equal to 0.25% per annum of the principal amount of the debt securities of the affected series from the 180th day following such notice to but not including the date on which the breach relating to
the reporting obligations referred to in this paragraph shall have been cured or waived; provided that in no event shall such liquidated damages accrue for more than 365 days. The provisions of the indenture described in this paragraph will not
affect the rights of the holders of the debt securities of any series in the event of the occurrence of any other event of default. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Modification and Waiver </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided in the two succeeding paragraphs, the indenture provides that we, any subsidiary guarantors and the trustee thereunder may,
with the consent of the holders of not less than a majority in aggregate principal amount of the debt securities of any series then outstanding (including, without limitation, consents obtained in connection with a purchase of, or tender offer or
exchange offer for, debt securities of that series), voting as one class, add any provisions to, or change in any manner, eliminate or modify in any way the provisions of, the indenture or modify in any manner the rights of the holders of the debt
securities of that series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, any subsidiary guarantors and the trustee may amend or supplement the indenture or the debt securities of
any series without the consent of any holder to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">convey, transfer, assign, mortgage or pledge to the trustee as security for the debt securities of any series,
any property or assets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evidence the assumption by a successor corporation of our obligations under the indenture and the debt securities
of any series in the case of a merger, amalgamation, consolidation or sale of all or substantially all of our assets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">add covenant(s) or events of default(s) for the protection of the holders of all or any series of debt
securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cure any ambiguity or correct or supplement any provision contained in the indenture or any supplemental
indenture that may be defective or inconsistent with any other provision contained in the indenture or in any supplemental indenture, or make any other provisions as we may deem necessary or desirable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evidence and provide for the acceptance of appointment by a successor trustee in accordance with the indenture
and add or change any of the provisions in the indenture as shall be necessary to provide for or facilitate the administration of trusts thereunder by more than one trustee; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide for uncertificated debt securities in addition to, or in place of, certificated debt securities of any
series in a manner that does not materially and adversely affect any holders of the debt securities of that series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">conform the text of the indenture or the debt securities of any series to any provision of this
&#8220;Description of Debt Securities&#8221; or &#8220;Description of Securities&#8221; in this prospectus or the applicable prospectus supplement for that series to the extent that the provision in that description was intended to be a verbatim
recitation of a provision of the indenture or the debt securities of that series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide for the issuance of additional debt securities of any series in accordance with the limitations set forth
in the indenture as of the date of the indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any change that would provide any additional rights or benefits to the holders of all or any series of debt
securities or that does not adversely affect the legal rights under the indenture of any such holder or any holder of a beneficial interest in the debt securities of that series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">comply with requirements of the SEC in order to effect or maintain the qualification of the indenture under the
Trust Indenture Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish the form or terms of debt securities of any series as permitted by the indenture;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">secure our obligations in respect of the debt securities of any series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the case of convertible or exchangeable debt securities of any series, subject to the provisions of the
supplemental indenture for that series, to provide for conversion rights, exchange rights and/or repurchase rights of holders of that series in connection with any reclassification or change of our common stock or in the event of any amalgamation,
consolidation, merger or sale of all or substantially all of the assets of us or our subsidiaries substantially as an entirety occurs; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the case of convertible or exchangeable debt securities of any series, to reduce the conversion price or
exchange price applicable to that series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the case of convertible or exchangeable debt securities of any series, to increase the conversion rate or
exchange ratio in the manner described in the supplemental indenture for that series, provided that the increase will not adversely affect the interests of the holders of that series in any material respect; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any amendment to or supplement of the indenture or the debt securities of any series that does not adversely
affect the rights of holders of any series of debt securities then outstanding in any material respect; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">add Guarantees with respect to the debt securities of any series. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, any subsidiary guarantors and the trustee may not, without the consent of the holder of each outstanding debt security affected thereby:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">change the final maturity date of any debt security; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the aggregate principal amount on any debt security; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the rate of or extend the stated time for payment of interest on any debt security; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce or alter the method of computation of any amount payable on any debt security upon redemption, prepayment
or purchase of any debt security or otherwise alter or waive any of the provisions with respect to the redemption or of any debt security, or waive a redemption payment with respect to any debt security; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any note payable in any money, or at a place of payment other than provided in any debt security of any
series or in accordance with the terms of any debt security of any series, the indenture or any supplemental indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impair the right to institute suit for the enforcement of any payment on any debt security when due, or otherwise
make any change in the provisions of the indenture or any supplemental indenture relating to waivers of past defaults or the rights of holders of any debt security to receive payments of principal of, or premium, if any, or interest on any debt
security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">modify the provisions of the indenture with respect to modification and waiver (including waiver of a default or
event of default in respect of debt securities of any series), except to increase the percentage required for modification or waiver or to provide for the consent of each affected holder; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the percentage of principal amount of outstanding debt securities of any series whose holders must consent
to an amendment, supplement or waiver of the indenture or the debt securities of that series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any change that adversely affects the conversion rights of holders of debt securities of any series that are
exchangeable or convertible to receive payment or delivery of any consideration due upon the conversion or exchange of the debt securities of that series; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">modify or amend any provisions of the indenture or the debt securities of any series as may be described in the
prospectus supplement with respect to that series of debt securities as requiring the consent of each holder affected thereby. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Defeasance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture provides that
we and any subsidiary guarantors will be discharged from any and all obligations in respect of the debt securities of any series (except for certain obligations to the trustee, to register the transfer or exchange of the debt securities, to replace
stolen, lost or mutilated debt securities, to maintain paying agencies and hold monies for payment in trust and to pay the principal of and interest, if any, on those debt securities), upon the irrevocable deposit with the applicable trustee, in
trust, of money and/or U.S. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
government obligations, which through the payment of interest and principal of the U.S. government obligations in accordance with their terms will provide money in an amount sufficient to pay any
installment of principal and premium, if any, and interest, if any, on the debt securities of that series on the stated maturity date thereof in accordance with the terms of the indenture and the debt securities of that series. Also, the
establishment of such a trust will be conditioned on the delivery by us or a subsidiary guarantor to the trustee of an opinion of counsel reasonably satisfactory to the trustee to the effect that, based upon applicable U.S. federal income tax law or
a ruling published by the IRS, such a defeasance and discharge will not be deemed, or result in, a taxable event with respect to the holders. For the avoidance of doubt, such an opinion would require a change in current U.S. tax law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and any subsidiary guarantors may also omit to comply with the restrictive covenants, if any, of any particular series of debt securities,
other than the covenant to pay the amounts due and owing with respect to that series. Any such omission will not be an event of default with respect to the debt securities of that series, upon the deposit with the applicable trustee, in trust, of
money and/or U.S. government obligations, which through the payment of interest and principal of the U.S. government obligations in accordance with their terms will provide money in an amount sufficient to pay any installment of principal and
premium, if any, and interest, if any, on the debt securities of that series on the stated maturity date thereof in accordance with the terms of the indenture and the debt securities of that series. Our and any subsidiary guarantors&#8217;
obligations under the indenture and the debt securities of that series other than with respect to those covenants will remain in full force and effect. Also, the establishment of such a trust will be conditioned on the delivery by us or a subsidiary
guarantor to the trustee of an opinion of counsel to the effect that such a defeasance and discharge will not be deemed, or result in, a taxable event with respect to the holders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Satisfaction and Discharge </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At our
option, we may satisfy and discharge the indenture with respect to the debt securities of any series (except for specified rights and obligations of the trustee and ours, including, among others, the obligations to apply money held in trust), as may
be reasonably requested by the Company when: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">either (a)&nbsp;all debt securities of that series previously authenticated under the indenture have been
delivered to the trustee for cancellation or (b)&nbsp;all debt securities of that series not yet delivered to the trustee for cancellation (i)&nbsp;have become due and payable by reason of the mailing of a notice of redemption or otherwise or
(ii)&nbsp;will become due and payable within one year, and we or a subsidiary guarantor has irrevocably deposited or caused to be deposited with the trustee as trust funds in trust solely for the benefit of the holders an amount sufficient to pay
and discharge the entire indebtedness on debt securities of that series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no default or event of default with respect to debt securities of that series has occurred or is continuing on
the date of the deposit or will occur as a result of the deposit and the deposit will not result in a breach or violation of any other instrument to which we are bound; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or a subsidiary guarantor have paid or caused to be paid all other sums payable by us under the indenture and
any applicable supplemental indenture with respect to the debt securities of that series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we have delivered irrevocable instructions to the trustee to apply the deposited funds toward the payment of
securities of that series at the stated maturity date or the redemption date, as applicable; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we have delivered to the trustee an officer&#8217;s certificate and an opinion of counsel stating that all
conditions precedent relating to the satisfaction and discharge of the indenture as to that series have been satisfied. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Unclaimed
Money </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to applicable abandoned property laws, if money deposited with the trustee or paying agent for the payment of principal
of, premium or accrued and unpaid interest, if any, on debt securities remains unclaimed for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
two years, the trustee and paying agent will pay the money back to us upon our request. After the trustee or paying agent pays the money back to us, holders of debt securities entitled to the
money must look to us for payment, subject to applicable law, and all liability of the trustee and the paying agent with respect to the money will cease. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Purchase and Cancellation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registrar
and paying agent will forward to the trustee any debt securities surrendered to them for transfer, exchange or payment, and the trustee will promptly cancel those debt securities in accordance with its customary procedures. We will not issue new
debt securities to replace debt securities that we have paid or delivered to the trustee for cancellation or that any holder has converted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may, to the extent permitted by law, purchase debt securities in the open market or by tender offer at any price or by private agreement.
We may, at our option and to the extent permitted by law, reissue, resell or surrender to the trustee for cancellation any debt securities we purchase in this manner; provided that we do not reissue or resell those debt securities if upon reissuance
or resale, they would constitute &#8220;restricted securities&#8221; within the meaning of Rule 144 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Debt securities surrendered to the trustee for cancellation may not
be reissued or resold and will be promptly cancelled. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Replacement of Debt Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will replace mutilated, lost, destroyed or stolen debt securities at the holder&#8217;s expense upon delivery to the trustee of the
mutilated debt securities or evidence of the loss, destruction or theft of the debt securities satisfactory to the trustee and us. In the case of a lost, destroyed or stolen debt security, we or the trustee may require, at the expense of the holder,
indemnity satisfactory to us and the trustee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Regarding the Trustee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">U.S. Bank Trust Company, National Association, is the trustee under the indenture. Except during the continuance of an event of default, the
trustee will perform only such duties as are specifically set forth in the indenture. During the existence of an event of default, the trustee will exercise such of the rights and powers vested in it under the indenture and use the same degree of
care and skill in its exercise as a prudent person would exercise under the circumstances in the conduct of such person&#8217;s own affairs. The holders of a majority in principal amount of the then outstanding debt securities of any series will
have the right to direct the time, method and place of conducting any proceeding for exercising any remedy available to the trustee, subject to certain exceptions. Subject to these provisions, the trustee will be under no obligation to exercise any
of its rights or powers under the indenture at the request of any holder of debt securities, unless such holder has offered, and, if requested, provided to the trustee security and indemnity satisfactory to it against any loss, liability or expense.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant and subject to the Trust Indenture Act, the trustee will be permitted to engage in other transactions with us; however, if the
trustee acquires any conflicting interest, it would be required to eliminate such conflict within 90 days, apply to the SEC for permission to continue as trustee or resign. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Individual Liability of Directors, Officers, Employees, Incorporators, Stockholders or Agents </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture provides that none of the past, present or future directors, officers, employees, incorporators, stockholders, other owners or
agents of PCT or any subsidiary guarantor in their capacity as such will have any liability for any of our obligations under the debt securities of any series or the indenture. Each holder of debt securities of any series by accepting a debt
security waives and releases all such liability. The waiver and release are part of the consideration for issuance of the debt securities. The waiver may not be effective to waive liabilities under the federal securities laws and it is the view of
the SEC that such a waiver is against public policy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Governing Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture and debt securities of each series are governed by, and construed in accordance with, the laws of the State of New York. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_14"></A>DESCRIPTION OF UNITS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As specified in the applicable prospectus supplement, we may issue units consisting of one or more shares of common stock, shares of preferred
stock, warrants, stock purchase contracts, stock purchase units, debt securities or any combination of such securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_15"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A summary of certain U.S. federal income tax considerations to persons investing in the securities offered by this prospectus may be set forth
in an applicable prospectus supplement. The summary will be prepared for information purposes only, however, and will not be intended as legal or tax advice to prospective purchasers. Prospective purchasers of securities are urged to consult their
own tax advisors prior to any acquisition of securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_16"></A>FORMS OF SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each warrant and unit will be represented either by a certificate issued in definitive form to a particular investor or by one or more global
securities representing the entire issuance of securities. Certificated securities in definitive form and global securities will be issued in registered form. Definitive securities name you or your nominee as the owner of the security, and in order
to transfer or exchange these securities or to receive payments other than interest or other interim payments, you or your nominee must physically deliver the securities to the registrar, paying agent or other agent, as applicable. Global securities
name a depositary or its nominee as the owner of the warrants or units represented by these global securities. The depositary maintains a computerized system that will reflect each investor&#8217;s beneficial ownership of the securities through an
account maintained by the investor with its broker/dealer, bank, trust company or other representative, as we explain more fully below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Global
Securities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue the registered warrants and units in the form of one or more fully registered global securities that will be
deposited with a depositary or its nominee identified in the applicable prospectus supplement and registered in the name of that depositary or nominee. In those cases, one or more registered global securities will be issued in a denomination or
aggregate denominations equal to the portion of the face amount of the securities to be represented by registered global securities. Unless and until it is exchanged in whole for securities in definitive registered form, a registered global security
may not be transferred except as a whole by and among the depositary for the registered global security, the nominees of the depositary or any successors of the depositary or those nominees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If not described below, any specific terms of the depositary arrangement with respect to any securities to be represented by a registered
global security will be described in the prospectus supplement relating to those securities. We anticipate that the following provisions will apply to all depositary arrangements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ownership of beneficial interests in a registered global security will be limited to persons, called participants, that have accounts with the
depositary or persons that may hold interests through participants. Upon the issuance of a registered global security, the depositary will credit, on its book-entry registration and transfer system, the participants&#8217; accounts with the
respective face amounts of the securities beneficially owned by the participants. Any dealers, underwriters or agents participating in the distribution of the securities will designate the accounts to be credited. Ownership of beneficial interests
in a registered global security will be shown on, and the transfer of ownership interests will be effected only through, records maintained by the depositary, with respect to interests of participants, and on the records of participants, with
respect to interests of persons holding through participants. The laws of some states may require that some purchasers of securities take physical delivery of these securities in definitive form. These laws may impair your ability to own, transfer
or pledge beneficial interests in registered global securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">So long as the depositary, or its nominee, is the registered owner of a
registered global security, that depositary or its nominee, as the case may be, will be considered the sole owner or holder of the securities represented by the registered global security for all purposes under the applicable warrant agreement or
unit agreement. Except as described below, owners of beneficial interests in a registered global security will not be entitled to have the securities represented by the registered global security registered in their names, will not receive or be
entitled to receive physical delivery of the securities in definitive form and will not be considered the owners or holders of the securities under the applicable warrant agreement or unit agreement. Accordingly, each person owning a beneficial
interest in a registered global security must rely on the procedures of the depositary for that registered global security and, if that person is not a participant, on the procedures of the participant through which the person owns its interest, to
exercise any rights of a holder under the applicable warrant agreement or unit agreement. We understand that under existing industry practices, if we request any action of holders or if an owner of a beneficial interest in a registered global
security desires to give or take any action that a holder is entitled to give or take under the applicable warrant agreement or unit agreement, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
depositary for the registered global security would authorize the participants holding the relevant beneficial interests to give or take that action, and the participants would authorize
beneficial owners owning through them to give or take that action or would otherwise act upon the instructions of beneficial owners holding through them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any payments to holders with respect to warrants or units, represented by a registered global security registered in the name of a depositary
or its nominee will be made to the depositary or its nominee, as the case may be, as the registered owner of the registered global security. None of the Company, any warrant agent, unit agent or any other agent of the Company, agent of such warrant
agent or unit agent will have any responsibility or liability for any aspect of the records relating to payments made on account of beneficial ownership interests in the registered global security or for maintaining, supervising or reviewing any
records relating to those beneficial ownership interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect that the depositary for any of the securities represented by a
registered global security, upon receipt of any payment of premium, interest or other distribution of underlying securities or other property to holders on that registered global security, will immediately credit participants&#8217; accounts in
amounts proportionate to their respective beneficial interests in that registered global security as shown on the records of the depositary. We also expect that payments by participants to owners of beneficial interests in a registered global
security held through participants will be governed by standing customer instructions and customary practices, as is now the case with the securities held for the accounts of customers in bearer form or registered in &#8220;street name,&#8221; and
will be the responsibility of those participants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the depositary for any of these securities represented by a registered global
security is at any time unwilling or unable to continue as depositary or ceases to be a clearing agency registered under the Exchange Act, and a successor depositary registered as a clearing agency under the Exchange Act is not appointed by us
within 90 days, we will issue securities in definitive form in exchange for the registered global security that had been held by the depositary. Any securities issued in definitive form in exchange for a registered global security will be registered
in the name or names that the depositary gives to the relevant warrant agent, unit agent or other relevant agent of ours or theirs. It is expected that the depositary&#8217;s instructions will be based upon directions received by the depositary from
participants with respect to ownership of beneficial interests in the registered global security that had been held by the depositary. In addition, we may at any time determine that the securities of any series shall no longer be represented by a
global security and will issue securities in definitive form in exchange for such global security pursuant to the procedure described above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_17"></A>SELLING SECURITYHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information about selling securityholders, where applicable, will be set forth in a prospectus supplement, in a post-effective amendment or in
filings we make with the SEC under the Exchange Act which are incorporated by reference into this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_18"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or selling securityholders may sell the securities in and outside the United States: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through underwriters or dealers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through agents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">directly to one or more purchasers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any combination of these; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through any method described in the applicable prospectus supplement. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The distribution of the securities may be effected, from time to time, in one or more transactions, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">block transactions (which may involve crosses) and transactions on any organized market where the securities may
be traded; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases by a dealer as principal and resale by the dealer for its own account pursuant to a prospectus
supplement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions and transactions in which a dealer solicits purchasers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sales &#8220;at the market&#8221; to or through a market maker or into an existing trading market, on an exchange
or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sales in other ways not involving market makers or established trading markets, including direct sales to
purchasers; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in any other manner described in the applicable prospectus supplement. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or selling securityholders may distribute the securities from time to time in one or more transactions at: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a fixed price or prices, which may be changed from time to time; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">market prices prevailing at the time of sale; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prices related to the prevailing market prices; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">negotiated prices; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prices determined according to the process described in the applicable prospectus supplement.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any selling stockholder will act independently of us in making decisions with respect to the timing, manner and size of
each of its sales of securities covered by this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospectus supplement will describe the terms of the offering of the
securities, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the name or names of any underwriters, dealers or agents; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the purchase price and the proceeds we will receive from the sale; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any underwriting discounts and other items constituting underwriters&#8217; compensation; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any initial public offering price and any discounts or concessions allowed or reallowed or paid to dealers.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sale through Underwriters or Dealers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If underwriters are used in the sale, the underwriters will acquire the securities for their own account. The underwriters may resell the
securities from time to time in one or more transactions, including negotiated </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transactions, at a fixed public offering price or at varying prices determined at the time of sale. Underwriters may offer the securities to the public either through underwriting syndicates
represented by one or more managing underwriters or directly by one or more firms acting as underwriters. Unless we inform you otherwise in the prospectus supplement, the obligations of the underwriters to purchase the securities will be subject to
certain conditions, and the underwriters will be obligated to purchase all of the securities if they purchase any of them. The underwriters may change from time to time any initial public offering price and any discounts or concessions allowed or
reallowed or paid to dealers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we offer the securities in a subscription rights offering to our existing holders of our securities, we
may enter into a standby underwriting agreement with dealers, acting as standby underwriters. We may pay the standby underwriters a commitment fee for the securities they commit to purchase on a standby basis. If we do not enter into a standby
underwriting agreement, we may retain a dealer-manager to manage a subscription rights offering for us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During and after an offering
through underwriters, the underwriters may purchase and sell the securities in the open market. These transactions may include over-allotment and stabilizing transactions and purchases to cover syndicate short positions created in connection with
the offering. The underwriters may also impose a penalty bid, which means that selling concessions allowed to syndicate members or other broker-dealers for the securities sold for their account may be reclaimed by the syndicate if the securities are
repurchased by the syndicate in stabilizing or covering transactions. These activities may stabilize, maintain or otherwise affect the market price of such securities, which may be higher than the price that might otherwise prevail in the open
market. If commenced, the underwriters may discontinue these activities at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If dealers are used in the sale of the securities,
we or the selling securityholders will sell the securities to them as principals. They may then resell those securities to the public at varying prices determined by the dealers at the time of resale. We will include in the prospectus supplement the
names of the dealers and the terms of the transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of Common Stock may also be exchanged for satisfaction of selling
securityholders&#8217; obligations or other liabilities to their creditors. Such transactions may or may not involve brokers or dealers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Direct Sales
and Sales through Agents </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or the selling securityholders may sell the securities directly. In this case, no underwriters or agents
would be involved. We or the selling securityholders may also sell the securities through agents designated from time to time at fixed prices or at varying prices determined at the time of sale. In the prospectus supplement, we will name any agent
involved in the offer or sale of the securities, and we will describe any commissions payable to the agent. Unless we inform you otherwise in the prospectus supplement, any agent will agree to use its reasonable best efforts to solicit purchases for
the period of its appointment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We or the selling securityholders may sell the securities directly to institutional investors or others
who may be deemed to be underwriters within the meaning of the Securities Act with respect to any sale of those securities. We will describe the terms of any sales of these securities in the prospectus supplement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Delayed Delivery Contracts </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we so
indicate in the prospectus supplement, we or the selling securityholders may authorize agents, underwriters or dealers to solicit offers from certain types of institutions to purchase the securities from us at the public offering price under delayed
delivery contracts. These contracts would provide for payment and delivery on a specified date in the future. The contracts would be subject only to those conditions described in the prospectus supplement. The prospectus supplement will describe the
commission payable for solicitation of those contracts. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and the selling securityholders may have agreements with the agents, dealers and underwriters to indemnify them against certain civil
liabilities, including liabilities under the Securities Act, or to contribute with respect to payments that the agents, dealers or underwriters may be required to make. Agents, dealers and underwriters may be customers of, engage in transactions
with or perform services for us in the ordinary course of their businesses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Selling securityholders might not sell any securities under
this prospectus. In addition, any shares of Common Stock covered by this prospectus that qualify for sale pursuant to Rule 144 under the Securities Act may be sold under Rule 144 rather than pursuant to this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_19"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Legal matters in connection with the issuance and sale of the securities offered hereby will be passed upon for us by Jones Day. Additional
legal matters will be passed upon for any underwriters, dealers or agents by counsel named in the applicable prospectus supplement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx137529_20"></A>EXPERTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The audited financial statements and management&#8217;s assessment of the effectiveness of internal control over
financial reporting incorporated by reference in this prospectus and elsewhere in the registration statement have been so incorporated by reference in reliance upon the reports of Grant Thornton LLP, independent registered public accountants, upon
the authority of said firm as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g113098g01q01.jpg" ALT="LOGO" STYLE="width:3.93333in;height:0.635167in;">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>PureCycle Technologies, Inc. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>4.75% Convertible Senior Notes due 2032 </B></P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Morgan Stanley </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Cantor </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>June 10, 2026
</B></P>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>d113098dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:ffd="http://xbrl.sec.gov/ffd/2026">
<head>
<title>EX-FILING FEES</title>
</head>
  <body>
  <div style="display: none"> <ix:header> <ix:hidden> <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-345">S-3</ix:nonNumeric> <ix:nonNumeric name="ffd:SubmissnTp" contextRef="rc" id="ixv-346">424B5</ix:nonNumeric> <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="rc" id="ixv-347">EX-FILING FEES</ix:nonNumeric> <ix:nonNumeric name="ffd:RegnFileNb" contextRef="rc" id="ixv-348">333-296672</ix:nonNumeric> <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="rc" id="ixv-349">0001830033</ix:nonNumeric> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-350">PureCycle Technologies, Inc.</ix:nonNumeric> <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"></ix:nonNumeric> <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ix:nonNumeric> <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="rc" id="hiddenrcCombinedProspectusTableNa">N/A</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2026/ffd-2026.xsd" xlink:type="simple"/> </ix:references> <ix:resources> <xbrli:context id="rc"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001830033</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-06-11</xbrli:startDate> <xbrli:endDate>2026-06-11</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_1"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001830033</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>1</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-06-11</xbrli:startDate> <xbrli:endDate>2026-06-11</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:unit id="USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit> <xbrli:unit id="pure"> <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit> <xbrli:unit id="Shares"> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit> </ix:resources> </ix:header> </div> <div>
<table style="width: 99%; font-family: Arial, Helvetica, sans-serif; font-size: 20pt; text-align: center;">
<tr>
<td colspan="4" style="padding-bottom: .5em"> <p> <b>Calculation of Filing Fee Tables</b> </p> </td> </tr>
<tr>
<td style="padding-bottom: .25em"> <p> <b> <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-378">S-3</ix:nonNumeric> </b> </p> </td> </tr>
<tr>
<td style="padding-bottom: .25em"> <p> <b> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-379">PureCycle Technologies, Inc.</ix:nonNumeric> </b> </p> </td> </tr> </table> </div> <div style="padding-bottom: 20px;">
<table style="float: center; width: 100%; text-align: left; ">
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
<th style="vertical-align: bottom; text-align: left; word-wrap: break-word"> <b>Table 1: Newly Registered and Carry Forward Securities</b> </th>
<th style="vertical-align: bottom; word-wrap: break-word; text-align: right;"> <span style="-sec-ix-hidden: hiddenrcOfferingTableNa">&#9744;Not Applicable</span> </th> </tr> </table>
<table style="font-family: Arial, Helvetica, sans-serif; float: center; width: 100%; text-align: center; border: 1px solid black; font-size: 16px;">
<tr style="background-color:#9ADAF6">
<th style="width: 12%;">
 </th>
<th style="width: 2%;">
 </th>
<th style="width: 12%;"> <p style="margin: 0pt; text-align: center;"> <b>Security Type</b> </p> </th>
<th style="width: 14%;"> <p style="margin: 0pt; text-align: center;"> <b>Security Class Title </b> </p> </th>
<th style="width: 2%;"> <p style="margin: 0pt; text-align: center;"> <b>Fee Calculation or Carry Forward Rule</b> </p> </th>
<th style="width: 5%;"> <p style="margin: 0pt; text-align: center;"> <b>Amount Registered</b> </p> </th>
<th style="width: 15%;"> <p style="margin: 0pt; text-align: center;"> <b>Proposed Maximum Offering Price Per Unit</b> </p> </th>
<th style="width: 10%;"> <p style="margin: 0pt; text-align: center;"> <b>Maximum Aggregate Offering Price</b> </p> </th>
<th style="width: 5%;"> <p style="margin: 0pt; text-align: center;"> <b>Fee Rate</b> </p> </th>
<th style="width: 6%;"> <p style="margin: 0pt; text-align: center;"> <b>Amount of Registration Fee</b> </p> </th>
<th style="width: 1%;"> <p style="margin: 0pt; text-align: center;"> <b>Carry Forward Form Type</b> </p> </th>
<th style="width: 7%;"> <p style="margin: 0pt; text-align: center;"> <b>Carry Forward File Number</b> </p> </th>
<th style="width: 6%;"> <p style="margin: 0pt; text-align: center;"> <b>Carry Forward Initial Effective Date</b> </p> </th>
<th style="width: 7%;"> <p style="margin: 0pt; text-align: center;"> <b>Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</b> </p> </th> </tr>
<tr>
<td colspan="14" style="text-align: center"> <b>Newly Registered Securities</b> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_1" format="ixt:booleanfalse" id="ixv-380">Fees to be Paid</ix:nonNumeric> </td>
<td style="text-align: center;"> 1 </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_1" id="ixv-381">Debt</ix:nonNumeric> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_1" id="ixv-382">4.75% Convertible Senior Notes due 2032</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:Rule457rFlg" contextRef="offrl_1" format="ixt:booleantrue" id="ixv-383">457(r)</ix:nonNumeric> </td>
<td style="text-align: right;"> <ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="Shares" decimals="0" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-384">287,500,000</ix:nonFraction> </td>
<td style="text-align: right;"> <span>$</span> <ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="2" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-385">1.00</ix:nonFraction> </td>
<td style="text-align: right;"> <span>$</span> <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="2" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-386">287,500,000.00</ix:nonFraction> </td>
<td style="text-align: right;"> <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="7" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-387">0.0001381</ix:nonFraction> </td>
<td style="text-align: right;"> <span>$</span> <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="2" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-388">39,703.75</ix:nonFraction> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Fees Previously Paid </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr>
<td colspan="14" style="text-align: center"> <b>Carry Forward Securities</b> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Carry Forward Securities </td>
<td style="text-align: center;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td colspan="3" style="vertical-align: top"> <p style="margin: 0pt; text-align: right">Total Offering Amounts:</p> </td>
<td>
 </td>
<td style="vertical-align: top; width: 16%;"> <p id="MaxAggtOfferingPrice" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-389">287,500,000.00</ix:nonFraction> </p> </td>
<td>
 </td>
<td style="vertical-align: top; border-bottom: 1px black; width: 16%;"> <p id="TotalFeeAmt" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:TtlFeeAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-390">39,703.75</ix:nonFraction> </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td>
 </td> </tr>
<tr>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td colspan="3" style="vertical-align: top"> <p style="margin: 0pt; text-align: right"> Total Fees Previously Paid: </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td style="vertical-align: top"> <p id="TotalPreviouslyPaidAmt" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-391">0.00</ix:nonFraction> </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td>
 </td> </tr>
<tr>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td colspan="3" style="vertical-align: top"> <p style="margin: 0pt; text-align: right"> Total Fee Offsets: </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td style="vertical-align: top"> <p id="TotalOffsetAmt" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-392">0.00</ix:nonFraction> </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td>
 </td> </tr>
<tr>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td colspan="3" style="vertical-align: top"> <p style="margin: 0pt; text-align: right"> Net Fee Due: </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td style="vertical-align: top"> <p id="NetFeeAmt" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:NetFeeAmt" contextRef="rc" decimals="2" format="ixt:numdotdecimal" unitRef="USD" id="ixv-393">39,703.75</ix:nonFraction> </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td>
 </td> </tr> </table> </div> <div>
<table style="width: 100%; text-indent: 0px;"> <tbody>
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
<td> <p style="margin:0pt;text-align:left; margin-bottom: 5px;"> <b>Offering Note</b> </p> </td>
<td/> </tr> </tbody> </table> </div> <div style="padding-bottom: 20px;">
<table style="width: 100%; text-indent: 0px;">
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
<td style="width:10pt;"> <p style="margin:0pt;text-align:left;"> <sup style="vertical-align:top;line-height:120%;font-size:10px">1</sup> </p> </td>
<td colspan="7" style="white-space: pre-line;"> <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_1" id="ixv-394">In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, this Calculation of Filing Fee Tables shall be deemed to update the Calculation of Filing Fee Tables filed as Exhibit 107.1 to PureCycle Technologies, Inc.'s registration statement on Form S-3 (File No. 333-296672) filed with the Securities and Exchange Commission on June 10, 2026. The Maximum Aggregate Offering Price of the securities to which the prospectus relates is $287,500,000. The prospectus to which this Exhibit is attached is a final prospectus for the related offering.</ix:nonNumeric> </td> </tr>
<tr>
<td colspan="7"> <hr style="width:100%;text-align:left;margin-left:0"/> </td> </tr> </table> </div> <div style="padding-bottom: 20px;">
<table style="float: center; width: 100%; text-align: left; ">
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
<th style="vertical-align: bottom; text-align: left; word-wrap: break-word"> <b>Table 2: Fee Offset Claims and Sources</b> </th>
<th style="vertical-align: bottom; word-wrap: break-word; text-align: right;"> <span style="-sec-ix-hidden: hiddenrcOffsetTableNa">&#9745;Not Applicable</span> </th> </tr> </table>
<table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 100%; text-align: center; border: 1px solid black;">
<tr style="background-color:#9ADAF6">
<th style="width: 10%; text-align: left;">
 </th>
<th style="width: 8%; text-align: left;">
 </th>
<th style="width: 16%;"> Registrant or Filer Name </th>
<th style="width: 6%;"> Form or Filing Type </th>
<th style="width: 7%;"> File Number </th>
<th style="width: 6%;"> Initial Filing Date </th>
<th style="width: 6%;"> Filing Date </th>
<th style="width: 6%;"> Fee Offset Claimed </th>
<th style="width: 6%;"> Security Type Associated with Fee Offset Claimed </th>
<th style="width: 8%;"> Security Title Associated with Fee Offset Claimed </th>
<th style="width: 6%;"> Unsold Securities Associated with Fee Offset Claimed </th>
<th style="width: 9%;"> Unsold Aggregate Offering Amount Associated with Fee Offset Claimed </th>
<th style="width: 6%;"> Fee Paid with Fee Offset Source </th> </tr>
<tr>
<td colspan="14" style="text-align: center"> <b>Rules 457(b) and 0-11(a)(2)</b> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Fee Offset Claims </td>
<td> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Fee Offset Sources </td>
<td> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr>
<td colspan="14" style="text-align: center"> <b>Rule 457(p)</b> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Fee Offset Claims </td>
<td> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: left;"> Fee Offset Sources </td>
<td> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td> </tr> </table> </div> <div style="padding-bottom: 20px;">
<table style="float: center; width: 100%; text-align: left; ">
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
<th style="vertical-align: bottom; text-align: left; word-wrap: break-word"> <b>Table 3: Combined Prospectuses</b> </th>
<th style="vertical-align: bottom; word-wrap: break-word; text-align: right;"> <span style="-sec-ix-hidden: hiddenrcCombinedProspectusTableNa">&#9745;Not Applicable</span> </th> </tr> </table>
<table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 100%; border: 1px solid black;">
<tr style="background-color:#9ADAF6">
<th style="width: 4%">
 </th>
<th style="width: 14%"> <p style="margin: 0pt; text-align: center;"> <b>Security Type</b> </p> </th>
<th style="width: 25%"> <p style="margin: 0pt; text-align: center;"> <b>Security Class Title</b> </p> </th>
<th style="width: 14%"> <p style="margin: 0pt; text-align: center;"> <b>Amount of Securities Previously Registered</b> </p> </th>
<th style="width: 18%"> <p style="margin: 0pt; text-align: center;"> <b>Maximum Aggregate Offering Price of Securities Previously Registered</b> </p> </th>
<th style="width: 6%"> <p style="margin: 0pt; text-align: center;"> <b>Form Type</b> </p> </th>
<th style="width: 10%"> <p style="margin: 0pt; text-align: center;"> <b>File Number</b> </p> </th>
<th style="width: 8%"> <p style="margin: 0pt; text-align: center;"> <b>Initial Effective Date</b> </p> </th> </tr>
<tr style="background-color:#E7E7E2;">
<td style="text-align: center;"> </td>
<td> </td>
<td> </td>
<td style="text-align: right;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td>
<td style="text-align: center;"> </td> </tr> </table> </div> <div style="padding-bottom: 20px;">
<table style="float: center; width: 100%; text-align: left;"> <tbody>
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
<th style="vertical-align: bottom; text-align: center; width: 90%;"> <b>Narrative Disclosure</b> </th> </tr> </tbody> </table>
<table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 100%; text-align: center; margin-left:auto; margin-right:auto;"> <tbody>
<tr>
<td> The maximum aggregate offering price of the securities to which the prospectus relates is <span>$</span><ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="2" format="ixt:numdotdecimal" unitRef="USD" contextRef="rc" id="ixv-395">287,500,000.00</ix:nonFraction>. <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="rc" format="ixt:booleantrue" id="ixv-396">The prospectus is a final prospectus for the related offering.</ix:nonNumeric> </td> </tr>
<tr>
<td> <div style="padding-top: 20px;"> </div> </td> </tr> </tbody> </table> </div> </body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g113098g01q01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g113098g01q01.jpg
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M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H_\  $0@
MOP2< P$B  (1 0,1 ?_$ !T  0 " @,! 0             '" 4& 0,$ @G_
MQ !8$  ! P(" P8-$08$!@$%     0(#! 4&$0<A,1(305%AD0@6%R)25G&!
ME+&RT=(4&#(U-C="5%5S='62DZ&SP14C-&)RTT-3@O SA*+#X>(D8X.CI,+_
MQ  ; 0$  @,! 0               P4"! 8!!__$ #D1  (! @(%"0<$ @,!
M       ! @,$!1$2(3%!4083%#)2<8&1T14B,V&AL<$6-%/P(^%"<O%#_]H
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MKL7^5>\JE=7LY4]<=:,U+,E< &F9
M
M
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M>Z!=(?3A8G4%SE1;W0-1)%7;/'L23N\"\N2\)57=MH_Y(;"2+W$I@ KS(
M
M
M
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MRYFIV7Y&'2J';7FC*@\E#<Z&O<]M%5PSN8F;DC>BY(>LP<7%Y,EA.,UI1>:
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MHRH,5TQ6?Y3I/O4,C3S15$+)H)&R1/3-KVKFBH8RA*/661G"M3J/*$D^YG8
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M  [4^1 G#!GN7MOS2>,@\G#!GN7MOS2>,J<7^%'O.GY+?N)_]?RC,@ Y\[@
M     \MW]JJWYA_DJ0 3_=_:JM^8?Y*D %[@_5GX'&<JNO3[G^  "Y.3
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MWKX?I<WC0U;[X7B>QVDK  IR0'17_P !4_-.\2G>=%?_  %3\T[Q*>H'YZ@
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MSYW      !Y;O[55OS#_ "5( )_N_M56_,/\E2 "]P?JS\#C.577I]S_
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MJ+P-7F+"=5_ G;#!]S+Z)47E.<JF:1)%ZC? :'U7\"=L,'W,OHGDN.FO U'
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MJ?X^@ !H%T    =5/4PU+7.IY62HQRL<K'9Y*FU%.T]:RU,\336:  /#T
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M?+;<+1=:FBO$$M/71.5)62^RSX\^'/;GPG@+VA1C2C[OF1-Y@ $YX
M            >BWT-5<JR*DM]/+4U,J[ED435<YR\B(6.T3Z#(Z!\-UQHR.:
MI;DZ*WHJ.8Q>.1=CE_E35QYD-6M&DLY'J69KV@C1*^Z34^(L34ZMMS%22EI9
M$UU"\#W)V'$GPNYMLXFK8$1$1$1,D3@0%+6K2JRS9(ED  1'H
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M/E];?"B1/:"?NA(]M,2?,P^4X@$G[H2/;3$GS,/E.,;OX,O[O/8[2R8 *,D
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M<G\L>WGR0L]@;!EGP7:_4=EI]RKLEFG?KDF5.%R_HFI#3KW<::RCK9DHYG.
M<)T6#<-4UIH.NW'7S3*F2S2+[)R_HG B(AL0!3R;D\V2 K)T6?NEL?T-WEJ6
M;*R=%G[I;']#=Y:FS9?%1C+802 "[(R:.A1]W]R^K'_FQ%J2JW0H^[^Y?5C_
M ,V(M24M[\4DCL! W1,8#]6T*8KMD6=33-1E:UJ:WQ\$G=;L7D[A/)\3Q1SP
MR0S,;)%(U6/8Y,T<BIDJ*G$04JCI24D>M9GYX@WK3#@B3!.+)::)KEME3G-1
MR+KZS/6Q5XVKJ[F2\)HI?PDIQ4D1@MET.N/.F+#ZV2XR[JZVUB(USEUS0;$=
MRJW4B]Y>$J:9?"5_K,,8@HKO;G93TS]UN574]NQS5Y%3-"*XHJK#+>$\B_1@
ML?>X7$?U;4_E./1A:^T>);!17:VOW5-4L1R(NUB[%:O*BYHO<//C[W"XC^K:
MG\IQ2134DF2E"P =$0@         L1T(VW%'_+?]PKN6(Z$;;BC_ );_ +AJ
MW?P9?W>91VEB0 4A(>>X44%PHY*:KC22&1,E1?&G*0]BK#%58IU=DZ6B<O63
M(FSD=Q+XR:3YFB9-$Z.5C7QN3)S7)FBH;=I>3MGJUK@5>)X52OXZ]4EL?K\B
MO ),O^CZ*9SIK/*D+EU[S)K;WEVI^)HESL=RMCE2MHY8VI\/+-OVDU'14+NE
M67NO7P.$N\+N;1_Y(ZN*UK^]YC@ ;)7@ R%LLMQN;D2BHY9$7X>63?M+J,92
M45G)Y&<*<ZCT8+-_(QYGL+8:JK[4(K46*C:O[R94U=Q.-3;+!H]CB<V:\RI*
MY->\1KUO?7:O>-\@AC@B9% QL<;$R:UJ9(B%5=8G&*T:.M\3IL-Y.SFU4NM2
MX;WW\/OW'3;:&GMM''2T<:,A8FI.%>5>4](!0MMO-G:1BH)1BLD@ #PR!%6E
M?V_IOHS?*>2J15I7]OZ;Z,WRGECA?Q_!E%RB_9/O1I8 .E/GIO>B7VRK_F4\
MHDXC'1+[95_S*>42<<QB7[A^!]$Y/?L8][^X !H%V   >"]6JFO% ^EJVYM7
M6UR;6+QH0YB*P5=CJECJ6[J%R_NYFIUKT_1>0G(Z:NF@K*=\%5$R6)Z9*UR9
MHINVE[*V>6V/ J,4PBG?K2V36Q_AE? 2)?M'BYNELTR9;=XE7Q.\_.:1<+57
M6YZMK:2:'E<WK5[B[%.AHW5*LO<?J<+=X=<VCRJQU<=WF>( &P:( ,K:\/72
MYJGJ2CD5B_XCTW+>=3&4XP6<GD24Z4ZLM&FFW\C%&T80PG/>96SU*.AMZ+K?
ML63D;YS:L/8!I:1S9KJ]*J9-:1IJC3N\*F[-:C&HUJ(UJ)DB(F2(4]UB:2T:
M/GZ'4X9R=DVJEWJ79]?0^*:"*EIXX*=C8XHTW+6MV(AV+L 784F>>MG8I)+)
M%=@ =J?(0         3KA7W-VSZ.SQ$%$ZX5]S=L^CL\148O\./>=1R6^-4[
MOR>J[^U5;\P_R5( )_N_M56_,/\ )4@ QP?JS\"3E5UZ?<_P  7)R8
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MO :EHSP#%@2:]Q452LU!6RLE@:_V<:(BHK57AVZE_P!KO /5.2BXK8S(  Q
M                                   !PYC7+FYJ*O*AQO;.P;S'T #Y
MWMG8-YCEK6M]BU$[B'(                !YJ^@H[C L-PI*>JA7:R>-'MY
ME0]( -/J=&6"ZAZNDPW;D5?\N/<)S-R.GJ4X([7*/_J\YNP,^=GQ9YD:6S19
M@ECD<F'*%5Y4<J<RJ;!:,/6:S>U-IH*)=F=/ UBKW51,U,H#QSD]K/<@ #$
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M9T/)ZZNKJI.56;<4OJ__  ]0 *<ZL
M
M
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MU<7$KB>G(^@6%E"RHJE#Q?%@ $!N@
M
M
<                                  '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g113098g59k01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g113098g59k01.jpg
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M*"@H*"@H_\  $0@ :P%/ P$B  (1 0,1 ?_$ !P  0 " P$! 0
M   &!P0%" ," ?_$ $H0  $#!  $ P0%" 4)"0    $  @,$!081!Q(A,1-!
M40@B88$4,D)5<148(Y&4H;'3%C=B<K,7)#-S=(*2D\$E4E-68Y6RT?#_Q  5
M 0$!                     ?_$ !41 0$                    !_]H
M# ,!  (1 Q$ /P#JE$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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M$1$$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$%)8;3W/A9E.34558[K<,?N51],H:FVTYJ.0G>V/:.H.M#?]GXK><*,
E;N9RS)\TO]&^@JKR]L=+22$>)%3MUKGUV<0UG3RY?BK11!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g113098g59k02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g113098g59k02.jpg
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M0U9C98*#E;*S_\0 %0$! 0                    '_Q  5$0$!
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MC%ER5XUXIJ(0[[ UVO[RNAURWPLJW\'>*5TQS)WF"UW(-;#6/Z1NY2?#D)[
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M9&A['L.VN![$$=PJ<BD_E'XO7^SW26=V-X_$V,4<<KHV3SN.BZ3E()UIP ^
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M;XC*"&E:PM81T+W=P?/0[>9[A%8"(@B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@*M_:(M$UWX3WEE,TOEIN2JY1YM8[;OW-YC]RL
MA?DC&R,<R1H<QPTYI&P1Z%!4/LKW&.LX5Q4K'#Q*&JEB>WS',><'_?\ X*WU
M2U%@M^X:9967?!*9MUQ^O_SJSF41RQ:)(,;G=#K9UOKHZZ]U+:C/;G+3EEKP
M;)9J]PTV.IBCIX@?ZTA>0!]FT%0>U8V2]9MB=AH&^)7/C<&L'?<L@:W_ .A7
M0SJNDL5/9J"=S@)Y&4,!UT+Q&YPWZ;$9^_2@F <.ZV'*JK,\WGAJ\EJ/Z*&'
MK#1,UH-:3W('3?EU[D[6=QKL=]OUDLL&+%K+I!=8JF.9YTR+D9(>9QT>F]#M
MUV!YHK+XA\,,<SF%SKG2^!<.73*ZGTV4>F_)P^!W\-*AL89D/!;BO;K%4U9J
MK)=)F,TW8CE8]W() W]5[3W^S74$*[Z3-<AM],R')<)O#JYHT9;2(ZJ&0^H]
MX.;OT(Z>JCL.+7O/^(UKR?)K8ZS66S@.H:&9[73S/#N8/>&[#1L ZW^J!YDH
M);><[='D\^.XU9Y[Y=J:(35;63L@BIVGL'/=^L=CH!_Q61@6=4>6R7&C^2U%
MNO%MD\*LH*C1?&>H!!'1S>AZC_#< ]G.5U9?^(M?.>:IFNNGD]]!TA _B5\6
M@&C]JR\L@Z,J[4UTH';8;'U/^J/WH+P4:FP'$IYI)9L9LTDLCBY[W4<9+B>I
M).NZDJ(BH+9A>,/XPWNA?C]J=1QVFFE9 :5G(UYDD!<&ZT"0!U^"GU#A&+4%
M7%54..VFGJ87!\<L5(QKF'U! Z%>]-CU/!EU;D#9I34U5)'2.C.N0-8YS@1Y
M[]XK=("(B"F/:MME)4\-FUTT+75='51^#)YM#SIP^P]/W!2K@12P4O"G'S!&
MUAG@\>4CN][G$EQ/F2M%Q^M^093BK[!CV/5E5(ZH9(^H=+"R/E;L]-R<Q).O
M(>:W?!MEXM>&VJQWZQ5E!5441B=*Z2%\3@"=$%KR=D$>2"?HB("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@I6Q
M4=SX9\1,HFDLURN..7V454,]N@,[H)=N)8Y@Z@>^X;^#?CK;<-L?N=?Q"R+.
M[Y02V[Y=&VDH*2?0E9"T-!<]H^B3R-Z=^I^&[41 1$0$1$!$1 1$0$1$'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g113098g60k60.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g113098g60k60.jpg
M_]C_X  02D9)1@ ! 0 #YP/G  #_X3DP:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 V+C M8S P,B W.2XQ
M-C0U,3DL(#(P,C O,#@O,C4M,3<Z-30Z,# @(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+R(*(" @(" @(" @(" @>&UL;G,Z>&UP1TEM9STB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O:6UG+R(*(" @(" @(" @(" @
M>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(@H@(" @
M(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S
M+S$N,2\B"B @(" @(" @(" @('AM;&YS.GAM<%109STB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+W0O<&<O(@H@(" @(" @(" @("!X;6QN<SIS=$1I
M;3TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+T1I;65N<VEO
M;G,C(@H@(" @(" @(" @("!X;6QN<SIS=$9N=#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+W-4>7!E+T9O;G0C(@H@(" @(" @(" @("!X;6QN<SIX
M;7!'/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R\B"B @(" @(" @
M(" @('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M;6TO(@H@(" @(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @(" @(" @
M>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP
M92]297-O=7)C945V96YT(R(*(" @(" @(" @(" @>&UL;G,Z:6QL=7-T<F%T
M;W(](FAT=' Z+R]N<RYA9&]B92YC;VTO:6QL=7-T<F%T;W(O,2XP+R(^"B @
M(" @(" @(#QX;7 Z0W)E871E1&%T93XR,#(V+3 V+3 X5#$U.C,U.C,Y*S U
M.C,P/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM<#I#<F5A=&]R5&]O
M;#Y!9&]B92!);&QU<W1R871O<B R-2XP("A7:6YD;W=S*3PO>&UP.D-R96%T
M;W)4;V]L/@H@(" @(" @(" \>&UP.DUO9&EF>41A=&4^,C R-BTP-BTP.%0Q
M-3HS-3HS.2LP-3HS,#PO>&UP.DUO9&EF>41A=&4^"B @(" @(" @(#QX;7 Z
M365T861A=&%$871E/C(P,C8M,#8M,#A4,34Z,S4Z,SDK,#4Z,S \+WAM<#I-
M971A9&%T841A=&4^"B @(" @(" @(#QX;7 Z5&AU;6)N86EL<SX*(" @(" @
M(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM
M9SIW:61T:#XR-38\+WAM<$=);6<Z=VED=&@^"B @(" @(" @(" @(" @(" @
M(#QX;7!'26UG.FAE:6=H=#XV,#PO>&UP1TEM9SIH96EG:'0^"B @(" @(" @
M(" @(" @(" @(#QX;7!'26UG.F9O<FUA=#Y*4$5'/"]X;7!'26UG.F9O<FUA
M=#X*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z:6UA9V4^+SEJ+S1!05%3
M:UI*4F=!0D%G14%304))04%$+S=107-51VAV9$<Y>F%'.7=)1$UU34%!-%%K
M;$Y!*S!!04%!04%"04%304%!04%%028C>$$[05%"24%!04%!44%"+RLT041K
M1FMB,DIL04=404%!04%!9B]B04E104)G445"055%0F=51D)G:T="45E*0W=G
M1T)G9TQ$06]+0W=O2R8C>$$[1$)!341!=TU$07=11$$T4$5!.$]$0DU41D)1
M5$5X=V)'>'-C2'@X9DAX.&9(>#AF2'=%2$)W8TY$03!914)!64=H55)&4F]F
M2'@X9B8C>$$[2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF
M2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF+SA!04519T%0045!07=%4B8C>$$[
M04%)4D%135)!9B]%06%)04%!04A!445"05%%04%!04%!04%!04%11D%W24=!
M44%(0T%K2T-W14%!9TE$05%%0D%114%!04%!04%!028C>$$[05%!0T%W449"
M9V-)0U%O3$5!04-!44U$06=10T)G8T1"04E'06Y-0D%G35)"04%&25))>%%6
M14=%,D5I8UE%54UP1VA">%=X46E00B8C>$$[571(:$UX6FDX0U)Y9W9%;%%Z
M4E1K<4MY63-00TY546YK-D]Z3FAD55I(5$0P=4E)2F]-2D-H9UIH2E)&4G%3
M,%9T3E9+0G)Y-"]0128C>$$[,4]4,%I85T9L85<Q>&18;#E76C)H<&%M='-B
M5S5V63-2,61N9#1E6' W9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;RM#:S535FQP
M95EM6B8C>$$[<6)N2C)E;C5+:G!+5VUP-FEP<7%U<W)A-G9O4D%!24-!44E$
M0E%514)1645#04U$8E%%04%H141"0T53355%1E523FA)9UIX9UI%>28C>$$[
M;V)(=T9-2%(T4TY#1E9*:6-V17I*1%)$9VAA4U5Y5VE9-TQ#0C-04TYE2D5G
M>&15:W=G2D-H9UI*:EI&1VED:V1&53,X<4]Z=WEG<"8C>$$[,"M0>FA*4VMT
M3515-5!2;&195U9P8EA&,658,5)L6FUD;V%7<')B1S%U8C)2,61N9#1E6' W
M9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;R8C>$$[*T1L2E=7;#5I6FUP=6-N6C9F
M:W%/:W!A86YQ2VUQ<39Y=')Q*W8O84%!=T1!44%#15%-4D%$.$$Y531Q-T98
M67$W1EA9<3=&6%EQ-R8C>$$[1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T98
M67$W1EA9<3=&5VU:5E5S>$-Q;W%39&=!35994F\S-6<V-7)U;5!R*V@K6'AE
M*UA/8R8C>$$[;W1P=G)I<&982U%U,&)00F%M3#!Q1FM015-80T4K07A61"M:
M9GI.,6)3+TM':F5A8DQ1-')U>#%:8E0Q24QI.&$R;F=E*TMI3E-Q,B8C>$$[
M.#9S1DPP63AG4C1(1E9E."]-8E5D0S$O4SE+.#-A4D9P<T=T4R]6=$\Q3WIV
M1&57>'5$5&I&3#9K1G!*1U=R<V5*2#0P5EIZ:7)S5B8C>$$[9&ER<U9D:7)S
M5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S
M5F1I<G-69&ER<U9A9FIW8FQU=$1Y0B8C>$$[,T9-5F5++S1).#AE5%E4<B]W
M0U9/<$IQ6&QM.$%V=CA+6&]*:DUC;SE3='!)94Q$:W R5W%N>$QD3598*V9F
M3E9T-7 O23=3=&4P;28C>$$[,E,R5S=V9% Y0S!C,%-/5TLY5TEX:V]0<W))
M:$91=E1T:7%++TU05&1C,5!6+TQ6-S5W1FY9-E)P,F]X4S)':C963%!Q1C=Q
M1B]U628C>$$[-'<X:TYK<4M!=%1T,#5623)X5C90-5HX,#98-6IS<')Q=SE2
M1W1:-4Q/.71:,$UC,$9X15)Z:6Q496I#;T]X26]C5E1F1EA9<3=&6"8C>$$[
M67$W1E=083,U-3!F4SE7:#!33T\T,5!8<# Y85!38D)"2DU)=6YQ>7,W4G=W
M<%AB;$Q);WA61' U+W15,5-Y,&DO,&I59$XQ6%542R8C>$$[=&IA6$UC2D5P
M:&AE9"M.>$1.3F)6-'@P-"MR5W!',4MK2W!B<#,U<71Q32MQ,CEL-50Q=65F
M4DI40G%54R]O,VQ(248U.%9"=F=:2R8C>$$[<C Y4&Q8=&EQ9F54=D]M9RMB
M=$MB571';%HT;W!8=#=M1U9$2$Y$36XR;S59,C-6:%=U2W W:7)S5F1I<G-6
M43)P86Q985I95#9H<28C>$$[1G=L<EI7<4=3-'5*4T921DA5:VY&5T]7;C5G
M+UA,6F(K>CAU-GIC85$T-7@V:W-%2W$X6D96:U,R:VU3.6170D9/34<K2V]$
M5E!Z928C>$$[,&%X,&)3.6)H,')5=%$P;E8U;'1B3S=T:W1L2')V2SA+4G5K
M.7A"2VA:;S8Q6F%$=5%D<U9282]M6G Q=G(Y:&]7=6%8<4=G6'5Q3B8C>$$[
M=S!X<C5,9#1B:50O04@R:S%P4&12:"MM>D5D4C0T<7I$1EA9<3=&6%EQ-T98
M67$W1EA9<3=&6%EQ,'EH;$MN;U)4-SA6669:+VQN828C>$$[-F1P34]J851R
M=7(V9&\X4T-),DU5.$UG6E%">4%L=4E:<#1W,CE21DEG1F1Q67%P*UEV>7 P
M4%=F3#EH-61I=G(S4TY$,#,P,F=S3B8C>$$[4$YU<6PT5S52=7IZ47IY17$R
M+S)Q13=M<'A62W9Z0G-D43!Z52])=7-45%A7<#)':6%J24Y6=D=I5U-92F-W
M3D5K.'$R,&-A:%59,"8C>$$[67)'0G9I<4LO2VTP=3-V9DXK=4Y(3$1P*W1A
M>$I0<&EZ23!44U%X>'!&-C12=W)"6D=5.&%I<$%R:7(P1$9867$W1EA9<3=&
M6&HO-28C>$$[2'E46'9N4#AY3E,Q158Q;CE,+U9P030K3T\R:$UI=V]T9'=N
M155(:E%9<3E:=7)#,'5N='!,:4U34&%3*W9B36%G<$IW85!K2V8U128C>$$[
M:D0V8U9E25<O;69Z8C5A,68X>CE7,%!2;TY7:'1D5&EK=755-W).1V]G6&LV
M,C9X15-Q<59:=C-Y;D-R3G9Y:3AV84QO2&Q'8E=O.28C>$$[5FHQ138O22MR
M-FIQ<$%H:$QZ1&LS1E-323%48T=P<E=T861!1EIJ;V5V-E!R=6YR<4]J,V-D
M-UEU-WAP8WA'<4TP8D9'-&YV4F@Q1R8C>$$[2W!,-7AV4'$Y>&)$.4PV-7!V
M2D=01%(Y32]30U!V,6MB-FAQ2$)H,DA*9FQI<5%287)75D(O:6IZ9S%72'=T
M-64T<60K:% V1E=G*R8C>$$[;D98<$=+=DAV*V-K6DHS,'9Y<G X<$DP8E5.
M8W1O9%8R<7)2,7%Q3V9!+T5A93)+=EE&5E952V]#<6]O04YG04U695AF;F9:
M4E=(:R8C>$$[+U(T9$YG:E0O;EER1V%+07-5:DTP,7DX<E990GEO85)Y4U%P
M<%A99'-64W4U1V]E95!Z4W,Y0C@S4G<V1R]L4U).5S O4W)D,G5$<28C>$$[
M0DA(:DUL,#915FI2;"M*4D='-TAO84MV5F1B.'AA3F]C154R<5A3,C9Z>4-'
M,U=J4$I*25%4=VIJ44TW;6=*;V\V67%Q-E)R1VPV>B8C>$$[<#!7;S988W!D
M,DTT2FEN:4Y64$5L5TAS45)19SE$:7%->%9H1W8S=7$V9'%L>D0U83E39%I"
M-G5U4F]N<FEY.5-H*W-125-/53=,5B8C>$$[=G$T<GDK,U-U,'%R2TY#9S V
M2%-B6F1/;$YX84UV<5(S2F-Y=$M:0UAA4FY0,FUD;4Q%-'%J.%992&-E9B]/
M,%9X3$A(*U@K<%12;R8C>$$[-TMK>3-.:T$T0F]'04UL84AR=FEQ;B]Y<U!Z
M>B]W0U<W,5 O04M3<DPO<7!I<G8K5F@K968O3&0V;B\P;%=8+T%&57A6,R]+
M=R]04"8C>$$[+VQU.50O-E-R3"]Q<&ER=BM6:"ME9CA!>3-E<"]W1%-66F8Y
M5DU69"]W07)$.#@O*U<W,5 O<$MS=CA!<7!I<G8K5F@K968O04,S928C>$$[
M<"\X05-66F8Y5DU69"]Y<U!Z>B]!3U<W,5 X0393<DPO<7!I<G8X06Q99FYN
M+WDS97 O.4I6;"\Q57A6,R]+=R]04"]!2F)V52\X028C>$$[<$MS=BMQ;4MU
M+S572#4U+SAT,W%F+U-66F8X05941EAF.')$.#@O*U<W,5 O<$MS=BMQ;4MU
M+S572#4U+W=$3&0V;B]!3DI6;"\Q528C>$$[>%9K,VQB5SE8,65Z;6XQ5%$W
M:E%P;S5/0U<Y>DI&2WIR>$(U9W=S-'!5,#-X5DIT5B],:R]W0THS.#%E5W13
M8E%T8W555TQ55#9+,R8C>$$[3G!E271/4#%I,TQ217-T3FY34E1I<6-7=6IA
M-4EY5#9V<6-.,V-W0FIB4E<Y<3%T84Q+83A:6&AA96534FPW07IC93E!,4-&
M56@X;28C>$$[*U%V365G95ED83%7.#%Y,3%'1%@U+W)6+V%*<#=W1EI!:%)2
M1$EB=6)I=$M61$LQ861E*TMO1%10>79J.'0S;"]W04Y9=%0U1G5B:R8C>$$[
M6'-N;'95<DY:;TQA5&M(3%%81'I)278S9T1,5D-"-%8S>%9R.&<Y4C R-#AK
M4$1A6$U-<DIQ1V]U631N5FEQ4&5336@T<61G>7-#4"8C>$$[8D98<$]+=7A6
M,DMP5#5Q.')A3#5O,$\U,%A725!8<W)K8C!01C!C8G)*1S,W3'%D=V8T67%L
M1VHK5R]05VY7.&1G+VUM2SES27AW4R8C>$$[930P.$A50D=&0V=F5T9U1F=:
M:%0W5#(U<C-R:7%!.#@O;'9Q=FU,5&10,'94.6%J,'EY<V)M2R]:-7)2-WDU
M;'5O6&%13SAV,6E&928C>$$[3$TQ4T](6'948D969GIJ*UAT-S5K<SE+=7AQ
M<6%8-74P95%3,F9M0WIT:4%T9'!9+W$W>D]41DEV5D=L4#-60E932'I(3'%E
M:V9M2"8C>$$[*U@Q,35N,4,S;G0T,#%3,V)5,&E.;&)I-FQG5#!U85!*3T9D
M-#!:4CAE-7)3;E1&57@O2E%/*V@V.65X-S9B<4AM2%9,<E-706]R5R8C>$$[
M:GHP4FLS,U5S<D55>%8V1FEQ;D)B5S%U2$5%4U)#4C)L:T-+1C5/-7%Z;6Y6
M;4\U3TMT=S(X14-S<T5A4DMZ=$EY;V]51C5'3$]X<"8C>$$[,UII4U0S3TMR
M.%99;&-E9'12=2]-*V]E6&9,96UW-FID84]K3#9T8UAD,F)30TIR;%,X55-&
M26)P,V-Q=%0X055E3F-69&(K8W1B=B8C>$$[3DDQ<35T9$)-1W V2F-',VXP
M*R]U4D%*3T9V2&--.&,P360P0W),3"LW*T@T=2](<W%X*T0X,G9-82M3<EAZ
M=&5E5TEF.$]44G)C6"8C>$$[0G,Y46%E.&=H3&-423!%;')B;S-(=49L3TMV
M43E,,4]X,5A48EA5<D-55#)6-T5K.79+=E)O-49$2V9U3TMO<D9867$W1E9S
M:&M%8B8C>$$[1TY1,&="-$MX2W%7<'-#=T152'91-'$X.3!,.'=V3RMS*UED
M93!+,SAT-F1&96586DE)-S$U=%=M16)M-5)P27I%53 Y>5)X6&9K1B8C>$$[
M>%9D-6HO34AZ>F]'9V%J<3$S-51T,T]M5')&3$)&<55H13!C=G!#2U<R8S)9
M.5-R>6Q75F=P5VYE=7ER2R]+6&UA=SAZ*U<Y4#$V=R8C>$$[4"MJ86A#<V]3
M=%-J9$AJ62M+3T-P*U=+<V,Q;CAY8GE$.'<W5'E4;RML4C,Y,TY!.7AD6&QX
M9$YA=W<X1D1M4#193&=U+W!U:E5(."8C>$$[>2M.8U95=$,O35!Z5F9E9C=R
M>61Q6&PR,3 V87IT,79:<G-A:S!W:W0S8F=S;'9(.55J850T.6E'2U4O5W%N
M4&UR>D@U;C!V5DY*<R8C>$$[9$<P4S,Q66%M-WA.2DYF1S!-2FI5=7IU;W0U
M-GAH4CEP9#8W8V1X:7)*<U9D:7)S5E4W:3-T-VE&;V)I2DIO6#)E3U)1>6UH
M<G5$528C>$$[2$961WHP<E,W2FUA>G,T3%IN1DAA1TY)>5(T17%":7%+>%8R
M2W5X5C)+=7A6,DMU>%93=6)7,75O5$1D47!00S%#,&-Q:#%.3GAS=R8C>$$[
M27A656IJ4TY&:FI526E!2VE+2T%!8D%!1$97.%9D:7)S5F1I<GDW>F0K6&5O
M86@U;'9V3F8U9C8V9$8X,E%&3%A665A5=EHS5%)X228C>$$[-E)Z;U%A3C9B
M<#A15FA3;3%D.%922&MB>G1Q,G9A6#5O,&IZ1G!K96PK871#45(V=DA!45EP
M9E=G67=Z25%74'A);CAX,G!V,D-R128C>$$[+TLR:RME.68O27)43D1I+U)7
M;#9,9#)*:G5T6FQU8FE79&)/<D9Z.58K<GAX<2]%54Y:>4M6*VA6;F8U92MB
M4$M35U=J959T3%<W9R8C>$$[:D=N<2MJ4S-S3%)#.71907%M94EN<E=O86A!
M3D150VU+<S9X5DDY47,O4$5L-4DK;F%V<&QV6D5J,%EB:E1B:31L555&955Q
M6#A#="8C>$$[=EAP1TU69' Q;C4S:G99,S%,5G1-=6))5CEA0S(P,C1T-5<K
M13AE37(S.7=Q,&%H3EEZ='0W-'%N;4MV2&9+5G0U;6TO3G(X>7AO;28C>$$[
M;U=D:E-F5%!83C5:>3-H66TQ8FE5.4\V=$]&3C8Q-58Y=39R2G9-5G9Q.70K
M5CER8C9X2UHY5FEF5$9V6FEA.#529E%C,G)5.51V,28C>$$[=W%X:E%T5VDO
M3%1Z;#5K.'-84VLV4'%34')N;&%"9'5C<FYJ4%EX+V%O>E,P-$0V92M"5E,Q
M,&EF4R]Z9SAO>%AB:5A56CE+,4\V,28C>$$[2UED2'5P-49E57(O04I)63A6
M2%I10FA6369Z:VIN,$<U,% X>')*5V%8>3=/24Y7:E%6375M6&)#3UEF-T)I
M1UAB871E,D)75"M88B8C>$$[,C,Q-U@W-UAR859:.4]T23$P-U1*5G)X8FQX
M;G4U1CEM9C T+VY'8U9:4&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-6
M9&ER<R8C>$$[5F1I<G-69&ER<U99>DXU171"<3)O-GAP=7%A:'!/<&%R26ML
M-TYA>7A/:BMN16M+1#!,;4\T='A222]T96YY,T\O4VEQ>4@X=G)#,B8C>$$[
M,&953$,P,4<K=#=Z5C(U-G)R46%#4RMU1'<Y4#0S;&AK:4AW9D-!:V$X9C)A
M67%L<"],>5124'EW,79Y;F\Y+V5A:6LR;5AD<'!C3B8C>$$[.#!"3513=WE+
M<4LX34U";UAF.$%B-54W67%X8GDQ3S)V*UDO>3!&;%I4>'8U5S V-B]4<&QI
M94PV<$I*6DIA3&)-6%92>F%49FE/>28C>$$[,7 T2W9:359D:7)S5E=Y2WIX
M<VEU63)914-286-L2DA58V=Y,4AU35999#5B+TQ+2%%F370O-6AG.'=A<F18
M;7)-:C9R1F-M>6%'-"8C>$$[35-L22M3>#)S6E1G1S(Y37(Y,C)+<'(U=SAP
M1'I065(R375Q,S)M,GEU<VMQ,D)T,4UR4G5K:V9.<#1:,DA"-'=2=TLQ-S%X
M5G$Y."8C>$$[;&%2<4YZ;U8U<7I386QQ2&PV5G)I>'9:+U174G!(46]7:U=&
M26\O-5<K1D8K2E9/2W!D<68U8G@S+VY#,S@Q=#5G,5-$56).2&AS-"8C>$$[
M;W9Q4&]247DO8FE#4&%U5U9V1GE7.3EH:7)*9%@P=7DQ8E,W=E,W-5!5<S<V
M1C=E-%1X4U)3<F1E.41I<48X<F57.4XX<RM8<DA19"8C>$$[3C4O5710:455
M3%-%1C(S3$UZ;%%O3$UX2DY!3CA65%A&6%EQ-T9867$W1EA9<3=&6%EQ-T98
M67$W1EA9<3=&6%EQ-T9867$W1EA9<28C>$$[-T9867$W1EA9<3=&6%EQ-T98
M67$W1EA9<3=&6%EQ-T9867$O+SEK/3PO>&UP1TEM9SII;6%G93X*(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*(" @
M(" @(" @/"]X;7 Z5&AU;6)N86EL<SX*(" @(" @(" @/'!D9CI0<F]D=6-E
M<CY!8W)O8F%T($1I<W1I;&QE<B R-2XP("A7:6YD;W=S*3PO<&1F.E!R;V1U
M8V5R/@H@(" @(" @(" \9&,Z=&ET;&4^"B @(" @(" @(" @(#QR9&8Z06QT
M/@H@(" @(" @(" @(" @(" \<F1F.FQI('AM;#IL86YG/2)X+61E9F%U;'0B
M/DUI8W)O<V]F="!7;W)D("T@4$-4("T@4')E;&EM:6YA<GD@4')O<W!E8W1U
M<R!3=7!P;&5M96YT(%].;W1E<R!/9F9E<FEN9R M($UA>2 R,#(V7S4P,3(T
M.#@S.30N,3!?+F1O8W@\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z06QT
M/@H@(" @(" @(" \+V1C.G1I=&QE/@H@(" @(" @(" \9&,Z9&5S8W)I<'1I
M;VX^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F
M.FQI('AM;#IL86YG/2)X+7)E<&%I<B(^1FEL92!.86UE.B @(" @(" @(" @
M(" @(&<V,&LV,"YA:28C>$$[57-E<FYA;64Z(" @(" @(" @(" @("!R<C8P
M,S4W-"8C>$$[3&]C86P@5&EM93H@(" @(" @(" @(" @,#@M2G5N+3(P,C8@
M,34Z,S4Z,S F(WA!.T535"!4:6UE.B @(" @(" @(" @(" @,#@M2G5N+3(P
M,C8@,#8Z,#4Z,S F(WA!.U-C<FEP="!697)S:6]N.B @(" @(" @(#(N-B8C
M>$$[26QL=7-T<F%T;W(@5F5R<VEO;CH@(" @,C4N,"XP)B-X03M'<F%P:&EC
M('1Y<&4Z(" @(" @(" @($%R='=O<FLF(WA!.R8C>$$[XH"B(#$W(&)L86-K
M('1E>'0@8VAA<F%C=&5R<R!C:&%N9V5D('1O(&]V97)P<FEN="XF(WA!.R8C
M>$$[5&AE(&9O;&QO=VEN9R!F;VYT<R!A<F4@<')E<V5N="!I;B!T:&4@9&]C
M=6UE;G0Z)B-X03L@(" @(" @(" @5&EM97-.97=2;VUA;E!3350F(WA!.R8C
M>$$[5&AE(&9O;&QO=VEN9R!C;VQO<G,@87)E('!R97-E;G0@:6X@=&AE(&1O
M8W5M96YT.B8C>$$[(" @(" @(" @($)L86-K)B-X03LF(WA!.RTM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+28C>$$[
M/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]D
M8SID97-C<FEP=&EO;CX*(" @(" @(" @/&1C.F-R96%T;W(^"B @(" @(" @
M(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI/G)R-C S-3<T
M/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]D
M8SIC<F5A=&]R/@H@(" @(" @(" \9&,Z9F]R;6%T/F%P<&QI8V%T:6]N+W!O
M<W1S8W)I<'0\+V1C.F9O<FUA=#X*(" @(" @(" @/'AM<%109SI-87A086=E
M4VEZ92!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(#QS
M=$1I;3IW/C$Q,RXY.3@P-#<\+W-T1&EM.G<^"B @(" @(" @(" @(#QS=$1I
M;3IH/C(U+C8W.38X.#PO<W1$:6TZ:#X*(" @(" @(" @(" @/'-T1&EM.G5N
M:70^4&]I;G1S/"]S=$1I;3IU;FET/@H@(" @(" @(" \+WAM<%109SI-87A0
M86=E4VEZ93X*(" @(" @(" @/'AM<%109SI.4&%G97,^,3PO>&UP5%!G.DY0
M86=E<SX*(" @(" @(" @/'AM<%109SI(87-6:7-I8FQE5')A;G-P87)E;F-Y
M/D9A;'-E/"]X;7!44&<Z2&%S5FES:6)L951R86YS<&%R96YC>3X*(" @(" @
M(" @/'AM<%109SI(87-6:7-I8FQE3W9E<G!R:6YT/E1R=64\+WAM<%109SI(
M87-6:7-I8FQE3W9E<G!R:6YT/@H@(" @(" @(" \>&UP5%!G.D9O;G1S/@H@
M(" @(" @(" @(" \<F1F.D)A9SX*(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS
M=$9N=#IF;VYT3F%M93Y4:6UE<TYE=U)O;6%N4%--5#PO<W1&;G0Z9F]N=$YA
M;64^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%M:6QY/E1I;65S
M($YE=R!2;VUA;CPO<W1&;G0Z9F]N=$9A;6EL>3X*(" @(" @(" @(" @(" @
M(" @/'-T1FYT.F9O;G1&86-E/E)E9W5L87(\+W-T1FYT.F9O;G1&86-E/@H@
M(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=%1Y<&4^5')U951Y<&4\+W-T
M1FYT.F9O;G14>7!E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z=F5R<VEO
M;E-T<FEN9SY697)S:6]N(#<N,3$\+W-T1FYT.G9E<G-I;VY3=')I;F<^"B @
M(" @(" @(" @(" @(" @(#QS=$9N=#IC;VUP;W-I=&4^1F%L<V4\+W-T1FYT
M.F-O;7!O<VET93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&:6QE
M3F%M93YT:6UE<RYT=&8\+W-T1FYT.F9O;G1&:6QE3F%M93X*(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D)A9SX*(" @(" @
M(" @/"]X;7!44&<Z1F]N=',^"B @(" @(" @(#QX;7!44&<Z4&QA=&5.86UE
M<SX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D^0FQA8VL\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @
M(" @(" \+WAM<%109SI0;&%T94YA;65S/@H@(" @(" @(" \>&UP5%!G.E-W
M871C:$=R;W5P<SX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" \>&UP1SIG<F]U<$YA;64^1&5F875L="!3=V%T8V@@1W)O
M=7 \+WAM<$<Z9W)O=7!.86UE/@H@(" @(" @(" @(" @(" @(" \>&UP1SIG
M<F]U<%1Y<&4^,#PO>&UP1SIG<F]U<%1Y<&4^"B @(" @(" @(" @(" @(#PO
M<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP
M5%!G.E-W871C:$=R;W5P<SX*(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F
M.FEN<W1A;F-E240^>&UP+FEI9#HX8S%F.3=C."TY-F%E+38P-&$M.31D9"TU
M93AF,&0Q,C!F9#4\+W-T4F5F.FEN<W1A;F-E240^"B @(" @(" @(" @(#QS
M=%)E9CID;V-U;65N=$E$/GAM<"YD:60Z.&,Q9CDW8S@M.39A92TV,#1A+3DT
M9&0M-64X9C!D,3(P9F0U/"]S=%)E9CID;V-U;65N=$E$/@H@(" @(" @(" @
M(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/GAM<"YD:60Z-S<V-&8P,3@M
M8V0X.2TU-#0W+3AC8S(M-S8T.34X-#-F.&%B/"]S=%)E9CIO<FEG:6YA;$1O
M8W5M96YT240^"B @(" @(" @(" @(#QS=%)E9CIR96YD:71I;VY#;&%S<SYD
M969A=6QT/"]S=%)E9CIR96YD:71I;VY#;&%S<SX*(" @(" @(" @/"]X;7!-
M33I$97)I=F5D1G)O;3X*(" @(" @(" @/'AM<$U-.D1O8W5M96YT240^>&UP
M+F1I9#HS-F5B968Q-BUC9C@P+38R-#,M.3EA8RTV-F4X9&4S8V%E,S \+WAM
M<$U-.D1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I);G-T86YC94E$/GAM
M<"YI:60Z,S9E8F5F,38M8V8X,"TV,C0S+3DY86,M-C9E.&1E,V-A93,P/"]X
M;7!-33I);G-T86YC94E$/@H@(" @(" @(" \>&UP34TZ3W)I9VEN86Q$;V-U
M;65N=$E$/GAM<"YD:60Z-S<V-&8P,3@M8V0X.2TU-#0W+3AC8S(M-S8T.34X
M-#-F.&%B/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#QX
M;7!-33I(:7-T;W)Y/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @
M(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO
M;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI
M9#HW-S8T9C Q."UC9#@Y+34T-#<M.&-C,BTW-C0Y-3@T,V8X86(\+W-T179T
M.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P
M,C8M,#8M,#A4,34Z,C@Z,3$K,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E($EL;'5S=')A
M=&]R(#(U+C @*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HS-F5B968Q
M-BUC9C@P+38R-#,M.3EA8RTV-F4X9&4S8V%E,S \+W-T179T.FEN<W1A;F-E
M240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C8M,#8M,#A4
M,34Z,S4Z,SDK,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E($EL;'5S=')A=&]R(#(U+C @
M*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @
M(" @(" \+WAM<$U-.DAI<W1O<GD^"B @(" @(" @(#QX;7!-33I296YD:71I
M;VY#;&%S<SYD969A=6QT/"]X;7!-33I296YD:71I;VY#;&%S<SX*(" @(" @
M(" @/&EL;'5S=')A=&]R.D-R96%T;W)3=6)4;V]L/D%D;V)E($EL;'5S=')A
M=&]R/"]I;&QU<W1R871O<CI#<F5A=&]R4W5B5&]O;#X*(" @(" @/"]R9&8Z
M1&5S8W)I<'1I;VX^"B @(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $, !@0%
M!@4$!@8%!@<'!@@*$ H*"0D*% X/#! 7%!@8%Q06%AH=)1\:&R,<%A8@+" C
M)B<I*BD9'RTP+2@P)2@I*/_; $,!!P<'"@@*$PH*$R@:%AHH*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*/_  !$(
M &L!VP,!(@ "$0$#$0'_Q  <  $  @,! 0$             !@<$!0@# @'_
MQ !1$  ! P," P,) P<&"0T    !  (#! 4&$1('(3$305$(&")587&!E-,4
M,K$5%B-"<I&A-#=2=(+1%R56DI.RL\+A)C948F-D<X.5HK3!TO_$ !4! 0$
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M1MJ9V'1S&R.VM8".8UZGV:>)5J8-B-JPVQP6VST[&!K1VLVT=I._O>\]Y/\
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M[=-B6M-#6"":2DBY,(>\L?'M\#MU [B1IT"*ZR1$1!$1 1$0$4:L.6T]RO\
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M',(Z@B-VBWZ\JNGCJZ6:GG:'PS,,;VGO:1H1^XH.>/(W9&+=E+QIVIEIP?<
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7"(B B(@(B("(B B(@(B("(B B(@__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g113098g61k61.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g113098g61k61.jpg
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M*"@H*"@H*"@H*"@H*/_  !$( &L![@,!(@ "$0$#$0'_Q  <  $  @,! 0$
M            !@<$!0@# @'_Q !4$  ! P,!! 4(! D%#0D    !  (#! 41
M!@<2(3$($T%18108(E5Q@933%3*1H18C-T)2<H*QLR568I/2%R0F-#9#<W1U
MDI6RPC-7HJ.DP='A\?_$ !4! 0$                    !_\0 %1$! 0
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M'_R1I^2**<CE)5S G=_98WW%Q"#H>CU18*T2FCO=LG$3#)(8JICMQHYN.#P
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M]E%,Z%]5.['!SVX<&CB, _F^*\])W:XZ2VRU&B*RXU=PL]?2^66YU9*9982
M26;YXEOH2<^X>.2+9NDU53VZIEM]**NK9&714YD$8D=C@W>/ 9[U"?PEU_\
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M (/,8**OQ%!MB-]KM1[,;+<;JYTE8YCXGR.YR;CW,#CXD-&?'*G*((B("(B
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MLU79*>Z66I9/3RM!(!]*-W:UP['#N16Y18=XNE%9[?+6W*H93TT0])[NT]@
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M?-5JR:?LTLCY);3;WR/)<YSJ9A))YDG"^?P<LGJ:V_"L_P#A!7FG[7LFBO=
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$B(/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g113098g62k01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g113098g62k01.jpg
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M*"@H*"@H*"@H*"@H_\  $0@ :P&< P$B  (1 0,1 ?_$ !P  0 " P$! 0
M           &!P0%" ," ?_$ $P0  $#!  $ @4(!@<"#P    $  @,$!081
M!Q(A,4%1"!,B88$4&#)5<9&4TQ46(T*AL1<T4E9RD]$S-T-38F-S=(*2E;.T
MPM+P\?_$ !4! 0$                    !_\0 %1$! 0
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M'%I=KWZ!^*FB((B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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M&@'=/I>2VW!W"J3+KG!Q(R"\B\W.9_K&4[(^2.EE;T#2-[)9TT.@['KT*EW
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M/;5Q@]RPO+MCX2M5WJ(93@%KO]ZIKTRHKK7>Z=GJV5UOE$<A9_9=L$.'VA!
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=^](YO[O=V@>OM>Y6NB("(B B(@(B("(B B(@_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g113098g62k02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g113098g62k02.jpg
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M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H_\  $0@
M:P(\ P$B  (1 0,1 ?_$ !P  0 " P$! 0             &!P0%" ,! O_$
M %(0  $#!  #! @"!@4'!PT   $" P0 !081!Q(A$S%!40@8(E5A<933%($5
M(S)"D:$64F)RL20W@I.BL]$S-%9S='6R%R4V.$-3DI6DP=+A\/_$ !4! 0$
M                   !_\0 %1$! 0                    '_V@ , P$
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MJ2/\),'=9<;./14\Z2GF25;&_$=>^BL_A7E"<OP2U7<J!D+;[.0!X.I]E?\
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M[M5>50##@1Q:XB$@Z*+;H^?ZE=!G6*^9A+NL=B[X:S;H*R>TDINK;Q;Z$CV
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M[][WT\.ZI54-M6)R<>RU<S'9#+-AGE2Y]M<WRH=UT=8U^R2=!2>[QJ94'/\
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MWI*$G2G8\)]UL?Z:4%/\ZJ:PS'.-W%67^/6M6&V3]8U#V0A\[(05CQ*M%7P
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M@ !Y  5):!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*#XXM+:%+<4$H2-J4HZ
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?F(>Q"5D$%2M]-==]*NNE*!2E*!2E*!2E*!2E*#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g137529g03x03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g137529g03x03.jpg
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M =*>&\9HR&CJ>E+BJ;M'4JC7JOZJZG=S=XD*^[B7+7+,:PRBJ)3L &LR
M
M
M
M
M                                        /#?;G3V6S5USK'94])"Z
M9_&C45<DXU/8C7D@4_LCM(K[#0)ARS3*RY5D>VJ96+NPPKN9)P.=X$Y4-5S)
M8EO-5B&_5]VKW;:HJY5D=N[C<]34XD3)$XD,:=!CV8LT;O.AF=9  3O
M                         /K'.8]KF.5KFKFBHN2HI\ %V:,=.URLKHK?
MBQ9;E;=QK:G7/"G&ONTY=WC74;.6.[T%]ML-PM%7%5T<J9LDC7-.1>!>)=U#
M\]R5Z/,>7C UU2IM<NWIGJG3%)(J]#F3C3>7@<FZG)N&AD85-?M4<DLZ:M.+
M>L$9P!C2U8VLK:^TRY/;DV>G>OYR%W Y.#@74I)BGJIFF=)2  /
M
M
M
M
M                             "G]E%>76_1['01.R?<JEL3DS]PW-Z^%
M&\Y<!K;LNZE5K<-4N?6MCGD5.-58GX&SB4[UZF'E7!KV "_0@
M                         #.8,Q3<\(7R&Z6>962LW'QKZB5F^QR;Z+X-
M:;INIH]QE;L;X?CN=M=M7IUD].Y<W0OWVKQ<"[Z&AY+-&>-JW V)(KA2*Z2F
M?DRJI\]R://5RIK1>'B534RL:+T:QQ94U:-Z@>&QW6COEHI+G;)DFHZF-)(W
MIP+O+P*FI4WE/<44QIR2E
M
M
M
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MW !6LP
M
M
M
M
M      !XKS7MMELGK'L5[8415:BY*J9HASMEPIKG1LJ:*5)(G<Z+P*F\IC,<
M^Q2X_,3QD*HP]?*NQUG1J5V;';DD3EZUZ>7C+'&PO2+,U4_FB5%G[7]!RZ;=
M<:T3'SCEGE7H#&V&]4E[HTGI'[J;CXU]4Q>!?*9(T*J9HF::HTE=6[E-VF*Z
M)UB0 &+,  &ONG?0^R>*HQ)A2G1L[<Y*RBC;N2)OR,3WW"F_K3=UZUGZ+&J6
MR,T=MP]=$Q!:(49:JZ3*:-B;D$R[NYP-=NKQ+FG 6N%E3/\ QU_)'53SJ6 !
M9L   "VMC7BI;%CIMMGDRHKLU(%15W$E3=C7[6_YBI3MI:B6DJ8:BG>L<T+T
MD8]-;7(N:+SF%RB+E$TSSO8G1^B(,3A&\QXAPQ:[O#DC:RG9*J)[ERIUS>XN
M:=PRQS<Q,3I*8 !X                 (;B#2=A##UVGMEXO#::N@VO1(EI
MY7;7-J.3=:U4U*F^8[T:, ?*!OU6?S"2+-R8UBF>YYK"PP5YZ-& /E WZK/Y
M@]&C 'R@;]5G\P]\Q<ZL]QK"PP5YZ-& /E WZK/YA]33/@%5W,0L[M+.G\@\
MQ<ZL]QK"P@5_Z,N OE#']6F\P>C+@+Y0Q_5IO,'F;G5GN-86 "O_ $9<!?*&
M/ZM-YAV0Z7L"2KDW$5.GSXI&_:T\\S<ZL]QK"> C5#C["5<J)38DM+G+J:M4
MQJ\RJBDAIYX:B-)*>6.6-=3F.1R+W4,9IFGC#UV  Q       (QBO'V&L)UD
M-+B"YI1U$T?16,6&1^;<U3/-K536BGM-,U3I3&HDX*\]&C 'R@;]5G\P>C1@
M#Y0-^JS^82>8N=6>YYK"PP5YZ-& /E WZK/Y@]&C 'R@;]5G\P>8N=6>XUA8
M8*\]&C 'R@;]5G\PG=MK:>Y6^FKJ*3HM+4QMEB?DJ;9CDS1<EW4W%WS&JW51
M^:-'NKT  P      !@<6XOL>$H:>7$->E''4.5L2K$]^V5-U?4HO"1KT:, ?
M*!OU6?S#.FU75&M-,R\UA88*\]&C 'R@;]5G\P>C1@#Y0-^JS^89>8N=6>XU
MA88*\]&C 'R@;]5G\P>C1@#Y0-^JS^8/,7.K/<:PL,&.P]>[?B&TPW.S5"5-
M#-MNARHQS=MDJM7<<B+K1=XR)',3$Z2] #!8LQ=8\)04\V(:Y*.*=RLC<L3W
M[943-4ZU%$4S5.D#.@KST:, ?*!OU6?S!Z-& /E WZK/YA)YBYU9[GFL+#!7
MGHT8 ^4#?JL_F#T:, ?*!OU6?S!YBYU9[C6%A@KST:, ?*!OU6?S!Z-& /E
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MV)MR6#%UWMRNR954:2HG"Z-Z9>![C:4H<RC=O2EIX  -5D
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MY8YSE_WE7;*:. 4)LN/6'#_;,GBH7V4)LN/6'#_;,GBH28?OJ7E7!K( "_1
M          'UCW,<CF.5KDW45%R5#X )AA[27B^P.;TA?:QT3?\ I5#^C,RX
M,GYY=S(M[!VR,8]S(,6VSH>>XM519JB<:QJN?,O<-<007,:W<XP]BJ8?H'AZ
M_6O$5O;6V2N@K*9WNHW9JU>!R:VKQ+NF3- <+8ENV%KFROL=9)33IZI$7-LB
M>]<W4Y.4VVT1Z5+?CJEZ5G1E'?(FYR4V?6R(FM\>>M.%-:<>LJLC#JM>U3RP
MDBK59  --D  #3S9+^VK6]KP^(586GLE_;5K>UX?$*L.BQ_=4]B&>( "9X
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M\G*L:I_O3F-0S>;3#3I5:,,31N3-$HGR?0Z[\#1DN=GU:VYCXHZ^( #?8
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MY5VRFC@%";+CUAP_VS)XJ%]E";+CUAP_VS)XJ$F'[ZEY5P:R  OT0
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MVYM><:/,69]N>,]$>+Y+(^:5\DKW/D>N;G.7-54X '1.%F=>60 !X
M      /7:[A4VRMCJJ.162LYE3@7A0N?#-\@OMO2>')DK=R6+/=8ODX%*-)#
M@5UR9?8G6N-9-Z9%7)NTW]LN]Q%?GXM-ZB:^$QSKO8FT;F+>BWRS35S?S"Z"
M,8^L7Y7M*RP-SJZ9%>S+6Y-]O_F^A)P<Y:N56JXKIXP[W)QZ,FU5:KX2UV!+
M-(=B_)ETZ:IV94E4JN3)-QC]]/Q3_L1,ZZS=IO4173PE\ORL:O%NU6:^,  )
M6N'HMU9+;ZZ&JIW92Q.1R<?$><'DQ$QI+*FJ:9BJGC"_K37Q7.W05E.OYN5N
M>7 N^G<4]95^C"]]+5C[9.[\U.NVB5=Y_!W4\*<9:!R67CSCW)HYN9]-V9FQ
MFX\7>?A/;_O*  UE@*N29KJ*6QM>ORS>7NC=G2PYQQ<"ION[OV9$[TC7O\G6
MKI2!V535(K=S6UF^O=U<Y4A>[*QM(F]5\G&^4N?K,8E$\.6?XC^>X !=.2
M +/T96+I>E==*EOYV9-K"B^Y9P]W[.4A>$+*Z]W>.%47I>/KYG<#>#E747;&
MQL;&L8U&L:F2(FI$*?:F3NT^9IXSQ=5Y-[/\Y7Z5<CDCAV]/R^_8^@!5R3-=
M10.U=-;5PT5+)4U4B1PQIFYRE-XLQ)47VJ5,UCHV+^;BS\*\*_8>S'F(UN]:
MM-2O_L,#LDR7]([WW)P?]R*'1;/PHM1YRN/:GZ.#VYM><FJ;%F?8CC\?\  +
M5S@               "=8"Q8M(^.VW*3.F<NUBE<OZ->!>+[.359YKL71@5U
MR6PQ-NL:L<W<B5Z]>YF]FF\4.U,6FC_EIY->,.T\G=HW+NN-<UG3A/1\)_CN
M2$XS?H7_ #5.1QF_0O\ FJ4\.JG@UX !VSY"   3?1-Z]5?:_P#,TA!-]$WK
MU5]K_P S34SOT]:SV-^MM]O\+2 !R;Z8           1[2![$:_D9X[20D>T
M@>Q&OY&>.TGQO?4=L?=I[0_2W?Z9^TJ7 !V#Y8                  #8.A
M_N5/_AM^P[CIH?[E3_X;?L.XXFKC+Z[1^6'ENOK76?X+_%4C6BSV-2=L.^QI
M+PB(FI$0EINZ6IMZ<9CZ->O&WLBF_K^6)C3MT\&,Q/['+GVM)XJG@T>>Q&A_
MS^.XD01$1,D3)#R+O_%-O3GU>SCZY$9&O"F8T^<3_#HHZ*FHFO;201PM>Y7N
M1B99KPE.XM]E-T_Q?P+I/BM:NMJ<Q-BY4X]<US&NK4VCLV,VU3:IJW8B=>'_
M (^@ U%H 'FN-;3VZCDJJN1(X8TS55W^).,]B)F=(8U513$U53I$/M?64]!2
M25-7*V.%B9JY?LY2I<68MJ;T]T$&V@H$7<C1=U_&[R'CQ3B&HOU9MWYQTS%_
M-0HNXG&O"IA#HL+9\68W[G+5]G";7VW5E3-FQ.E'UG_'P[P %HYT
M                         ,C8[/5WFL2GHV9[[WKZEB<*J8U511&]5.D,
M[=NJ[5%%$:S+SVZAJ+C5LIJ.)9)GZD3>XUX$+KPQ:I+/:8Z2:I?.]-U574WB
M;Q'S#EAI+%2="IF[:5WZ29R=<]?P3B,L<WG9WI$[E/Y8=]L;8\84>=N3K7/=
M'P^( "N7R+Z4WHS1OBA7+N?DZ=.=BH:(FZNGVN2@T47UV>3YF,@:G#MI&HO@
MS-*BXV='L3/Q1U\0 %@P  !*M%*9Z2L,9?&,'CH;V&D&A&G6ITJ8<C1,\JGH
MGT6N=^!N^4^T9]N(^"2C@  KV8               #2[9#>V[??]#[EA718N
MR&]MV^_Z'W+"NCH['NZ>R$,\0 $KP,EABU_EO$=KM71>@]/545-T7:[;:;=R
M-SRW,\L]1C22Z,O;&PM^]*;[UIC7.E,S#V%S^EH;\J5^H_U!Z6AORI7ZC_4-
MB@4?IM[K?9)NPUT=L:.M7:XIW=[.A_J&!O.QTQ'31N?:[E;J[+W#E="]>3-%
M3G5#:D'L9UZ.<W8: XEPS><,UG2U]MU112KZGHC>M?\ -<FX[N*8<_0:_66W
MW^V36^\4D5522IDYDB9Y<:+K1>--TTLTL8'FP+BF2@5SI:&9.C4DSM;X\]2_
MK(NXO<7?+'&RXO>S/)+":=$, !N,0  >_#]TGLE\H+G2+E/23,F;Q[5<\N1=
M1^@%OJXJ^@IJRF=MH*B)LL;N%KDS1>93\\#=K05<%N6BJP2O=F^*)U.O^F]6
M)X$0K=HT>S%;.A/#5K9:>S*S]H?\CS:4U:V6GLRL_:'_ "/-7!]]#*K@HX %
MXB   -\]&OM>X9_=M/\ =M-##?/1K[7N&?W;3_=M*[:/Y:6="1@ J$@
MH'9<^LV'>V)?%::SFS&RY]9L.]L2^*TUG+W!]S"*KB  VV(  -S]CM[4=DY9
M_OGECE<;';VH[)RS_?/+'.<O^\J[931P"A-EQZPX?[9D\5"^RA-EQZPX?[9D
M\5"3#]]2\JX-9  7Z(   L["^A/$^)+#1W>WSVMM+5LV\:2S/1R)FJ;J(Q>#
MA*Q-WM!_M4X<[77QW&IEWJK-,32RIC50?I=\8=DV;ZP__P"L>EWQAV39OK#_
M /ZS;0%?Z?=^#/<AJ7Z7?&'9-F^L/\P\-?H&QQ2L5T5)1U>6]!4MS_W;4W"
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MJ[RU*JJ0IUD35WFIJ[JZ^Z8@ ["BB**8IIX0^6W;M5ZN;E<ZS( #)& !-W4
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M35N5=HYV4:<#$W$_\XS>V;C^=N[T\*5/M_.G&Q]RB?:KY/ES^'S8P '3/GH
M  !E<.V*JOM9T&F3:QMW9)7)UK$\O$8UUTT4S55.D0DM6J[U<6[<:S+&1QOE
M>UD;7/>Y<D:U,U4DUMP->:QJ/DCCI6+OS.R7F3-><LNP8?H+)"C:6)'3*F3I
MG[KW=W>3B0RQ27]K5:Z6HY.F77X?DQ1$;V35K/1'BK>/1K*J?G;FQJ\#857\
M4.NHT;5347I>X0/7@>Q6?9F68#4C:61K^;Z0LI\G\&8TW/K/BI*Z84N]M:Y\
MU(Z2)-<D*[=/!NIW4,&;$D:Q+A"AO#7RQ-2FK-:2,3<<OZR;_+K-W'VMK.EZ
M/G"HS?)G=B:L6K7X3_$_[VJ;![+K;:JU5CZ:MC5DC=U.!R<*+OH>,NJ:HJC6
M.#DZZ*J*IIJC28#NHZ6:LJ&04L3I9GKDUK4S53WX?L59?*GH=(S*-J]?*[U+
M/^_$6[AW#]'8Z?:4S=M,Y/SDSDZYWD3B-++SJ,>-(Y:NCQ6^S-CW<Z=Z?9HZ
M>GL87"6"X+9M*JXHV>MUM;K9'R<*\9,0#F[UZN]5O5R[[%Q+6);\W:C2/]XA
MQF_0O^:IR.,WZ%_S5(X3SP:\  [9\A   )OHF]>JOM?^9I"";Z)O7JK[7_F:
M:F=^GK6>QOUMOM_A:0 .3?3           "/:0/8C7\C/':2$CVD#V(U_(SQ
MVD^-[ZCMC[M/:'Z6[_3/VE2X .P?+   "3X<P?47RWK5PU4434>K-J]%5=S+
MRD8+;T7>QEW^._[&FEGWJ[-K?HXZK?8N):R\GS=V-8TE'_0WK>SJ?Z+AZ&];
MV=3_ $7%G I?6>1T_1UOX>P>K/?*L?0WK>SJ?Z+AZ&];V=3_ $7%G >L\CI^
MA^'L'JSWRK'T-ZWLZG^BX>AO6]G4_P!%Q9P'K/(Z?H?A[!ZL]\JQ]#>M[.I_
MHN'H;UO9U/\ 1<6<!ZSR.GZ'X>P>K/?*L?0WK>SJ?Z+AZ&];V=3_ $7%G >L
M\CI^A^'L'JSWRX4\:Q01QJN:L:C<^1#F 5ZZB-(T  'H       #C+(R*-\D
MKD8QB*YSE7)$1-\IO&>(WWRNVL2JVAB7*)OOOUEX_L)!I,Q JN6T4C]Q,EJ'
M)O[Z-_%>YQE>%_LS#W8\]7QG@XGR@VI-RJ<6U/LQQ^,]'R^X "X<L      "
M(JJB(F:J2&U8.O%Q1'-I^EXE]W.NU\&OP$=R[1;C6N=$UG'NWZMVU3,S\$>!
M9-%HWA1$6MKY'+OMB8C?"N?V&6AP%9&)UT<\G&Z5?PR-*K:F/3PF9^2WM^3N
M;7&LQ$=L^&JH 7'U#6'L5_?G>4=0UA[$?WY_E,/6UCHG_?FE_#&7UJ>^?!3@
M+DZA[#V&[OS_ "CJ'L/8;N_/\H];6>B?IXO?PQE]:GOGP4V"Y.H>P]AN[\_R
MCJ'L/8;N_/\ */6UGHGZ>)^&,OK4]\^"FP7)U#V'L-W?G^4=0]A[#=WY_E'K
M:ST3]/$_#&7UJ>^?!38+DZA[#V&[OS_*.H>P]AN[\_RCUM9Z)^GB?AC+ZU/?
M/@IL%S=1-@[!7OS_ "CJ)L'8*]^?Y1ZWL]$_3Q/PQE]:GOGP4R"YNHFP=@KW
MY_E'438.P5[\_P H];V>B?IXGX8R^M3WSX*9!:.*<*6:AL%;4TM(K)HV9M=T
M5ZY+FF\JE7&YC9-&33-5',JL_9]S KBW=F)F8UY/_( "48/PG/>I$GJ-M#0-
M7=?OR<3?*27;M-JG?KG2$&/C7,FY%NU&LR\6&,.U5^J<HD6.F8OYR94W$XDX
M5+AL]KI;31MIJ*-&,3=5=]R\*KOJ=]%2P45,RGI8FQ0L3)K6G<<SEYM61.G"
MGH?0ME[)MX%.O&N>,_Q  #26P -0%![+.]I%9;-9(W)MZB9U5(B:T:Q%:W/E
M5R_1-92<:9\4)BS']QK8'[>B@7I6F5-2QL5=U.)55SNZ0<Z#%M^;M1$H:IUD
M !L/   6SL8:!:O2?%499I14DLV?!FB1_P YMZ:\;$>TJD&(+P]NXYT=)&[D
M17/3PL-ARCSJMZ]/P2T<  &FR                :7;(;VW;[_H?<L*Z+%V
M0WMNWW_0^Y85T='8]W3V0AGB  E>!)=&7MC86_>E-]ZTC1)=&7MC86_>E-]Z
MTPK_ "R]AOB #FDP  !2VRKM<=5@6BN&U3H]%6-:COU'HJ*G.C.8NDJ79/U+
M(=&+XGKUT]9$QB<*IMG?8U2?&F8NTZ=+R>#4, '0H0  #;W8P2*_1>QJKN1U
MDS4\"_B:A&W^QCA6+1; ]4W):J9Z<Z-_E-'/]U\V='%:YJULM/9E9^T/^1YM
M*:M;+3V96?M#_D>:.#[Z&57!1P +Q$   ;YZ-?:]PS^[:?[MIH8;YZ-?:]PS
M^[:?[MI7;1_+2SH2, %0D     % [+GUFP[VQ+XK36<V8V7/K-AWMB7Q6FLY
M>X/N815<0 &VQ  !N?L=O:CLG+/]\\L<KC8[>U'9.6?[YY8YSE_WE7;*:. 4
M)LN/6'#_ &S)XJ%]E";+CUAP_P!LR>*A)A^^I>5<&L@ +]$   ;O:#_:IPYV
MNOCN-(3=[0?[5.'.UU\=Q7[1]W':SHXIP "G2   $%TXVN.ZZ+K_ !R-1700
M=-,7WKHUVV:=Q%3NDZ(5IIN,=MT7XBEE5$Z+3+3M3A=)UB>,26=?.4Z=+R>#
M1X '2(0  #8K8@N7;8K;NY94J_>FNILGL1*96V_$U4J=;)+!&B_-1Z_S(:N;
M[FKY?=E3Q;!@ H4K3S9+^VK6]KP^(586GLE_;5K>UX?$*L.BQ_=4]B&>( "9
MX&>T?^SO#G[RI_O6F!,EAFX1VG$=JN,S'/BI*J*H<UNMR,>CE1./<,:HUIF"
M'Z" HSTR.'_B:Z\\?G#TR.'_ (FNO/'YQ0^B7NJFWH7F"C6[)##V?76:[(G%
MT-?YCEZ9##GQ1=^:/SQZ)>ZIO0O %'^F0PY\47?FC\\>F0PY\47?FC\\>B7N
MJ;T+P!1_ID,.?%%WYH_/'ID,.?%%WYH_/'HE[JF]"\ 4?Z9##GQ1=^:/SR7Z
M-M*EJQ[<ZNBMM#74TE/#T9SJA&9*FV1,DR<N[NF-6/=IC>JCD-86" "%Z%,Z
M0+@M=B6I1%SCI\H6]S7X54N&KF;34LT[_4Q,<]>1$S-?II'32ODD7-[W*YR\
M*J7&R+>M=5<\SE?*B_NVJ+,<\Z]W_K@ "_<4   3W1KAUM0_\JUC,XHW90-5
M-QSDUN[F]Q\A":"EDK:V"FA_23/1B=U2^Z"EBH:.&E@3**)J,:G(5>T\F;5&
MY3QG[.B\G<",B]-ZN/9I^_\ CP=X .<=Z     "[J;I6^,L%RK6-J;+#MF3.
MR?"W<VBKOIQ?860"?'R*\>K>H:6=@VLVWYN[\IYX1;">$*:S-;456UJ*[WV7
M6Q_-\I*0#"[=KNU;U<ZRFQL:UC41;M1I  "-.   <)XF3POBF:CXWM5KFKJ5
M%UH<P.#R8UC25&8GL[[+=Y:5V:Q+UT3E]TQ=7D[AB2YL<V/\LVARPMSJZ?-\
M7"[A;W?M1"F5W%W3JL')](MZSQCB^;[8V?Z%D3%/Y9Y8\/D  W52  "V,,XJ
MB=A2:IK7YST+=H]%7=?[U>[JY<RKZ^KEKJV:JJ';:65RN<IT(JHBHBKDNM.$
M^&K8Q:+%555/.L<S:5W+MV[=?_6.^>GN_P!Y0 &TK@  >RT6^:Z7&"CITSDE
M=EGO-3?5>1"]+910VZ@AI*9N443=JG'PJO&NLBNC:Q=(V];A4,RJ:E.L1=;8
M][GU\Q,SF]I97G:]RGA'W=_Y/[/]&L^>KCVJOI'^>( "L= CFD"X=(8:J$:[
M*2HRA;W=?@12F2P=+55G/04B+N-:Z5R<JY)]BE?'3;,M[EB)Z>5\]\H;\W<R
M:>:F(C^?Y  6*B  !Z;;137&NAI*9N<LKMJG%QKQ)K+QL=JI[/;HZ2F3<;NN
M=ENO=OJI"]%-K3:U-SD;NY]!BSYW+]B<Y89SNU,F:Z_-1PC[NZ\G,"+5GTBJ
M/:JX?"/\^  "J=*     ,3B6QT]\H'03(C96[L4N6ZQ?)PH0"P8#K*BM?^5$
M6GIHG[5<EZZ7+WO%QEJ@V[.;=LT311/)/T5F5LG&RKM-ZY'+'U[710T=/0TS
M*>DB;%"Q,D:U#O -69F9UE94TQ3&[3&D  /'H<9OT+_FJ<CC-^A?\U3V'D\&
MO  .V?(0  ";Z)O7JK[7_F:0@F^B;UZJ^U_YFFIG?IZUGL;];;[?X6D #DWT
MP           CVD#V(U_(SQVDA(]I ]B-?R,\=I/C>^H[8^[3VA^EN_TS]I4
MN #L'RP   MO1=[&7?X[_L:5(37!^+Z6QVE:2>GGD>LBOVS,LLERX5XC1VA:
MKNV=VB-9U7.PLBUC96_=G2-)6H"#^B/;^PJK_;Y1Z(]O["JO]OE*'T#(ZCLO
M7.#^Y'U3@$']$>W]A57^WRCT1[?V%5?[?*/0,CJ'KG!_<CZIP"#^B/;^PJK_
M &^4>B/;^PJK_;Y1Z!D=0]<X/[D?5. 0?T1[?V%5?[?*/1'M_855_M\H] R.
MH>N<']R/JG (/Z(]O["JO]OE)NU=LU%X4S(KMBY9T\Y&FK:QLVQE:^9JUTXO
MH (6T        &*Q/=F6:SS52Y+)ZB)J^Z>NKR]PRI4VDN[=.WGI.)V<%)UJ
MY:E>NOFW$YS;PL?S]V*9X1Q5FU\WT/&FN/S3R1V_X1*:1\TKY97*^1ZJYSEU
MJJZU. !UCYI,Z\L@ #P   SV&L+UU\>CXTZ#2(N3IWIN<B)OJ9;!&$%N>UK;
MDUS:)%S8S4LOD;]I:<4;(8FQQ,:R-J9-:U,D1.(J<W:,6IFW:Y9^SI=D[!G(
MB+V1R4\T<\^$,/8<,VVS-:M/"DE0FN:3==W.#N&: *&NY5<G>KG67:V;-NQ3
MN6XTCX  ,$H >:YU]):Z">MN-1'34D#=O)+([)K4'$>D'51U$=9205,#MM#,
MQLC%RRS:J9HO,=H             !A,;^Q6X_P"'^*%(EW8U15PM<41%55C1
M$1/G(1G!>"DCVE=>8\W^JCIW)JXW<?%SEU@9%&/8JJKZ?X<GMK!NYN;1;M1_
MUY9YHY98[!>#'5VTK;JUS*76R)=Q9.->!/M+0C8R*-K(VM8QJ9-:U,D1. Y
MK<G)KR*MZKN7N!L^U@V]RWQYYYY  :[?   *HV0N.FX7PJ^V44J)=[FQ8V;5
M=V*+4]_%P)QJJ[Q-\=8LMV#</SW2Z/ZUO6Q0HO7S/WFM\N\FZ:18PQ'7XKQ!
M5W>Z2;:>=VXU/4QM3U+&\2)Y=\W</'\Y5OU<(8U3HPP +M$    2?1GAMV*\
M;6NU;55@DE1\ZIO1-W7^!,N54/*JHIB:IYAMIH.L*X?T:6>"1NUJ*AG3<J+K
MVTG7)GR-VJ=PG9\:U&-1K41K43)$34B'TYJNJ:ZIJGG3QR  ,0
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M< "\1   &^>C7VO<,_NVG^[::&&^>C7VO<,_NVG^[:5VT?RTLZ$C !4)
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M "9X             !>>Q*]EUZ[13[QI1A>>Q*]EUZ[13[QIKY?N:F5/%M&
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M21W*[KE^TRYUTK$CIHF)J:Q$3F.PXNY5OUS5/.^M6+<6K=-$<T1  #!*
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MO)QJAO/04<%OH:>CHXVQ4U/&V*-C=36M3)$YBNS[V[3YN.=G1'.[P 5"0
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M=_W+-*:T>UB4>**;;+DR=%A7NZO"B%RG-;4HFF_KTP^@>3=V*\/=ZLS'\_R
M K5^                     ()I-L71Z9+K3-_.PIM9D3W3-Y>Y]G(5B;#R
M,;)&YDC4<QR*US5U*B[Q26+;*ZR7>2!$5:=_7PN7?;P<J:B_V5D[U/F:N,<'
M$^4>S_-U^E41R3Q[>GY_?M84 %PY8    R%@M<MXND-'#FFW7-[O>M36IC55
M%,35/"&=NW5<JBBB-9E,-&%BZ)*Z[5+>L8JM@1=]V^[N:N?@+).FCIHJ.EBI
MZ=J,BB:C6IQ(=QR63?F_<FN?D^G;.PJ<*Q%J.//\9  :[>  !2V/6;3%EP3A
M<U>=B$?);I.A6+$[GY;DL+'_ &M_ B1U^+.]9HGX0^6[2HW,N['_ /4_< !L
M-(  &P5!*DU#32IJ?&UR=U,SO(_@.L2LPO1KGFZ%.@NXMKN)X,B0'&7:-RNJ
MF>:7UC&NQ>LT7(YXB0 $:<             #C-^A?\U3D==1N4\OS5^P]CB\
MJX2UZ !VSY"   3?1-Z]5?:_\S2$$WT3>O57VO\ S--3._3UK/8WZVWV_P +
M2 !R;Z8           1[2![$:_D9X[20D>T@>Q&OY&>.TGQO?4=L?=I[0_2W
M?Z9^TJ7 !V#Y8                (;#Q?HF?-0UX0V'B_1,^:A2;8_Z?/\
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M-V]1PHB_2=ME3N*5S<[E6W2J=4W.LJ*RH=KDGD61R]U5/*">BW11^6-'FNH
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M5>16+_,ILD4GLKK<M1@BVUS4S6DK4:Y>!KVN3[6M-G#JTO4L:N#54 %^B
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M]#VWZJ(BY<ZE9%IZ)_6.K[87Q6E?M.=,>?DO/)Z(G.IUZ)^R;  YA]#
M%>:6J3-E!6-34KHG+X4^QQ7)=V-+>MRPY5Q-3.5C>BLY6[OA3-.Z4B=+LNYO
MV=WH?/\ RCQ_-9>_S51K_  "R4   )QHNNR4UPEMTSLHZGKH\]YZ;W=3[$+1
M->(I'PRLDB<K9&*CFN36BIJ4N?!V(8K[0)MU:VMB1$E9P_K)Q+X"AVIBS%7G
MJ>$\7:>3FT8JH]$KGECA\8Z/]_A(  4SJP     .EE5 ^JDIF31NJ(T1SXT<
MFV:BZE5# 8QQ1%9*=88%;)<'IUC-:,3WSO(5(ROJHZY:UE1(E4KMNLJ+NJI8
MXNSJ[]$US.D<RAVCMVWAW(M4QO3S_#_+8 $)PICB&MVE-=E;!4ZFRZF/Y>!?
M 38T[UBNS5NUPM<7,LY='G+,ZQ]NT !$V0ZZG^[R_,7[#L.NI_N\OS%^P]CB
M\JX2UZ !VSY"   3?1-Z]5?:_P#,TA!-]$WKU5]K_P S34SOT]:SV-^MM]O\
M+2 !R;Z8           1[2![$:_D9X[20D>T@>Q&OY&>.TGQO?4=L?=I[0_2
MW?Z9^TJ7 !V#Y8   6SHOC8[#3E<UJKT=VM.)"IBV]%WL9=_CO\ L:5NU/<?
M.%_Y-Q_\SY3_  E?0H_@V<R#H4?P;.9#F#F]9=_NPX="C^#9S(.A1_!LYD.8
M&LF[#AT*/X-G,@Z%'\&SF0Y@:R;L.'0H_@V<R#H4?P;.9#F!K)NPX="C^#9S
M(<P#PB(@  >@       -?*V3HM9/)[^1SN=5.D [:(TC1\AF=9U  >O   7_
M &B%*>U4<*)ET.%C<N1J'J/C$1&(B:LCZ<35.LS+Z[13NTQ3', %7[(%N+%P
M>_J47^RY.Z?2'/IA8_U?U=>VRW>YF96Z-^J*==&4HKIHTU,MO1['@^=LE=NL
MJ*YNZV'A;'PNX]2<NK6661\TKY9GNDD>JN<]RYJY5UJJ[ZG$%_9L4V:=*4,S
MJ  F>                                 /3;:"JN=;#1V^GEJ:J9VUC
MBB:KG.7B1#9[0_H3@L+H;QBML=5=4R?%2[CHZ=>%=YS_  )QZR&]?ILQK4]B
M-4?T%Z''/=3XBQ=39,3*2DH9$W7<#Y$X.!O=7@78\ HKUZJ[5O5)8C0 !$]
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M)J<_@1-YO=7=RRK6Z72ONU4M3=*VIK*A=<E1*LCN=5/(;F/A4VIWIY9835J
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MV7MNWFZ6Z_9K^D]G@SYUU/\ =Y?F+]AV'74_W>7YB_8:$<5W5PEKT #MGR$
M  F^B;UZJ^U_YFD(.R&:6!RNAD?&Y4R56.5"'(M>>MS;UTU;6%D1BWZ;TQKH
MV%!K_P!/UG9=1WQ?*.GZSLNH[XOE*CU/5U_HZG\54?M3W_X;  U_Z?K.RZCO
MB^4=/UG9=1WQ?*/4]77^A^*J/VI[_P##8 &O_3]9V74=\7RCI^L[+J.^+Y1Z
MGJZ_T/Q51^U/?_AL #7_ *?K.RZCOB^4=/UG9=1WQ?*/4]77^A^*J/VI[_\
M#8 &O_3]9V74=\7REH:+IY)[#4+-(^1R5*IF]55<MJTU\G9TX]O?FK5N[/V[
M3G7O,Q1I\TP(]I ]B-?R,\=I(2/:0/8C7\C/'::F-[ZCMC[K/:'Z6[_3/VE2
MX .P?+   "V]%WL9=_CO^QI4AD[=?KG;:?H%#5OABVRNVJ(FONH:F;CU9%O<
MIE9[)S:,&_YVY$S&DQR+V!2?5;??C&7Z+?(.JV^_&,OT6^0J?5%WK1]?!TWX
MHQNI5]/%=@*3ZK;[\8R_1;Y!U6WWXQE^BWR#U1=ZT?7P/Q1C=2KZ>*[ 4GU6
MWWXQE^BWR#JMOOQC+]%OD'JB[UH^O@?BC&ZE7T\5V I/JMOOQC+]%OD'5;??
MC&7Z+?(/5%WK1]? _%&-U*OIXKL!2?5;??C&7Z+?(.JV^_&,OT6^0>J+O6CZ
M^!^*,;J5?3Q78#%X5J9:S#]#45#UDFDCS<Y=]<U,H5==,T533/,Z*U<B[13<
MCA,1/>  Q2     #7NKCZ%531K[A[F\RJ=1E,40=+XBN4>K*=ZIR*N:?:8L[
M2W5O4Q/2^27J/-W*J.B9@ !FC  !?]JFZ8ME),BY]$A8[G1#U$=T?U:5>%J3
M=S=#G"[N+N>#(D1QEZC<N54]$OJ^)=B]8HN1SQ$@ (VPH733H69<^CWS"$#8
MZ[=?44+=QLW"YG [BU+RZ]998WPROCE8YDC%5KFN3)6JFM%3A/T4*ETR:(:3
M&$4MTLR1TM_:F:KJ959;S^!W [N+Q66+F;OL7.'2PJIZ&H8/3<[?5VNOGHKC
M3R4U7 [:212)DYJGF+:.5&                           #W6BSW*\U'0
M+3055;+[VGB<]4Y<DW"U,)['_$]U5DEZDI[/3+NJCU267+B:U<N=4(Z[M%O\
MTZ/8B94Z61H]T/8BQ<Z.HEB6V6IV2]-5+517I^HS6[EW$XS8O!.B#"N%5CGC
MI%N%>W=Z9K,GJB\+6Y;5O-GQEAE?>VAS6X^;.*.E$L :/[%@BCZ':*;;53TR
MEJYNNED[N\G$F2$M *VJJ:IUJEF  Q                        &EFR"]
MM[$'SH?N(RO"P]D%[;V(/G0_<1E>'1V/=T]D(9X@ )7@271E[8V%OWI3?>M(
MT271E[8V%OWI3?>M,*_RR]AOB #FDP               "H-D?@=V(\+MO%O
MBV]RM37/5K4W9(-;DXU3U2?YN$U(/T65,TR74:FZ?=%[\-7"6^V2!762I?G+
M&Q/[J]5U?,5=7!JX,[3 R(C_ (JODPJCG4V "T1@              =E+3S5
M=3%3TL3YIY7(R.-C<W.<JY(B)OJ!D\(X?K,48AHK1;FYSU+]KME3<8W6YR\2
M)FIO=ARSTN'['16JWLVM-21)&SA7+6J\:KFJ\:D!T&Z-68(L[JRXM:Z_5C$Z
M,J;J0,UI&B^%5WUY$+/*3,R/.U;M/"$M,:  -)D%";+CUAP_VS)XJ%]E";+C
MUAP_VS)XJ&SA^^I8U<&L@ +]$   ;PZ%/:LPWVK_ #*:/&[VA!5715AS/L=?
M'<5^T?=QVLZ.*<  IT@:D[(G1_U-7_\ +5LBVMHN+U5S6IN0S:U;Q([=5.ZF
M\;;&*Q58:+$U@K;1<F;:FJ6;5536Q=:.3C1<E3D)\>]-FO7F>3&L/S^!F,7X
M>K<+8AK;1<FY3T[\D<B;DC?<O3B5,E,.=!$Q,:PA  >@3W0UCR3 V*633.<Z
MTU>459&F[DW/<>B<+<\^3--\@0,:Z(KIFFKA+V.1^B=/-'401SP2-DAD:CV/
M:N:.:J9HJ+P',UZV,ND+HT281NTWYQB*ZWR.7U3=;HNYNJG%FF\AL*<]>M3:
MKFF4L3J  B>M/-DO[:M;VO#XA5A:>R7]M6M[7A\0JPZ+']U3V(9X@ )G@
M            "S=C=[;-K_PI_NG&Y)IML;O;9M?^%/\ =.-R2EVA[V.Q+1P
M :+)C<0VB&]6R2EGW'+UT;\MUCMY2D;E0SVZMEI:MBLEC7)4WEXTXC8 P&+<
M-P7ZDW%2.LC3\W+E_M7B^PLL#-\Q.Y7^6?HH-M;)],I\[:_/'UCH\%*@]%PH
MJBWU;Z:LB=%,Q=UJ_:G"AYSI(F)C6' U4S3,TU1I,  /6(             $
MUT?886X3MN-<S^QQK^;:J?I')^"?^;YY<%X4EO$K:FK:Z.WM77J65>!.+A4M
MN&)D,3(H6-9&Q$:UK4R1$3>*C:&=%$3:MSR\_P '4;#V/-V8R;\>S'".GX]G
MW<P <^[<     ".:0_8A7\L?WC21D<TA^Q"OY8_O&D^+[ZCMC[M/:/Z2[_35
M]I4R #L'RP   M/1/ZQU?;"^*TJPM/1/ZQU?;"^*TKMJ?IY[87OD[^MCLE-@
M <R^A        *QTBX:6FF?=*%GYAZYS,:GJ'>^Y%^WE((;#R,;)&YDC4<QR
M9.:J9HJ<!5&-<(R6I[ZR@:Y] JYJFM8N7BXR_P!G9T51%JY/+S.*V[L>;<SD
MV(]F>,='Q[/LAX +ARH              '?14D]=51T])&Z69ZY-:T\F8B-9
M>TTS5.D<7VWT<]PK(J6E8KYI%R:B?:O$77AFRPV.VMIXLG2KUTLGOW>3@/)A
M##4-AI=L_*2MD3\Y)P?JMXOM)"<WGYOGYW*/RQ]7?;$V1Z'3YZ[^>?I'CTAU
MU/\ =Y?F+]AV'74_W>7YB_85T<5_5PEKT #MGR$                +3T3K
M_P#@ZI/_ '"^*TJPM/1/ZQU?;"^*TKMJ?IY[87OD[^MCLE-B/:0/8C7\C/':
M2$CVD#V(U_(SQVE!C>^H[8^[MMH?I;O],_:5+@ [!\L
M !=V"?8K;O\ #_%3-F$P3[%;=_A_BIFSC;_O:NV?N^K87Z:W_3'V  1-D
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MV:BY9]%W=9ZO2S?M;_#?ZI>^%/8O9^TX?$0RA1SF7HG\WTA+NPUT]+-^UO\
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MT]U5*Z?/N/54\!.P1U9%VKC5+W2'324M/1PMAI((H(6ZF1,1K4[B'< 0O0
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M0I6GFR7]M6M[7A\0JPM/9+^VK6]KP^(58=%C^ZI[$,\0 $SP
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M='204T"*V&&-L;$5<\FHF2>!#M->9UG5D  \
M                             !UO@A>Y7/BC<Y=:JU%4^=*P? 1?00[0
M!U=*P? 1?00=*P? 1?00[0!U=*P? 1?00-IX6JBMAC14W45&H=H
M                'FN%OH[C L-PI*>JA7W$\:/;S*AZ0. @MTT28'N*N=-A
MZFB<N_3N=#X&*B$=JMC[@N9V<?Y3ITX(ZE%\9JEN EB_<IX52\TA3#MCGA%5
MW+A?4Y)XO_J.<6QUP@Q>NK+W)\Z>/\(T+D!EZ5=ZQNPJZBT$X&IE19*"JJ<O
MAJI_\JH2NSX"PI9W-=;L/VZ*1NJ184>]/\SLU\))@857KE7&J32!$1$1$3)$
M !&]        #C)&R1$21C7(GODS.0 ZNE8/@(OH(.E8/@(OH(=H ZNE8/@(
MOH(.E8/@(OH(=H ZNE8/@(OH(=C6HQJ-:B-:FI$3(^@      'Q[&R-VKVM<
MG J9GT =72L'P$7T$'2L'P$7T$.T =72L'P$7T$'2L'P$7T$.T =72L'P$7T
M$'2L'P$7T$.T ?&M1C4:U$:U-2(F1]  ZWP1/=MGQ,<O"K44^=*P? 1?00[0
M!U=*P? 1?00=*P? 1?00[0!U=*P? 1?00=*P? 1?00[0!U=*P? 1?00=*P?
M1?00[0!U=*P? 1?00=*P? 1?00[0!U=*P? 1?00=*P? 1?00[0!U=*P? 1?0
M0=*P? 1?00[0!U=*P? 1?00=*P? 1?00[0!UL@B8[;,B8UW"C40[
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M9B.Q);S,>[5N6[D3/1$PR  (FR
M
M
M
M
M   .JKIHJNFDIZAB20R-VKFKOH4KBJPS6*X+$[-],_-89/?)P+QH7>>*\6RF
MNU"^EK&;9CMU%36U=Y4XS=PLN<:KE_+/%4[6V73GV^3DKCA/\2H,&5Q#8ZJQ
MUJP5+<XUW8Y43K7IY>(Q1U%%=-=,54SK#YU=M5VJYHN1I,  ,D8
M                         !:^BJ%8\/S2*GZ2=53D1$3[<RJ"]<+4"VVP
M45,Y,GMCVST_67=7PJ5>UJ]VS%/3+H_)FS->5-SFIC[_ .RR@ .<=X
M
M
M
M
M                                  \ETMU-=*-]-6QI)$[G:O"B[RE1
MXIPM5V.1TB(LU$J];,B:N)W O@+G.,C&21N9(UKV.3)6N3-%0W,7,KQIY.6.
MA5[2V5:SZ?:Y*HX3X],-> 63B7 +9%?46148[6M.Y=Q?FKO<BE>5=+/1SNAJ
MHGQ2MUM>F2G1V,FWD1K1/R<%F[/OX56[=CDZ>:72 #8:(
M               'IMU%/<:R.EI(UDFD7)$3>XUXCR9B(UEE33-4Q33&LRS>
M K,MUO<;I&YTU,J22+O*N\WNKX$4N4Q>&K-#9+8REBR<]>NDDR]6[AY#*'*Y
MN3Z1<UCA'!](V/L_T''W:OS3RSX?( !IK4
M
M
M
M
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M !H+H
M
M
M
B                                          ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Jun. 11, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001830033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">PureCycle Technologies, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-296672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Jun. 11, 2026 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">4.75% Convertible Senior Notes due 2032<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">287,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 287,500,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 39,703.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, this Calculation of Filing Fee Tables shall be deemed to update the Calculation of Filing Fee Tables filed as Exhibit 107.1 to PureCycle Technologies, Inc.'s registration statement on Form S-3 (File No. 333-296672) filed with the Securities and Exchange Commission on June 10, 2026. The Maximum Aggregate Offering Price of the securities to which the prospectus relates is $287,500,000. The prospectus to which this Exhibit is attached is a final prospectus for the related offering.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Jun. 11, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 287,500,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">39,703.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">39,703.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 287,500,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="d113098dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d113098dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d113098dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="d113098dexfilingfees.htm">d113098dexfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://xbrl.sec.gov/dei/2026</BaseTaxonomy>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/ffd/2026</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d113098dexfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "d113098dexfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026.xsd",
      "https://xbrl.sec.gov/ffd/2026/ffd-2026.xsd"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 9,
    "http://xbrl.sec.gov/ffd/2026": 7,
    "http://xbrl.sec.gov/dei/2026": 2
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2026": 25,
    "http://xbrl.sec.gov/dei/2026": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d113098dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d113098dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d113098dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d113098dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal8ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0001193125-26-269542-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-269542-xbrl.zip
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M[KW^MMF]5 #XC8K/V=,J4< H%I$!9*UM8GN&2 R$1,;7;#3>Y2W(IA.PJ<B
MDL$[F6?SU%^$B&8Q(ECJX1 [IA8R7<;!DQ=8ZE-@^  44..[B@\4.3O2"$E3
M(W?TR7XFX61 VK2(X5KDT@B"9P(6]&0$%AE1<QXPP1*C%;-J')72SS,:L.E,
MH*H'Z%XQ0EQ-J6RAAE6$1E957/H_?NWW.IWS.T^0H>_;P 2\&-015\QH8?:+
M4[K%K%2<_1A@#,+2 "#\!>&>S2PRM@WS^]+TGA<,90Q T\";NY8*4<<+M%_[
MPZOAS6G!#&+ZK7<20<FT1! ; 2(4 S]^[AC!E($D:T(CF%!D%L_D 9)LSN=6
MD.GL1^;2-C@G#[BF)!7([284!NA<Z X*SO!E;E<1MKL3]:$#TRXRWEA%K;N1
M@F+>]SCX^V=CP9RY0V+?(O<01"FYA_KK*R3G*APT=N(@)CR<3@,ZA<JHP,+1
MM(QS_ 7H52!PNL\T0MJ/DYRT):!;19L[D<P;*>;^JF[9.P0]!CX)^1?*[*,I
M-4_Q%DP3@C6Y!I,Q!7NDY*K:C.XF;J9\NP_H(_/F'++FO0%!G;GDTG-=Y +F
M^(D!Q:\NQ/MLWB3"(V,J(PFC5BQ$D=NE0BLI.IMIU;G,8LCA4AY?SMJY6FYU
MMKGNP4]+R1=[2\6%LJ;T1!6!?NZM&WN:+^SBY24)MT&QPA/:V/-L:K@3P\:]
MS:3N.VLHZ*JQ\E#9):4>2K6*T70*FQL@-XH4AZ:1*9Z+574B5,HZ+*"OZ%AL
MR>]V7$ BW,@'3&.GUNN^0Q.551J6/B/J,LAK4#2!<JTYA7*W7;()6%&UJW<B
M(5-VNKU@*R.0.V<9 =H@0+?W(?BX)7]I71D.NPF,T$%3_H:. #V"?X#36 K!
ME:AD+UK/$HN:S &;O% :>5;=N6-Y(GJ]<0HZBMXZZYUT&XV31J,1BQ'S4UT.
M6=/^EM2V*\6"M!J;":91R.-H+1GY<#<A(UQK'^&ZBMZLO9!44">(K&1'$NDT
M-U][";=2&@AK6(!D))![,AD1>ON(T%-T9+S1A$!T_*D!8<"5CC0;>%#1/^DU
MVA#%MA4E$Z->%"Y5X>%SKDR(Q1+D,&PGV>< 4#NJZN\(]NJL;(?B<=-^SZ&M
M>!6]-TM^L^0E2X[VKJS-=ZG-MQ.3+^Y-"L^OMOZ37"GZ@R=@F9GL3(1+>ZYE
MMI=+^%A-.]TW3%;!F.Q*RANJ5&6Q>JI^$'9RB(8IN[CG7C5IYU-]FJW[56JG
M7147[J<F>_2XK1IMJ):J5$Y<7)L<0Y,Q[@,KL=_84/*LT5^UN]?E8"3TL++"
M1MM=VHW<)2:2TD221[.69$_D*#;3#"O^G\I<2-@*PU_$2D):1[..#/I#FT;K
MYS&-.RJD85S-Z;&- D@=+;=D<!_:&-HODUO*SMKU%;T;F0-4YF*#$*I0'HH.
MA&P7/= I^CDIJRJ46( E,\-YS$QC>*(>ODMJD&[$Z%A/"D3<52TV(""%>D8W
MH5@':$C8J,(74%V>ER:JK<QKR]0IG6+NKW XI($-7>J,H@=IS19(F7(&E!8*
M-GX!AB5MI^&EESCHTXP)JL)3$\3R ZHB\DK;[3BG"J'<-+#=L+EITZK?4?1;
MEQBF"14KMEZ'IT*X'\Y)IWOZ8?Q1=EF$&]O@JU#6$C&CV87PT)3GA\U^NWU"
M#$Z )P"S3@".<;*IN8CPF6';>&IB4>I0"X]0YKZ%9ZQ(9^/P";.Q$X23J%L9
M+*Q7:R*6=8TX[SD)LN>=7 !![+0C>/B)1Y(CM4T^A(>%7HVD'<@?(XI23P5-
MH*:N%^;,<*? N>=@8[9DW"7_FKL46#LALB^4/,# 38?**"\2X+FS.3 -,R3L
M)SVN( NH"-Z#OG_+KFHDG0Q<9CQ+-0:7AA"&.0.Q\!HD=*%NR8R#\"U)AG0L
MX"QDM*RA:?T.3P^->!84/1'<I>AQ4?S":ZT1=LRNC]H_>X=42\N4FMB"PIS0
M)$=AK^(KZ(C*MH/+?JCN"_5#%9/$H1JD]NN'*C6U]0U09]L/B?8:TB9&[!3"
MR!80;&=</3 <)Z-A. )#$[9JK!X2MBQD>BPV88^;(R+LV!FQD:$M0 O^0*U-
M(W*=8F3(N6<R&?)DO-\&WUD!GVP&VP=AR.!RP\8^./M9G"6)*&H/VI]MV8Z"
M!T#%\6%PRCG\CB<#<='2BXN6AMIL?C ^?FA]/-;AP'*\S2XTMMW3W_9ZC_WS
M0QX['/4 X%C3%>7$M_DZVGSMZ,'2@?TWC_T_L( WC_W[S-?;@FIY0=762/P]
M*4D_*/WQ"ZDU'[F^VD754190G7<;5CX2X-@?B[2Z>U')?"M2[<N4'8BE7?Z9
M=4/F!'.[KSC.=F&ARF[7 9@[W86W;;Y!@$7[+A2V^NI@)P57^\R@>G8N;IIO
M:I<Y0@Y])<U /R9#'OQ4:8=$6>"T'WT]-=;OC !WSM'(&#=MC\MOL<=Z,<<4
MCH]^X Y>=CO9F LO>2*-+'Q44'ELR[B)[D3ARTC"5[P'3OS=-^OSYZQKCEF#
M0#R6]I7O=LJZ\@/F?G=C6U1MS7?<KGT?<-\4?.E#"J2R^1N*/B3ZPI'%<0XD
MRMU7>'[JN[&;YT/ BO/0NGP^J.-?I=+_!U!+ 0(4 Q0    ( +FCS%RA]^!_
MJ@L  .=*   8              "  0    !D,3$S,#DX9&5X9FEL:6YG9F5E
;<RYH=&U02P4&      $  0!&    X L

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>d113098dexfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2026/ffd-2026.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001830033</identifier>
        </entity>
        <period>
            <startDate>2026-06-11</startDate>
            <endDate>2026-06-11</endDate>
        </period>
    </context>
    <context id="offrl_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001830033</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-11</startDate>
            <endDate>2026-06-11</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-345">S-3</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-346">424B5</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-347">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:RegnFileNb contextRef="rc" id="ixv-348">333-296672</ffd:RegnFileNb>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-349">0001830033</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-350">PureCycle Technologies, Inc.</dei:EntityRegistrantName>
    <ffd:OfferingTableNa contextRef="rc" id="hiddenrcOfferingTableNa" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="rc" id="hiddenrcOffsetTableNa">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="rc" id="hiddenrcCombinedProspectusTableNa">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FormTp contextRef="rc" id="ixv-378">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-379">PureCycle Technologies, Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="offrl_1" id="ixv-380">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="offrl_1" id="ixv-381">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_1" id="ixv-382">4.75% Convertible Senior Notes due 2032</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="offrl_1" id="ixv-383">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="offrl_1"
      decimals="0"
      id="ixv-384"
      unitRef="Shares">287500000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="offrl_1"
      decimals="2"
      id="ixv-385"
      unitRef="USD">1.00</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_1"
      decimals="2"
      id="ixv-386"
      unitRef="USD">287500000.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_1"
      decimals="7"
      id="ixv-387"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_1"
      decimals="2"
      id="ixv-388"
      unitRef="USD">39703.75</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="rc" decimals="2" id="ixv-389" unitRef="USD">287500000.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="rc" decimals="2" id="ixv-390" unitRef="USD">39703.75</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="rc" decimals="2" id="ixv-391" unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="rc" decimals="2" id="ixv-392" unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="rc" decimals="2" id="ixv-393" unitRef="USD">39703.75</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="offrl_1" id="ixv-394">In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, this Calculation of Filing Fee Tables shall be deemed to update the Calculation of Filing Fee Tables filed as Exhibit 107.1 to PureCycle Technologies, Inc.'s registration statement on Form S-3 (File No. 333-296672) filed with the Securities and Exchange Commission on June 10, 2026. The Maximum Aggregate Offering Price of the securities to which the prospectus relates is $287,500,000. The prospectus to which this Exhibit is attached is a final prospectus for the related offering.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric contextRef="rc" decimals="2" id="ixv-395" unitRef="USD">287500000.00</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="rc" id="ixv-396">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
